Improving the detection of correctable low vision in older people by Jessa, Zahra
Jessa, Zahra (2009). Improving the detection of correctable low vision in older people. 
(Unpublished Doctoral thesis, City University London) 
City Research Online
Original citation: Jessa, Zahra (2009). Improving the detection of correctable low vision in older 
people. (Unpublished Doctoral thesis, City University London) 
Permanent City Research Online URL: http://openaccess.city.ac.uk/12443/
 
Copyright & reuse
City University London has developed City Research Online so that its users may access the 
research outputs of City University London's staff. Copyright © and Moral Rights for this paper are 
retained by the individual author(s) and/ or other copyright holders.  All material in City Research 
Online is checked for eligibility for copyright before being made available in the live archive. URLs 
from City Research Online may be freely distributed and linked to from other web pages. 
Versions of research
The version in City Research Online may differ from the final published version. Users are advised 
to check the Permanent City Research Online URL above for the status of the paper.
Enquiries
If you have any enquiries about any aspect of City Research Online, or if you wish to make contact 
with the author(s) of this paper, please email the team at publications@city.ac.uk.
 Improving the detection of 
correctable low vision in older 
people 
ZAHRA JESSA 
Doctor of Philosophy 
 
The Department of Optometry and Visual Science, City University, 
Northampton Square, London EC1V 0HB, UK  
 
Research Conducted at: 
The Institute of Optometry,                                                          
56-62 Newington Causeway, London SE1 6DS, UK 
 
March 2009 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
                                                                                                                   
www.city.ac.uk/library 
 
 
 
 
THE FOLLOWING PREVIOUSLY PUBLISHED PAPER HAS BEEN 
REDACTED FOR COPYRIGHT REASONS: 
 
pp348-367: 
Jessa, Z., Evans, B., Thomson, D., Rowlands, G. (2007) Vision screening of older people. 
Ophthal. Physiol. Opt. 27, 527-546 
Contents 
                                                                                                                Page 
Tables             1 
Figures and illustrations          8 
Acknowledgments               15 
Declaration                           16 
Thesis Abstract                     18 
Chapter 1 Introduction 
1.1 The ageing population                                             19 
1.2  The ageing eye                                                       20 
1.3  Neurodegenerative changes with age 36 
1.4  Changes in visual performance and function 40 
1.5  Systemic conditions that have ocular manifestations 44 
1.6  Eyecare for older people 47 
1.7  Screening 52 
1.8  Chapter summary 53 
Chapter 2 A review of vision screening in older people 
2.1 Introduction 55 
2.2 Objectives and methodology of review 58 
2.3 Results of literature review 61 
2.4 Discussion 75 
2.5 Conclusions and chapter summary 91 
Chapter 3 New screening methods & research aims  
3.1 Introduction 92 
3.2 New methods of vision screening 92 
3.3 General Research Question 98 
3.4 General aims 98 
3.5 Brief overview of research design 99 
3.6 Objectives and expected outcomes 101 
3.7 Chapter summary 103 
Chapter 4 Methods 
4.1 General methods 104 
4.2 First study procedure 117 
4.3 Second study 137 
4.4 Chapter summary 149 
Chapter 5 Provision of NHS primary eyecare in South London  
5.1 Background 150 
5.2 Methods 153 
5.3 Statistical analyses 153 
5.4 Results 154 
5.5 Discussion 154 
Chapter 6 Comparison of cataract grading performed with a 
standard and portable slit-lamp biomicroscope  
6.1 Background 159 
6.2 Methods 162 
6.3 Results 165 
6.4 Further analyses 172 
6.5 Discussion 173 
6.6 Conclusions 173 
Chapter 7 General descriptive data and conventions in 
statistical analysis for detection of target conditions  
 
7.1 General descriptive data 175 
7.2 Conventions for statistical analysis of ability of screening 
instruments to detect target conditions 
194 
7.3 Importance of ROC curves in evaluating screening tests  196 
7.4 Combining tests 199 
7.5 Either eye or both eyes 200 
7.6 Binocular summation 200 
7.7 A note on confidence intervals 203 
Chapter 8 Study one:  Preliminary investigation of the effectiveness 
of a computer-based system for screening the vision of older people 
in the community  
8.1 Introduction 205 
8.2 Monocular data: selection of appropriate cut offs 206 
8.3 Evaluation of near acuity vision screening test  220 
8.4 Combining tests in CVS1 225 
Chapter 9 Study two: Investigation of the effectiveness of a refined 
computer-based system for screening the vision of older people in 
the community  
9.1 Introduction 233 
9.2 Monocular data: selection of appropriate cut offs for distance 
acuity 
235 
9.3 Evaluation of near acuity vision screening test 245 
9.4 Combining tests 249 
9.5 Glaucoma 257 
9.6 Conclusions 262 
 Chapter 10 Investigation of the effectiveness of a rapid flipchart 
screener for screening the vision of older people in the community  
10.1 Rapid flipchart screener 264 
10.2 Descriptive statistics of FVS results 266 
10.3 Monocular data: selection of appropriate cut offs  276 
10.4 Evaluation of near acuity screening test 287 
10.5 Rapid Flipchart Screener test combinations 292 
Chapter 11 Quality of Life 
11.1 Introduction 295 
11.2 Quality of life descriptive data 295 
11.3 Further analyses 297 
Chapter 12 Discussion 
12.1 Participants, descriptive data and prevalence of visual 
problems 
304 
12.2 Supplementary studies 306 
12.3 Are the screening instruments valid? 307 
12.4 Overview of results for computerised vision screener  310 
12.5 Overview of results for flipchart screener 314 
12.6 Are the screening instruments useful? 315 
12.7 Ethics of screening 321 
12.8 Have the research objectives been met? 323 
12.9 Quality of life and Hawthorne effect 326 
12.10 Suggestions for future research 327 
 
Chapter 13 Conclusions 
13.1 General conclusions 330 
13.2 Considering the aims of screening 331 
13.3 Inferences for designing visual screening tools for older people 332 
Appendices, supporting published work and references 
Appendices 334 
Supporting published work 347 
References 387 
 
Page 1 of 389 
 
Tables 
Table  Page 
Table 1.1 Barriers to eyecare 51 
Table 1.2 Wilson and Jungner screening criteria   53 
Table 2.1 Effectiveness of screening programmes: Criteria for assessment  56 
Table 2.2 Objectives (key questions) and methodology of review 58 
Table 2.3  Summary of prevalence studies.  67 
Table 2.4 Summary of screening studies involving older people but not meeting 
age criteria.  
73 
Table 2.5 Limitations of the pinhole test 75 
Table 2.6 Possible venues for Vision Screening 80 
Table 2.7 Research systematically comparing methods of vision screening of 
older people.  
85 
Table 3.1 Ensuring a valid diagnostic study   100 
Table 4.1 Assumptions for sample size calculation     105 
Table 4.2 Assumptions for revised sample size calculation       106 
Table 4.3 Possible venues for vision screening, with comments on their suitability 
for the present research  
107 
Table 4.4 Venues used in present study  108 
Table 4.5 Defining Correctable visual loss      112 
Table 4.6 Clinical Age Related Maculopathy Staging System   113 
Table 4.7 First study procedure.  117 
Page 2 of 389 
 
Table 4.8 Battery of tests included in CVS1 119 
Table 4.9 History and symptoms 125 
Table 4.10  Recording Motility  130 
Table 4.11 Structures examined and grading scales used for external eye 
examination 
134 
Table 4.12 Structures examined and grading scales used for internal eye 
examination 
135 
Table 4.13 Tests incorporated in to screening tools.     139 
Table 4.14 Tests included in Rapid Flipchart Screener  140 
Table 4.15 Scoring near acuity on the rapid flipchart screener  142 
Table 4.16 Scoring distance visual acuity on the rapid flipchart screener. Four 
optotypes were present on each page.  
145 
Table 6.1 Testing details illustrating counterbalanced design.  164 
Table 6.2 Wilcoxon signed rank test  172 
Table 7.1 Key statistics from Study 1 and Study 2  177 
Table 7.2 Descriptive data from gold standard eye examination  183 
Table 7.3 Summary of evaluation of screening test.  195 
Table 7.4 Properties of ROC curves  197 
Table 8.1 The key statistics for the LogMAR acuity cut off values obtained from 
Figure 8.1  
207 
Table 8.2 The key statistics for the LogMAR acuity cut off values obtained from 
Figure 8.2  
208 
Table 8.3 The key statistics for the LogMAR acuity cut off values obtained from 210 
Page 3 of 389 
 
Figure 8.3  
Table 8.4 The key statistics for the LogMAR acuity cut off values obtained from 
Figure 8.4  
211 
Table 8.5 The key statistics for the LogMAR acuity cut off values obtained from 
Figure 8.5   
212 
Table 8.6 The key statistics for the LogMAR acuity cut off values obtained from 
Figure 8.6  
214 
Table 8.7 Summary of CVS1 HCVA and LCVA cut off values 214 
Table 8.8 Performance of screener from an optometric perspective  215 
Table 8.9 Evaluation of the fixation disparity screening test in CVS1.  216 
Table 8.10 The key statistics for the visual field test cut off value obtained from 
Figure 8.8   
219 
Table 8.11 The key statistics for near acuity cut off values obtained from Figure 
8.9  
221 
Table 8.12 The key statistics for near acuity cut off values obtained from Figure 
8.10 
222 
Table 8.13 The key statistics for near acuity cut off values obtained from Figure 
8.11 
224 
Table 8.14 Summary of CVS1 near acuity cut off values 224 
Table 8.15 Test combinations from CVS1 for the detection of uncorrected 
refractive error.  
227 
Table 8.16 Test combinations from CVS1 for the detection of significant cataract.  229 
Table 8.17 Test combinations from CVS1 for the detection of correctable visual 
loss.  
230 
Page 4 of 389 
 
Table 8.18 Test combinations from CVS1 for the detection of SAIEC.  231 
Table 8.19 Summary table incorporating the best test combinations from CVS1 
for the detection of the target conditions 
232 
Table 9.1 The key statistics for the LogMAR acuity cut off values obtained from 
Figure 9.1   
236 
Table 9.2 The key statistics for the LogMAR acuity cut off values obtained from 
Figure 9.2  
237 
Table 9.3 The key statistics for the LogMAR acuity cut off values obtained from 
Figure 9.3  
238 
Table 9.4 The key statistics for the LogMAR acuity cut off values obtained from 
Figure 9.4  
239 
Table 9.5 The key statistics for the LogMAR acuity cut off values obtained from 
Figure 9.5  
240 
Table 9.6 The key statistics for the LogMAR acuity cut off values obtained from 
Figure 9.6  
242 
Table 9.7 The key statistics for the LogMAR acuity cut off values obtained from 
Figure 9.7  
243 
Table 9.8 Summary of CVS2 HCVA and LCVA cut off values 244 
Table 9.9 Performance of screener from an optometric perspective 245 
Table 9.10 The key statistics for near acuity cut off values obtained from Figure 
9.8 
246 
Table 9.11 The key statistics for near acuity cut off values obtained from Figure 
9.9 
247 
Table 9.12 The key statistics for near acuity cut off values obtained from Figure 
9.10 
249 
Page 5 of 389 
 
Table 9.13 Summary of CVS2 near acuity cut off values 249 
Table 9.14 Defining significant acuity impairing eye conditions (SAIEC)  250 
Table 9.15 Defining overall performance of screener 250 
Table 9.16 Combinations of vision tests to be used in analyses 251 
Table 9.17  Overall screener performance for detecting SAIEC.  252 
Table 9.18 Overall screener performance (excluding presenting NVA) for 
detecting SAIEC.   
252 
Table 9.19 Overall screener performance (excluding presenting LCVA) for 
detecting SAIEC.  
253 
Table 9.20 Overall screener performance (excluding presenting LCVA & NVA) for 
detecting SAIEC.  
253 
Table 9.21  Overall screener performance (excluding presenting HCVA) for 
detecting SAIEC.  
254 
Table 9.22 Overall screener performance (excluding presenting HCVA & NVA) 
for detecting SAIEC.  
254 
Table 9.23  Best test combinations for detecting SAIEC.  255 
Table 9.24 Defining ‘with or at risk of glaucoma’ 257 
Table 9.25 Clinical characteristics of patients ‘with or at risk of glaucoma’ as 
defined in Table 9.24 
258 
Table 9.26  Defining SAIEC, incorporating glaucoma 260 
Table 9.27 Test combinations with visual fields for the detection of  SAIEC  
including glaucoma.  
261 
Table 9.28  Summary table of test combinations for the detection of SAIEC.  262 
Table 10.1 Conversion table for distance HCVA FVS scores to LogMAR and 265 
Page 6 of 389 
 
Snellen acuities 
Table 10.2 Conversion table for converting distance LCVA FVS scores to 
LogMAR and Snellen acuities 
265 
Table 10.3 Conversion table for converting NVA FVS scores to N notation 265 
Table 10.4 The key statistics for the FVS score cut off values obtained from 
Figure 10.10 
277 
Table 10.5 The key statistics for the FVS score cut off values obtained from 
Figure 10.11 
278 
Table 10.6 The key statistics for the FVS score cut off values obtained from 
Figure 10.12 
279 
Table 10.7 The key statistics for the FVS score cut off values obtained from 
Figure 10.13 
281 
Table 10.8 The key statistics for the FVS score cut off values obtained from  
Figure 10.14 
282 
Table 10.9 The key statistics for the FVS score cut off values obtained from 
Figure 10.15 
283 
Table 10.10 The key statistics for the FVS score cut off values obtained from 
Figure 10.16  
285 
Table 10.11 Summary of FVS HCVA and LCVA cut off values 285 
Table 10.12 Performance of screener from an optometric perspective 286 
Table 10.13 The key statistics for near acuity cut off values obtained from Figure 
10.17 
288 
Table 10.14 The key statistics for near acuity cut off values obtained from Figure 
10.18 
289 
Table 10.15 The key statistics for near acuity cut off values obtained from Figure 290 
Page 7 of 389 
 
10.19 
Table 10.16 Summary of FVS near acuity cut off values 291 
Table 10.17 Performance of FVS for near vision 292 
Table 10.18 Defining overall performance of FVS 293 
Table 10.19  Overall FVS screener performance for detecting SAIEC.  293 
Table 11.1 Key statistics from Quality of Life questionnaires.  296 
Table 11.2 Quality of life scores, including gain in quality of life for different 
patient groups 
297 
Table 11.3 Case study of a participant in the research who benefited from 
refractive correction.  
303 
Table 12.1 Comparing sensitivity and specificity values obtained for a) HCVA and 
b) LCVA for predicting the presence of the target conditions.  
311 
Table 12.2 Types of cataract  312 
Table 12.3 Summary of best combinations from CVS2 for detecting SAIEC 313 
Table 12.4 Summary of best combinations from flip chart screener for detecting 
SAIEC 
314 
Table 12.5 Summary table: Performance of screening tools from an optometric 
perspective  
321 
Table 12.6 Summary of suitability of screening tools 324 
Table 12.7 Direct comparison between QoL scores from patients in spectacle 
intervention group and those in the no intervention required group 
327 
Table 13.1 Recommended tests for various screening aims 332 
Table 13.2 Inferences for designing visual screening tools for older people 333 
 
Page 8 of 389 
 
Figures and illustrations 
Figures Page 
Figure 1.1 Horizontal section through the eye 20 
Figure 1.2 The common types age related cataract a) Cortical lens opacities b) 
Nuclear sclerosis c) Posterior subcapsular opacification d) Mature cataract 
indicating total opacification of the lens.  
27 
Figure 1.3 Retinal layers 29 
Figure 1.4 Glaucomatous cupping of the optic disc (a) and normal fellow optic 
disc (b)  
31 
Figure 1.5 Early age related macular degeneration 33 
Figure 1.6 Background diabetic retinopathy 45 
Figure 2.1 Visual Functions and Age.  83 
Figure 4.1 Tests incorporated in to CVS1  124 
Figure 4.2 The Institute of Optometry Near Test Card 127 
Figure 4.3 Score sheet for rapid flipchart screener 141 
Figure 4.4 Testing of near acuity with flipchart screener 144 
Figure 4.5 Testing of high contrast distance acuity with flipchart screener  148 
Figure 6.1The Lens Opacity Classification System III  160 
Figure 6.2 Kowa SL-15 portable slit lamp biomicroscope  162 
Figure 6.3 Frequency distributions of cataract grading   166 
Figure 6.4 Bland and Altman (difference v mean) plots for inter-observer 
repeatability  
168 
 
 
Page 9 of 389 
 
Figure 6.5 Bland and Altman (difference v mean) plots for inter-instrument 
repeatability  
170 
Figure 7.1. Overview of analyses      175 
Figure 7.2 Last eye examination      179 
Figure 7.3 Distribution of age in the combined sample  179 
Figure 7.4 Prevalence of symptoms     180 
Figure 7.5 Prevalence of positive history.  181 
Figure 7.6 Distribution of significant cataract 182 
Figure 7.7 Cataract type 182 
Figure 7.8 Distribution of spherical refractive error.  184 
Figure 7.9 Distribution of cylindrical refractive error  185 
Figure 7.10 Distribution of cyl axis  185 
Figure 7.11 Distribution of presenting HCVA in RE.  186 
Figure 7.12 Distribution of presenting HCVA in LE.  187 
Figure 7.13 Correlation between screener and clinical VA (right eye).  188 
Figure 7.14 Correlation between screener and clinical VA (left eye).  188 
Figure 7.15  Bland and Altman plot of the difference in VA v mean VA in right 
eye, for gold standard and screener high contrast VA.  
189 
Figure 7.16 Bland and Altman plot of the difference in VA v mean VA in right 
eye, for gold standard and screener high contrast VA.  
190 
Figure 7.17 Distribution of presenting LCVA in RE.  191 
Figure 7.18 Distribution of presenting LCVA in LE.  191 
Page 10 of 389 
 
Figure 7.19 Correlation between screener and clinical LCVA (right eye).  192 
Figure 7.20 Correlation between screener and clinical LCVA (left eye).  192 
Figure 7.21 Bland and Altman plot of the difference in LCVA v mean LCVA in 
right eye for gold standard and screener high contrast VA.  
193 
Figure 7.22 Bland and Altman plot of the difference in LCVA v mean LCVA in 
left eye for gold standard and screener high contrast VA.  
194 
Figure 7.23 Example of an ROC curve showing the suitability of various cut off 
values of high contrast visual acuity (HCVA) for determining significant gain in 
acuity through refractive correction.  
197 
Figure 8.1 Graph illustrating the sensitivity versus 1-specificity for (a) high 
contrast visual acuity and (b) low contrast visual acuity of the left eye obtained 
with CVS1 for predicting presence of significant cataract in the left eye  
207 
Figure 8.2 Graph illustrating the sensitivity versus 1-specificity for (a) high 
contrast visual acuity and (b) low contrast visual acuity of the left eye obtained 
with CVS1 for predicting presence of significant gain in acuity with new 
refractive correction 
208 
Figure 8.3 Graph illustrating the sensitivity versus 1-specificity for (a) high 
contrast visual acuity and (b) low contrast visual acuity of the left eye obtained 
with CVS1 for predicting presence of CVL 
209 
Figure 8.4 Graph illustrating the sensitivity versus 1-specificity for (a) high 
contrast visual acuity and (b) low contrast visual acuity of the left eye obtained 
with CVS1 for predicting presence of significant macular degeneration  
211 
Figure 8.5 Graph illustrating the sensitivity versus 1-specificity for (a) high 
contrast visual acuity and (b) low contrast visual acuity of the left eye obtained 
with CVS1 for predicting SAIEC 
212 
Figure 8.6 Graph illustrating the sensitivity versus 1-specificity for (a) high 
contrast visual acuity and (b) low contrast visual acuity of the worst eye 
obtained with CVS1 for predicting SAIEC 
213 
Page 11 of 389 
 
Figure 8.7 Graph illustrating the sensitivity versus 1-specificity for stereoacuity 
data obtained with the gold standard eye examination for detecting a history of 
falls within the last year.  
218 
Figure 8.8 Graph illustrating the sensitivity versus 1-specificity for the visual 
field test data of the left eye obtained with CVS1 for detecting patients with or 
at risk of glaucoma in the left eye.  
219 
Figure 8.9 Graph illustrating the sensitivity versus 1-specificity for binocular 
near acuity obtained with CVS1 for predicting significant gain in binocular near 
acuity with new refractive correction  
221 
Figure 8.10 Graph illustrating the sensitivity versus 1-specificity for binocular 
near acuity obtained with CVS1 for predicting significant binocular cataract  
222 
Figure 8.11 Graph illustrating the sensitivity versus 1-specificity for binocular 
near acuity obtained with CVS1 for predicting binocular correctable visual loss  
223 
Figure 9.1 Graph illustrating the sensitivity versus 1-specificity for (a) high 
contrast visual acuity and (b) low contrast visual acuity of the left eye obtained 
with CVS2 for predicting presence of significant cataract in the left eye 
235 
Figure 9.2 Graph illustrating the sensitivity versus 1-specificity for (a) high 
contrast visual acuity and (b) low contrast visual acuity of the left eye obtained 
with CVS2 for predicting presence of significant gain in acuity with new 
refractive correction 
236 
Figure 9.3 Graph illustrating the sensitivity versus 1-specificity for (a) high 
contrast visual acuity and (b) low contrast visual acuity of the left eye obtained 
with CVS2 for predicting presence of CVL 
238 
Figure 9.4 Graph illustrating the sensitivity versus 1-specificity for (a) high 
contrast visual acuity and (b) low contrast visual acuity of the left eye obtained 
with CVS2 for predicting presence of significant macular degeneration 
239 
Figure 9.5 Graph illustrating the sensitivity versus 1-specificity for (a) high 
contrast visual acuity and (b) low contrast visual acuity of the left eye obtained 
240 
Page 12 of 389 
 
with CVS2 for predicting presence macular degeneration at risk of progression 
Figure 9.6 Graph illustrating the sensitivity versus 1-specificity for (a) high 
contrast visual acuity and (b) low contrast visual acuity of the left eye obtained 
with CVS2 for predicting SAIEC 
242 
Figure 9.7 Graph illustrating the sensitivity versus 1-specificity for (a) high 
contrast visual acuity and (b) low contrast visual acuity of either eye obtained 
with CVS2 for predicting SAIEC 
243 
Figure 9.8 Graph illustrating the sensitivity versus 1-specificity for binocular 
near acuity obtained with CVS2 for predicting significant gain in binocular near 
acuity with new refractive correction 
246 
Figure 9.9 Graph illustrating the sensitivity versus 1-specificity for binocular 
near acuity obtained with CVS2 for predicting significant binocular cataract 
247 
Figure 9.10 Graph illustrating the sensitivity versus 1-specificity for binocular 
near acuity obtained with CVS2 for predicting binocular correctable visual loss 
248 
Figure 10.1 Distribution of presenting HCVA in RE for Study 2 266 
Figure 10.2 Distribution of presenting HCVA in LE for Study 2.  267 
Figure 10.3 Bland and Altman plot of the difference in VA v mean VA in right 
eye, for gold standard and FVS high contrast VA.  
268 
Figure 10.4 Bland and Altman plot of the difference in VA v mean VA in left 
eye, for gold standard and FVS high contrast VA. 
269 
Figure 10.5 Distribution of presenting LCVA in RE for Study 2.  270 
Figure 10.6 Distribution of presenting LCVA in LE for Study 2.  270 
Figure 10.7 Bland and Altman plot of the difference in LCVA v mean LCVA in 
right eye, for gold standard and FVS low contrast VA 
272 
Figure 10.8 Bland and Altman plot of the difference in LCVA v mean LCVA in 
left eye, for gold standard and FVS low contrast VA. 
273 
Page 13 of 389 
 
Figure 10.9 Bland and Altman plot of the difference in near acuity v mean near 
acuity, for gold standard and FVS. 
275 
Figure 10.10. Graph illustrating the sensitivity versus 1-specificity for (a) high 
contrast visual acuity and (b) low contrast visual acuity of the left eye obtained 
with FVS for predicting presence of significant cataract in the left eye  
276 
Figure 10.11 Graph illustrating the sensitivity versus 1-specificity for (a) high 
contrast visual acuity and (b) low contrast visual acuity of the left eye obtained 
with FVS for determining significant gain in acuity with new refractive 
correction  
277 
Figure 10.12 Graph illustrating the sensitivity versus 1-specificity for (a) high 
contrast visual acuity and (b) low contrast visual acuity of the left eye obtained 
with FVS for determining correctable visual loss 
279 
Figure 10.13 Graph illustrating the sensitivity versus 1-specificity for (a) high 
contrast visual acuity and (b) low contrast visual acuity of the left eye obtained 
with FVS for determining macular degeneration 
280 
Figure 10.14 Graph illustrating the sensitivity versus 1-specificity for (a) high 
contrast visual acuity and (b) low contrast visual acuity of the left eye obtained 
with FVS for determining macular degeneration at risk of progression 
281 
Figure 10.15 Graph illustrating the sensitivity versus 1-specificity for (a) high 
contrast visual acuity and (b) low contrast visual acuity of the left eye obtained 
with FVS for determining SAIEC 
283 
Figure 10.16 Graph illustrating the sensitivity versus 1-specificity for (a) high 
contrast visual acuity and (b) low contrast visual acuity of either eye obtained 
with FVS for determining SAIEC  
284 
Figure 10.17 Graph illustrating the sensitivity versus 1-specificity for binocular 
near acuity obtained with CVS2 for predicting significant gain in binocular near 
acuity with new refractive correction 
288 
Figure 10.18 Graph illustrating the sensitivity versus 1-specificity for binocular 289 
Page 14 of 389 
 
near acuity obtained with FVS for predicting significant binocular cataract  
Figure 10.19 Graph illustrating the sensitivity versus 1-specificity for binocular 
near acuity obtained with CVS2 for predicting binocular correctable visual loss 
290 
Figure 11.1The gain in quality of life in 3 groups of participants  298 
Figure 11.2 Graphs showing quality of life gain with spectacle intervention in a) 
patients that did not have a significant increase in acuity due to refractive 
correction and b) patients with a significant gain in acuity with refractive 
correction.  
301 
Figure 11.3 Average gain in VA (from the gold standard eye examination) 
against the gain in QoL. 
302 
 
 
 
 
 
 
 
 
 
 
Page 15 of 389 
 
Acknowledgements 
I am grateful to the following for their assistance during the research and 
compilation of the thesis; 
Professor Bruce Evans, my external supervisor, for his guidance, patience, advice 
and for taking the time to share his knowledge and experience. 
Professor David Thomson, my internal supervisor, for his inventiveness, 
enthusiasm, support and advice 
Mitesh Amin for assisting throughout Study 1 and in the cataract grading study  
John Cooper and Hannah Sawyerr, for their assistance in administering the vision 
screening 
Advisory group: Jenny Evans, Anita Lightstone, Angela McCullagh, Ann Taket , Gill 
Rowlands, for their time and helpful comments 
To all the staff and participants at Woodlawns day centre, Pulross intermediate 
care centre and Blairderry road surgery for their time and willingness to participant 
in the study 
The Thomas Pocklington Trust for funding this research 
And to many friends and colleagues the Institute of Optometry for their help and 
support 
 
 
 
 
 
Page 16 of 389 
 
Declaration 
I grant powers of discretion to the University Librarian to allow this thesis to be 
copied on whole or in part without further reference to me. This permission covers 
only single copies made for study purposes, subject to normal conditions of 
acknowledgement. 
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
Page 17 of 389 
 
 
 
 
 
 
 
 
 
 To my parents 
 PARVIZ AND NIZAR JESSA 
Thank you for your invaluable support and 
encouragement and for believing in me 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Page 18 of 389 
 
Improving the detection of correctable low vision in the older population 
Zahra Jessa 
Doctor of Philosophy 
2009 
Thesis Abstract 
In the UK, 20-50% of older people have undetected reduced vision and in most of 
these cases the poor vision can be readily corrected by new spectacles and/or cataract 
surgery. It is often assumed that older people with vision loss will have regular eye 
examinations so that these problems can be detected, but for many older people this 
assumption is wrong. One approach to improving the take-up of eyecare services is to 
carry out vision screening of older people in the community to raise awareness of the 
need for professional eyecare. 
The present study aimed to investigate which tests would be most appropriate to 
screen for correctable visual loss in the older population and to incorporate these tests 
in a screening tool that would be effective yet simple to administer. The present 
research sought to investigate whether computerised techniques would be an effective 
method to screen vision in older people.  
In Study 1, a computerised vision screener was used to test 180 older people in South 
London. All participants also received a full, ‘gold standard’, eye examination.  
Significant cataract was present in 32%, correctable refractive error in 39%, and overall 
58% had at least one of these forms of correctable visual problems. The computerised 
vision screener was able to detect these conditions in about 80% of cases.  In Study 2, 
200 participants were screened using a revised version of the computerised vision 
screener.  A new flipchart vision screener including the main tests from the computer 
vision screener was also investigated.  31% of participants in Study 2 had significant 
cataracts, 30% had correctable refractive errors, and 51% had at least one of these 
conditions.  
The computer screener and flipchart tool were both good at detecting significant 
cataract and refractive errors. About 80% of cases of visual loss due to these problems 
or due to AMD could be detected with either of the screening tools. Using a pragmatic 
operational criterion, the screening tools detect about 94% of cases who might be 
considered by an optometrist to be in need of an eye examination (either overdue or 
reduced visual acuity). Glaucoma is a difficult disease to diagnose and it was found, as 
expected, that neither screening instrument was very good at detecting glaucoma. 
The results showed that the best single test to use for screening of visual loss is HCVA 
which provides both a high sensitivity (77%) and specificity (73%). Greater sensitivity 
(80%) is achieved when high contract acuity, low contrast acuity and near acuity are 
used in combination. Greater specificity (77%) can be achieved by using low contrast 
acuity alone. 
It is concluded that vision screening does not replace the need for professional 
eyecare, but acts as a tool to better inform the public of the need for regular eyecare. 
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Chapter 1  
Introduction 
1.1 The ageing population 
The UK has a growing population and an ageing population. Recent national 
statistics published in August 2007 by the Office for National Statistics state that 
the population grew by 8% in the last 35 years, from 55.9 million in 1971 to 60.6 
million in mid 2006. This change has not occurred evenly across all age groups. 
The population aged over 65 grew by 31%, from 7.4 to 9.7 million, whilst the 
population aged under 16 declined by 19%, from 14.2 to 11.5 million.  
The statistics also indicate that the largest percentage growth in the population in 
the year to mid-2006 was at ages 85 years and over (5.9%). The number of people 
aged 85 years and over grew by 69,000 in the year to 2006, reaching a record 1.2 
million. This large increase reflects improving survival of older people and it is 
predicted that the increase in the ageing population will continue throughout the 
first half of this century. The rise in the proportion of the population aged 65 and 
over is set to continue as the large numbers of people born after the Second World 
War and during the 1960s baby boom approach this age. Advances in medicine, 
health policies and socioeconomic development have all contributed to people 
living longer. 
With the rising number of older people, research into the ageing process and 
conditions that are more prevalent with age is becoming increasingly important. 
The section below outlines how the eye changes with age and eye disorders that 
are common among the elderly. 
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1.2 The ageing eye 
Figure 1.1 below, shows a horizontal section through the eye outlining the main 
structures that will be discussed in this section. As the eye ages, certain changes 
occur that can be attributed to the ageing process. Most of these anatomic and 
physiological processes follow a gradual decline. The section below has been 
structured in 3 parts, the first focusing on the changes and disorders that affect the 
front of the eye followed by the lens and then changes and disorders that affect the 
back of the eye. The section will end with a brief outline of common systemic 
conditions that may have an effect on the eye. 
 
Figure 1.1 Horizontal section through the eye 
Reproduced with permission from: Snell, R.S and Lemp, M; Clinical anatomy of the eye (second 
edition). Page 137. Copyright © (1998) Blackwell Science, Inc.  All rights reserved. 
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1.2.1 Anterior Eye 
The areas covered in this part include the structure surrounding the eye, tears, 
conjunctiva, cornea, sclera, trabecular meshwork and aqueous humour. 
1.2.1.1 Structures surrounding the eye 
A review by Buckley (2004) discussed the changes that occur in the anterior 
segment with age. The review suggested that many  of changes in the external 
appearance of the ageing eye are caused by an increase in the parasympathetic 
tone over the sympathetic tone with age. Ageing causes laxity and downward shift 
of eyelid tissues and atrophy of the orbital fat. These changes contribute to the 
aetiology of several eye lid disorders such as ectropion (turning out of the eyelid- 
usually lower lid), entropion (turning in of the eyelid - usually the lower lid) and 
ptosis (drooping of the upper eyelid). The loss of orbital fat with age causes the 
globe to sink deeper in the orbit, (enopthalmos). With age, there is also a reduction 
in pupil size (miosis) which is thought to be attributable to atrophy of the pupillary 
dilator. Miosis reduces retinal illuminance and adds to light scatter from the edge of 
the pupil.  
Lid margin disease (typically blepharitis) is a common problem in the older 
population. Blepharitis is the chronic inflammation of the lid margins usually caused 
by chronic staphylococcal infection which results in an uncomfortable burning 
sensation (Coakes & Sellors, 1995). Other symptoms that patients may experience 
are crusting of the eyelid margin, redness of the eyes and a feeling of dryness or 
sometimes tearing of the eyes. In severe cases, the condition may lead to 
secondary involvement of the conjunctiva and cornea (Coakes & Sellors, 1995). 
The goal of management is to relieve symptoms and reduce the risk of 
complications. This usually includes lid cleansing and the use of an antibiotic 
ointment. 
1.2.1.2 Tears 
The tear film is secreted by the lacrimal glands, which together with the secretions 
from the meibomian glands, the goblet cells, the glands of Zeiss and the accessory 
lacrimal glands, help to keep the conjunctiva and cornea moist and healthy 
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(Millodot, 2000). Tear secretion is established at birth and decreases linearly with 
age. Most patients remain asymptomatic despite the steady decrease in tear 
secretion. However, symptomatic tear deficiency may occur as part of the natural 
ageing process or as a result of age-related systemic disease (Buckley, 2004d). 
1.2.1.3 Conjunctiva 
The conjunctiva is a delicate mucous membrane that covers the front of the eye 
and lines the inside of the eyelids (Martin, 1996). The ageing conjunctiva shows a 
reduction in transparency, a yellowish discoloration and increased tortuosity and 
irregularity of blood vessels. 
Common degenerations associated with age include pingueculae and pterygia. A 
pinguecula is a yellowish white elevation of the bulbar conjunctiva at the limbus. It 
represents the degeneration of stromal collagen fibres accompanied by epithelial 
thinning. In most cases surgical intervention is not required. A pterygium is a 
triangular fold of bulbar conjunctiva with its apex advancing progressively towards 
the cornea, usually from the nasal side. It is considered to be a degenerative 
process caused by recurrent dryness or irritation from wind and dust or prolonged 
exposure to sunlight (Millodot, 2000). In time, pterygia may encroach on the cornea 
and threaten vision both by changes in refractive error and in severe cases by 
visual loss from involvement of the visual axis (Kanski, 1999). Surgical intervention 
is indicated if the pterygium is threatening the visual axis, if the eye is perpetually 
uncomfortable or if the patient is unhappy with the cosmetic appearance. 
Recurrence of ptyergia following surgical excision is common (Coakes & Sellors, 
1995). 
1.2.1.4 Cornea 
The cornea is the transparent circular media at the front of the eye. It refracts the 
light entering the eye on to the lens which then focuses it on to the retina. The 
cornea should contain no blood vessels and is extremely sensitive to pain (Martin, 
1996). The cornea consists of 5 layers; the epithelium, Bowman’s layer, stroma, 
Descemet’s membrane and the endothelium (Kanski, 1999). Each of these layers 
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responds to the ageing process in different ways and a few of the degenerations 
that occur in the layers of the cornea will be discussed in this section 
Ocular astigmatism is a refractive condition which most commonly originates in the 
cornea, but can also originate from the crystalline lens. It occurs when the image of 
a point object is not a single point but two focal lines at different distances from the 
eye. It is generally caused by one or several toroidal shapes of the refracting 
surfaces, or by light entering the eye obliquely. This refractive condition can be 
corrected by wearing cylindrical lenses. The axis of astigmatism tends to change 
with age from ‘with the rule’ (optical power of the eye greatest in the vertical 
meridian) in youth to ‘against the rule’ (optical power of the eye greatest in the 
horizontal meridian) in old age. The literature review by Buckley (2004) suggests 
that  this change may be due to the decreasing pressure from the lids as they 
become more lax (Buckley, 2004c).  
A very common feature of the ageing eye is arcus senilis. This is characterised by 
a greyish white ring (or part of a ring) opacity occurring in the periphery of the 
cornea (Millodot, 2000). It occurs in the stromal layer of the cornea and the 
peripheral annulus of opacity is separated from the limbus by a clear interval. Its 
presence is due to the increased permeability of local blood vessels to lipids and is 
related to serum cholesterol level. 
Another change that occurs in the structure of the stroma is an increase in the 
spacing of collagen fibres resulting in opacities that are termed ‘Crocodile 
Shagreen’. This is characterised by the presence of usually asymptomatic, greyish-
white, polygonal stromal opacities separated by relatively clear spaces. The 
opacities frequently involve the anterior two thirds of the stroma (anterior crocodile 
shagreen) although on occasion they may be found more posteriorly (posterior 
crocodile shagreen) (Kanski, 1999). A further degeneration originating in the 
stromal layer is Vogt’s white limbal girdle. This is present in all patients aged over 
80 years. It consists of fine white radial lines, usually seen in the nasal cornea. 
Vogt’s limbal girdle is similar histologically to pingueculae and pterygia (Buckley, 
2004e). 
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The corneal endothelium consists of a single layer of hexagonal cells. It plays a 
vital role in maintaining the deturgescence of the cornea. With age, the number of 
endothelial cells gradually decreases but because they cannot regenerate, 
neighbouring cells have to spread out to fill the space (Kanski, 1999). Not only 
does the total number of cells reduce, they become increasing irregular in shape 
and variable in size with age. Corneal guttata is an age-related corneal 
degeneration involving the endothelium and is due to the focal accumulation of 
collagen on the posterior surface of Descemet’s membrane. It is formed by 
abnormal endothelial cells and examination will show dark spots caused by the 
disruption of the endothelial mosaic. These lesions are usually innocuous although 
they may be indicative of early stages of Fuchs’ endothelial dystrophy (Kanski, 
1999) 
Fuchs’ dystrophy is a fairly common condition among older people. The review by 
Buckley (2004) explains that Fuch’s dystrophy is characterised by a new layer of 
abnormal fibrillar collagen forming between the normal Descemet membrane and 
the endothelial cells. In the later stages of the condition, abnormal collagen also 
accumulates under the epithelium. Fuchs’ dystrophy is an autosomal dominant 
condition but is surprisingly more common in females than males with a ratio of 
4:1. In the early stages of Fuchs’ dystrophy patients are asymptomatic and as 
there is no reduction in vision, no treatment is required at this stage. As the 
condition progresses, vision may decline and the patient may suffer pain from 
corneal oedema leading to bullous keratopathy. At this stage hypertonic agents 
may be required to dehydrate the cornea and soft contact lenses may be used to 
reduce the pain of keratopathy. The later stages of Fuchs’ dystrophy result in a 
more significant reduction in vision which may require a penetrating keratoplasty 
(full thickness corneal transplant).  
1.2.1.5 Sclera 
The sclera is an envelope of dense collagenous tissue that protects the eye 
against mechanical damage and helps to maintain the shape of the eye. The sclera 
also provides attachment for the tendons of the recti muscles. In common with 
other connective tissues, the lipid composition of the sclera increases with age. 
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The increase in lipid content accounts for the yellowing of the sclera with age (Snell 
& Lemp, 1998). Calcium deposited between the collagen fibres results in sclera 
plaque. The lesions appear as yellow or grey/black vertical bands and are more 
common in patients over 60 years of age. Scleral rigidity also increases with age 
due to the increase in the number of elastic fibres with age (Buckley, 2004b). 
1.2.1.6 Trabecular meshwork, aqueous humour, and primary open angle glaucoma 
The aqueous humour is a thick watery substance that fills the space between the 
lens and the cornea (Martin, 1996). Its functions include maintaining intraocular 
pressure of the eye and contributing to the dioptric power to the cornea. Aqueous 
humour is continually produced by the ciliary processes (part of the ciliary body) 
and this rate of production must be balanced by an equal rate of aqueous humour 
drainage. Small variations in the rate of production or outflow of aqueous humour 
will have a large effect on the intraocular pressure. The trabecular meshwork is an 
area of tissue in the eye located around the base of the cornea near the ciliary 
body which is responsible for draining the aqueous humor from the eye.  
Numerous morphological changes have been described in the aqueous outflow 
system in glaucomatous eyes. Many of these are also seen in normal aged eyes 
without glaucoma. This has led to the speculation that glaucomatous changes in 
the outflow pathway may represent an accelerated ageing process (Buckley, 
2004f). 
Primary open angle glaucoma is a progressive optic neuropathy characterized by 
excavation of the optic nerve head and a distinctive pattern of visual field defects 
(Kanski, 1999). There may also be raised intraocular pressure although this is not 
always the case (Millodot, 2000). This type of glaucoma is uncommon under the 
age of 40 but there is a strong hereditary component and particular care should be 
taken to examine first degree relatives (Coakes & Sellors, 1995). It is not 
understood how ageing predisposes to the development of glaucoma, but it may 
increase the vulnerability of the optic nerve head to pressure-related damage 
(Buckley, 2004a).The visual impairment caused by glaucoma is irreversible but the 
disease is treatable and this makes early detection of glaucoma essential in the 
management of the condition (Weinreb & Khaw, 2004c). 
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1.2.1.7 Lens 
The lens is a biconvex, usually transparent body, situated between the iris and the 
vitreous body of the eye and suspended from the ciliary body by the zonular fibres. 
It consists of the capsule which envelopes the lens, the anterior epithelium and the 
cortex which surrounds the nucleus (Millodot, 2000). The primary function of the 
lens is to transmit visible light and sharply focus it on the retina.  It contributes 
approximately one third of the eye’s total optical power and by changing its shape, 
the pre-presbyopic lens is able to fulfil the requirements of the accommodative 
process (Lawrenson, 2004a). 
Accommodation is the adjustment of the shape of the lens to change the focus of 
the eye. When the ciliary muscle is relaxed, suspensory ligaments attached to the 
ciliary body and holding the lens in position are stretched which causes the lens to 
be flattened. The eye is then able to focus on distant objects. To focus on near 
objects the ciliary muscles contract and the tension in the ligaments is thus 
reduced, allowing the lens to increase in curvature and become rounder. With age, 
the lens undergoes structural changes resulting in a gradual loss of elasticity of the 
lens which thus becomes progressively less able to increase its curvature in order 
to focus on near objects. This is known as presbyopia and results in difficulty in 
performing close work, for example reading at the usual distance (Martin, 1996). 
In addition to loss of accommodation, another almost invariable change in the lens 
with age is a loss of transparency. It has been suggested that 90% of patients aged 
over the age of 70  have some loss of lens transparency (Zadnik, 1997). Age-
related lens opacities can be divided into three categories: nuclear, cortical and 
posterior subcapsular. The figure below shows where in the lens the opacities 
occur. 
Nuclear opacities are the most common and are often referred to as nuclear 
sclerosis. Nuclear opacification is an acceleration of the normal ageing of the lens 
nucleus. The patient experiences a slow, gradual, progressive reduction in the 
quality of vision. The nucleus begins to take on a milky appearance owing to 
increased light scatter and yellows as a result of increased absorption of shorter 
wavelengths. The change in lens colour is also referred to as brunescence. There 
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may also be a concurrent increase in refractive index of the nucleus, which can 
result in a myopic shift in refractive error. Finally, localised changes in refractive 
error may manifest as monocular diplopia. Cortical opacities occur in the cortex of 
the lens and usually begin outside of the pupil area and in the inferior nasal 
quadrant. For this reason, the clinician is likely to observe them before the patient 
is aware they exist.  Posterior subcapsular opacities develop near the posterior 
pole of the lens and can have a dramatic effect on vision owing to their proximity to 
the visual axis and nodal point of the eye (Zadnik, 1997).  
 
Figure 1.2 The common types age related cataract a) Cortical lens opacities b) Nuclear sclerosis c) 
Posterior subcapsular opacification d) Mature cataract indicating total opacification of the lens. 
Reproduced with permission from: Outline of Ophthalmology (second edition), Coakes R & Sellors PH, 
Page 27. Copyright © (1995) Butterworth-Heinemann 
Surgical management is the mainstay of treatment for cataract and a number of 
studies have shown that surgery significantly enhances the quality of patients’ 
lives. In the early stages of cataract, optimal refractive management and advice on 
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glare reduction can lessen the functional impact of cataracts. Surgery is considered 
when these measures are no longer adequate for patients’ visual needs 
(Lawrenson, 2004b). 
1.2.2 Posterior Eye 
This section will outline changes in the vitreous, retina and choroid. Eye disorders 
prevalent in the older population that are related to these structures will also be 
discussed. These will include primary open angle glaucoma, age-related macular 
degeneration and retinal vessel occlusions. 
1.2.2.1 Vitreous 
The vitreous is a transparent jelly-like structure that fills the chamber behind the 
lens (Martin, 1996). In ageing eyes, the vitreous gel changes in structure. Synchisis 
senilis occurs in which the gel becomes liquefied and also syneresis, which 
describes the process of the gel collapsing in on itself. The ‘collapse’ of this gel can 
cause traction on the retina resulting in posterior vitreous detachment which in turn 
is a risk factor for retinal tears and detachment (Hammond, 2004c). Another less 
common ageing change in the vitreous gel is Asteroid Hyalosis in which numerous 
small stellate or discoid opacities develop in the vitreous (Millodot, 2000). These 
opacities are usually found in one eye and although they are more common with 
age, no other systemic associations have been found (Hammond, 2004d). 
1.2.2.2 Retina and choroid 
The retina is the light receptive, innermost nervous tunic of the eye. It is a thin 
transparent membrane lying between the vitreous and the choroid and extends 
from the optic disc to the ora serrata (Millodot, 2000) . It contains many layers (see 
Figure 1.3): the outer part of the retina (retinal pigment epithelium, RPE) next to the 
choroid is pigmented, acting as a solar barrier protecting the inner retina against 
excess light damage. The inner part of the retina contains rods and cones 
(photoreceptor cells) and their associated neural network. The retinal pigment 
epithelium also regulates the nutrition of photoreceptors and is of vital importance 
in the health of these cells.  
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There is interaction between the numerous cells and layers and indeed between 
the retina and the choroid posterior to it. The retina shows significant change with 
age and this is because the retina undergoes considerable stresses during a 
person’s lifetime. Unlike so many parts of the body where there is a very high 
turnover of cells, there is much lower turnover in the retina. This means that the 
retina is vulnerable to changes with age (Hammond, 2004e).  
 
Figure 1.3 Retinal layers 
Reproduced with permission from: Outline of Ophthalmology (second edition), Coakes R & Sellors PH, 
Page 4. Copyright © (1995) Butterworth-Heinemann 
The retina is prone to oxidative stress, which is cellular damage caused by reactive 
oxygen intermediates produced during chemical reactions. The retina is very 
susceptible to this damage as it has a very high oxygen demand and therefore 
there are numerous chemical reactions producing reactive oxygen intermediates 
(Hammond, 2004b). 
The choroid is a highly vascular tunic of the eye lying between the retina and the 
sclera and its main function is to nourish the retina. It has five layers: the supra 
choroid, the vessel layers (Haller’s layer and Sattler’s layer), the chorio-capillaris 
and Bruch’s membrane (Millodot, 2000). As the eye ages, it is thought that there is 
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reduced choriocapillaris blood flow, the choroidal blood vessels commonly show 
evidence of sclerosis after the age of 60 years (Snell & Lemp, 1998). There is also 
accumulation of waste products (lipofuscin) in Bruch’s membrane, which is derived 
from the RPE. Subretinal epithelial deposits, known as drusen are a common 
feature and there is some evidence that there is reduced RPE function (with loss of 
rods) with advancing age. Large, soft drusen and RPE changes predispose the eye 
to subretinal neovascularisation. There is some evidence that oxidative stress, 
particularly blue light and the high oxygen usage of the retina, is important in the 
aetiology of many of the changes seen in ageing eyes (Hammond, 2004a). 
1.2.2.3 Glaucoma 
Primary open angle glaucoma (POAG) has been defined earlier and is generally a 
bilateral condition but not necessarily symmetrical. Age is an important risk factor 
for primary open angle glaucoma and it is unusual for the diagnosis to be made 
before the age of 40. Raised intraocular pressure, myopia, race (African racial 
descent), and a family history of glaucoma are also risk factors for glaucoma 
(Kanski, 1999). 
Patients with POAG are usually asymptomatic until a significant loss of visual field 
has occurred. This is because the initial visual field loss involves parts of the visual 
field which are also covered by the field of the other eye. Although the disease is 
usually bilateral, progression is often asymmetrical so patients frequently present 
with less advanced disease in the other eye. Frequently POAG is first diagnosed 
by finding a suspicious optic disc or asymmetrical discs during a routine eye 
examination (Figure 1.4) indicating the importance of regular eye examinations for 
older people. Population screening for glaucoma using tonometry (measurement of 
intraocular pressure) alone is not satisfactory because it will label as ‘normal’ a 
significant number of cases with other features of POAG such as optic nerve head 
changes and visual field loss (Kanski, 1999). Glaucoma can be a challenging 
condition to detect and diagnose and this issue, and the sensitivity and specificity 
of screening tests is returned to in Chapter 9. 
The purpose of treatment of POAG is to preserve visual function by controlling 
intraocular pressure and thereby preventing or retarding further optic nerve 
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damage. Regular and careful follow up is also important to ensure that any 
progression is detected early (Kanski, 1999). 
(a)                                                     (b)                 
                  
Figure 1.4 Glaucomatous cupping of the optic disc (a) and normal fellow optic disc (b) 
Reproduced with permission from: Outline of Ophthalmology (second edition), Coakes R & Sellors PH, 
Page 29. Copyright © (1995) Butterworth-Heinemann 
1.2.2.4 Macular degeneration 
Macular degeneration is a condition found in a large percentage of older patients 
(Millodot, 2000). Age-related macular degeneration (AMD) is the leading cause of 
irreversible severe visual loss in the western world in individuals over 60 years of 
age. AMD can be classified into two types: Non exudative (dry) or Exudative (wet). 
Non Exudative AMD (Figure 1.5) is a slow progressive disease which accounts for 
90% of cases (Kanski, 1999). Exudative, although much less common, is 
frequently devastating and in some cases all useful vision may be lost within a few 
days. In fact 88% of legal blindness attributable to AMD is the result of this type. 
Two important features of exudative AMD are detachment of the RPE and 
choroidal neovascularisation (CNV) (Kanski, 1999). Exudative AMD occurs when 
new vessels form to improve the blood supply to oxygen-deprived retinal tissue.  
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However, the new vessels are very delicate and break easily, causing bleeding and 
damage to surrounding tissue. 
As the disorder involves the central retina or macula, reduced vision and/or 
distortion of vision are noted quite early in the disease. This is particularly 
noticeable if the centre of the macula (fovea) is involved. Visual acuity, contrast 
sensitivity and colour vision are all reduced together with metamorphopsia or 
distortion seen more commonly in exudative AMD (Saeed & Lee, 2004c;Buckley, 
2004g). Loss of central vision in macular degeneration is the result of changes that 
occur in response to deposition of abnormal material in Bruch’s membrane. This 
abnormal material is derived from the RPE and its accumulation is thought to result 
from failure to clear debris discharged into this region. Drusen consist of discrete 
deposits of this abnormal material in the inner portion of Bruch’s membrane 
between the basement membrane of the RPE and the inner collagenous layer. The 
abnormal material also accumulates diffusely throughout Bruch’s membrane. The 
appearance of drusen represents the earliest clinically detectable feature of 
macular degeneration. Drusen may vary in number, size, shape, degree of 
elevation and extent of associated changes in the RPE. In some patients, drusen 
may be confined to the region of the fovea, whereas in others the deposits may 
encircle the fovea itself. Drusen are rarely clinically visible before the age of 45 
years; they are not uncommon between the ages 45 and 60 years and almost 
universal thereafter. With advancing age they increase in size and number (Kanski, 
1999). 
A central scotoma is the hallmark of the condition, which is initially noted on 
wakening (Saeed & Lee, 2004b). The central scotoma is usually surrounded by a 
variable degree of distortion, which further hampers visual function. Patients may 
also experience difficulty in seeing in bright light as well as dim light. This may be 
due to compromised light adaptation mechanism of photoreceptors. Recovery from 
bright to dim light is slow. Drusen may be associated with mild symptoms but not 
necessarily significant visual loss (Saeed & Lee, 2004a). 
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Figure 1.5 Early age related macular degeneration 
Reproduced with permission from: Clinical Ophthalmology (4th edition),  Kanski, J.J, Page 407, Figure 
10.28. Copyright © (1999) Reed Educational and Professional Publishing Ltd 
Increasing awareness of the condition among the population can lead to early 
identification of AMD. Patients with dry AMD can be given advice on how to 
monitor their own vision and signs of wet macular degeneration should be reported 
immediately with immediate referral for ophthalmological investigation and possible 
treatment (Saeed & Lee, 2004d).  
Extensive research is ongoing into developing new treatments to restore vision and 
prevent further vision loss in patients with macular degeneration. Significant 
advances have been made which began with the introduction of photodynamic 
therapy for the treatment of wet AMD. Visudyne drug treatment (photodynamic 
therapy) was the first drug therapy for treatment of the wet form of the disease. It is 
only effective for those patients who have new blood vessel growth under the 
retina in a well-defined, distinctive pattern known as "predominantly classic." The 
treatment involves an injection of Visudyne which when activated by a laser light, 
produces a chemical reaction that destroys abnormal blood vessels.  
Further developments have been made since the introduction of photodynamic 
therapy. While no treatment for macular degeneration is likely to completely restore 
vision, some drugs may be able to preserve or even improve remaining vision. 
Also, certain treatments have shown promise for reversing at least some vision 
loss in many AMD patients. These treatments involve the use of Avastin. Like 
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Macugen and Lucentis (which is a form of Avastin), the drug is injected directly into 
the vitreous at the back of the eye and is aimed at stopping the action of a naturally 
occurring protein (VEGF) responsible for formation of abnormal blood vessel 
growth that causes eye damage in wet AMD.  
It is likely that the efficacy of treatments for macular degeneration will continue to 
improve which in turn will mean that fewer older people will suffer the devastating 
consequences of visual loss resulting from macular degeneration. 
1.2.2.5 Retinal vein and artery occlusion 
The retina receives its blood supply from the central retinal artery and 
deoxygenated blood exits the eye through the central retinal vein. A blockage in 
either a retinal vein or artery is known as a 'retinal vessel occlusion'.  
A retinal artery occlusion prevents fresh blood reaching the retinal cells. When this 
happens the retinal cells quickly suffer from the lack of oxygen. The main cause of 
a retinal artery occlusion is atherosclerosis causing hardening or thinning of the 
arteries and veins. A patient with an artery occlusion will experience painless loss 
of vision which usually happens very suddenly with little or no warning. In nearly all 
cases, one eye is affected. Some people may experience short periods of sight 
loss (amaurosis fugax) before the sight loss becomes permanent. 
Occlusion of the central retinal artery is characterised by a sudden loss of vision 
and a defective direct pupil light reflex. The retina appears white and swollen and 
the choroid is seen through it as a cherry red spot (Kanski, 1999). Occlusion is 
more frequently limited to one branch of the central retinal artery. In this case, the 
clinical picture is limited to the area supplied by that branch and this is associated 
with a visual field defect in that region (Millodot, 2000). 
Unfortunately there is little treatment available for retinal artery occlusions because 
the cells on the retina are very sensitive to a lack of blood supply. Depriving the 
retinal cells of a blood supply for even a short period of time results in permanent 
sight loss. In some people the blockage that causes the first sight loss may 
become dislodged and if the blood supply is started again after only a short delay 
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then some improvement in vision may be seen. However, in most cases there is 
some vision loss. 
The retinal veins drain away the deoxygenated blood from the retina. In a retinal 
vein occlusion, one of these veins becomes blocked and the blood cannot drain 
away properly. This obstruction in circulation causes pooling of blood resulting in 
swelling and areas of haemorrhage. These areas of swelling and backed up blood 
damage the cells of the retina and therefore damage sight and cause permanent 
changes to the retinal circulation.  There are a number of common risk factors for 
retinal vessel occlusions including increasing age, high blood pressure and 
diabetes. Raised intraocular pressure also increases the risk of a central retinal 
vein occlusion (Kanski, 1999). 
Occlusion of the central retinal vein can be either ischaemic or non-ischaemic. The 
non-ischaemic type is characterised by some loss in vision and slight impairment of 
pupil responses to light. The ischaemic type which affects older people is a more 
severe type and the signs and symptoms are much more marked than in the non 
ischaemic type (Millodot, 2000). Occlusion is more frequently limited to one branch 
of the central retinal vein. In this case the picture is limited to the retinal area 
drained by the occluded branch. The extent of vision loss will depend on the 
involvement of the macular. 
In a vein occlusion, sight loss may be gradual and in nearly all cases only one eye 
is affected. The sight loss caused by this kind of occlusion can sometimes improve 
on its own. Because the blood 'backing-up' can cause swelling and bleeding, 
sometimes when this swelling and the blood that has leaked clears up, sight can 
improve a little. In a few but not all cases, a laser can be used in this type of 
occlusion to help control bleeding and swelling and this can mean that sight 
improves a little.  
The treatment of vein occlusions depends on the primary cause. In some cases 
photocoagulation may be used (Millodot, 2000) to stop more damage occurring so 
although no sight is restored the likelihood of losing more sight is reduced. 
Ischaemic central retinal vein occlusion may result in glaucoma - in fact it is the 
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most common cause of secondary neovascular glaucoma. Approximately 50% of 
eyes with ischaemic central retinal vein occlusion develop neovascular glaucoma 
within 3 months (Kanski, 1999). Neovascular glaucoma results from the attempt of 
the retina to revascularise hypoxic areas of the retina by releasing heparin binding 
growth factors. These factors induce the development of secondary 
neovascularisation of the retina and are capable of diffusing in to the anterior 
segment, where they initiate neovascularisation of the iris. The subsequent 
invasion of the angle by fibrovascular tissue results in elevation of the intraocular 
pressure as a result of impairment of aqueous outflow. The fibrovascular 
membrane later contracts to produce secondary angle closure glaucoma (Kanski, 
1999). 
Since retinal vessel occlusions are often connected to other more general 
circulation problems, it is important that retinal vessel occlusions are identified 
early so that steps can be taken to treat the systemic conditions associated with 
retinal vessel occlusions. This can help to reduce the likelihood of a similar 
occlusion in the other eye.  
1.3 Neurodegenerative changes with age 
The quality of visual perception is related to the integrity of the entire visual system. 
Therefore any consideration of the effects of ageing on visual function must take 
into account changes in the entire system, not just the eye. There are a wide range 
of neurodegenerative diseases that occur in adult life and in this section two key 
conditions; Alzheimer’s disease and Parkinson’s disease together with their neuro-
ophthalmological features will be discussed briefly below. 
1.3.1 Alzheimer’s disease 
Dementia is a loss of mental function in two or more areas such as language, 
memory, visual and spatial abilities or judgment severe enough to interfere with 
daily life (Solomons, 2005c). There are currently about 700,000 people in the UK 
with a form of dementia. One in 14 people over 65 years of age and one in six 
people over 80 years of age has a form of dementia.  It is estimated that by 2021 
there will be about 940,000 people with dementia in the UK and this is expected to 
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rise to over 1.7 million people by 2051 (Alzheimer's society, 2007a).  Dementia 
itself is not a disease but a broader set of symptoms that accompanies certain 
diseases, e.g., Creutzfeldt-Jakob disease and Alzheimer’s disease. Alzheimer’s 
disease is the most common type of dementia accounting for 62% of all patients 
with dementia (Alzheimer's society, 2007b).  
Alzheimer’s disease is a degenerative condition that affects the brain. In this 
disease there is a deposit of abnormal protein outside nerve cells and also an 
accumulation of abnormal filaments of protein inside nerve cells in the brain. There 
can also be atrophy of the affected areas of the brain and enlargement of the 
ventricles as well as loss of certain neurotransmitters (Solomons, 2005b). 
Alzheimer’s disease begins gradually and progresses at a variable rate. Although 
the condition may manifest in different ways, the pattern of cognitive decline 
usually follows a recognised series of stages. Initially patients suffer from short 
term memory defects. More profound deficits follow, including selective and 
sustained attention, planning, understanding of the consequences of actions, 
recognition of what is socially appropriate and control of own emotions. Depression 
and paranoia are common and compounded by social isolation. Specific cognitive 
effects, such as problems recognising and naming familiar objects generally occur 
later in the disease (Mort & Kennard, 2000a). 
Patients with Alzheimer’s disease can suffer from visual disturbances caused by 
the brain rather than the visual system. That is, their problem can be having 
difficulty perceiving what they see rather than how sharply they see it. Problems 
most commonly occur in four areas- motion, depth, colour and contrast (Solomons, 
2005a). Visual hallucinations have been reported to increase with loss in acuity in 
some patients with Alzheimer’s disease (Chapman et al., 1999). It has also been 
reported that patients can appear to be confused and lost due to a form of motion 
blindness, as if the world is seen in a series of still frames (Tetewsky & Duffy, 
1999). This damage to the area of the brain concerned with perception of motion 
may cause patients to appear lost even in familiar surroundings.  
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Patients with Alzheimer’s disease seem to be impaired at low spatial frequencies 
instead of the high spatial frequencies as in old age. This implies that regions 
controlling the low spatial frequency processing in the primary visual cortex would 
be more affected than those for high frequency processing (Wong-Riley et al., 
1997). The affect of Alzheimer’s disease on the visual areas of the brain was also 
investigated by Hof et al.  Hof and colleagues conducted neuropathological 
examination of the brains of those with visual impairment and their research 
showed that correlations could be established between clinical symptoms and the 
distribution of neurodegenerative lesions. They found a high density of pathological 
lesions in brains with Alzheimer’s disease in the primary visual areas of the brain 
with Alzheimer’s and certain visual association areas within the occipital lobe and 
posterior parietal cortex. A high distribution of pathological lesions in the cerebral 
cortex of Alzheimer's disease cases with visual symptoms was also noted (Hof et 
al., 1997).  
1.3.2 Parkinson’s disease 
Parkinson's disease is a progressive neurological condition affecting movements 
such as walking, talking, and writing. The Parkinson’s disease society states that in 
the UK one in 500 people (approximately 120,000 individuals) have Parkinson’s 
and about 10,000 people in the UK are diagnosed each year. The condition 
commonly affects middle-aged and elderly people. The symptoms first appear, on 
average, when a patient is older than 50 and statistically, men are slightly more 
likely to develop Parkinson's than women (Parkinson's disease society, 2008). 
Parkinson’s disease occurs as result of a loss of nerve cells in the part of the brain 
known as the substantia nigra. These cells are responsible for producing a 
chemical known as dopamine, which allows messages to be sent to the parts of 
the brain that co-ordinate movement. With the depletion of dopamine-producing 
cells, these parts of the brain are unable to function normally. 
The three most characteristic signs of Parkinson’s disease are akinesia (slowness 
of movement), rigidity and tremor. In addition, patients treated with levodopa may 
exhibit dyskinesia or dystonia. Dyskinesia is a state in which the patient fidgets, 
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twitches or is generally restless, while dystonia is a spasm of one of the set of 
muscles often deforming a limb into an abnormal position (Armstrong, 2008a). 
Some patients with Parkinson’s disease develop memory problems and mood 
changes and a few individuals develop dementia similar to that found in 
Alzheimer’s disease (Armstrong & Syed, 1996).  
Many patients with Parkinson’s disease may be visually asymptomatic. However, 
the disease can be associated with visual signs and symptoms including defects in 
eye movements and pupillary function and in more complex visual tasks involving 
the ability to judge distance or the shape of an object (Armstrong, 2008b). Repka 
and colleagues found that visual complaints were significantly more common in 
patients with Parkinson's disease than in the age-matched controls and this 
seemed to be correlated with a decline in visual acuity (Repka et al., 1996) with low 
contrast acuity also being affected (Jones & Donaldson, 1995). The decline in 
visual acuity can be attributed to the lack of dopamine in the retina (Jones et al., 
1992) and this can also contribute to the development of hallucinations in 
Parkinson’s disease (Matsui et al., 2006a). Visual hallucinations are experienced 
by 30-60% of people treated for Parkinson’s disease (Diederich et al., 2005) and 
this is especially associated with those that are treated with L-dopa. 
Eye movement problems are a particularly important aspect of Parkinson’s disease 
and abnormal saccadic and pursuit movements have been reported in about 75% 
of patients (Shibasaki et al., 1979). Abnormal optokinetic nystagmus and 
convergence (Corin et al., 1970) have also been reported. It is possible that the 
abnormal convergence can be associated with an exophoria and sometimes leads 
to the complaint of diplopia for near vision only (Mort & Kennard, 2000b).  
Pupil reactivity is also affected in Parkinson’s disease. Different varieties of 
pupillary abnormalities have been described in Parkinson's disease but it is not 
clear if this is due to the disease itself or to the pharmacological treatment. 
Significantly larger pupil diameters with anisocoria after light adaptation have been 
reported with no differences being observed after dark adaptation. In addition 
reduced amplitude of contraction and a prolonged contraction time at light reflex 
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have also been observed indicating an autonomic imbalance involving the 
parasympathetic system (Micieli et al., 1991).  
The exact presentation of Parkinson’s disease seems to be highly variable and it is 
likely that many patients with Parkinson’s disease will be visually asymptomatic. 
Visual deficits may develop during the course of the disease and may be an 
important factor in influencing overall motor function (Diederich et al., 2002) and a 
risk factor for developing hallucinations (Matsui et al., 2006b). Some of the visual 
problems that may develop may be adverse reactions to treatment. 
The beginning of this Chapter has highlighted that the ageing population is 
increasing and with this it is likely that the prevalence of neurodegenerative 
disorders such as Alzheimer’s disease and Parkinson’s disease will also increase. 
While it could be argued that those with cognitive dysfunction such as that seen in 
dementia are less likely to notice reduced vision, a counter argument is that 
everything possible should be done to help improve the quality of life of those with 
these conditions and this should include identifying and correcting any visual 
defects.  
1.4 Changes in visual performance and function 
This section will briefly explore how age affects visual performance and relate this 
to changes in the anatomy and physiology of the eye described above. The change 
in visual function with age is also highlighted in Chapter 2 and Figure 2.1 shows a 
wide range in decline among visual functions with age. 
The formation of a retinal image is the first stage in perception and any degradation 
in the optics of the eye with age will have a corresponding impact on visual 
performance. A review by Thomson (2008) describes the principal changes that 
occur in the structure of normal, healthy, ageing eyes and how these changes 
relate to changes in visual function. The review explains that the main age related 
changes in the eye affecting visual function  are: (1) an increase in light scatter in 
the lens; (2) a reduction in optical quality resulting in some degree of defocus; (3) a 
decrease in retinal illuminance caused by age related miosis and increasing 
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absorption of light by the crystalline lens; and (4) neural loss in the retina and the 
visual cortex.. 
The affect of age on a few key aspects of visual function will be briefly discussed 
below. 
1.4.1 Visual acuity 
Most studies report a decline in visual acuity with age, although there is some 
dispute as to when the decline commences. The commonly held belief among 
clinicians is that visual acuity remains stable throughout adulthood until the age of 
approximately 50 years, after which it shows more or less a linear decline. This 
belief is largely based on the reviews of Pitts and Weale (Pitts, 1982;Weale, 1975). 
The age related decline in visual acuity has also been noted by Elliott et al where 
acuity was shown to decrease by approximately one line on the letter chart across 
the third and sixth decades of life (Elliott et al., 1995). 
1.4.2 Contrast sensitivity 
Contrast sensitivity is the reciprocal of the contrast threshold, defined as the ratio 
between threshold stimulus difference and a base line stimulus (Weale, 2004). The 
contrast sensitivity function provides information about visual performance over the 
entire spectrum of spatial frequencies, whereas visual acuity measures the highest 
spatial frequency that can be resolved at maximum contrast (Thomson, 2008). 
Most studies have shown a preferential loss at high and medium spatial 
frequencies with age and much of the reduction in contrast sensitivity is attributable 
to a neural loss (Elliott, 1987). The review by Thomson (2008) suggests other 
possible explanations for this loss in contrast sensitivity including a reduction in 
retinal luminance and an increase in light scatter. 
1.4.3 Binocular vision 
Accurate and steady fixation is a prerequisite for binocular vision and stereopsis. 
While there is some evidence that fixation is less stable in older subjects under 
scotopic conditions (Dannheim & Drance, 1971), under photopic conditions 
accurate fixation seems to be maintained into old age. 
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Binocular summation is defined as an increase in the binocular response 
compared with the monocular occurring when the sensitivities of the two eyes are 
equal or similar so that two eyes produce a better sensitivity than one (Pardhan et 
al., 1990a).  The threshold for perceiving a stimulus should be lower when 
undertaken binocularly than monocularly and  this has been shown to be the case 
with a wide range of visual stimuli (Thomson, 2008). The degree of binocular 
summation is reduced in older subjects, for central high spatial frequency stimuli 
(Gagnon & Kline, 2003a) and for peripheral stimuli (Pardhan & Whitaker, 2003a). 
The decline in binocular summation with age has been attributed to an age related 
loss in cortical cells, a decline in binocular stability or an increasing asymmetry 
between the two eyes (Pardhan, 1996;Pardhan & Whitaker, 2003b). 
Studies have shown that stereoacuity declines with age, although the extent of the 
decline is dependent on the test used (Garnham & Sloper, 2006b;Lee & Koo, 
2005). The reasons for the reduction in stereoacuity include a decrease in retinal 
illuminance, a deterioration in VA and perhaps a loss in cortical cells (Yap et al., 
1994). 
1.4.4 Visual Fields 
Visual field thresholds decline with age at a rate in the range of 0.5-1.0dB per 
decade (Weale, 2004). Spry and Johnson showed that this age related reduction in 
sensitivity is non-linear, showing a small decline in the early decades of life which 
increases particularly from the seventh decade onwards. The reduction in 
sensitivity tends to be greater in the periphery and the superior hemifield (Spry & 
Johnson, 2001a).  
The reduction in sensitivity with age is likely to be partly attributable to the 
reduction in pupil size and increased absorption of the lens, but there is also good 
evidence that neural changes play an important role (Spry & Johnson, 2001b). 
1.4.5 Dark adaptation and absolute threshold 
Thomson (2008) explains that the eye operates over a large range of light levels 
and it achieves this by having two classes of photoreceptors; rods and cones (see 
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Figure 1.3). The sensitivity of the eye can be measured by determining the 
absolute threshold, that is, the minimum luminance of a test spot required to 
produce a visual sensation. This can be measured by placing a subject in a dark 
room and increasing the luminance of the test spot until the subject reports its 
presence. Consequently, dark adaptation refers to how the eye recovers its 
sensitivity in the dark following exposure to bright lights. The time course of dark 
adaptation is a two branched function; starting with a cone phase followed by a 
longer rod phase with a characteristic rod-cone break after approximately 5 
minutes. Dark adaptation is relatively slow taking 30 -40 minutes to reach the 
absolute threshold for the rods. 
Absolute threshold tends to increase with age as sensitivity decreases (DOMEY et 
al., 1960). This is an expected finding taking into account age related miosis and 
the reduced transmittance of the lens. Jackson et al controlled pupil diameter and 
individual lens absorption. They recorded an age related slow down in the recovery 
of rod sensitivity following light adaptation and hypothesized that this may be due 
to a reduction in the regeneration of rhodopsin (Jackson et al., 1999). Whatever the 
cause, it is important to note that the absolute threshold of an 80 year old is likely 
to be about 2 log units (100 times) less than that of a 20 year old (Thomson, 2008). 
Studies have shown that it takes longer for visual acuity to recover in older people 
following exposure to bright light (Margrain & Thomson, 2002). Not only does 
recovery time increase with age, but also increases significantly in the presence of 
age related macular degeneration (Binns & Margrain, 2007;Wu et al., 1990). 
This section has given a brief overview of the changes in visual function with age. 
The section below will discuss common systemic conditions that are prevalent in 
the older population and the ocular effects of these conditions will be described. 
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1.5 Systemic conditions that have ocular manifestations 
Systemic diseases may affect the eye at any age. However, the manifestations of 
systemic diseases in the ageing eye represent in general a more significant 
problem. First, certain systemic diseases are much more common in old age and 
second, even disorders which manifest from an early age can deteriorate in the 
ageing eye as a result of cumulative damage over the years. 
1.5.1 Diabetes 
Diabetes mellitus is characterised by sustained hyperglycaemia secondary to lack, 
or diminished efficacy, of endogenous insulin (Kanski, 1999). The two common 
types of diabetes are Type 1 diabetes (insulin dependent) and Type 2 diabetes 
(non insulin dependent) (Millodot, 2000). Type 2 diabetes is the most prevalent 
form of diabetes. It usually develops in older people, most often between 50 and 70 
years (Kanski, 1999;Karadimas, 2004e). In addition to these two main types, other 
more rare specific types of diabetes also exist. Diabetes is not exclusively a 
problem of older people. However, at an older age the consequences of the 
disease are more evident, reflecting the accumulated damage over the years 
(Karadimas, 2004d). 
Diabetes can result in retinal vascular complications known as diabetic retinopathy 
(Figure 1.6). The most important factor for the development of diabetic retinopathy 
is the duration of the diabetes (Kanski, 1999). This explains the frequency and 
severity of diabetic retinopathy with increasing age. Other risk factors include poor 
metabolic control, vascular hypertension, elevated lipids and renal disease 
(Karadimas, 2004c;Kanski, 1999).  
Diabetes can also result in extraretinal ocular pathology; corneal abrasions are 
more common in diabetes compared to normals and corneal sensitivity is also 
reduced in diabetic patients in accordance with the duration of the disease. 
Transient changes in refractive error may occur in diabetic patients possibly as a 
result of secondary osmotic swelling of the lens. Diabetes may also result in 
isolated nerve palsies and the presence of a nerve palsy may be the first indication 
of a latent diabetic condition (Karadimas, 2004b).  
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Figure 1.6 Background diabetic retinopathy 
Reproduced with permission from: Outline of Ophthalmology (second edition), Coakes R & Sellors PH, 
Page 115. Copyright © (1995) Butterworth-Heinemann 
The presence of diabetes has shown to significantly increase the risk of cataract. In 
diabetic patients under the age of 65 years, the prevalence of cataract increases 3 
to 4 fold compared to demographically similar individuals without diabetes. In those 
patients over the age of 65 with diabetes, the prevalence of cataract increases 2 
fold compared with demographically similar individuals without the disease (Negi & 
Vernon, 2003;Klein et al., 1998a). The Beaver Dam Eye Study evaluated diabetes, 
cardiovascular disease, selected cardiovascular disease risk factors and the 5-year 
incidence of cataract and progressive lens opacification. The investigators found 
that diabetes was associated with an increased incidence of cortical and posterior 
subcapsular cataract and with progression of cortical and posterior subcapsular 
lens opacities (Klein et al., 1998b). 
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There is also a possible correlation between diabetes and age-related macular 
degeneration. In the recent Age-Related Eye Disease Study (AREDS) (Chiu et al., 
2007), a positive correlation was found both between dietary glycemic index and 
age related macular degeneration and between dietary glycemic index and the 
severity of age-related macular degeneration. There was a 49% increase in the risk 
of advanced macular degeneration in subjects with glycemic ratings higher than 
the median. The investigators concluded that higher glycemic dietary levels 
increase the risk not only for diabetes and heart disease, but also for age-related 
macular degeneration. 
Fundus photography has been shown to be a useful screening tool for the 
detection of diabetic retinopathy. A study by Rhatigan and colleagues showed that 
the majority of visual impairment in patients with diabetes is not from diabetic 
retinopathy (Rhatigan et al., 1999). The factors contributing to loss of vision were 
found to be failure of laser treatment, rapidly progressive disease and poor patient 
attendance. This has important implications for screening programmes and also 
highlights the importance of regular eye examinations despite regular screening for 
diabetic retinopathy.  
 1.5.2 Vascular hypertension 
Hypertension is a major public health problem due to its high prevalence and 
severe consequences. It is a risk factor for coronary artery disease and is also the 
most important risk factor for cerebral vascular disease. Increasing age represents 
a major risk factor for the presence of the hypertension and it is well known from 
epidemiological studies that the prevalence of hypertension increases with each 
decade of life. Over half of the population above 60 years of age in most 
industrialised countries have hypertension (Karadimas, 2004a). 
The ocular fundus picture in hypertension is related directly to the status of the 
retinal arteries and the rate of rise and degree of systemic blood pressure. The 
term hypertensive retinopathy refers to any retinal vascular change related directly 
to the systemic hypertension. Changes in typical chronic hypertension include focal 
narrowing and dilation of retinal vessels. When hypertension is severe, additional 
Page 47 of 389 
 
retinal changes may develop. These include arteriolar closure, retinal 
haemorrhages and lipid exudates (Karadimas, 2004f). Systemic hypertension may 
also result in branch retinal vein occlusions and retinal artery occlusions. 
Uncontrolled systemic hypertension also has an adverse effect on diabetic 
retinopathy (Kanski, 1999)  
The signs of hypertensive retinopathy are associated with severity and duration of 
the disease. These signs are encountered much more commonly in older people. 
The treatment of hypertensive retinopathy, choroidopathy and optic neuropathy 
consists of blood pressure control. No specific ocular therapies exist to reverse the 
changes. Treatment of the underlying systemic condition usually slows down the 
progression of the retinal changes, but arteriolar narrowing and arteriovenous 
crossing signs are usually permanent (Karadimas, 2004g). 
Hypertension and diabetes mellitus are classic examples of systemic diseases 
affecting the eye. Both are very common and both are accompanied frequently by 
ophthalmic manifestations. Both diseases represent a more significant risk for older 
people, given their long duration and the accumulating damage that they both 
create. 
The above section indicates that older people need regular eyecare to monitor 
age-related changes to the eye that may affect vision or that may be indicative of 
other systemic disorders. The next section will look at the eyecare that is currently 
available for older people and the accessibility of and participation in these eyecare 
services. 
1.6 Eyecare for older people 
There is a wide range of eyecare services available to the elderly in the UK. These 
services span different sectors of the National Health Service (NHS) and can be 
divided in to two areas; primary eyecare and secondary eyecare. In Chapter 5, the 
provision of NHS eyecare will be looked at more closely.   
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1.6.1 Primary eyecare 
The term primary eyecare refers to eye services that are readily available in local 
communities. Optometrists are the main providers of primary eyecare. They are 
usually based in community practices and are more often than not, the first point of 
contact that a patient may have with eyecare services. The role of an optometrist 
within a primary care setting is to perform sight tests. This not only involves 
assessing a patient’s need for spectacles but also an external and internal eye 
health check (Association of Optometrists, 2003) in which signs of injury, disease 
or abnormality in the eye can be detected. It is then the role of the optometrist to 
decide on the course of management for the patient. This may involve 
management of the condition within the primary care setting or an accurate referral 
to the hospital eye service where secondary eyecare is available. Most referrals to 
the hospital eye departments are initiated following a routine eye examination by 
an optometrist (Association of Optometrists, 2001). Primary care optometrists are 
now increasingly able to provide a range of services within a community based 
setting, often in conjunction with GPs and ophthalmologists, in order to screen for 
and monitor eye disease.  
Primary eyecare is the most accessible form of eyecare for the elderly. Patients 
aged 60 and above are entitled to an eye examination, the cost of which is fully 
covered by the NHS. In contrast to NHS dentistry, nearly all community 
optometrists provide NHS eye examinations (see Chapter 5). Older patients are 
entitled to have an NHS eye examination once every two years until the age of 70 
after which they are entitled to annual examinations. If a patient has diabetes, 
glaucoma or is experiencing eye related symptoms then they are entitled to have 
an eye examination earlier than the intervals recommended. Although the NHS 
funds the eye examinations for people aged 60 and over, they do not automatically 
contribute towards the cost of spectacles. However, older people on low incomes 
who receive Pension Credit are also entitled to an NHS voucher and this 
contributes towards the cost of spectacles. In some practices the NHS voucher 
may cover the complete cost of the spectacles (see Chapter 5).  
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1.6.2 Secondary eyecare 
The term secondary eyecare refers to eyecare that is delivered by the hospital eye 
service. Secondary eyecare is usually provided by a team of eyecare professionals 
including ophthalmologists, optometrists and orthoptists. Secondary eyecare 
enables various conditions such as glaucoma to be diagnosed and treated. 
Recently there has been an increased overlap between primary eyecare and 
secondary eyecare and this trend is likely to continue in the future. Referral 
management, diagnostic and treatment services of eye conditions normally seen in 
secondary care have been developed within community settings. This change from 
delivering certain types of secondary care in primary care settings will make the 
eyecare services even more accessible for older patients and reduce the time that 
patients wait to receive treatment, and the distances that they have to travel. 
1.6.3 Take-up of eyecare services 
The above section indicates that eyecare is readily available for older people, yet a 
recent systematic review revealed that 20-50% of older people have undetected 
reduced vision (Evans & Rowlands, 2004d). The majority of these people have 
correctable visual problems (refractive errors or cataract). It is particularly startling 
that, in a “developed country”, between 7% and 34% of older people have visual 
impairment that could be corrected by appropriate spectacles.  
Intuitively, one would have thought that symptoms (e.g., worsening vision) would 
cause older people to seek eyecare to discover whether their vision could be 
improved. Clearly, for many older people this assumption is wrong and the review 
suggests that this is particularly the case for people from ethnic minorities and 
those who are suffering from the effects of poverty. 
In a large study of a North London population, the prevalence of bilateral visual 
impairment (visual acuity <6/12) was 30%, of which 72% was potentially 
remediable (Reidy et al., 1998m). The study outlined several reasons that may be 
responsible for the high level of undetected and untreated morbidity in the 
population. These are, firstly, inadequate levels of attendance at the high street 
optometrist or failure to purchase corrective spectacles; secondly, suboptimal 
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integration of vision checks into the general primary care of elderly people, possibly 
linked with a reluctance to add to the lengthy waiting lists; and, thirdly, patients' 
perception of the extent to which their vision has gradually diminished, the point at 
which help should be sought, and uncertainties about the treatment and the 
outcome.  
Although the cost of an eye examination for people aged 60 and over is covered by 
the NHS, it has been suggested that many older people are deterred from visiting 
an optometrist because of fear of the cost of spectacles.  Older patients may not be 
aware of their entitlement to Pension Credit or those that are claiming it may have 
difficulty in finding a practice that will dispense glasses where the complete cost is 
completely covered by the NHS voucher (see Chapter 5).  
A recent report by the RNIB (Conway & McLaughlan, 2007) also highlights the cost 
of spectacles and a lack of appreciation of the importance of eye tests as an 
essential health check as significant barriers to  the uptake of primary eyecare 
services among older people. The report stated that the most common reason 
among older people for not having an eye examination in the past two years was 
because they were not having any problems with their eyes. This suggests that a 
significant barrier to having an eye test is people’s assumption that sight tests are 
for people with problems already, yet conditions such as glaucoma and diabetic 
retinopathy can progress significantly before patients notice any symptoms. 
The survey conducted by RNIB (Conway & McLaughlan, 2007) also identified 
transport problems as a potential barrier for older people not receiving regular 
eyecare. The number of practising optometrists working in the UK has increased 
by 37 per cent between 1996 and 2006. However, lack of coverage by optometrists 
in certain geographical areas or difficulties in older people traveling to community 
optometrists has been thought to be a barrier to older people going for an eye test 
(FODO, 2007). Social isolation problems are pronounced in less mobile older 
people and may well be a factor in preventing them from having regular eye tests. 
Lack of awareness and availability of domiciliary services has been highlighted 
before by the RNIB and the Domiciliary Eyecare Committee (FODO, 2007).  
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Many of the reasons outlined above regarding the low uptake of eyecare services 
among the elderly stem from a lack of awareness about eye health and accessing 
eyecare services. Table 1.1 below summarises the main barriers to eyecare and 
highlights the importance of increasing awareness among the older population.   
Table 1.1 Barriers to eyecare 
Barriers to eyecare Increasing awareness 
Cost of spectacles Older people need to be made aware of their 
entitlement to benefits that may help towards the cost 
of spectacles. 
Older people report that they have 
no problems with their eyes and 
see no need to have an eye 
examination. 
Older people need to be made aware of eye health, 
eye disease and its management to encourage them 
to have an eye examination even if they feel their eye 
sight is good.  
 
The assumption that reduced vision 
is a consequence of ageing and 
nothing can be done to help 
A significant number of visual problems may be 
correctable, possibly by updating spectacles or by 
routine cataract procedures 
Poor mobility and lack of transport 
facilities to access eyecare services 
in the community 
Domiciliary services are available and older people 
need to be made aware of this and their entitlement 
to it. 
Fear of eye disease Older people need to be made aware that most eye 
conditions can be treated or stabilised by treatment 
from the hospital eye service and may not 
necessarily result in losing vision. 
Fear of being told to cease driving A simple change in spectacles or cataract procedure 
may help to improve vision to meet driving standards. 
Older patients may not necessarily be told to stop 
driving completely but possibly to refrain from driving 
at night or in poor weather conditions. 
 
It is clear the barriers to eyecare outlined above need to be addressed and older 
people need to be encouraged to attend for regular eye examinations. Two 
different (but not mutually exclusive) approaches to improving the detection of 
visual problems in older people are to better publicise the need for regular 
optometric eye examinations and to screen for visual problems. Publicising the 
need for regular eye examinations is important, but the limitation of this approach is 
that many older people seem to assume that such publicity is “not for them”. Often, 
older people fail to seek eyecare because they assume that nothing can be done to 
improve their vision (Evans & Rowlands, 2004c;Reidy et al., 1998l;Reidy et al., 
1998k;Reidy et al., 1998j;Reidy et al., 1998i). If the person attended a vision 
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screening programme and was told directly that their visual problem has a high 
likelihood of being treatable, or at least that they might benefit from low vision 
services, then perhaps they would be more likely to seek help. It is likely that such 
personalised information, taking account of a person’s individual situation, would 
increase the individual’s understanding of their correctable visual loss in a way that 
generalised publicity would not. 
1.7 Screening 
The chapter so far has established that older people need to have regular eye 
examinations in order to monitor age-related changes in the eye and changes in 
spectacle prescriptions. The chapter has also outlined what eyecare is available 
and reasons why older people might be reluctant to access eyecare services. The 
next section will give a general overview on what screening is and the accepted 
criteria that is advocated for any screening programme. 
1.7.1 What is screening? 
The UK National Screening Committee (2007) defines screening as ‘a public health 
service in which members of a defined population, who do not necessarily perceive 
they are at risk of, or are already affected by a disease or its complications, are 
asked a question or offered a test, to identify those individuals who are more likely 
to be helped than harmed by further tests or treatment to reduce the risk of a 
disease or its complications.’ Screening has important ethical differences from 
clinical practice as screening targets apparently healthy people, offering to help 
individuals to make better informed choices about their health. 
Whilst intuitively screening seems beneficial because it has the potential to 
improve quality of life through early diagnosis of conditions, it is not a fool-proof 
process. Screening can reduce the risk of developing a condition or its 
complications but it cannot offer a guarantee of protection. In any screening 
programme, there is an irreducible minimum of false positive results (people 
wrongly reported as having the condition) and false negative results (people 
wrongly reported as not having the condition). The National Screening Committee 
is increasingly presenting screening as risk reduction to emphasise this point. 
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1.7.2 The Wilson criteria: when is screening appropriate? 
The National Screening Committee employs set criteria for appraising the viability, 
effectiveness and appropriateness of a screening programme. These criteria are 
based on those developed by Wilson and Jungner in 1968 (Wilson & Jungner, 
1968) and address the condition, the test, the treatment and the screening 
programme.  
Table  below states the Wilson-Jungner criteria for screening. 
Table 1.2 Wilson and Jungner screening criteria (Wilson & Jungner, 1968) 
Knowledge of the 
disease 
The condition being screened for should be an important health 
problem 
 The natural course of the condition should be well understood, 
including development from latent to declared disease 
 There should be a detectable early stage or early symptomatic 
stage. 
Knowledge of the 
test 
There should be a suitable test or examination to detect the 
condition 
 The test should be acceptable to the population 
 Case findings should be continuous (not just a ‘once and for all’ 
project) 
Knowledge of the 
treatment 
The treatment for patients recognised with the disease should be 
acceptable. The risks of treatment should be less than the benefits. 
 Adequate health service provision should be made for the extra 
clinical workload resulting from screening.  
 There should be agreed policy on whom to treat as patients 
Cost Considerations Costs of case findings (including diagnosis and treatment of 
patients diagnosed) should be economically balanced in relation to 
possible expenditures on medical care as a whole. 
 
1.8 Chapter summary  
This chapter has shown that the population in the UK is increasing and ageing. 
With age, the eye changes and certain eye disorders are more prevalent in the 
older population. Older people are also more at risk from certain systemic 
disorders and many of these have ocular manifestations. As such, there is a need 
for older patients to have regular eye examinations. However, there is a low uptake 
of eyecare services among the elderly. 
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Vision screening may be of value as a tool to encourage older people to have eye 
examinations but any screening programme would need to conform with guidelines 
accepted by the UK National Screening Committee. In the next chapter, the 
literature on vision screening in older people will be reviewed to see whether it 
possible to determine from the available evidence whether the Wilson and Jungner 
screening criteria are met. 
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Chapter 2  
A review of vision screening in 
older people 
2.1 Introduction 
A recent systematic review (Evans & Rowlands, 2004b) investigated the 
prevalence of correctable visual impairment (VI; defined below) in older people in 
the UK. The review also sought to determine to what extent these cases are 
undetected by current healthcare systems, to suggest reasons for the poor 
detection, and to make suggestions for improving detection. As outlined in Chapter 
1, the main conclusions of this review were that between 20% and 50% of older 
people have undetected reduced vision. The majority of these people have 
correctable visual problems (refractive errors or cataract).  
The effects of this undetected, yet correctable, reduced vision are significant. The 
systematic review (Evans & Rowlands, 2004a) found considerable evidence that 
the reduced vision is associated with impaired quality of life and ability to carry out 
activities of daily living, depression, falls and other accidents. Those with low vision 
are approximately twice as likely to have falls compared with people with normal 
vision (Legood et al., 2002;Harwood, 2001)  
For older people to suffer these disadvantages when in many cases the low vision 
is easily corrected with spectacles or cataract surgery is clearly unacceptable. 
Furthermore, this correctable reduced vision is likely to be particularly prevalent 
amongst people who suffer from the effects of poverty (Reidy et al., 1998h) and/or 
are from ethnic minorities (Lindesay et al., 1997;Pardhan & Mahomed, 2002). 
At present, it seems to be widely assumed that older people with low vision will 
automatically detect their problems and seek optometric and/or medical care. Yet, 
88% of older people with treatable visual disorders do not avail themselves of eye 
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care services (Reidy et al., 1998g). It is possible that screening for visual problems 
may prompt older people to attend for an eye examination. 
Screening for visual problems in older people has also been suggested in the 
context of general health screening (Bulpitt et al., 1990). Another study that 
advocated widespread screening calculated that the cost of falls attributable to VI 
in the UK is £¼ billion (Scuffham et al., 2003). In addition to falls, VI alone will have 
an adverse economic impact, although discussion of this is beyond the scope of 
the present review. 
Although screening seems intuitively beneficial, several authors (Smeeth, 1998) 
have pointed out that vision screening of older people would need to meet the 
accepted criteria that are advocated for any screening programme for disease as 
outlined in Chapter 1 (Wilson & Jungner, 1968). An adaptation of the criteria has 
been proposed in Table 2.1 (Cadman et al., 1984) and also used in other reviews 
(Mulrow & Lichtenstein, 1991). 
Table 2.1 Effectiveness of screening programmes: Criteria for assessment (Cadman et al. 1984) 
1. Does the burden of suffering warrant screening? 
2. Is there a good screening test? 
3. Are efficacious treatments or preventative measures available? 
4. Will those at risk attend for or accept screening? 
5. Do people with positive screening results accept interventions or advice? 
6. Can the health system cope with the programme? 
 
The criteria in Table 2.1 have been discussed in the context of vision screening of 
older people in a previous review by Smeeth (Smeeth, 1998). The present review 
seeks to build on this earlier work and also to specifically address two issues that 
were highlighted in Smeeth’s paper. Smeeth (1998) noted, concerning point 2 in 
Table 2.1 that “the assessment of visual screening tests is hampered by the lack of 
a ‘gold standard’, and the literature in this area is far from comprehensive” and that 
“there are no agreed criteria for the level of visual acuity which warrants 
intervention”. This last point assumes that vision screening should only rely on one 
vision test and that this vision test should be visual acuity. This assumption will 
now be discussed below. 
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The usual aim of vision screening of older people is to detect a range of visual 
problems that are likely to impact on visual performance in a variety of ways. It 
therefore seems unlikely that one test of visual function will be adequate; although 
it must be acknowledged that increasing the number of tests will increase the cost 
of screening. Several previous researchers have only used visual acuity 
measurements in their studies (Strahlman et al., 1990a;van der Pols et al., 2000a), 
and it is thought that if one test of visual function is to be assessed in screening 
programmes, then the best single test is likely to be visual acuity. This chapter 
attempts to broaden this discussion by reviewing whether a battery of vision tests 
might provide a more complete assessment of visual function in older people and 
might be better related to the consequences of a range of visual problems in terms 
of adverse effects on daily living. For example, most definitions of blindness and 
some definitions of low vision (visual impairment) include criteria for visual field 
loss as well as visual acuity loss. In addition, standard visual acuity charts have 
high contrast optotypes, yet most visual objects in the real world are of lower 
contrast. Many visual problems affecting older people have a greater effect on low 
contrast resolution than high contrast resolution, and many authors have therefore 
highlighted the potential of contrast sensitivity for vision screening (Brabyn et al., 
2001f;Brabyn et al., 2001e;Lord & Dayhew, 2001). Another factor that has often 
been ignored is the issue of binocularity. Stereopsis has been described as the 
“barometer of binocularity” (Saladin, 2005) and may play an important role in 
preventing falls (Evans & Rowlands, 2004n). 
Another issue that Smeeth (1998) raised is the most appropriate venue(s) for 
vision screening. This was not addressed in detail in the review by Smeeth (1998), 
and therefore the literature on this subject was searched for the present review. 
To summarise, the purpose of this chapter is to review the research on vision 
screening in older people to evaluate the effectiveness of screening, to assess 
which screening tests are most appropriate and to consider the most appropriate 
venues for screening. The questions in Table 2.1 are returned to in the Discussion 
of the review at the end of this chapter. 
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It became apparent when reading the literature on this subject that the terms VI 
and low vision do not have consistent meanings in the literature. Different 
definitions are used by various authors. The terms VI and low vision will now be 
defined and then when a paper is cited which uses different terminology, this is 
noted in the thesis.  
The World Health Organisation (WHO) (2007) refers to VI as poor vision resulting 
from any cause including uncorrected refractive error. The term low vision is used 
to describe visual impairment for which full remediation is not possible by 
conventional spectacles, contact lenses or medical intervention.  The terms VI and 
low vision can be quantified. The WHO definition of visual impairment includes low 
vision and also blindness: blindness is defined as visual acuity of less than 3/60 or 
a corresponding visual field loss to less than 10 degrees in the better eye with best 
possible correction (ICD-10:54 visual impairment categories 3,4,5); low vision is 
defined as visual acuity of less than 6/18 but equal to or better than 3/60, or a 
corresponding visual field loss of 20 degrees in the better eye with best possible 
correction (ICD-10 categories 1 and 2). 
2.2 Objectives and methodology of review 
The key objectives are summarised in terms of research questions inTable 2.2. 
Table 2.2 also summarises the search methodology. The search was last updated 
on 03/02/2009. 
Table 2.2 Objectives (key questions) and methodology of review 
Question Rationale/detail Initial search & keywords 
PRIMARY QUESTION 
Is vision 
screening 
effective at 
detecting 
correctable low 
vision in older 
people? 
Correctable is taken to mean 
refractive errors and cataracts. 
 
 
PubMed, Visugate, Lighthouse 
International, Low Vision: The 
Reference and Health information 
for London online for: (vision 
screening AND aged OR aged, 65 
and over). 
SECONDARY QUESTIONS 
Which tests 
should be 
included in vision 
screening of 
Self reported measures are not 
an adequate method of 
screening for visual problems. 
Can the effectiveness of 
PubMed, Visugate, Lighthouse 
International, Low Vision: The 
Reference and Health information 
for London online for: (Vision 
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older people screening be improved by using 
tests of visual function and if so 
which tests? 
screening tests) and “older 
population). 
Which venues 
are appropriate 
for vision 
screening of 
older people 
This secondary question aimed 
to compare the feasibility of 
using different venues for vision 
screening in older people 
Publications identified from the 
above searches were inspected for 
details of venues. Also, PubMed, 
Visugate, Lighthouse International, 
Low Vision: The Reference and 
Health information for London 
online were searched for: (Vision 
screening and community setting) 
2.2.1 Selection criteria 
This review is confined to publications in English. After applying the search criteria, 
publications that are obviously inappropriate to the review were excluded by 
viewing the abstract. For the remaining publications, the full manuscript was 
studied and other relevant publications were identified from the bibliographies. This 
review chapter concentrates on papers in refereed journals, but any relevant 
manuscripts that were discovered from other sources have also been included. 
For the primary question a literature search was carried out to identify research on 
the effectiveness of vision screening for detecting reduced vision in older people. 
The search was carried out in February 2009 from the databases listed in Table 
2.2 using the terms: vision screening AND (aged OR aged, 65 and over). This 
revealed 318 papers. Titles and abstracts were inspected to reveal those obviously 
irrelevant (e.g., amiodarone and optic neuropathy). Of the remaining, 43 were 
found which described or proposed methods of screening vision in older people 
and these were studied in more detail. Further appropriate references were 
identified from the bibliographies of these papers and from an earlier review (Evans 
& Rowlands, 2004m). Only  8 papers were identified which investigated 
experimentally methods of screening vision in older people in the UK (Evans et al., 
2002;Evans et al., 2004b;Jack et al., 1995;Reidy et al., 1998f;Scott et al., 
2002;Smeeth et al., 2003a;Squirrell et al., 2005a;Squirrell et al., 2005d;van der 
Pols et al., 2000c;Wormald et al., 1992). 
The purpose of vision screening is to detect remedial visual problems. The 
effectiveness of a screening test is normally described in terms of its sensitivity and 
specificity relative to a “gold standard”. In practice, this involves comparing the 
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outcome of the vision screening test(s) with a comprehensive eye examination. 
This “gold standard” should be ideally carried out on all participants that had the 
screening tests (Haynes et al., 2006). The gold standard should be conducted on 
participants that test positive on the screening test and those that test negative to 
avoid verification bias (Haynes et al., 2006). The only study that was found which 
has closely followed this approach is that of Squirrell et al (2005). This study used 
several tests to identify common easily corrected visual problems in the older 
population including the presence of cataract and uncorrected refractive error. 
Although other studies have assessed sensitivity and specificity of screening tests 
for identifying individual visual conditions, they do not meet the primary objective of 
this review which relates to correctable low vision (from refractive error or 
cataracts).  
For the secondary questions, “which tests should be included in vision screening of 
older people?” and “which venues are most appropriate for vision screening of 
older people?” an initial literature search (using [vision screening and older 
population] AND [setting OR primary care OR test methods]) revealed publications, 
several of which were expert opinion or anecdotal comments. The additional term 
“control” was added to refine this search by concentrating on case-control studies 
or cohort or cross-sectional studies, which controlled for confounding variables. 
The literature suggests that quite basic tests will be able to detect uncorrected 
refractive errors and cataract. The review has focused on these two conditions 
because a) they have a relatively high prevalence, (b) they are remediable, and (c) 
their treatment is of direct and immediate benefit to the public through correcting VI 
and improving quality of life (Koole et al., 2001a). Vision screening systems 
inevitably include a test of visual acuity, which will also detect other forms of VI 
including age-related macular degeneration. Although this is not readily correctable 
in most cases, it is helpful to detect cases so that they can be referred when 
appropriate for ophthalmological investigation and for further support and low 
vision aids. Although visual acuity testing will detect cases of significant macular 
disease, the diagnosis of age-related macular degeneration can only be made 
following ophthalmoscopic evaluation, preferably through dilated pupils. Other tests 
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of macular function (e.g., Amsler grid, photostress test) may also be helpful in 
making the diagnosis. Fluorescein angiography is a powerful diagnostic tool but is 
impractical in screening studies because, amongst other reasons, of the risk of 
complications. 
Glaucoma is also relatively common in the older population but this poses a 
significant challenge for community-based vision screening programmes. Although 
visual loss from glaucoma is irreversible, early detection and treatment has been 
shown to slow progression of the associated visual loss. It is difficult to screen for 
glaucoma, since all three commonly used glaucoma tests have a low sensitivity 
and/or specificity in isolation (Ivers et al., 2001e) and using all three tests (Tuck & 
Crick, 1997a) in screening by non-healthcare professionals is impractical. This 
issue is considered further below. 
2.3 Results of literature review 
Most research in this field has not set out to specifically answer one of the 
objectives of the present review Table 2.2, but nonetheless produces results that 
are pertinent to these objectives. The research will be considered in this section 
under two headings: studies that meet the selection criteria and relevant studies 
that do not meet the selection criteria. Within each of these sections, studies will be 
described in chronological order. The objectives of the review are each addressed 
under specific subheadings in the Discussion. 
2.3.1 Research meeting selection criteria 
Squirrell and colleagues targeted a selected group of patients who were recruited 
from an orthopaedic rehabilitation ward recuperating from hip fractures after a fall 
(Squirrell et al., 2005b). The study aimed to test the validity of a simple screening 
programme to identify patients with visual impairment. A nurse and ophthalmologist 
independently screened 89 patients aged 75 years and older. The screening 
included high contrast VA using a 3m chart, pinhole, confrontation and assessment 
of red reflex with a direct ophthalmoscope (an attempt to detect cataract). The 
“gold standard” included “full ocular examination using slit lamp biomicroscopy”. 
However, the eye examination appeared to lack an assessment of refractive error, 
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ocular motor tests, cataract grading, and visual fields. The screening proved to be 
reliable, with a high sensitivity (94%) and specificity (92%) for detecting VI. The 
screening had a sensitivity of 70% and a specificity of 92% for identifying patients 
with potentially remediable VI. The difference in sensitivity for the detection of VI 
and potentially remedial VI was due to the inadequacy of the test to identify early 
cataracts. The nurse screener identified 28 of the 40 patients with potentially 
remediable VI.  
The above study represents a relatively small sample of older patients all of whom 
achieved a good mental test score and as such it is difficult to generalise the 
results to the wider population of older people. The participants in this study were 
all patients who had sustained a fracture after a fall and only those patients with 
medical or social needs that necessitated a period of rehabilitation after surgery 
were recruited. Those patients who did not require rehabilitation were not included 
as they were often discharged before assessments could be undertaken. 
This study by Squirrell indicates that there is a strong argument for performing 
visual assessment in all patients after hip fracture as part of a strategy to prevent 
further falls, regain independence and improve the patients’ overall well being. 
However, it would be preferable to detect VI and provide appropriate intervention 
before a fall occurs.  
The literature review revealed several papers that, although not meeting the 
selection criteria, nonetheless included information that is relevant to the present 
review. These papers are now briefly summarised under the headings of: 
prevalence studies, screening studies involving older people but not meeting the 
age criteria, and other studies.  
2.3.2 Prevalence Studies 
These studies are summarised in Table 2.3. Wormald and colleagues (1992) 
examined 207 participants sampled at random from the database of people aged 
65 years and over at an inner London health centre. Binocular Snellen acuity was 
assessed with any habitual correction and central visual fields were also tested. 
The prevalence of blindness was 1% by the WHO criteria and 3.9% by the 
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American criteria. The prevalence of low vision (WHO criteria; worse than 6/18) 
was 7.7%. The prevalence of VI (American criteria; worse than 6/12) was 10.6%. 
Cataract accounted for 75% of cases of low vision and it was argued that 27% of 
participants would probably have benefited from refraction. This latter conclusion is 
based on testing with a pinhole, and the limitations of this are discussed later in the 
chapter. The study found that only half the patients with low vision were known by 
their GP to have an eye problem.  
Wormald’s study concludes that a significant proportion of VI in older people can 
be attributed to causes such as refractive error and cataract. These causes of 
visual impairment are not only remediable but easily detectable by screening tests 
that are simple, quick and well suited to use in primary care, for example those 
implemented by Squirrell and colleagues (Squirrell et al., 2005c). When reduced 
vision is detected, the first step should be referral to an optometrist (Wormald et al., 
1992) but it is suggested that the costs associated with the eye examination may 
act as a disincentive for the older population. In April 1999 the UK government 
reinstated state funding for primary care sight tests for people aged 60 or over. In 
most community optical practices, this has eliminated the cost of a basic sight test. 
However, the cost of supplementary tests and of spectacles may still discourage 
older people from having an eye examination as discussed in the previous chapter. 
Another prevalence study by Jack et al (1995) investigated 200 consecutive 
patients aged 65 years and over with acute medical illness at the Royal Liverpool 
University Hospital. Using distance Snellen acuities with any distance glasses that 
were usually worn, 50.5% were found to have impaired vision (binocular acuity 
6/18 or worse). This figure rose to 66% for those over the age of 85 years. The 
patients with impaired vision were given a full eye examination. Of the 101 patients 
with impaired vision, 79% could be corrected or cured and there was a higher 
prevalence of low vision than in community studies. In the group with refractive 
errors, 59.5% had not visited an optometrist in the past three years. The 
prevalence of uncorrected refractive errors contributing to the impaired vision was 
40%. These authors found a particularly high prevalence (76%) of VI in people who 
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were admitted with falls. The study concluded that VI may be compounding or 
causing falls. 
Jack et al’s study included hospital in-patients only and therefore, like Squirrell et 
al’s study, represented a selected population of frail older patients. Severe 
cognitively impaired patients were excluded to ensure accuracy in the vision 
screening methods. For these reasons it is difficult to generalise the results to the 
wider population. 
It was recommended by Jack and colleagues that screening of the older population 
may be beneficial to the patient and cost effective as in many cases the VI was 
remediable. The authors recognise that this may not be feasible due to resource 
limitations. Therefore it was suggested that selected groups be targeted such as 
fallers or those aged 80 and over. 
A detailed study of the prevalence of VI in North London was carried out by Reidy 
et al. (1998). These authors sampled patients aged 65 or older registered with 
general medical practices, and obtained data from 84% of those contacted. Reidy 
et al. assessed the effect of refractive errors using a pinhole and with an 
autorefractor, but it is not clear how they used these data to determine which cases 
of VI were remediable by spectacles. In the study population of 1,547, the 
prevalence of bilateral VI (visual acuity <6/12) was 30%, of which 72% was 
potentially remediable (by spectacles or surgery). In other words, the unmet need 
in this population-based study was 22% of the population aged 65 or over. Overall, 
88% of those with VI or glaucoma were not in touch with eye care services. Three 
quarters of the people with confirmed glaucoma were not known to the eye care 
services.  The study conducted by Evans et al. (2002) described below, found 
reduced visual acuity (VA<6/12) in 20% of the sample, less than the 30% found by 
Reidy et al. This could be because Reidy et al. concentrated on the North London 
area which may not be representative of the wider UK population.  
The reasons for this high level of remediable low vision are under-researched, but 
Reidy and colleagues noted that most of this morbidity was not known to the eye 
services. They suggested several factors that could be responsible for the high 
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level of undetected and untreated morbidity in the population. These include 
amongst others: inadequate levels of attendance at community optometrists, failure 
to purchase corrective spectacles and suboptimal integration of vision checks into 
the general primary care of older people. Furthermore, some older people may 
accept reduced vision as an inevitable effect of ageing. 
Van der Pols et al. (2000) measured visual acuity at 3m with and without a pinhole 
in 1,362 randomly selected people aged 65 and over who were not mentally 
impaired. A nurse that visited participants at their home measured visual acuity and 
a brief questionnaire relating to ocular health was also administered. It was found 
that the prevalence of VI increased significantly with age and was more common in 
participants living in nursing homes.  Vision improved 0.2 log units or more 
(typically, 2 Snellen lines) with a pinhole in 21% of participants.  
The study concluded that a substantial proportion of the older population have poor 
distance acuity. It was suggested that undetected refractive errors are probably an 
important cause of visual problems among the elderly in Britain. Van der Pols 
acknowledges that further study of the measurement of vision and the role of visual 
function in the well being of mentally impaired elderly will be needed (van der Pols 
et al., 2000b). 
In a large scale MRC study, Evans et al. (2002) investigated the prevalence of VI in 
people aged 75 years and older in Britain. Acuities were measured with Glasgow 
acuity cards with subjects wearing their usual spectacles. The sample was 
obtained from 53 practices in the MRC general practice framework. Of the 21,241 
people who were invited to participate, visual acuity measurements were available 
for 14,600 (69%). Of these, 12% had a binocular visual acuity worse than 6/18 
(WHO criterion), of whom 10% had a binocular visual acuity between 6/18 and 
3/60 (low vision) and 2% worse than 3/60 (blind). Even when age was controlled 
for, women had poorer acuity than men. Overall, 19.9% of study participants had a 
binocular VA worse than 6/12 (the American definition of VI). The risk of VI 
increased markedly with age: for example, at ages 75-79 years, 5.6% had low 
vision compared with 30.0% for those over 90 years of age. Using mid-2001 
population estimates for the United Kingdom, the authors estimated that 
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approximately 506,000 people are living in the community with low vision in the 
UK. Evans et al (2002) noted that their estimates of the prevalence of VI in older 
people are likely to be conservative. In particular, they did not measure visual fields 
and excluded patients in nursing homes. Taylor et al. (1997) found that three times 
more people have VI because of visual field loss than visual acuity loss and Klein 
et al. (1991) showed that people who are resident in nursing homes are 3.3 times 
more likely to have VI than those living independently. Recent prevalence figures 
for sight loss in the UK have been derived from an as yet unpublished review by 
Fletcher et al (2006) available from the RNIB website. The figures for this recent 
estimate are given at the end of this section. 
A supplementary study to the MRC trial investigated the causes of vision loss in a 
large sample of visually impaired people aged 75 years and older drawn from 49 
general practices selected to be representative of the population of Britain (Evans 
et al., 2004a). For all patients, data regarding the cause of visual loss were 
extracted from medical notes. Additional follow up questionnaires were also sent to 
the hospital ophthalmologist to confirm the cause of visual loss. Based on a 
definition of VI of binocular acuity worse than 6/18, 12.5% of the sample was 
visually impaired. Measuring VA with and without a pinhole suggested that 
refractive error was likely to be the principal reason for vision loss in 26% of the 
visually impaired participants.  Macular degeneration was also an  important cause 
of visual loss in people aged 75 years and older affecting 52.9% of people as a 
main or contributory cause of their VI. This was followed by cataract (35.9%) and 
glaucoma (11.6%). 
One limitation of the Evans et al. data is that the study population was selected 
through GPs practices. There may be a subpopulation of older people with visual 
disability who are not active participants in health care services and who have 
accepted low vision as an inevitable consequence of ageing and thus not sought 
optometric or ophthalmic services. However, detecting low vision in a sub-
population who might avoid healthcare services would clearly be extremely difficult. 
In addition, some may be deterred from seeking health care because of social or 
ethnic factors.  
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Evans et al. concluded that a substantial proportion of VI in the older population is 
caused by refractive error and cataract - conditions that have safe and effective 
interventions. With regard to AMD, advances are continuing in developing effective 
interventions. In cases for which treatment is not appropriate low vision services 
are important (Reeves et al., 2004a). 
Table 2.3  Summary of prevalence studies. VA, visual acuity; LVA, low contrast visual acuity; HCVA, 
high contrast visual acuity; WHO, World Health Organisation; ARMD, Age Related Macular 
Degeneration; POAG, Primary Open Angle Glaucoma 
Authors Study design Outcome Comment 
Wormald et al. 
1992 
Cross sectional random 
sample survey involving 
207 people aged 65 
and over. VA was 
measured to classify 
the prevalence of 
blindness, visual 
impairment and low 
vision. 
The prevalence of low vision 
was 7.7%. Cataract 
accounted for 75% of cases 
of low vision and 27% of 
those with VI may have 
benefited from refraction. 
The prevalence of blindness 
was 1% (WHO, criteria) and 
3.9% by American criteria. 
The prevalence of visual 
impairment was 10.6%. 
The study suggests that there is 
considerable amount of 
undetected ocular disease and 
potentially remedial disability in 
the community. Only half the 
visually disabled subjects were 
known to their doctor. The only 
measure of visual function was 
VA and the only assessment of 
refractive error was based on 
the pinhole test  
Jack et al, 1995 Prospective study 
involving 200 patients 
over the age of 64 at 
the department of 
Geriatric medicine at 
Liverpool Hospital. 
Visual impairment was 
assessed binocularly 
with a Snellen chart.  
101 patients (50.5%) were 
found to have visual 
impairment ( binocular 
VA<6/18). The figure rose to 
66%   for those over the age 
of 85 years. 79% had a 
reversible cause including 
uncorrected refractive error 
(40%) and cataracts (37%). 
 
The study involved hospital in-
patients and therefore 
represented a selected 
population.  
The only measure of visual 
function was VA. 
 
Reidy et al. 1998 Cross sectional study of 
a random sample of 
1547 people aged over 
64. The sample of 
people was drawn from 
a defined population of 
older people registered 
from 17 general 
practice groups. 
VA was measured and there 
was a detailed 
ophthalmological 
assessment. Participants 
were classified into 4 groups: 
cataract, ARMD, POAG, and 
refractive error causing 
visual impairment. 
The population prevalence of 
bilateral visual impairment 
(VA<6/12) was 30%, of 
which 72% was potentially 
remedial. The prevalence of 
cataract was 30% and 88% 
of these were not in touch 
with eye care services.  
The study concluded that 
untreated visual impairment and 
eye disorders affect a 
substantial proportion of people 
aged 65 years and older.  
The ability of visual acuity to 
predict eye disease was not 
calculated, although visual 
acuity was used as part of the 
definition of several eye 
diseases.                                       
Van der pols 
2000 
1362 participants aged 
65 and over, living in 80 
different randomly 
VI (WHO criteria) was 
detected in 14.3% of 
subjects and it was found 
The study shows that poor 
distance VA exists in a 
substantial part of the older 
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selected postcode 
areas of mainland 
Britain, were visited at 
their home by a nurse 
who measured VA. In 
addition a brief 
questionnaire related to 
ocular health was 
administered. 
that the prevalence of VI 
increased significantly with 
age. 11.5% had been 
informed that they had a 
cataract. In 21.2% of 
participants, vision improved 
by at least one Snellen line 
with the aid of a pinhole. 
community. Undetected 
refractive errors are probably an 
important cause of visual 
problems in British older people. 
The only measure of visual 
function was VA and the only 
assessment of refractive error 
was based on the pinhole test.   
Evans et al. 
2002 
The aim of this study 
was to measure the 
prevalence of visual 
impairment in a large 
representative sample 
of older people. The 
study involved 14600 
participants aged > 74y 
from 53 general 
practices.  
Participants were classified 
as having low vision 
(binocular acuity of <6/18-
3/60), visual impairment 
(binocular acuity of <6/18) or 
were classified blind (<3/60) 
The results indicate that 
visual impairment is common 
in the older population and 
that this risk increases 
rapidly with age, especially 
for women.                               
The only measure of visual 
function was VA and the only 
assessment of refractive error 
was based on the pinhole test. 
Only 62% of people with visual 
acuity less than 6/18 in either 
eye could complete a pinhole 
test satisfactorily.                                         
Evans 2004 Tested VA in patients 
aged >74y in 53 
general practices. For 
visually impaired people 
in 49 of the 53 practices 
(1742 patients) data 
regarding the cause of 
visual impairment were 
extracted from medical 
notes.  
It was found that the 
principal reason for visual 
loss was uncorrected 
refractive error. This was 
detected by an improvement 
in VA with a pinhole 
occluder. This was followed 
by age related macular 
degeneration, cataract, 
glaucoma and diabetes.  
There is considerable 
potential for visual 
rehabilitation in this age 
group as many conditions 
causing VI can be attributed 
to remediable causes. 
The size of the study improves 
the precision of the results. 
However a limitation of the study 
was that the assessment of the 
cause of visual loss relied upon 
abstraction of correspondence 
between the hospital eye 
service and the general 
practitioner.  
The only measure of visual 
function was VA and the only 
assessment of refractive error 
was based on the pinhole test 
Table 2.5.                                               
 
The data on prevalence have recently been reviewed by (Reeves et al., 
2004b;Tate et al., 2006). These figures have been used by RNIB to produce 
estimates of the number of people in the UK with sight problems  (RNIB, 2006). 
This concluded that in the UK there are approximately 1.7 million people aged 65 
or over with visual acuity worse than 6/12 and 0.7 million with visual acuity worse 
than 6/18.  Furthermore, there are approximately 0.5 million people aged 75 and 
over with acuity of worse than 6/12 and approximately a quarter of a million with 
acuity of worse than 6/18.  
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2.3.3 Screening studies not meeting age criteria 
These studies are summarised in Table 2.4.  
A door-to-door survey was carried out in Australia to identify non-institutionalised 
residents aged 40 or over, who were invited to attend a clinic for an eye 
examination (Taylor et al., 1997). Of those eligible, 83% (3,271) participated and 
the eye examination included refraction and visual field testing. Refraction 
improved the best eye’s acuity by at least one Snellen line in 60% of people. It 
should be noted that one line is not a very demanding criterion, and is close to the 
test-retest confidence intervals for some individuals (Lovie-Kitchin & Brown, 2000). 
Taylor and colleagues concluded that “it is quite extraordinary that the number of 
people with VI could be halved simply by the provision of new spectacle 
correction”, despite primary eyecare in Australia being covered by a national health 
insurance system (Taylor et al., 1997). This study is likely to have under-estimated 
the prevalence of VI, since people in nursing homes were excluded and these 
people are 3.3 times more likely to have VI than those not residing in a nursing 
home (Klein et al., 1991). Taylor and colleagues (1997) also highlighted the 
desirability of an assessment of visual fields. These authors found that nearly three 
times more people had VI because of visual field loss than visual acuity loss. In this 
study, VI was defined as best corrected visual acuity score of less than 6/18 or 
visual field constriction to within 20 degrees of fixation, or both. 
A study conducted by Woods and colleagues (1998) investigated whether contrast 
sensitivity and visual acuity had a role in primary care screening. This retrospective 
cross sectional study involved 3283 participants aged 50 years and older. 
Ophthalmic diagnosis was confirmed for 2522 of the participants. The aim was to 
investigate the ability of visual acuity and contrast sensitivity to detect any disease 
condition identified by ophthalmic diagnosis. The analysis of results showed that 
contrast sensitivity could better discriminate ophthalmic disease in an older 
population than Snellen visual acuity. Woods and colleagues did not actually detect 
eye disease but used the diagnosis by the subject’s ophthalmologist in the 
previous three years as a measure of eye disease. It was concluded that in a 
primary care setting, a person older than 50 years of age with reduced contrast 
Page 70 of 389 
 
sensitivity requires extra care in subsequent examinations because this person is 
likely to have an ophthalmic disease (Woods et al., 1998c). 
Another study conducted by Wang et al (1998) aimed to evaluate a questionnaire 
and a battery of tests for their performance in eye disease screening at a primary 
care clinic. The study involved 405 patients aged 40 years or older who were 
interviewed and received a comprehensive eye examination. The tests included 
VA, VF, tonometry, slit lamp biomicroscopy, dilated fundoscopy and fundus 
photography. Sensitivity and specificity for the identification of eye disease were 
calculated for each test and various combinations of tests, giving the following 
results: questionnaire, sensitivity 90%, specificity 44%; distance VA with presenting 
correction, sensitivity 61%, specificity 72%; dilated fundus examination, sensitivity 
79%, specificity 82%. In screening for glaucoma, tonometry gave a sensitivity of 
27% and a specificity 96%. Suprathreshold visual field testing gave a sensitivity of 
70% and a specificity of 67%. It was found that in screening for glaucoma a two-
stage strategy with the questionnaire then VA and ophthalmoscopy, gave a 
sensitivity of 83% and specificity of 76%. Wang and colleagues noted the 
importance of fundus examination in the detection of eye disease. However, for 
vision screening to be cost-effective, it should be able to be carried out by lay 
personnel, which precludes ophthalmoscopy. 
Lord and Dayhew (2001) investigated which screening tests are most predictive of 
falls in older people. This study involved 156 participants aged 63 to 90, which is 
only just outside the age range of the present review. They evaluated a range of 
vision tests (high and low contrast visual acuity, edge contrast sensitivity, depth 
perception, visual fields) and a range of general tests (measures of sensation, 
strength, reaction time, balance). Visual factors were associated with increased 
risk of falls, with the strongest risk factors being impaired depth perception, 
contrast sensitivity, and low-contrast visual acuity. 
Ivers and colleagues in 2001 conducted a cross-sectional study involving 3654 
participants aged 49 years and older. The study involved each of the participants 
having a comprehensive eye examination in order to compare the ability of each 
test to detect the presence of eye disease. Although best corrected distance visual 
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acuity or contrast sensitivity proved to be significantly better than other tests of 
visual function, Ivers et al. stated that neither they nor other potential screening 
tests have sufficiently good sensitivity or specificity to be widely used as screening 
tests for common eye disorders. The study concluded that a detailed eye 
examination was the gold standard at detecting eye disease and primary care 
workers suspicious of eye disease in the older population should recommend a full 
eye examination rather than attempting vision screening. 
Ivers and colleagues (2001) did not combine the results of various tests in an 
attempt to find a combination with both good sensitivity and specificity. They felt 
that a combination of tests would take away the ease and simplicity of screening 
for non-ophthalmic personnel administering the screening.  Ariyasu and colleagues 
(1996) found that combining tests did not result in a more accurate detection of 
ocular disease. Their study assessed four commonly available visual function tests 
to detect visually disabling or vision threatening eye conditions among new patients 
of a general ophthalmology clinic.  The sample size of 317 aged between 61 and 
27 were tested for contrast sensitivity, Amsler grid abnormalities and visual acuity 
for distance and near and they also had a complete eye examination. Of the four 
screening tests studied, distance and near threshold acuities were judged to have 
the best correlations of an abnormal result with ocular disease.  
A large study by Brabyn et al. (2001), which investigated 900 participants, listed as 
one of its goals the establishment of a practical test protocol for assessing vision in 
older people. Participants aged between 58-102 years at the first visit were 
screened using a battery of tests including high and low contrast acuity, disability 
glare, contrast sensitivity, colour vision, stereo-acuity, recovery from glare and 
attentional visual fields (Haegerstrom-Portnoy et al., 1999). The results indicate 
that high contrast acuity is reasonably well maintained on average, even into very 
old ages. Spatial vision measures under conditions of reduced contrast or 
luminance reveal significant impairment in a large proportion of older people. Many 
older individuals were found to have greatly reduced stereopsis, poor colour 
discrimination and restricted peripheral fields under conditions of divided attention. 
The results indicate that spatial vision of individuals cannot be well predicted from 
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acuity measurements alone (Brabyn et al., 2001d). This highlights the importance 
of incorporating additional vision tests, and particularly those that more closely 
resemble everyday viewing conditions.  
Foran et al (2002) described data from the Blue Mountains Eye Study, which 
initially evaluated 3,654 (a participation rate of 82%) non-institutionalised 
permanent residents aged 49 years or older. After five years another cross-section 
of the population was examined, comprising 3,509 persons, 2,335 of who were in 
the original cohort and 1,174 of whom had moved into the area and age group. The 
eye examination included distance visual acuity with the patients’ usual spectacles 
and testing with an auto-refractor. VI was defined as acuity worse than 6/12. 
Despite the relatively young age of the study population, in the initial cross-section 
7.5% of participants had correctable VI and 3.6% had non-correctable impairment. 
The corresponding rates in the second cross-section were 5.6% and 2.7%. 
Correctable VI was associated with poorer general health, living alone, and lower 
socio-economic status and/or increasing dependency. Uncorrected refractive 
errors accounted for over two thirds of cases of VI in both cohorts (Foran et al., 
2002a). This study is likely to have under-estimated the prevalence of VI, since 
people in nursing homes were excluded and these people are 3.3 times more likely 
to have VI than those not residing in a nursing home (Klein et al., 1991;Klein et al., 
1983a).  
Quigley and colleagues used a combination of tests including a risk factor 
questionnaire, visual acuity measurement and a screening visual field test 
administered by lay volunteers and technicians. This cross-sectional retrospective 
study involved 5352 participants with a median age of 45. The study entailed a 
screening examination and a definitive eye examination (Quigley et al., 2002d). 
The eye examination was offered if any of the following referral criteria were met: 
greater than 1 positive answer to risk factor questions, less than 20/30 distance 
acuity despite pinhole, less than 20/40 near acuity, more than 1 missed point on 
the Damato or FDT visual field test. From the 2000 participants who were offered 
eye examinations, 1331 scheduled an appointment and only 480 had the 
examination. In 53% of those examined the sole diagnosis was uncorrected 
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refractive error while cataract accounted for 15%. It was found that 72% of 
examinees needed new spectacles (Quigley et al., 2002c). 
Although the study by Quigley and colleagues outlined above proved that 
community screening for eye disease in an urban setting identifies many people 
with VI and eye disease, screening did not result in a significant proportion 
accessing eye care. Failure of patients screened to come for examination and loss 
to follow up were serious problems. There were a number of reasons found for this: 
defaulters predominantly blamed poor memory, failure to receive an appointment, 
confirmation letter, or personal scheduling conflicts as the reasons that they did not 
attend. However, among those who rescheduled visits after missing the first one, 
many still failed to attend the examination (Quigley et al., 2002b). It was suggested 
by Quigley and colleagues that perhaps fear of the medical care system or of the 
health care facility is deeper than originally thought. 
Table 2.4 Summary of screening studies involving older people but not meeting age criteria. VA, visual 
acuity; LVA, low contrast visual acuity; HCVA, high contrast visual acuity; CS, contrast sensitivity; VF, 
visual field; D, distance; N, near; IOP, intraocular pressure 
Authors Study design Outcome Comment 
(Taylor et 
al., 1997)  
Population-based 
screening of D & N VA & 
VF in 3,271 people aged 
40-98. 
Nearly three times more 
people had visual impairment 
because of VF loss than VA 
loss. 
It is desirable for visual 
screening to include VF testing. 
(Woods 
et al., 
1998a) 
A retrospective cross 
sectional study involving 
3283 participants aged 
>49 years. Snellen VA, 
CS and ophthalmic 
diagnosis were reported 
previously.  Ophthalmic 
diagnosis was confirmed 
for 2522 of the 
participants. 
The aim was to evaluate 
whether CS and VA had a role 
in primary care screening for 
ophthalmic disease. CS 
proved to be a more effective 
measure than VA in screening 
for ophthalmic disease.  
‘If those in need of ophthalmic 
care could be identified simply 
with a CS measure, for example 
in general medical practice or 
health clinics there may be long 
term savings.’ 
(Wang et 
al., 
1998b) 
Tested 405 patients aged 
>39y attending primary 
care clinic using a 
questionnaire and a 
battery of tests. 
The sensitivity and specificity 
for the identification of eye 
diseases were calculated for 
each test and various 
combinations of tests. HCVA 
had only a 61% sensitivity and 
72% specificity 
The authors conclude “More 
effective tests are needed to 
improve performance of eye 
disease screening”. 
(Lord & 
Dayhew, 
2001)  
Prospective cohort study 
to determine the tests 
most predictive of falls in 
156 people aged 63-90y.  
Multiple fallers had decreased 
vision as indicated by all tests, 
with impaired stereo-acuity, 
edge CS, & LCVA being the 
HCVA, the most common single 
visual screening test, did not 
feature in the main visual 
predictors of falls. 
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Assessed HCVA, LCVA , 
CS, VF, stereo-acuity. 
best predictors. Poor vision in 
one eye with good vision in the 
other had a similar risk to poor 
vision in both eyes. Stereopsis 
and edge CS found to be 
particularly important. 
(Ivers et 
al., 
2001b)  
Study of 3,654 people 
aged >48y. Assessed: 
VA, CS, VF, IOP, lens & 
retinal photos with 
grading. 
No single vision test predicted 
the presence of eye disease 
with any consistency. VA & 
CS were best, but still poor 
sensitivity & specificity.  
“Further work in this area should 
be carried out before vision 
screening programs can be 
recommended for 
implementation among older 
people”.  
(Brabyn 
et al., 
2001c)  
Longitudinal study of 
visual function in 900 
older people. Assessed 
HCVA ,LCVA at D & N 
with & without glare 
source, glare recovery, 
CS, dark adaptation, 
reading, VF, stereo. 
Wide range of decline in visual 
functions with age. Concerning 
the establishment of a 
practical test protocol for vision 
in the elderly: “spatial vision of 
individuals cannot be well 
predicted from acuity 
measurements alone”. 
Advocate testing vision under 
real-world situations (e.g., 
glare, low contrast). 
Many older individuals were 
found to have greatly reduced 
stereopsis, poor colour 
discrimination and restricted 
peripheral fields under 
conditions of divided attention. 
The results indicate that spatial 
vision of individuals cannot be 
well predicted from acuity 
measurements alone. 
(Quigley 
et al., 
2002a) 
Cross sectional 
retrospective study 
involving 5352 
participants with a 
median age of 45 years 
who presented at multiple 
community sites.  
The screening examination 
had a questionnaire, VA 
measurement and a screening 
field test. Participants also 
received a full eye 
examination. Among 1331 
who scheduled an eye 
examination, only 41% 
completed the visit.  
After community screening for 
eye disease, efforts to provide 
ophthalmic examination were 
only modestly effective. Failure 
of patients screened to come for 
examination and loss to follow 
up were serious problems.  
(Foran et 
al., 
2002b) 
Study of two cross 
sections of a community, 
6 years apart. The Blue 
Mountains Eye Study 
examined 3654 persons 
aged 47-97 during 1992-
1994 and 3509 (2335 
cohort survivors plus 
1174 new recruits) during 
1997-2000.   
VA was measured before and 
after refraction. 
In both cross sections, similar 
proportions of those visually 
impaired had correctable 
visual impairment (68%). 
Persons with correctable 
visual impairment were older 
than those with no impairment 
or non-correctable impairment. 
Correctable visual impairment 
accounted for two thirds of all 
cases of visual impairment in 2 
cross sections of an older 
community. It was further 
suggested that practitioners 
conducting aged care services 
should also screen VA and 
actively refer those found 
impaired. 
 
2.3.4 Other studies 
Smeeth and colleagues conducted a cluster randomised trial involving 4,340 
home-dwelling people aged 75 years or over randomly selected from the lists of 20 
general practices. The screening programme involved a questionnaire and 
distance visual acuity. Vision screening was carried out either (a) universally or (b) 
only in patients with health problems. At an interval of 3-5 years after screening, 
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the risk of VA<6/18 in either eye was not significantly different in the two groups. 
As such, the study concluded that although some people benefited from screening, 
the number was small in the context of a population-based screening programme 
(Smeeth et al., 2003f). 
The above study by Smeeth and colleagues revealed 29% of participants to have 
presenting distance acuity of worse than 6/18 in either eye. Of these, 17% had 
pinhole corrected acuity of better than 6/18, suggesting that the reduced 
vision could be at least partly attributed to refractive error. However, the authors 
note the proportion attributable to refractive error will have been under-estimated 
because many people did not complete a pinhole assessment, reporting that it was 
difficult to use (Smeeth et al., 2003b).  Table 2.5 summarises the limitations of the 
pinhole test. These factors may explain why some studies such as that conducted 
by Smeeth et al. have reported difficulties in using the pinhole test in older people.  
Table 2.5 Limitations of the pinhole test 
Limitation  Reference 
Prone to errors from imprecise positioning (Rabbetts, 2000) 
Prone to errors from non-uniform cataracts (Rabbetts, 2000) 
The pinhole test produces extremely variable 
results, underestimating and overestimating 
post refraction acuity. 
 (Eagan et al., 1999) 
Prone to errors from luminance effects. (Eagan et al., 1999) 
“the pinhole test result should not be used as a 
dichotomizer for clinical decisions regarding the 
need for a refraction” 
(Eagan et al., 1999) 
 
The only measure of visual function that Smeeth and colleagues included was VA. 
There was a long interval between screening and assessment of outcome (median 
3.9 years), so visual status will have changed in many cases. Just over one third of 
participants died by the time of assessment. 
2.4 Discussion 
In this section, the extent to which previous reviews have addressed the objectives 
outlined in Table 2.2 will be discussed. Then the various venues in which vision 
Page 76 of 389 
 
screening can be implemented together with the best tests that can be used in 
vision screening will be discussed. Finally, the effectiveness of detecting 
correctable low vision in people aged 65 and older, will be addressed. 
2.4.1. Previous reviews 
Smeeth and Iliffe reported a systematic review of evidence from randomised 
controlled trials on the effectiveness of screening older people for impaired vision 
in community settings (Smeeth & Iliffe, 1998). An updated version of this review 
was published in 2000 and a further update was published in 2006, both as 
Cochrane reviews, which will now be summarised. The outcome measure of this 
review was the level of VI in the population at the end of the trial, at least six 
months after screening (Smeeth & Iliffe, 2006;Smeeth & Iliffe, 2000). Only five such 
trials were found, and surprisingly in all five trials the “vision screening” was simply 
questions about vision and the outcome was assessed by an interview or postal 
questionnaire. A similar proportion of participants in the screened and non-
screened groups reported visual problems at follow-up, so the reviewers concluded 
that there is no evidence that community-based screening of asymptomatic older 
people results in a change in the prevalence of VI. The reviewers note several 
possible explanations for the lack of effectiveness: the visual assessment was just 
one component of multi-phasic screening; failure to access effective interventions; 
participants may not have perceived a need for intervention; and questions about 
vision have been shown to have a poor sensitivity for detecting VI. None of the 
trials used any clinical assessment of visual function, so it is likely that the last 
factor regarding the poor sensitivity of questions for detecting VI is the most 
significant in the possible explanations for the lack of effectiveness of screening.  
Smeeth conducted a systematic review of evidence from randomised controlled 
trials to assess the likely effectiveness of screening older people for impaired vision 
in primary care (Smeeth, 1998). It is noted that in a primary care setting, screening 
tests need to be quick, inexpensive, available and able to be carried out easily by 
different members of the primary health care team. However, the assessment of 
visual function is hampered by the lack of a ‘gold standard’, and literature in this 
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area is far from comprehensive (Smeeth, 1998). Also, no firm recommendations 
can be made about what level of reduced vision should prompt further action.  
The review by Smeeth (1998)  indicated that little is known about the needs of 
older people who have not previously reported a visual problem but are found to 
have VI on screening. Furthermore it is unclear whether older people accept 
interventions for visual problems discovered by screening. Fear of costs may 
prevent some older people from accepting a recommendation to attend an 
optometrist for an eye examination. It is recognised that interventions are effective 
for symptomatic patients (e.g. cataract surgery and correction of refractive errors) 
but the effects of treating older people with unreported visual problems have not 
been evaluated. The review concluded that visual screening is of unproven value, 
but that the care of older people with symptomatic eye problems could be markedly 
improved through improving education of eye care in general practice and 
improving eye services to meet demand 
A review by Abdelhafiz and Austin (2003) explored visual factors associated with 
falls. Whilst some studies identified VI as one of the predictors of falls in older 
people (Tromp et al., 2001; Oliver et al. 1997), others have found that poor visual 
acuity is not related to falling (Campbell et al. 1989, Lord et al. 1991). These 
studies used standard tests of visual acuity to measure VI. However, the review 
suggests that investigation of VI should not be limited to visual acuity but should 
also include contrast sensitivity and depth perception. The review included 
evidence that correcting VI results in improved mobility, orientation and avoidance 
of falls. Simple intervention strategies (e.g., change of glasses or cataract 
extraction) may have the potential of improving visual function and preventing falls 
in older people. Improving vision will not only help in preventing falls but is also 
likely to lead to improved physical and social function and improved health-related 
quality of life (Ivers et al., 2002). 
The literature on the risks and types of injuries associated with VI was reviewed by 
Legood and colleagues (2002). From the 30 studies reviewed, the majority 
assessed falls. The evidence from these studies suggests that those with reduced 
visual acuity are 1.7 times more likely to have a fall and 1.9 times more likely to 
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have multiple falls compared with “fully sighted” populations. The review stated that 
effective vision screening programmes are required but cautioned that any vision 
screening programme would require careful design with objective measures and 
appropriate treatment to be available. 
2.4.2 Venues for screening 
A general conclusion of this review is that more research is necessary to determine 
whether vision screening in older people is worthwhile. Researchers will need to 
determine appropriate venues for their research and the question of suitable 
venues for screening is therefore now discussed. 
Screening by general medical practitioners has the potential for reaching the vast 
majority of older people: 98.5% of patients aged 65 years and over who attended 
an Accident and Emergency Department were registered with a GP (Reinstein et 
al., 1993). Bulpitt  and colleagues reviewed the history of health screening in older 
people and concluded that screening by general practitioners may be worthwhile 
for VI (Bulpitt et al., 1990). Reinstein and colleagues felt that a pinhole test would 
be a useful procedure for GPs to carry out as part of their general health screen to 
detect correctable undetected visual acuity deficits. However, as noted above there 
are limitations to the usefulness of the pinhole test (Table 2.5). Evans et al. (2002), 
in a large-scale study, attempted to use a pinhole test to detect uncorrected 
refractive errors. They noted that the pinhole test was not easily used in their 
population. Indeed, only 62% of people with visual acuity less than 6/18 in either 
eye completed a pinhole test satisfactorily, and this aspect of the study could not 
be described as a success (Evans et al., 2002). Smeeth and colleagues also 
reported that many people with reduced acuity could not complete a pinhole 
assessment (Smeeth et al., 2003e). 
Smeeth noted that although attendance rates for the over-75 GP screening (that 
was mandatory at the time), was reported to be 48-63%, a total of 90% of people in 
the over-75 age group see their GP at least once a year, making high coverage 
rates feasible (Smeeth, 1998). On the other hand, doubts about the usefulness of 
screening for visual problems by GPs have been raised (Mangione et al., 
Page 79 of 389 
 
1992;Brabyn et al., 2001b;Brabyn et al., 2001a).  Where opportunistic screening of 
vision occurs, for example during a consultation with a GP, this typically consists of 
measuring high contrast distance visual acuity. Several studies reviewed above 
confirm that this is of limited use as an indicator of visual function in older people. 
Additionally, this approach to vision screening would not be likely to detect the 
visual problems that are most strongly associated with falls (Abdelhafiz & Austin, 
2003). 
Annual health checks for older people, including at least verbal questioning about 
visual health, have been part of general medical practitioners’ statutory 
requirements under the GP contract (The Department of Health, 1989). This was 
then superseded by a new contract making no mention of screening for health 
problems in older people, or of screening for visual problems in the wider 
population (The Department of Health, 2003c). More recent re-organisation in GP 
services, with its focus on quality of care for patients with chronic conditions, has 
shifted GP focus back towards screening for visual problems, at least for those 
patients with Diabetes Mellitus (The Department of Health, 2003a),  but there is still 
no incentive, training, or resources to screen patients, young or old, for visual 
problems not related to this disorder. However, the new GP contract has , 
introduced more flexible commissioning and provision of services to enable GPs to 
develop the services needed by the populations they serve (The Department of 
Health, 2003d), raising the possibility of the development of vision screening 
services. In addition the NHS is developing and piloting new eye care pathways, 
including pathways for low vision and age-related macular degeneration, focusing 
on delivery of eye services by optometrists (NHS eye care services, 2007). Given 
these opportunities it may be that screening for VI can be best offered by those 
primary care practitioners with specialist skills and equipment, namely 
optometrists, with funding flowing through new GP commissioning services (The 
Department of Health, 2003b). However, whatever solution is proposed should 
note the finding of Smeeth (1998), namely that fear of costs is consistently cited by 
a proportion of older people in studies looking at reasons for non-attendance at 
optometrists (Smeeth, 1998;Smeeth & Iliffe, 1998). 
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Research that is relevant to a consideration of the optimum venues for vision 
screening in older people is summarised in Table 2.6 together with comments on 
the advantages and disadvantages of potential venues. Comparative studies of 
which venues are likely to be most effective at detecting correctable visual 
problems have not been found. Further research is needed to compare the 
feasibility of using different venues for vision screening in older people. Suitability 
of potential venues will be linked to the screening method that is used and this is 
discussed in the next section. 
Table 2.6 Possible venues for Vision Screening 
Venue Advantages Disadvantages 
GP surgery  
 
(Brabyn et al., 
2001i;Bulpitt et al., 
1990;Mangione et al., 
1992;Reinstein et al., 
1993;Smeeth, 1998) 
 
 98.5% of people aged >64y 
attending A&E are registered 
with GPs  Only half of patients with low 
vision are known by GPs to have 
an eye problem  43% of people aged >64y 
attended their GP at least once a 
month, but 87% said their GP 
had never checked their eyes or 
vision  90% of people aged >75y see 
their GP at least once a year 
 There might be a small, but 
neglected, body of people who 
avoid healthcare services  Attendance rates for the over-75 
GP  health screening  was reported 
to be 48-63% 
Surgical & 
orthopaedic wards 
(Grisso et al., 1991) 
 In older people, over 90% of 
hip fractures are associated with 
falls and both are correlated with 
visual impairment(Grisso et al., 
1991) 
 It would be preferable to detect 
visual problems before people have 
falls  Most falls are not associated with 
fractures (Grisso et al., 1991) 
Accident & 
emergency (A&E) 
clinics  
(Reinstein et al., 
1993) 
 Helps to detect people whose 
vision might have caused an 
accident 
 It would be preferable to detect 
visual problems before people have 
falls  In one study of A&E patients, 
41% could not be screened 
because the department was too 
busy  Most medical & surgical 
problems are independent of vision  Not all falls occurring in the 
community present to A&E 
Out patient clinics 
(McMurdo & 
Baines, 1988) 
 Even patients in the care of 
several medical practitioners 
have high levels of treatable but 
severe visual disability 
 there might be a small, but 
neglected, body of people who 
avoid health services 
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Falls clinics   Conducting vision screening in 
“Falls clinics” would target the 
more vulnerable population. This 
may  prevent falls occurring due 
to undetected yet correctable low 
vision in the future. 
 there might be a small, but 
neglected, body of people who 
avoid healthcare services   It would be preferable to detect 
visual problems before people have 
falls 
Residential 
rehabilitation 
centres 
 Often, older people who have 
been hospitalised (e.g., after falls 
or strokes) stay in rehabilitation 
centres before returning home.  Staff at these centres can be 
less pressured for time than in 
hospital  
 There appears to be no previous 
research using these centres 
Community centres 
 
 An opportunity to test large 
groups of older people 
 People attending community 
centres might tend to be those with 
better vision  These people might tend to be 
the more confident, who may be 
likely to already use eye care 
services 
Nursing homes 
(Grisso et al., 
1991;Lord et al., 
1991)  
 People in nursing homes are 
more than three times more likely 
to have visual impairment than 
those living at home (Klein et al. 
1991). 
 
 Some nursing homes already 
receive domiciliary optometric 
services. 
Individual residencies  
(Sinclair et al., 2000) 
 Certain areas, for example with 
a concentration of people on low 
income, could be targeted 
 Logistically difficult and 
expensive 
 
 
2.4.3 Methods for screening: which tests might be appropriate? 
2.4.3.1 Self reported measures 
A questionnaire is probably the simplest method of screening for visual problems 
among the elderly. A systematic review evaluated five trials, all of which used self-
reported measures to assess impaired vision, both as the screening assessment 
and as the outcome measure (Smeeth & Iliffe, 1998). This review found a 
reduction, associated with screening, of only 11% in the number of older people 
with VI. The review states several factors that may have contributed to the lack of 
improvement seen in these trials which are discussed in the section on Previous 
Reviews. The most obvious limitation of self-reported measures is that a patient’s 
perception of their visual status may only weakly correlate with their actual visual 
function. This is particularly likely when the vision deteriorates slowly or only in one 
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eye and additionally older people with poor vision may feel that their visual function 
is ‘normal for age’, when in fact it could be improved. 
2.4.3.2 High Contrast Visual Acuity 
Most studies that have screened for visual problems in older people have solely 
relied on visual acuity testing (Long et al., 1991;Strahlman et al., 1990b). Some of 
these studies repeated the visual acuity testing with a pinhole, assuming that an 
improvement with a pinhole is indicative of reduced vision attributable to refractive 
errors (McCarty et al., 2002). However, this assumption is unsafe because the 
pinhole test is prone to the errors outlined in Table 2.5. Many studies evaluating 
visual acuity still use the standard Snellen chart (Evans & Rowlands, 2004i;Evans 
& Rowlands, 2004j), although others use improved designs such as Bailey-Lovie 
(Bailey & Lovie, 1976) and ETDRS charts (Klein et al., 1983b) and other designs 
(Johansen et al., 2003). Many authors have noted the limitations of visual acuity 
tests for screening vision in older people (see Table 2.5).  
It is understandable why many studies have used visual acuity to screen for visual 
problems because the WHO-ICD 10 definition of VI is based on high contrast 
visual acuity (World health organisation, 2006a). However, the world health 
organization does have an alternative definition that does take account of visual 
field (World health organisation, 2006b). As noted elsewhere in this thesis, there 
are a variety of visual problems affecting older people which impair vision in 
different ways.  
2.4.3.3 Low Contrast Visual Acuity 
The study by Brabyn and colleagues described above showed that spatial vision of 
individuals cannot be well predicted from acuity measurements alone (Brabyn et 
al., 2001j). This highlights the importance of incorporating additional vision tests, 
and particularly those that more closely resemble everyday viewing conditions. 
Figure 2.1 shows a wide range in decline among visual functions with age. It can 
be seen that high contrast acuity changes very little with age but despite 
maintained acuity, many older people are effectively visually impaired under 
conditions of everyday life (e.g., in situations of changing light levels).  Figure 2.1 
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below shows that measures of low contrast visual acuity and glare decrease more 
rapidly with age than measures of high contrast visual acuity. 
 
Figure 2.1 Visual Functions and Age. Illustrating the factor by which older individuals’ median values 
are worse than those of young normal values as a function of age. Reproduced with permission from: 
Brabyn J, Chneck M, Haegerstrom-Portnoy G, Lott L; The Smith-Kettlewell Institute (SKI) longitudinal 
study of vision function and its impact among the elderly: an overview; Optom Vis Sci.78(5):264-9; 
©The American Academy of Optometry, 2001.  
The importance of low contrast acuity was emphasised by Schneck and colleagues 
(2004). Their study revealed that tests of low contrast spatial vision are strong 
predictors of significant subsequent vision loss. It was found that 55% of those in 
the worst category of low contrast low luminance acuity at baseline subsequently 
had acuity loss, compared to none of those with good initial low contrast low 
luminance acuity. The results also showed that glare recovery time, stereopsis and 
sensitivity to flicker were not significant predictors of future acuity loss in the 
multivariate analysis. 
This raises the question of which other vision tests might be useful to identify 
significant and correctable visual problems in older people? Several authors have 
therefore attempted to determine a screening test battery that will detect visual 
problems, these are summarised in Table 2.7. Lord and Dayhew investigated 
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which screening tests are most predictive of falls in older people. They evaluated a 
range of visual tests (high and low contrast visual acuity, edge contrast sensitivity, 
depth perception, visual fields) and non-visual tests (measures of sensation, 
strength, reaction time, balance). Visual parameters were associated with 
increased risk of falls, with the strongest visual risk factors being impaired depth 
perception, contrast sensitivity, and low-contrast visual acuity (Lord & Dayhew, 
2001). 
2.4.3.4 Visual Field Testing 
The present review is primarily concerned with correctable visual problems, but 
clearly it is desirable to detect glaucoma since modern treatments often can arrest 
visual loss from this disease which is prevalent in older people (Weinreb & Khaw, 
2004b). The desirability of an assessment of visual field was highlighted by Taylor 
and colleagues who evaluated 3,271 residents (83% of those eligible) aged 40-98 
years. These authors found that nearly three times more people had VI because of 
visual field loss than visual acuity loss (Taylor et al., 1997).  Testing visual fields is 
difficult to administer in a screening situation and is dependent on the testing 
protocol that is adopted (Topouzis et al., 2004). 
Visual field testing on a modern automated instrument has been shown to be 
successfully administered with 81% of unselected people aged 65 years and over 
(Wormald et al., 1992). Taylor and colleagues also managed to carry out 
automated perimetry on 89% of those aged 40 years or over (Taylor et al., 1997). 
Oculo-kinetic perimetry is one possible test for screening for visual field defects in 
glaucoma (Greve & Chisholm, 1993). Recent developments have led to new rapid 
methods of screening visual fields. The best known of these is frequency-doubling 
perimetry, which compares well with conventional visual field testing for the 
detection of glaucoma (Allen et al., 2002b;Tatemichi et al., 2002b), but is less 
effective at detecting rarer visual field defects from neurological causes (Fong et 
al., 2003a). However, other relatively simple approaches have also shown promise 
(Schiefer et al., 1996).  
Recently, computerised methods of automated vision testing and reporting have 
been used with success in occupational vision screening (Thomson, 1994) and in 
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children's vision screening (Thomson & Evans, 1999;Thomson & Evans, 
2001;Thomson, 2002). A combination of tests could be included in a computerised 
program. This is discussed further in Chapter 3. Such a system might be an 
effective method of screening for visual problems in older people, for example, in 
GP surgeries and falls clinics. 
In summary, the literature allows some inferences to be drawn about which vision 
tests might potentially be most useful in vision screening of older people. Table 2.7 
summarises the tests that could be used for vision screening in the older 
population. These include: high contrast visual acuity, low contrast visual acuity, 
contrast sensitivity, visual fields, stereo-acuity. Other tests may also be useful (e.g., 
glare recovery, vertical heterophoria). Further work is needed to evaluate these 
tests to determine which combination of tests is most effective for vision screening 
and indeed to determine the effectiveness of this combination of tests. 
Table 2.7 Research systematically comparing methods of vision screening of older people. VA, visual 
acuity; CS, contrast sensitivity; VF, visual field; D, distance; N, near 
Authors Study design Outcome Comment 
(Davison, 
1985) 
Screened drivers 
using battery of tests
on Keystone 
Telebinocular to 
determine  
correlation with 
driving accidents. 
In those over the age of 55y and 
65y, hyperphoria >1prism Dioptre was 
significantly correlated with accidents. 
This is the only study 
suggesting that measuring  
hyperphoria would be a 
relevant test,  
Study only used Keystone 
Telebinocular. 
(Taylor et al., 
1997)  
Population-based 
screening of D&N 
VA & VF in 3,271 
people aged 40-98. 
Nearly three times more people  
had visual impairment because  
of VF loss than VA loss. 
Although measuring VA is 
important, it is also desirable for
visual screening to include VF 
testing. 
(Wang et al., 
1998) 
 
Tested 405  
patients aged >39y 
attending primary 
care clinic using: 
questionnaire, VA, 
VF, tonometry, slit 
lamp biomicroscopy,
dilated fundoscopy, 
fundus photograph. 
Questionnaire for detection of eye 
disease was sensitive (90%) but  
not specific (44%). D VA with 
presenting correction: sensitivity 61%, 
specificity 72%.  
Dilated fundus examination: sensitivity 
79%, specificity 82%.  
In screening for glaucoma,  
tonometry was ineffective (sensitivity 
27%, specificity 96%), suprathreshold 
visual field testing: sensitivity 70%, 
specificity 67%. Two-stage strategy with
the questionnaire then VA & 
ophthalmoscopy gave best sensitivity 
The study found that the  
desirable tests included a 
combination of  questionnaires,
VA measurements and 
ophthalmoscopy . This 
combination gave the best  
sensitivity and specificity. 
However for vision screening to
be cost-effective, it should be  
able to be carried out by lay 
personnel. This precludes 
ophthalmoscopy.  
The authors conclude “More 
effective tests are needed to 
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(83%) & specificity (76%).  improve performance of eye 
disease screening”. 
 
(Woods et al., 
1998) 
  
 
Compared ability of 
VA and CS to  
detect presence of 
ophthalmic disease 
in 2,522  randomly 
selected people 
aged >49y. 
 
Arden plate 7 (6.4cpd) correctly 
identified 96% of patients with disease 
and was better than  
Snellen VA at detecting disease.  
 
As in the above study, using 
one test alone proved not to be
sufficient and the results  
showed that a combination of 
 VA and CS was little better 
than CS alone.  
(Lord & 
Dayhew, 
2001) 
  
Prospective cohort 
study to determine 
the tests most 
predictive of falls in 
156 people aged 
63-90y.  Assessed 
high & low contrast 
VA, CS, VF, stereo-
acuity. 
Multiple fallers had decreased  
vision as indicated by all tests, with 
impaired stereo-acuity, edge CS, & low 
contrast VA being the best predictors. 
Poor vision in one eye with good vision 
in the other had a similar risk to poor 
vision in both eyes.  
High contrast VA, the most 
common single visual 
screening test, did not feature 
in the main visual predictors of 
falls. Stereopsis and edge CS 
found  
to be particularly important tests
when assessing visual risk  
factors for falls 
(Brabyn et al., 
2001) 
Longitudinal study  
of visual function in 
900 older people. 
Assessed high and 
low contrast VA at 
 D & N with &  
without glare  
source, glare 
recovery, CS, dark 
adaptation, reading, 
VF, stereo. 
Wide range of decline in visual  
functions with age. Concerning the 
establishment of a practical test 
protocol for vision in the elderly:  
“spatial vision of individuals cannot be 
well predicted from acuity 
measurements alone”. 
 Advocate testing vision under real-
world situations (e.g., glare, low 
contrast). 
Another study demonstrating  
that measures other than just 
 high contrast VA needs to be 
assessed. 
It was found that vision in the 
presence of glare; glare  
recovery time and attentional 
visual field size are the 
functions that decrease most 
rapidly with age. It would then 
be appropriate to use tests 
such as these when  
screening the older population 
(Ivers et al., 
2001) 
  
Study of 3,654 
people aged >48y. 
Assessed: VA, CS, 
VF, IOP, lens & 
retinal photos with 
grading. 
No single vision test predicted the 
presence of eye disease with any 
consistency. VA & CS were best, but 
still poor sensitivity & specificity. 
The study did not investigate 
combinations of tests. 
The study concluded that 
current vision tests are not 
good at detecting eye disease 
compared with a full eye 
examination. 
 “Further work in this area 
should be carried out before 
vision screening programs  
can be recommended for 
implementation among older 
people”. 
(Smeeth et al.
2003). 
Trial of 4,340  
people aged >74y 
sampled from  
20 GP practices.  
Screening by 
questionnaire & VA 
only. 
Vision screening was carried out  
either (a) universally or (b) only in 
patients with health problems. 3-5y  
after screening the risk of VA<6/18 in 
either eye was not significantly  
different in the two groups. 
The only measure of visual 
function was VA. The results 
suggest that screening solely 
by questions about vision &  
VA assessment is inadequate. 
(Rubin et al., 
2007) 
The role of vision 
and visual attention 
Glare sensitivity and binocular visual 
field loss were significant predictors of 
This study suggests that 
current vision screening for 
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factors in  
automobile 'crash' 
involvement was 
determined on 120 
older people aged 
between 65-84  
years.  
 
crash involvement. Acuity, contrast 
sensitivity and stereoacuity were not 
associated with crashes. 
drivers’ licenses based  
primarily on visual acuity may 
miss important aspects of 
visual impairment 
 
Vision screening may lead to a referral to an optometrist. The optometric eye 
examination would detect the many cases where visual acuity can be improved by 
refractive correction alone (Tielsch et al., 1990a;Taylor et al., 1997;Liou et al., 
1999;Foran et al., 2002c). Additionally, more than 40% of older eyes with ocular 
pathology have more than one type of pathology (Leibowitz et al., 1980) and the 
optometrist can diagnose the disease(s) and prioritise the referral when this is 
required. 
2.4.4 Does vision screening for older people meet the Wilson criteria? 
 The questions raised in Table 2.1 will now be discussed: 
2.4.4.1 Does the burden of suffering warrant screening? 
The systematic review of Evans and Rowlands established that low vision is 
relatively common among older people and that this has a significant effect on the 
quality of life of those affected and is associated with an increased risk of falls 
(Evans & Rowlands, 2004e). Identifying and treating VI is an important 
preventative intervention in the older population with a history of falls. Studies such 
as those conducted by Wolffsohn and Cochrane support the intuitive notion that 
clinical vision impairment measures are highly correlated with the capacity to 
perform activities associated with everyday life (Wolffsohn & Cochrane, 2000). 
Based on the available evidence, the burden of suffering due to undetected, 
remediable low vision among the elderly warrants further research.  
However, it is important to recognise the limitations of screening as outlined by the 
National Screening Committee (2007) in Chapter 1. They emphasise that whilst 
screening has the potential to save lives or improve quality of life through early 
diagnosis of serious conditions, it is not a foolproof process. Screening can reduce 
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the risk of developing a condition or its complications but it cannot offer a 
guarantee of protection. 
2.4.4.2 Is there a good screening test? 
The UK National Screening Committee states that the screening test should be 
simple, safe, precise and validated. The test should also be acceptable to the 
population and the distribution of test values in the target population should be 
known and a suitable cut off level defined (UK National Screening Committee, 
2003).  
Smeeth suggests that in a primary care setting a screening test needs to be quick, 
cheap, available and able to be carried out easily by different members of the 
primary health care team (Smeeth, 1998). Different methods of screening are 
discussed above. There is a definite need for more research to evaluate whether a 
vision screening tool comprising a battery of relevant tests can be developed with 
adequate sensitivity and specificity. If it cannot, then it would seem to be more 
appropriate to devote resources to increasing the number of older people having 
regular eye examinations with optometrists.   
2.4.4.3 Are efficacious treatments or preventative measures available? 
The UK National Screening Committee suggests that there should be an effective 
treatment or intervention for patients identified through early detection with 
evidence of early treatment leading to better outcomes than late treatment (UK 
National Screening Committee, 2003). The evidence reviewed suggests that many 
older people with low vision could be helped greatly by refractive correction or 
cataract surgery. Treatment for symptomatic cataracts is effective (NHS Centre for 
reviews and dissemination, 1996b), improving quality of life and physical and 
mental functioning (Javitt et al., 1993). Visual acuity can be improved for most 
patients with refractive defects (Tielsch et al., 1990b). Reidy and colleagues found 
that the prevalence of cataract causing VI was 30% and the prevalence of 
refractive error causing VI was 21% (Reidy et al., 1998e). The fact that these 
conditions are so easy to detect and correct makes it likely that this criterion is met 
on the basis of these conditions alone. 
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Quality of life and functioning are also improved by the treatment of a variety of 
other chronic eye disorders (Brenner et al., 1993). For example new treatments for 
age-related macular degeneration are now becoming available. Even cases that 
are not treatable will benefit from support and low vision aids. Registration as blind, 
and to a lesser extent registration as partially sighted, mobilizes social support 
(Bruce et al., 1991). 
2.4.4.4 Will those at risk attend for and accept screening outcomes? 
This issue is related to the choice of venue in which to conduct a screening 
programme. A good venue would ensure high coverage rates and should be easily 
accessible to the older population. The new integration of primary health care 
services can be used as an opportunity to develop more acceptable and patient-
centred eye care for older people, especially those not presently in contact with the 
NHS. Various venues for screening are discussed above. More research is needed 
in this area to investigate the most appropriate venues to conduct vision screening 
in the older population to ensure that those at risk attend for screening. Other 
factors that are likely to affect whether older people attend for screening include 
their perceived benefit from the screening, which will also influence whether they 
accept any recommendations that they are given on completion of the screening. 
These effects are poorly quantified, but good publicity for screening that stresses 
the high prevalence of correctable visual problems is likely to help. 
2.4.4.5 Do people with positive screening results accept interventions or advice? 
A study conducted by Quigley and colleagues found that from the 2000 participants 
who were offered eye examinations after being screened, 1331 scheduled an 
appointment and only 480 had the examination. It was suggested that fear of the 
medical care system or of the health care facility is deeper than originally thought 
(Quigley et al., 2002e). Smeeth suggests that fear of costs may prevent some older 
people from accepting a recommendation to attend an optometrist for sight testing 
and vouchers towards the cost of glasses for those on income support may cover 
only a fraction of the cost of glasses (Smeeth, 1998).  
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Mansberger and colleagues conducted a study involving community visual field 
screening with frequency doubling technology. Those with abnormal screening 
results were encouraged to have an eye examination and were followed up 3-6 
months later. The results indicated that although more than two thirds of patients 
with abnormal results did have an eye examination following the screening, the 
most common reason not to undergo an eye examination was failing to recognise 
the importance of an abnormal screening result (Mansberger et al., 2007). A paper 
by Charles and colleagues also identified barriers to the uptake of eye 
examinations by older people and these included : perceived lack of need for 
eyecare, caring for a spouse, attitudes to eye health, poor knowledge of the causes 
of sight loss and of the role of optometrists, affordability of spectacles and 
language barriers in people from ethnic minorities (Charles et al., 2005).  
Further investigation is required into patients' perspectives on the extent to which 
their own vision has gradually reduced, the point at which they feel help should be 
sought, uncertainties about the treatment and the outcome and barriers to effective 
interventions to reduce VI among older people.  
2.4.4.6 Can the health system cope with the programme?  
Smeeth suggests that the development of a national vision screening programme 
may lead to an increase in referrals to the eye services and acknowledges that this 
would need to be resourced (Smeeth, 1998). On the other hand it can be argued 
that in addition to the pain and distress that low vision causes to the person 
affected, uncorrected visual problems may also cause a considerable drain on 
resources, both of the NHS and of care providers, due to the increase in falls and 
accidents that are associated with VI. 
Smeeth also stated that cataract surgery is likely to be a large part of the workload 
generated by vision screening in older people and many regions already have long 
waiting lists (NHS Centre for reviews and dissemination, 1996a). However, due to 
investment in the health system, waiting lists for cataract procedures in the UK 
have been shortened. Literature issued by The Department of Health states that no 
one was waiting more than 3 months for their operation and most patients can be 
expected to be treated within 6 weeks (The Department of Health, 2005). 
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2.5 Conclusions and chapter summary 
The notion that older people with poor vision will all regularly attend optometrists 
for refractive corrections and the detection of ocular pathology is clearly little more 
than an ideal. Properly funded publicity may help to encourage more of the older 
population to view optometric care as an essential annual health check. However, 
this approach seems intrinsically limited and it seems likely that even a major 
publicity campaign will still leave many older people avoiding regular eye care. 
If older people will not come to the consulting room for clinical tests then a 
complementary approach is to take the clinical tests to the public. This already 
happens through domiciliary eye care services, but again the take up of these is 
“patchy”. A more universal and affordable approach might be a vision screening 
program using a battery of vision tests. The literature reviewed indicates that vision 
screening of older people meets most of the Wilson criteria for an effective 
screening programme, but there is still uncertainty over which tests are most 
appropriate. Only when this question has been answered can another issue, of 
suitable venues, be fully addressed because the appropriateness of venues will 
partly depend on the type of testing that needs to be carried out. 
If a vision screening programme using a battery of vision tests, perhaps 
computerised, can be established then this should be tested to determine the 
sensitivity and specificity for detecting the target conditions. Ultimately, longitudinal 
studies are necessary to determine whether such a screening programme will lead 
to improved visual performance and quality of life in older people. 
Having established that vision screening in the older population may be an 
effective way to detect vision loss in the older population and encourage older 
people to have eye examinations, the following chapter will focus on the 
development of two particular types of screening tools that can be used to screen 
for vision loss in the older population. The next chapter will also outline the aims of 
the research study. 
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Chapter 3  
New screening methods & 
research aims 
3.1 Introduction 
In Chapter 1 the need for improved detection and management of visual problems 
in older people was established and the Wilson criteria for determining whether a 
screening programme is appropriate were reviewed (Wilson & Jungner, 1968). In 
Chapter 2 the literature on vision screening of older people was reviewed and it 
was concluded that more research is needed to establish whether vision screening 
of older people is appropriate. In particular, new screening tools might be more 
effective than those previously studied and ought to be developed and 
investigated. If a vision screening programme using a battery of vision tests, 
perhaps computerised, can be developed then the sensitivity and specificity for 
detecting the target conditions can be established. Furthermore the screening 
programme can be used to determine which tests are most appropriate for 
screening and which venues are most appropriate. 
Previous research on screening vision in older people was summarised in Chapter 
2. It was noted that methods have ranged from simply asking patients if they have 
any visual problems (Smeeth & Iliffe, 1998) to combining various tests (Woods et 
al., 1998e;Wang et al., 1998a). Recent developments in computerised screening 
may have an application in vision screening in older people and these 
developments will be reviewed here. 
3.2 New methods of vision screening 
Vision screeners are instruments designed to allow semi-skilled personnel to 
identify those with various forms of visual anomalies.  Conventional screeners are 
capable of presenting a variety of targets at various optically simulated distances, 
e.g. infinity (to simulate distance vision), 30cm (to simulate near vision) and more 
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recently at intermediate distances to simulate visual display unit (VDU) distances. 
The range of visual functions  assessed by these instruments and the degree of 
automation varies between models but most instruments permit an assessment of 
visual acuity, ocular motor balance, binocularity, stereopsis and colour vision 
(Henson D, 1995). A limitation of these devices is that they are based on the 
Brewster-Holmes stereoscopic design (Evans 2007) which has the disadvantage of 
creating unnatural viewing conditions. 
The recent development of computerised vision screening has opened up exciting 
new opportunities for vision screening. Not only are computer displays well suited 
to presenting visual stimuli but the implementation of computerised vision 
screening also means that expert systems can be built in to help analyse the 
results and perform back-office tasks such as maintaining a database and printing 
reports. So far, this approach has been applied successfully to visual screening for 
vocational requirements and for visual problems in children. The potential for vision 
screening of older people using computerised methods merits further investigation 
and the exploration of this is a key part of the study. Computerised vision screening 
can be considered as an evolution of earlier methods of automated vision and 
these approaches will now be described.  
3.2.1 Automated vision screening 
 Automated vision screening has enabled vision tests to be administered quickly 
and effectively and increasingly without much input from personnel and in a 
number of screeners the only input that is needed is for the scoring of results. 
Examples of automated screening are outlined below. 
The Titmus Vision Screener is compact (Madigan, 2005a) and is therefore 
lightweight and portable with a number of screening tests including near acuity, 
distance acuity, depth perception, colour perception, muscle balance (lateral and 
vertical heterophoria) and visual fields (peripheral vision of 130 degrees in each 
eye). The Titmus Vision Screener can also test visual acuity at intermediate 
distances. The screener has a number of testing sequences enabling it to be used 
on children (preschool testing and school testing), adults and for occupational 
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purposes. The scoring system requires the input of a test assistant to record the 
results on a score sheet (Madigan, 2005b). 
The Keystone Vision Screener is another automated screener which incorporates a 
number of tests including distance acuity, near acuity, intermediate distance acuity, 
depth perception, binocular function, colour, field of vision and low light vision. 
Although the screening system is automated, the scoring system is manual as with 
the Titmus Screener. However, more recently the Keystone Vision Screener has 
been modified to be under computer control. The results are stored in a database 
from which reports can be easily generated. The screening system is not 
completely computerised but ‘computer controlled’ and the actual screening tests 
are still administered through the original screening unit. Keystone has a range of 
computer controlled vision screeners which are suitable for different patients 
including a Standard Screener, Paediatric Screener and Drivers’ Screener; each 
including tests suitable for that situation. 
The screeners outlined above are typical of those that are commercially available 
and these have been reviewed by Madigan (Madigan, 2005c). It is evident when 
reviewing these screeners that the tests incorporated have been geared towards 
screening in schools or screening for occupational purposes and these screeners 
have not been used to test older people nor have they been adapted to be suitable 
for use with older people. 
Despite the advantages of automated screeners there are also a number of 
disadvantages. The screeners tend to be ‘luggable’ rather than portable and the 
Brewster-Holmes optics that are typically used can result in instrument 
accommodation and convergence. The simulated viewing distances may not be 
appropriate and there can also be problems using the screeners with bifocal or 
varifocal spectacles. There may also be hygiene issues with the head rest and chin 
rest. 
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3.2.2 Computerised vision screening 
The vision screeners discussed below are computer vision screeners which are 
completely computer based, only requiring the use of a laptop or desk top 
computer. 
The City Vision Screener for Schools provided a radical new computerised solution 
to provide high quality vision screening for children of a variety of ages (Thomson 
& Evans, 1999). The program manages the entire process from obtaining parental 
consent, performing the vision tests, and producing customised reports for parents, 
teachers and optometrists. All of the tests (except for colour vision), are presented 
on the computer screen. The operator simply has to record the children’s response 
to each test by clicking on the buttons at the bottom of the screen. The tests 
include colour vision, stereopsis, fixation disparity, visual acuity and a blur test. The 
program automatically analyses the symptoms, history, family history and test 
results to put together a customised letter for the child’s parents. The letter 
explains the exact nature of any problems and explains what action the parents 
should take.   
The City Vision Screener also has a version suitable for VDU users and is 
designed to be a cost effective way for employers to comply with Display Screen 
Equipment (DSE) Regulation (The Health and Safety (Display Screen Equipment) 
Regulations, 1992). This screening system is based on a computer program with 
the basic aim of identifying those individuals who are experiencing eye problems 
and to determine if the symptoms are related to visual defects or environmental 
factors or a combination of these (Thomson, 1994). The test conditions for the City 
Vision VDU Screener are the same as the normal DSE viewing conditions and as a 
result this computerised screening technique for VDU occupational purposes 
provides a very reliable measure of the user’s vision under their normal working 
conditions. The screening can be conducted in a supervised environment or if 
conducted in an unsupervised environment the program can be configured to give 
more detailed on-screen instructions (Thomson, 1994). The program performs an 
analysis of the results and automatically generates reports for the user and the 
employer. 
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As stated above methods of computerised screening allow results to be 
automatically stored, reports to be generated and gives a level of flexibility not 
found in other screening techniques. The screeners discussed above are once 
again geared towards screening in schools or for occupational purposes, but not 
towards older patients. Computerised vision screening for the older population is 
under researched and warrants further investigation. 
3.2.2.1 Adaptation of computerised vision screening to older people 
Thomson has researched extensively in the field of vision screening and developed 
the City Vision Screeners discussed above (Thomson, 1994;Thomson & Evans, 
1999). Recently, Thomson implemented a modular approach to the City Vision 
Screeners and this facilitates adaptation to new applications. This modular design 
means that the user can customise the screening tool for a specific use. This 
customisation involves the user selecting from a list of symptom and history 
questions and from a list of tests to define a test battery that is appropriate for the 
population that is being screened. This would be an ideal way to adapt an existing 
successful screener to test the older population. The flexibility of being able to 
choose the most appropriate tests to include in the computer screener enables the 
test methods discussed in Chapter 2 to be incorporated in order to evaluate their 
suitability in detecting correctable visual loss. Initially this may involve adding a 
significant number of tests. However, once the suitability of the tests has been 
evaluated, the computer screener can be easily refined to only include the tests 
that are shown to be of most value in detecting the target conditions.  
Implementing the above method for adapting a current vision screener is an 
effective way of experimenting with certain tests resulting in a battery of tests most 
suited to a specific population. This level of flexibility would not be possible with a 
non computerised screening technique (i.e. a paper based screener) and would 
require a lot of time in reproducing various versions of the screener. 
3.2.3 Flipchart screeners 
While there are limitations to non-computerised screening methods, there are 
nonetheless some situations where simpler approaches might still be of value.  
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This may be the case in situations where computer screening is too complex either 
for the patient, the person administering the screening, or where there are logistic 
constraints on the use of computers. For example, computerised screening may 
not be suitable in developing countries where the cost of running a computerised 
screening program may be too high. In these conditions paper based screening 
tests would be easy to administer and cost effective. Advances in computerised 
technology have enabled paper based testing to be more easily generated and 
reproduced. 
As discussed above, despite the developments in automated, computerised 
screening the need for simple, perhaps paper-based screening still exists in some 
situations and this raises the question of to what degree a simplified paper test 
would reduce the test performance at detecting visual problems compared with a 
more sophisticated computerised method. It can be argued that perhaps a 
computer screener is necessary to ascertain the correct battery of tests (due to 
ease of including and excluding tests) that can then be reproduced as a paper 
based screener. This is an important part of the research described in this thesis 
and the development of two screening tools; one computerised and the other a 
rapid flipchart will enable a comparison between the two techniques to be made. 
Testing visual acuity with a flipchart is commonly used in children and there are  a 
variety of paper-based acuity tests that are commercially available for children, 
including the Cambridge Crowding Cards and the LogMAR crowded test 
(Rabbetts, 2000). Smeeth and colleagues used the Glasgow acuity test (later 
renamed the LogMAR crowded test) when screening older people (Smeeth et al., 
2003c). However, this is rare and paper-based testing is not commonly used in 
older people. 
The section above has outlined how computerised vision screening and flipchart 
tools can be used in the older population. The section below explores the research 
design, aims and objectives. 
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3.3 General research question 
The general research question is: can a computerised vision screening tool and a 
rapid flipchart vision screener be used among the older population to detect (with 
adequate sensitivity & specificity) correctable visual loss as established by a ‘gold 
standard’ eye examination? Furthermore, what battery of screening tests would be 
most appropriate to incorporate into the screening tools and what venues would be 
most appropriate to conduct the vision screening? 
3.4 General aims  
The main aim of the research described in this thesis was to evaluate new 
screening tools and to evaluate their effectiveness in improving the detection of 
correctable visual loss in older people. Screening tools are not seen as a method 
of replacing professional eyecare, but rather as a communication tool to increase 
public awareness among the elderly of the need for regular eye examinations. If, 
as the literature suggests, (Evans & Rowlands, 2004f) there is a large number of 
older people who avoid eyecare services then screening may be a way of re-
engaging these people with the eyecare services. The screening itself would act as 
a safety net for people who have hitherto failed to participate in regular full eye 
examinations. When the vision screening detects correctable visual impairment 
then the patient will be given individual personal advice that an eye problem has 
been detected and they must seek professional care. It seems likely that people 
who are thus identified will be more likely to seek professional care than if they had 
not received the specific targeted advice that will result from vision screening. 
This last point highlights a hypothesis that was not directly tested in the present 
research: that individual advice to older people as an outcome of screening will be 
more effective than, for example, an advertising campaign, in persuading them to 
seek professional eyecare. It should be noted though that the value of the 
screening software is not solely contingent on this hypothesis. The screening tools 
could ultimately be used for a different purpose, either in addition to or in place of 
their potential direct role in improving the take up of eyecare services in older 
people. This other role might be to carry out research in a given community to 
establish the prevalence of undetected visual problems so as to determine whether 
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further action is necessary. Further action might include publicity campaigns, 
outreach clinics, or increased funding of community optometric eyecare services. 
The present research therefore concentrates on evaluating the sensitivity and 
specificity of the screening tools at detecting correctable visual problems. This 
information will provide data on the validity of the screeners which will allow 
informed decisions about their potential uses. 
3.5 Brief overview of research design 
Most research can be classified as having a certain research design. Typical 
examples are cohort studies (one or more groups are followed over time, of which 
a randomised controlled trial is a specific interventional type), case control study 
(two populations are compared at a point in time), cross-sectional studies 
(prevalence surveys), and evaluations of diagnostic tests (which determine the 
ability of a test to detect a condition). The research described in this thesis is 
predominantly a diagnostic (screening) test evaluation (see below). Although not 
the primary goal, some epidemiological data was analysed in what was in essence 
a cross-sectional survey. In another facet of the research some cohorts of patients 
were followed over a brief period of time to monitor the effect of interventions on 
quality of life. This was a small cohort study. 
 It is important to note that although this is not a diagnostic study, screening can be 
considered a subcategory of diagnosis (Haynes et al., 2006). Because of the 
similarities between diagnostic studies and screening studies, the key aspects of 
research design applied in this study closely resemble those of a diagnostic study.   
Haynes and colleagues outline four points that ensure a valid diagnostic study. 
These points are outlined in Table 3.1 below with comments on how the criteria 
relate to the present study 
 
 
 
Page 100 of 389 
 
Table 3.1 Ensuring a valid diagnostic study (Haynes et al., 2006) 
Criteria for a diagnostic study Comment 
Assemble an appropriate spectrum of 
patients 
Patients will all be aged 65 and over living in 
the South London area where there is likely to 
be a significant unmet need for eyecare. 
Apply  both the diagnostic test and 
reference standard to all of them 
The screening tests and the gold standard eye 
examination will be applied to all participants. 
This is discussed in more detail below. 
Interpreters each blind to each other A double masked protocol will be adopted. 
Both the optometrist and the screener will be 
masked to the results of the other. 
Study is repeated in a second, 
independent set of patients 
The study will be repeated on another set of 
older patients. This is discussed in more detail 
below. 
3.5.1 The need for two studies 
External validation for the study can be ensured by conducting a second study 
involving an independent but similar population (Haynes et al., 2006).The results 
from the first study will enable the development of a more refined computerised 
screener. In addition to the computerised screener, the key tests will also be made 
available in a flipchart format for places where computerised testing is not 
appropriate.  Both these screening tools will be evaluated in the second study in 
the same way as the initial computerised screener was evaluated in the first study. 
3.5.2 The need for a Gold standard 
The accuracy of a screening test in detecting the target condition can be evaluated 
by comparing the results obtained with an established ‘Gold Standard’ (Haynes et 
al., 2006). In this study the gold standard is a full eye examination that will be 
accepted as the definitive determination of whether patients have correctable 
visual loss. 
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Harper and Reeves (1999) outline two crucial points surrounding the gold standard 
for a diagnostic test. The first point is that the gold standard definition of normality 
should be clearly defined. Methodological standards for the evaluation of 
diagnostic tests summarised by Harper and Reeves state that all participants 
should be assigned to receive both diagnostic testing and gold standard 
verification.  However there may be times when the definitive examination is 
impractical or too invasive to be administered to all participants and as such may 
only be assigned to those participants who fail the diagnostic test. It is particularly 
important in these situations that the gold standard definition of normality clarifies 
this and highlights the possibility of work –up bias (Harper & Reeves, 1999e). Work 
up- bias is the bias that occurs when the definitive gold standard is conducted only 
on those participants who fail the diagnostic test. The end result of this is a high 
sensitivity for diagnosing the disease, but no or insignificant results to rule out the 
disease. In other words, no specificity may be calculated as there is no control 
group  of negatives (Kelly et al., 1997a). The second point with reference to the 
gold standard highlighted by Harper and Reeves is that it should be independent of 
the diagnostic test under evaluation. This means that the diagnostic tests should 
not be performed as part of the gold standard (Harper & Reeves, 1999f). This is 
known as incorporation bias and occurs when the test under evaluation is itself 
used as a gold standard (Kelly et al., 1997b). 
In order to avoid the biases discussed above, the study will take into account both 
the above points and the gold standard eye examination will be applied to all 
participants in the study. The vision screening tests will be assigned independently 
of the gold standard.  
3.6 Objectives and expected outcomes 
The study will result in the development of two vision screening tools for the older 
population. A computerised vision screener and a rapid flipchart vision screening 
tool. The objectives and expected outcomes of the study are outlined below. 
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Primary Objective 1: Determine the battery of vision tests and questions for a 
computerised vision screener that has greatest sensitivity (and specificity) for 
detecting correctable visual problems in older people.  
Primary Objective 2:  Determine the battery of vision tests and questions for a 
rapid flipchart vision screener that has greatest sensitivity (and specificity) for 
detecting correctable visual problems in older people. 
Primary Objective 3:  Calculate the sensitivity and specificity of the final version of 
the computerised vision screener for detecting correctable visual problems in older 
people. 
Primary Objective 4:  Calculate the sensitivity and specificity of the final flipchart 
rapid screener for detecting correctable visual problems in older people. 
The effectiveness of the above screening tools will be evaluated and information 
will also be obtained on the most appropriate venue(s) for screening and on 
participants’ opinion of the screening process. It is expected that the rapid flipchart 
will be more suited to community based settings where the use of computerised 
techniques may not be appropriate for example in hospital wards. 
It is expected that the research will not only provide information on the most 
appropriate tests for a vision screener but also provide additional information on 
issues surrounding access to eye care. Below are secondary objectives and 
additional observations that hope to be made as a result of the research.  
Secondary Objective: Determine whether people whose visual problems are 
detected with screening do, as a result of the screening, receive treatment of their 
visual problems and appropriate support. When this does not occur, we will seek to 
discover the reasons 
Additional observation 1: Provide a commentary on the suitability of different 
venues for screening vision in older people.  
Additional observation 2: Comment on the characteristics of older people with 
poor vision in South London. In particular, make observations on the relationship 
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between ethnicity and correctable visual loss and also between poverty and 
correctable visual loss. 
It is anticipated that the research will detect correctable visual impairment in 
approximately one third of participants as suggested by the systematic review by 
Evans and Rowlands (Evans & Rowlands, 2004g), and these people will obtain a 
direct and immediate benefit, in terms of correcting visual impairment and in 
reduced risk of falls and improved quality of life.  
At the planning stage of the study it was acknowledged that the research may 
produce a negative result: it is possible that vision screening in older people is not 
effective. The following factors that could lead to this conclusion were considered: 
screening might not be able to detect the relevant visual problems, screening might 
not be cost effective, or screening might not be successful at encouraging older 
people with visual problems to engage in eyecare services. 
Some of the literature appears to support this point of view, but always without a 
full analysis of the options for vision screening. For example, a systematic review 
that reached this conclusion set extremely strict selection criteria (Smeeth & Iliffe, 
2000;Smeeth & Iliffe, 1998). This meant that only five trials met the inclusion 
criteria and all of these used self-reported measures to assess impaired vision. 
Vision was not assessed at all: only participants’ opinions of their vision. Another  
paper points out that visual acuity assessments “are probably preferable to 
questions about visual problems” but does not consider in detail screening to 
assess additional visual functions as well as acuity (Smeeth, 1998). Regardless of 
whether computerised screening proves to be effective, this approach is a valuable 
tool for investigating which tests are most useful for vision screening generally in 
older people. 
3.7 Chapter summary 
This chapter has outlined the design of the screening tools to be used in the study. 
The main research question, aims and objectives have also been explored. Key 
aspects of the research design have been outlined and the next chapter will focus 
in detail on the methods of conducting the study. 
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Chapter 4  
Methods 
4.1 General Methods 
4.1.1 Introduction  
This thesis describes two studies which were designed to assess the sensitivity, 
specificity and validity of two new screening tools which have been developed to 
identify poor vision among the elderly. Both studies followed a double masked 
randomised design. The sensitivity and specificity of the screeners was determined 
by comparing the results of the screeners to a gold standard eye examination 
carried out by an experienced optometrist.  
4.1.2 Participants 
The inclusion criteria for both studies were that all participants had to be over the 
age of 65 years and living in South London. This area provides a population with 
diverse cultural and socio-economic profiles. Older people of all ethnicities and 
levels of ability were included in the studies.  In order to include older people who 
were not already under the care of an eyecare practitioner, a variety of recruitment 
campaigns were conducted including leaflet drops, posters, open days, press 
releases and word of mouth. Local newsagents, churches, community centres’, GP 
practices, care homes were all contacted. Several open days at community centres 
also enabled the researcher to speak personally to older people and this proved to 
be the most effective method of recruiting participants. Word of mouth then 
generated a steady flow of patients at a variety of venues.  No exclusion criterion 
was set and all older people over the age of 65 years were encouraged to 
participate. 
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 The sample size for the first study was calculated according to the methods 
described by Jones et al. for screening tests (Jones et al., 2003). The calculations 
require a stipulation of acceptable sensitivity and specificity and estimate of the 
prevalence of the target condition (see Table 4.1). The systematic review by Evans 
and Rowlands suggested that the prevalence of the target conditions is likely to be 
30% (Evans & Rowlands, 2004o) 
Table 4.1 Assumptions for sample size calculation. 
Question Assumption 
What is the lowest sensitivity that is acceptable? 95% 
What is the lowest specificity that is acceptable? 95% 
What do we want the confidence intervals to be? 5% 
Likely prevalence of target disorders (cataract or uncorrected refractive error)? 30% 
 
Using these figures it was estimated that a sample size of approximately 250-300 
would be required. This estimate of sample size was based on assumptions about 
prevalence that may not be appropriate for the previously un-researched South 
London population. It was therefore planned to repeat the sample size calculation 
approximately halfway through the study, using the real data obtained thus far. At 
this time (N=150), the prevalence of the target conditions was 52.3% and the 
revised sample size calculation suggested that 140 participants would be required. 
To allow for a margin of error, the study was continued until 180 subjects had been 
tested in Study 1 and 200 subjects in Study 2. Table 4.2 outlines the assumptions 
for the revised calculation.  
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Table 4.2 Assumptions for revised sample size calculation 
Question Assumption 
What is the lowest sensitivity that is acceptable? 95% 
What is the lowest specificity that is acceptable? 95% 
What do we want the confidence intervals to be? 5% 
Likely prevalence of target disorders (cataract or uncorrected refractive error)? 52.3% 
 
The calculations above use sensitivity and specificity values that were used by 
Jones et al (2003) to calculate the sample size for a diagnostic test to detect ankle 
fractures. In hindsight, these values were unrealistically high for vision screening 
and we could have lowered the level of sensitivity and specificity, which would 
have reduced the sample size required. However, in research of the type described 
in the thesis the basic principle is to provide the maximum precision in estimates of 
sensitivity and specificity by using the largest sample size that is practical given the 
inevitable constraints imposed by time and finances, which is the overarching 
principle that was followed. 
4.1.3 Venues for conducting research 
The screening was carried out in a variety of venues of clinical and “non-clinical” 
settings in order to a) encourage participation from older people who were not 
receiving eyecare and who were perhaps fearful of a more clinical environment and 
b) establish the effectiveness of the screening tools in a typical community setting.  
The screening tools were designed to be used in non-clinical environments and the 
only requirement was a viewing distance of at least 3m and “normal” room lighting.  
A darkened room of a least 3m in length was required for the gold standard 
examination. Another major consideration when selecting venues for the study was 
ease of access for elderly participants. 
Several authors have suggested GP surgeries as a possible venue to conduct 
screening, (Bulpitt et al., 1990;Reinstein et al., 1993;Smeeth, 1998) although 
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others have expressed doubts (Mangione et al., 1992;Brabyn et al., 2001g). 
Possible venues have been reviewed in Chapter 2, Table 2.6. A list of potential 
venues and whether or not these would be suitable for present research is shown 
in Table 4.3 below.  
Table 4.3 Possible venues for vision screening, with comments on their suitability for the present 
research. 
Venue Conclusions for present research 
GP surgery  Suitable for present research 
Surgical & orthopaedic wards  Suitable for present research 
Accident & emergency (A&E) 
clinics 
 
 These clinics are usually very busy 
 Patients in these clinics do not have time for a full eye 
examination 
 Not suitable for present research 
 If a flip-chart screener is found to be useful, it could 
be used here in the future 
Outpatient clinics 
 
 Patients in these clinics do not have time for a full 
eye examination 
 Not suitable for present research 
 If a flip-chart screener is found to be useful, it 
could be used here in the future 
Falls clinics  Patients in these clinics do not have time for a full 
eye examination 
 Not suitable for present research 
 If a flip-chart screener is found to be useful, it 
could be used here in the future 
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Residential rehabilitation 
centres 
 Suitable for present research 
Community centres  Suitable for present research 
Nursing homes  Suitable for present research 
Individual residences 
 
 Health & Safety issues raised by PCT, so not 
suitable for present research 
 If a flip-chart screener is found to be useful, it 
could be used here in the future by community 
health care staff 
 
The table above shows that the most appropriate venues are those where 
participants will be tested either in the place where they are resident permanently 
(e.g., residential home) or temporarily (e.g., rehabilitation centre) or in a place that 
is local to them and which they regularly visit (e.g., GP surgery, community centre). 
The venues used in the present study are outlined in the following section. 
4.1.3.2 Venues used for present research 
Table 4.4 below shows the venues that were used in the study.  
Table 4.4 Venues used in present study 
Venue Study Comment 
The Institute of 
Optometry 
1 and 2 The Institute of Optometry (IoO) is based in South East 
London and provides optometric care in a clinic based 
environment. It is open to all members of the public 
regardless of their visual needs 
Tower Hill residential 
care home 
1 This is a large, purpose built care home located in 
South East London, providing facilities for the nursing, 
social and personal care of the elderly. A separate unit 
is provided for the care of those suffering with dementia 
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related illnesses. The home has a total capacity of 128 
places.  
Pulross intermediate 
healthcare centre 
1 This healthcare centre is located in Brixton, South West 
London. Intermediate Care is an emerging approach to 
healthcare where primary care is located in the 
community rather than relying solely on resources in 
central hospital situations. The centre is a partnership 
between community health services and local general 
practitioners. Other service providers such as local 
hospitals and social services have close links with the 
Centre.  
The range of services that the Centre provides includes 
physiotherapy, occupational therapy and speech 
therapy. They also have a range of clinics such as falls 
clinics and post surgery follow up. In addition the 
Centre has a number of short-stay inpatient wards and 
individual rooms. 
Community based 
optometric practice 
1 A community based optometric practice with a high 
number of older people from ethnic minorities. 
Blairderry Road 
surgery 
2 This GP practice is located in the heart of the 
Streatham community in South West London.  
Woodlawns day 
centre 
2 Woodlawns Day Centre is situated in South West 
London and is managed by Age Concern Lambeth. The 
Centre provides activities and facilities for older people 
of all cultures in Lambeth. Services include a luncheon 
club, welfare advice, snooker, bingo, bridge, line 
dancing, hairdressers, day trips, outings and holidays.  
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4.1.4 Diagnostic criteria for defining target eye disease 
The purpose of the gold standard eye examination was to give a true indication of 
the presence of correctable visual loss. It was important to specify diagnostic 
criteria for defining the target eye conditions in order to establish when these 
conditions became clinically significant. The presence of cataract or refractive error 
may not cause vision loss in the early stages and the diagnostic criteria outlined in 
this section give a clear indication of when an optometrist may consider correcting 
this vision loss and when an older person would benefit from intervention. 
The diagnostic criteria for the main target conditions are stated below. 
4.1.4.1 Cataract 
Cataract was defined using the Lens Opacities Classification System III (LOCSIII). 
This grading system consists of six slit-lamp images for grading nuclear colour 
(NC) and nuclear opalescence (NO), five retroillumination images for grading 
cortical cataract (C), and five retroillumination images for grading posterior 
subcapsular (P) cataract. An illustration of the LOCS III grading scale can be found 
in Chapter 5 (Figure 5.1). 
The diagnostic criteria for cataract used in this study have been used by previous 
researchers based on the LOCS criteria of LOCS III score of 4 or more for nuclear 
cataract, and 2 or more for cortical or posterior sub-capsular cataract (Foster et al., 
2003a;Saw et al., 2003b). It has been shown that performance at using the LOCS 
III scale improves with practice (Karbassi et al., 1993a). In view of this practice 
effect, the LOCS III scale was used by the researcher for 6 months prior to the 
study in order to gain experience. This criterion was applied monocularly, i.e. the 
presence of cataract (as defined above) in one eye or both was taken to be 
significant. 
4.1.4.2 Refractive error 
Saw and colleagues defined significant uncorrected or under-corrected refractive 
error as uncorrected myopia, hypermetropia, or astigmatism of at least 1.00D and 
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an improvement of at least two lines of visual acuity with correction (Saw et al., 
2003a). This criterion was modified in the present research because of problems 
with applying the 1D criterion as well as the 2 line improvement in VA. The three 
main reasons for modifying the criterion for this study are listed below.  
 Some patients attended with spectacles which were in such poor condition 
(e.g., scratched lenses) that the VA was greatly impaired with the spectacles 
and these needed changing even though the change in refractive error may 
have been minimal. It was felt that these people should be included since 
they were in need of primary eyecare services. 
 Focimetry of spectacles was not always possible because a focimeter was 
not available in some community centres. . An estimate of the prescription 
was made by hand neutralisation in these cases, but this has relatively low 
accuracy, especially for varifocals. 
 Even if a 1D or more change in refractive error is found, it is debatable 
whether it is advisable to prescribe such a large change in prescription. 
Such large changes can be disorientating and could increase the risk of a 
fall (Cumming et al., 2007). 
It was therefore decided to modify the criterion so that any patient whose visual 
acuity was at least two lines (0.2 LogMAR units) better with subjective refractive 
findings than presenting visual acuity was defined as having a significant change in 
prescription. This criterion was applied monocularly: a 2 line improvement in 
distance acuity in either eye was regarded as significant. It was important to take 
monocular deficits into consideration for distance because of the risk of falls and 
driving accidents. The same criterion was used for near vision. However, the 
criterion was applied binocularly because monocular deficits for near are unlikely to 
impact on safety in the same way they would for distance. Distance visual acuities 
were measured using a computerised letter chart (Test chart 2000) and the 
optotypes were frequently randomised during the eye examinations so it was not 
possible for participants to memorise the chart.  
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4.1.4.3 Correctable vision loss 
Correctable vision loss is a term used throughout the study to describe the 
presence of significant cataract or significant gain in acuity through refractive 
correction.  In Table 4.5 below the criteria for correctable visual loss are shown.  
Table 4.5 Defining Correctable visual loss 
Correctable Vision loss Monocular/Binocular 
Significant gain in distance acuity through 
refractive correction. 
The gain in acuity can be monocular or 
binocular 
Significant gain in near acuity through 
refractive correction 
Binocular only. This criterion was introduced 
when near acuity was being evaluated 
Significant cataract The presence of cataract can be monocular 
or binocular 
 
4.1.4.4 Macular degeneration  
The literature suggests that quite basic tests will be able to detect uncorrected 
refractive errors and cataract. These are the main target conditions for this study 
because: (a) they have a very high prevalence, (b) they can readily be cured, and 
(c) their treatment is of direct and immediate benefit to the public through 
correcting visual impairment and improving quality of life (Koole et al., 
2001b;Crabtree et al., 1999;McGwin, Jr. et al., 2003).  
Macular degeneration is a common cause of reduced visual acuity among the 
elderly. Although this is not readily correctable in most cases, patients with this 
condition may benefit from ophthalmological investigation, possible treatment and 
for further support and low vision aids. Additionally, as outlined in Chapter 1 (p.33), 
new treatments for some forms of macular degeneration recently have been 
developed. In view of this, macular degeneration was considered as a target 
condition for the screener. The diagnostic criteria (based on the gold standard eye 
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examination) used for age-related maculopathy (ARM) was based on the Clinical 
Age Related Maculopathy Staging System (Seddon et al., 2006a). This is a 5 stage 
grading system; stage 1 being no drusen and 5 being exudative macular changes.  
An abbreviated form of the table is shown below.  
Table 4.6 Clinical Age Related Maculopathy Staging System (Seddon et al., 2006b) 
Maculopathy 
grade 
Clinical features 
1 No drusen or <10 small drusen without pigment abnormalities 
2 Approximately ≥10 small drusen or <15 intermediate drusen, or 
pigment abnormalities associated with ARM 
3 Approximately ≥15 intermediate drusen or any large drusen 
4 Geographic atrophy with involvement of the macular center, or 
noncentral geographic atrophy at least 350 μm in size 
5 Exudative AMD, including nondrusenoid pigment epithelial 
detachments, serous or hemorrhagic retinal detachments, CNVM with 
subretinal or sub-RPE haemorrhages or fibrosis, or scars consistent 
with treatment of AMD 
 
For the purposes of analysing whether visual acuity screening identifies macular 
changes, the gold standard data was re-coded into; 0-no macular changes and 1- 
macular changes present. This enabled ROC curves to be drawn and cut-off 
values to be calculated (this is explained in Chapter 7). 
4.1.4.5 Macular degeneration risk of progression.  
This category was introduced in study 2 in response to comments from the expert 
advisory group (see Section 4.1.6) and is based on the risk of macular 
degeneration progressing to advanced macular degeneration (neovascular disease 
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or geographic atrophy).   A study conducted by Ferris et al (Ferris FL & Age-
Related Eye Disease Study (AREDS) Research Group., 2005), indicated that large 
drusen and any pigmentary changes were particularly predictive of advanced AMD. 
Using the study by Ferris et al as a guide for the definition of AMD progression, it 
has been defined as greater than a stage 2 using the Clinical Age Related 
Maculopathy Staging System. 
4.1.4.6 Glaucoma 
Visual loss resulting from glaucoma cannot be treated and is not a primary target 
condition for this study. However vision loss from glaucoma may be prevented 
through early detection. It is difficult to screen for glaucoma, since all three 
commonly used glaucoma tests have a low sensitivity and/or specificity in isolation 
(Ivers et al., 2001d) and using all three tests (Tuck & Crick, 1997b) in screening by 
non-healthcare professionals is impractical.  
However, a simple central visual field test was developed for the computer-based 
vision screener and its efficacy was assessed in the first study. Participants were 
advised that this screening test was not an alternative to the glaucoma screening 
carried out as part of a full eye examination. 
The diagnosis of glaucoma in the gold standard is multi-factorial, (Weinreb & 
Khaw, 2004a;Harper & Reeves, 1999c) and the diagnostic criteria of Foster and 
colleagues were used in this study (Foster et al., 2002). In terms of glaucoma, the 
detection abilities of the screening tools were judged by their ability to detect three 
categories of patients; firstly those patients that had already been diagnosed with 
glaucoma; secondly, those patients that had been referred for further 
ophthalmological investigation for possible glaucoma as a result of the gold 
standard eye examination and finally those patients that the gold standard had 
identified as needing to be closely monitored for glaucomatous changes. 
4.1.4.7 Summary of assumptions made 
There are certain assumptions made during this study and these are outlined 
below: 
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 There are other ocular diseases that may decrease vision in addition to 
those mentioned above in Section 4.1.4. However, the literature reviewed in 
Chapter 2 indicates that the target conditions in this research are the main 
causes of reduced vision in older people. In this study the screening tools 
were designed specifically to screen for correctable loss of vision, in 
particular significant cataract and uncorrected refractive error. 
 In the present research, all cataracts are assumed to be a form of 
correctable vision loss.  
 There may be an overlap between those patients that had significant 
cataracts and those that had uncorrected refractive error. 
4.1.5 Ethical considerations 
The research followed the tenets of the Helsinki declaration (World Medical 
Assembly, 1989) for research involving human subjects and conformed to the 
Department of Health’s Research Governance Framework (Department of Health, 
2001). The research has been approved by the Institute of Optometry and City 
University RECs and approved by the NHS LREC. The research was also been 
approved by the local PCT Research Support Unit. 
All participants were given full information about the research, both verbally and in 
writing, and it was explained that participation was optional and that refusal to 
participate would not in any way influence their continued medical, optometric, or 
social care.  
Particular care was taken not to alarm or confuse older people. Participants were 
offered the opportunity of having the researcher speak to a family member or carer 
about the research, and every participant was given written information, which they 
were able to discuss with their family or carers. Any queries that potential 
participants and their family or carers had were fully answered before their consent 
to participate was sought.  
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Some older people might avoid eye care services because they are afraid that the 
outcome of an eye examination might prevent them from continuing to drive. 
Participants were asked whether this was a factor in order to determine the scale 
of the problem. Additionally, it is possible that this may have been a reason why 
some people might have declined to participate in the research. Therefore, when 
people declined participation they were offered a stamp-addressed envelope 
containing an anonymous questionnaire. This questionnaire included questions 
aimed at identifying reasons for non-participation, including fears about being 
prevented from driving. A record was kept of the number of participants who 
declined participation so that this could be compared with the number of completed 
“non-participation questionnaires” that were received. 
The tests that were used were all based on standard visual tests that are in 
widespread clinical use. Participants were allowed to opt out of the research at any 
time without having to give a reason. Where visual problems were detected, every 
effort was made to help participants by referring (with consent) for optometric 
and/or medical investigation and treatment as appropriate. The usual referral 
pathways were followed. For most conditions, this is for the optometrist to refer the 
patient to the GP and for the GP to then refer to an ophthalmologist. Exceptions 
include a few conditions which are considered to be emergencies (e.g., retinal 
detachment) when the patient is referred directly to an ophthalmologist, who would 
be contacted first by telephone. The referrals were based on the gold standard eye 
examination; however the results from the screener were compared to the gold 
standard eye examination regularly in case the screener had detected a problem 
that the gold standard had not. In this situation, the participant was referred if 
necessary. 
4.1.6 Expert Advisory Group 
This research benefited from the input of an expert advisory group, established at 
the suggestion of the funding body (The Thomas Pocklington Trust). This group 
comprised the following multidisciplinary members: 
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 Dr. Angela McCullagh –Research and development director, Thomas 
Pocklington Trust 
 Anita Lightstone- Head of Eye Health; RNIB 
 Prof Ann Taket- Faculty of Health and Social  Care, London South Bank 
University 
 Prof Bruce Evans- Director of Research, Institute of Optometry, London 
 Prof David Thomson- Department of Optometry  and Visual Science, City 
University, London 
 Prof Gill Rowlands -Clinical lead for the Primary Care Research Network-
Greater London 
 Prof Jennifer Evans- Department of Epidemiology & Population Health, 
London School of Hygiene & Tropical Medicine 
This group met regularly throughout the research, on a total of 4 occasions. The 
group provided helpful suggestions on all aspects of the research. 
4.2 First Study Procedure 
The first study was divided in to 4 main sections these are shown in Table 4.7, 
which also indicated the order in which all the procedures were conducted. 
Table 4.7 First study procedure. The tests are described in more detail later on in this chapter 
 
Tests Order 
pre study 
briefing 
consent form, questionnaire on previous eye care, lifestyle 
questionnaire.  
1 
vision 
Screening 
Computer Vision Screener (CVS1) 2 
 history and symptoms 3 
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gold 
standard eye 
examination 
basic refractive tests 
   distance/ Near vision and visual acuities  
   retinoscopy 
   distance subjective refraction and visual acuities             
   near subjective refraction and visual acuities 
 
4 
8 
9 
12 
binocular vision tests 
          cover test 
           fixation disparity 
           near point of convergence 
           stereoacuity 
           motility 
 
5, 10, 13 
11,14 
15 
16 
6 
pupils 7 
amsler 17 
tonometry 18 
visual field assessment  20 
external eye examination (slit lamp biomicroscopy; see 
below) 
19 
internal eye examination (see below) 21 
post study 
debriefing 
prescription and advice issued, together with list of local 
optometric practices 
22 
 
The 4 main parts to the first study will now be looked at in more detail.  
4.2.1 Pre study briefing 
Each participant was issued with a pack which included a selection of forms and 
information sheets. Participants were sent the information pack prior to their 
appointment or were asked to come in earlier so that they had an opportunity to 
read through the information prior to consenting to take part. Below is a list of all 
the documents in the information pack. The information was also available in large 
print and participants were given the opportunity of having the research discussed 
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with a family or friend. Participants who did not speak English were encouraged to 
bring a friend or a family member who could help translate during the eye 
examination and the screening. The study literature would have been translated in 
to different languages if this was needed, however this situation did not arise.  
Copies of all of these are included in the Appendix 
1) Participant information pack covering letter 
2) Information sheet 
3) Information leaflet 
4) Consent form 
5) Questionnaire on previous eye care 
6) Non participation questionnaire 
 
4.2.2 Study 1 Computer Vision Screener (CVS1) 
The literature review in Chapter 2 informed the selection of tests that were included 
in the first version of the computer vision screener. The table below shows the 
battery of tests that were included in CVS1. 
Table 4.8 Battery of tests included in CVS1 
Tests included 
in CVS1 
Test Description Studies indicating that test 
may be useful in screening  
Symptoms and 
history 
CVS1 contains questions 
regarding details of the last 
eye examination, any visual 
symptoms and details 
regarding current spectacles. 
It also contains a section on 
history and family history of 
eye conditions.  
(Smeeth et al., 2003d) 
Screening by solely asking 
questions about vision is 
inadequate. However the 
battery of tests in CVS1 will 
enable screening by asking 
questions to be evaluated in 
conjunction with other tests. 
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Near acuity 
 
 
This was tested binocularly 
with near correction in place. 
The reading passage was 
made up of words from the 
Wilkins Rate of Reading Test 
(Evans & Wilkins, 2000). The 
words are arranged in a 
pseudo-random order, rather 
than forming a ‘story’. The 
words were made larger until 
the patient was able to read 
the middle line of passage 
without any errors. The size 
of print ranged from font size 
8 to font size 24 
(Brabyn et al., 2001h) (Taylor et 
al., 1997) 
Although NV acuity may not be 
a suitable test in isolation it may 
be useful when combined with 
other tests.  
Visual field test This was conducted 
monocularly with habitual 
near correction in place. The 
test was based on the 
Henson multiple stimulus 
supra threshold programme. 
The number of points 
correctly identified was 
noted. There were a total of 
26 points shown over 8 
presentations 
(Taylor et al., 1997) 
Nearly three times more people 
had visual impairment because 
of VF loss than VA loss.  
Fixation 
disparity 
 
Both these tests were 
conducted at near with 
habitual near correction and 
red green filters. The level of 
stereoacuity was noted and 
(Davison, 1985) 
It may be possible that 
decompensated phorias 
especially vertical phorias as 
investigated by Davison may be 
correlated with driving 
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the presence of a vertical or 
horizontal slip was noted. 
accidents. 
Stereoacuity (Lord & Dayhew, 2001) 
Stereopsis was found to be a 
particularly important visual 
predictor of falls 
High contrast 
distance VA 
 
The distance acuity tests 
were conducted monocularly 
at 3m with habitual distance 
correction in place. The tests 
consisted of 4 letters in a box 
and the number of letters 
correctly read was noted. 
The letters were made larger 
until all letters were correctly 
seen. The low contrast acuity 
test was set at 10% contrast. 
The font size for high 
contrast acuity ranged from 
0.1 LogMAR to 0.5 LogMAR 
in 0.1 steps. The font size for 
low contrast acuity ranged 
from 0.3 LogMAR to 0.7 
LogMAR in 0.1 steps. 
(Ivers et al., 2001) 
In isolation Ivers and 
colleagues showed that 
measuring acuity had a poor 
sensitivity & specificity for 
detecting eye disease. However 
they did not evaluate the 
effectiveness of acuity testing 
when combined with other 
tests.  
Low contrast 
distance VA 
 (Lord & Dayhew, 2001) 
Low contrast VA was found to 
be one of the best predictors of 
falls. It was also found that 
measuring acuity monocularly 
was important because poor 
vision in one eye with good 
vision in the other had a similar 
risk to poor vision in both eyes. 
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Figure 4.1 below shows the tests that were incorporated into the first version of 
the computer screener. 
(a) Visual field test 
 
(b) Stereoacuity test 
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(c) Fixation Disparity 
 
(d) High contrast acuity 
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(e) Low contrast acuity 
 
Figure 4.1 Tests incorporated in to CVS1 
4.2.3 Gold Standard eye examination 
At the time of the eye examination, the results from the vision screening were not 
known to the research optometrist carrying out the eye examination nor to the 
patient. The screening was conducted first by a research assistant. The research 
optometrist was not present in the room when the screening was taking place. 
There were three research assistants in total working at various times during the 
study. All three assistants were given training in correctly administering the 
screening before they screened participants. The gold standard eye examinations 
were all conducted by the present author after the screening had taken place. This 
masked protocol was only broken after the record card of the eye examination had 
been completed. The computer screener took approximately 10 minutes to 
administer and the flipchart took approximately 5 minutes. The gold standard eye 
examination took approximately 1 hour. Participants were encouraged to take their 
time and were offered regular breaks. The tests used in the gold standard are 
discussed below. 
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4.2.3.1 History and Symptoms 
Participants were asked a number of detailed questions regarding their vision and 
current spectacles. The areas covered in the history and symptoms are 
summarised in Table 4.9. 
Table 4.9 History and symptoms 
Date of last eye examination 
Patients’ perception of their vision with current spectacles for distance, near, VDU use and driving 
(if applicable) 
Details of current spectacles, type of spectacles, age of spectacles, how many spectacles 
Details regarding any particular symptoms that the patient may be having including headaches, 
flashing lights, floaters, and double vision 
History of falls within the last year 
Questions regarding general health including high blood pressure, diabetes and glaucoma 
Details regarding any medication 
Previous ocular history including details of any eye procedures and appointments at the eye 
hospital.  
Family history of eye disease including high blood pressure, diabetes, glaucoma 
Details regarding contact lens wear if applicable  
History of falls within the last year 
Details regarding any particular hobbies and interests 
 
A Standardised quality of life measure was also applied at this stage. The Quality 
of Life (QoL) questionnaire (Wolffsohn & Cochrane, 2000) is a brief questionnaire 
(one side of A4) and typically take less than 10 minutes to administer (see 
Appendix). 
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The patient’s current spectacles were checked to determine what refractive 
correction was being worn by the patient (focimetry). It was possible to accurately 
focimeter the current spectacles for patients seen at the Institute of Optometry but 
this became more difficult as the study extended into community based settings. In 
these community settings an attempt was made at hand neutralisation in many 
cases, but this has relatively low accuracy, especially for varifocals. 
4.2.3.2 Distance/ near vision and visual acuities  
Monocular and binocular distance high contrast visual acuities with and without the 
patient’s habitual spectacles were measured. This was done at a distance of 6m 
when using the Institute of Optometry clinics and at a distance of 3m (using a 
laptop) when in community venues. The chart used in all situations was a LogMAR 
chart on the computerised Test Chart 2000 programme. Distance low contrast 
acuity was also measured with the patient’s habitual correction in place. The same 
chart was used at the same distance but the contrast was reduced to 10% in order 
to match the contrast of the low contrast acuity test on the screening tools. 
Monocular and binocular near acuity was measured with the patient’s habitual 
correction in place and was measured at the distance at which the patient usually 
reads and this was noted. The chart that was used was the Institute of Optometry 
Near Test Card. This card is based on a logarithmic scale and is held at the 
participant’s usual reading distance. Each passage starts with an isolated word on 
the left hand side of the card which can be used to obtain the participant’s near 
acuity threshold. The patient then reads the paragraph above their threshold on the 
right hand side of the card. This consists of words from the Wilkins Rate of 
Reading Test (Evans & Wilkins, 2000). As with the near acuity test on the 
computer screener, the words are arranged in a pseudo-random order (Figure 4.2). 
 
Page 127 of 389 
 
 
Figure 4.2 The Institute of Optometry Near Test Card 
4.2.3.3 Retinoscopy 
Retinoscopy is an objective technique for determining the refractive error of the eye 
by observing the movement of light reflected from the patient’s fundus (Henson D, 
1995).  Lenses of different powers are positioned in front of the eye until ‘neutrality’ 
of the reflex is obtained. A trial frame and lenses were used and conventional static 
distance retinoscopy using a streak retinoscope was employed with the patient 
fixating on the green rings of the duochrome (Rabbetts, 2000).  
4.2.3.4 Distance subjective refraction and visual acuities 
A conventional monocular subjective refraction was carried out to determine the 
refractive error using a trial frame and lenses and corrected monocular and 
binocular VAs were recorded. A cross cylinder technique was used to measure 
astigmatism and the refraction was checked with a +1.00 D blur test. The clinical 
procedure used  to obtain the distance subjective refraction including any 
astigmatic correction has been described in detail by Elliott (Elliott, 1997).  
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4.2.3.5 Near subjective refraction and visual acuities 
The patient’s working distance for doing near work determined the starting point for 
the near addition.  The near add was refined by placing plus and minus spheres in 
front of the initial add. Near visual acuities were also measured according to the 
procedures outlined previously. The range of clear vision with the add was noted.   
4.2.3.6 Cover test 
The cover test is a dissociation test in which each eye is covered in turn whilst the 
patient fixates a specified target at a given fixation distance. The practitioner 
observes the eye movements, from which the type of binocular anomaly can be 
diagnosed (Evans, 2002). The procedure and grading system for the cover test is 
outlined by Evans (Evans, 2002). A unilateral and alternate cover test was 
conducted for distance and near with the patient’s habitual correction and with the 
optimal correction in place.  
4.2.3.7 Aligning prism (associated heterophoria) 
When both eyes are fixating at one point which is seen in binocular single vision, 
the eyes can be slightly misaligned without causing double vision. This 
misalignment is called fixation disparity (Evans, 2002).  Although the tests used in 
this study did not measure the degree of fixation disparity; that is the amount by 
which the eye is actually deviated, the test measured the amount of aligning prism 
(associated phoria). This is the minimum strength of prismatic lens required to 
neutralise the fixation disparity (Evans, 2002).  
The aligning prism for distance and near was determined with the optimal refractive 
correction in place.  The Mallett fixation disparity unit was used to measure the 
aligning prism at near and when the study was being conducted at the Institute of 
Optometry, the Mallett fixation disparity test for distance was used. When the study 
was based at community venues, a distance Mallett fixation disparity test was not 
available and so the fixation disparity test on Test Chart 2000 was used. This 
follows the same principles as the Mallett test, but uses red/green filters instead of 
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polarised filters. The procedure used for the measurement of aligning prism is that 
described by Evans (Evans, 2002). 
4.2.3.8 Near point of convergence 
The near point of convergence (NPC) is the nearest point where the lines of sight 
intersect when the eyes converge to the maximum. This point is usually 8-10cm 
from the spectacle plane (Millodot, 2000).  
This test was conducted with the patient’s optimal near refractive correction in 
place and the patient was instructed to look at a single letter at near, one size 
larger than their near threshold acuity. The target was moved towards the patient 
and they were asked to report when the letter appeared double (break point). The 
target was then withdrawn until recovery occurred. The break and recovery NPC 
points were recorded in centimetres (to nearest 1cm) from the corneal plane. The 
break point was recorded first followed by the recovery point.  
 4.2.3.9 Stereoacuity 
Stereoacuity is a measure of stereopsis which is the awareness of the relative 
distance of objects from the observer by means of binocular vision and based on 
retinal disparity. Stereoacuity represents the ability to detect the smallest difference 
in depth between two objects (Millodot, 2000). There are a number of stereoacuity 
tests available and the test used in this study was the Randot stereo test. 
Two subtests of the Randot stereo test were used to facilitate the testing of 
individuals at different levels. As outlined by the manufacturer’s manual, the first 
subtest consisted of large homogenous areas containing simple forms at two levels 
of gross disparity, with each set having one blank to act as control. The patients 
wore polarised analysers and were asked to identify the forms within the boxes at a 
distance of 40cm .The patients were given the time they needed without feeling 
rushed. The level of stereopsis measured in this subtest is 500 and 250 seconds of 
arc. 
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The second subtest consists of 10 sets of 3 circles of which only one circle of each 
set has crossed disparity, which, when seen binocularly, should appear to stand 
forward from the other two. The level of stereopsis of the last circle to be chosen 
correctly is recorded. If one is missed, the preceding line is tested again to 
determine whether the subject can achieve this level of stereopsis or whether they 
were just guessing. The score on this variation ranged from 400 to 20 seconds of 
arc.  
4.2.3.10 Motility 
This test is designed to assess the integrity of the extraocular muscles and their 
associated neural pathways. The patient was asked to fixate a penlight, which was 
moved in eight meridians (following a star pattern) whilst keeping his or her head 
still (Millodot, 2000). 
The test was carried out binocularly in 8 directions of gaze at a distance of 50 cm 
as outlined by Elliott (Elliott, 1997).  It was noted if the patient was experiencing 
any pain, discomfort or double vision. The results were recorded using the 
acronym S.A.F.E (see Table 4.10 below). 
Table 4.10  Recording Motility 
Recording 
Motility 
Comment 
Smooth if jerky, grade as 1 (minimal), 2 (definite but mild, 3 
(moderate), 4 (markedly jerky, unusual), 5 very jerky, 
highly unusual 
Accurate  
Full degrees of restriction was noted in degrees 
Extensive 
 
For a patient with strabismus, normal motility can be recorded as ‘No incomitancy 
detected’. 
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4.2.3.11 Pupils 
The size and shape of the pupils were noted and with the room lighting reduced, a 
pen torch was used to examine the direct and consensual reflexes.  The light was 
directed towards each eye from the side and the presence of direct and 
consensual reflexes were noted and whether or not the response was equal in 
each eye. The pupils in older patients are often small and this can make assessing 
pupil reactions difficult. 
The afferent pupil pathway was also tested in every case but was particularly 
important where the vision in one eye was reduced as an afferent pupillary defect 
may indicate a causative lesion, typically an optic nerve lesion or severe retinal 
disease. An afferent defect may also be present when the eyes have equal 
acuities, as it often precedes the reduction in acuity caused by certain conditions 
such as optic neuritis. The afferent pupil pathway was evaluated using the 
swinging flashlight test where each eye is illuminated in turn. The affected eye will 
show pupil dilation despite being illuminated. The procedure used and the notation 
used to record the pupil reactions have been described by Elliott (Elliott, 1997). 
4.2.3.12 Amsler 
The Amsler chart is designed to detect abnormalities in the central visual field. The 
chart consists of a white grid of 5mm squares on a black background with a central 
fixation dot. When fixated at a distance of 30cm, the entire chart subtends an angle 
of 20 degrees (Millodot, 2000). The test is carried out monocularly with the 
patient’s best corrected near prescription in place. The patient was asked to look 
directly at the central spot with the uncovered eye and to mark out any black spots, 
distortion of lines or blurred areas on grid. The number of small squares within the 
area delineated by the patient was counted and scotoma and metamorphopsia 
score was graded numerically as outlined by Verma and colleagues (Verma et al., 
2004). 
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4.2.3.13 Tonometry 
Tonometry was an important part of the gold standard eye examination because it 
was used as part of a battery of tests (including visual field examination and optic 
nerve head examination) to screen for glaucoma, The Perkins Tonometer is a 
portable contact tonometer based on the same principle as a Goldmann 
Tonometer (Henson D, 1995) and it was used as recommended by Elliott (Elliott, 
1997). Contact tonometry requires the instillation of a topical anaesthetic 
(Benoxinate hydrochloride 0.4%) and Fluorescein Sodium Chloride. When the 
study was based in the community, the Perkins tonometer was the only method of 
assessing intraocular pressure. However, at the Institute of Optometry other 
methods of non-contact tonometry were also available. These other methods were 
only used for those patients who were not willing to have drops administered for 
contact tonometry. 
4.2.3.14 Visual Field assessment 
Two types of visual field instruments were used in the gold standard eye 
examination. When based at the Institute of Optometry the Humphrey Visual Field 
Analyser (HFA) was used.  When based in the community, a Frequency Doubling 
Technology instrument (FDT) was used because this is compact enough to be 
transported to the venues. 
The FDT is a method of testing the visual field based on the frequency doubling 
illusion and thus assessing the functional integrity of the large diameter 
magnocellular retinal ganglion cells which are very susceptible to early 
glaucomatous damage (Litwak A B, 2000). This is a self-contained computerised 
perimeter in which the stimulus display consists of a low spatial frequency 
sinusoidal grating which flickers in a counterphase fashion. The grating is 
presented in many locations throughout the visual field and the patient’s task is to 
detect the stimulus by identifying the quadrant in which it is present (Millodot, 
2000). FDT perimetry compares well with conventional visual field testing for the 
detection of glaucoma,(Allen et al., 2002a;Tatemichi et al., 2002a) but is less 
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effective at detecting rarer visual field defects from neurological causes (Fong et 
al., 2003b). 
The FDT is portable and ideal for a community- based setting because it is 
independent of room illumination and independent of refractive error up to a certain 
degree as stated in the manufacturer’s manual. This is because the contrast 
grating is affected little by defocus therefore the stimuli should be relatively 
resistant to blur (Delgado et al., 2002). It is also suggested that pupil size has no 
effect on the outcome of the test and this made it particularly appropriate for the 
current study as the effect of the dilating drops did not impact the visual field 
results.   
An N-30 threshold test was carried out on all patients. 19 test locations were 
examined and the visual field eccentricity tested extends 30 degrees nasally to 20 
degrees temporally. The central test location is circular and has a diameter of 10 
degrees. The remaining 18 locations cover squares of 10 degrees by 10 degrees. 
The HFA (model 750) used at the Institute of Optometry is a computerised 
perimeter. It uses 31.5 apostilb background illumination (10.0 cd/m2) and a 
stimulus size III (with the capability of changing size from I to V).  During the test, 
the intensity of the stimulus changes depending on the patient’s response. 
However, the stimulus size remains the same throughout the test (Dersu & 
Wiggins, 2006a).  
A SITA fast threshold strategy was used (24-2 SITA Fast) which has been shown 
to produce repeatable thresholds in a short test duration. Threshold values are 
constantly calculated throughout the test at the same points. If results are too 
different, those points are tested again. The test strategy used incorporates the 
Glaucoma Hemifield Test (GHT) and this compares points on the upper field to 
corresponding points on the lower one. It is based on the idea that the sensitivity of 
the field should be similar in both hemifields. It describes the field as normal, 
borderline or outside normal limits. When the GHT reads "outside normal limits" it 
is stating that the difference in the upper and lower sets of points would not be 
found in 99% of patients without glaucoma. "Borderline" means the difference 
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detected would not be found in 97% of patients without glaucoma (Dersu & 
Wiggins, 2006b). 
4.2.3.15 External eye examination 
The external eye was examined using a slit lamp biomicroscope. The structures 
observed are listed below in Table 4.11 together with the grading scales that were 
used to aid investigation.  
Table 4.11 Structures examined and grading scales used for external eye examination 
Structure Grading scale 
Blepharitis  Each of these conditions was graded from 0 
(normal) to 4 (severe) using the Efron grading 
scale (Efron, 1998)  Meibomian Gland dysfunction 
Conjunctival redness 
Limbal redness 
Pingueculae/Pterygium  This was graded using photographs from a 
contact lens management handbook (Anderson 
et al., 2002) 
Cornea The presence of any corneal abnormality was 
noted 
Anterior Chamber angle  The angle was graded from 0 to 4 using the Van 
Herick technique (Van Herick W. et al., 1969a) 
Anterior Chamber cells/flare This was graded according to the scale outlined 
by Kanski (Kanski, 1999) 
  
The depth of the anterior chamber was assessed by grading the angle between the 
posterior cornea and the anterior iris. This was measured using an optic section at 
an angle of 60 degrees at the limbal edge. This method is known as the Van 
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Herrick Technique and includes 5 ratios where 0 indicates a closed angle and 4 
indicates an angle that is wide open. This test allows some prediction of the risk of 
angle closure glaucoma and as such is important prior to the installation of any 
mydriatic drugs (Elliott, 1997).  
At this stage in the routine, one drop of tropicamide hydrochloride 0.5% was 
instilled in to each eye. Tropicamide is an antimuscarinic and causes pupillary 
dilation within 20 minutes of instillation so that internal eye examination could take 
place. 
4.2.3.16 Internal eye examination 
The internal eye was assessed using a combination of direct and indirect 
ophthalmoscopy. The structures investigated and the grading scales used are 
included in Table 4.12 below. 
Table 4.12 Structures examined and grading scales used for internal eye examination 
Structure Grading Scale 
Lens The LOCS III grading scale was used in the assessment of the lens for the 
presence of any age related lens opacities as explained earlier in this 
chapter. The grading scale is a series of colour slit lamp and retro 
illumination photographs that are used as standards for grading the 
opacities. 
The pupil was at least 6mm in diameter when dilated for the grading 
technique to be conducted. A slit beam (0.2mm in width) at an angle of 45 
degrees to the line of vision was used in order to grade nuclear cataract. 
The beam height was just tall enough to overlap the pupil margin. In order to 
grade cortical or posterior sub capsular cataract the height and width of the 
slit beam was reduced. The slit beam was positioned to enter the pupillary 
space at either the 3 or 9 o’clock position 
Vitreous Any abnormalities of the vitreous were noted, including vitreous floaters and 
signs of synchisis and syneresis as explained in Chapter 1 
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Optic Disc The cup to disc ratio was graded using the Pearson Optometric Grading 
Scale (Pearson R M, 2003b). Disc features were evaluated with specific 
reference to glaucoma as this is a common condition prevalent in the older 
population. An optic nerve head evaluation checklist was used as a 
guideline. The checklist included the assessment of clinical features such as 
the presence of acquired pits, disc haemorrhages, peripapillary atrophy, 
neural retinal rim colour, notches and thinning (Litwak A B, 2000). 
Retinal 
vessels 
Retinal vasculature was graded using the Pearson Optometric Grading 
Scale. The grading scale evaluates the vessels in term of AV ratio, arterial 
reflex and tortuosity (Pearson R M, 2003c). It is known that these features 
are important in the detection of hypertension. 
Background  The background was assessed for common age related conditions such as 
diabetes and hypertensive retinopathy, these have been explained in 
Chapter 1. The presence of any other abnormal features was noted.  
Macular The degree of macular degeneration present was also noted using a staging 
system (Seddon et al., 2006c). Any other abnormalities were noted. 
 
4.2.4 Post study debriefing 
Where visual problems were detected, every effort was made to help participants 
by referring (with consent) for optometric and/or medical investigation and 
treatment as appropriate. The usual referral pathways were followed and these 
have been outlined earlier in the chapter. For most conditions, the usual procedure 
is for the optometrist to refer the patient to the GP and for the GP to then refer to 
an ophthalmologist. If the condition is an ocular emergency then the patient is 
referred directly to an ophthalmologist. A prescription was issued to each 
participant at the end of the eye examination stating whether there had been a 
change. Advice was given on the type of spectacles needed and what they should 
be used for. Further information was given on their eligibility for free NHS glasses 
and the provision of these by local optical practices in the South London area. 
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Investigation into the provision of NHS eyecare in South London was conducted as 
a preliminary study and is described in Chapter 5.  
When the eye examination was being conducted the practitioner was not aware of 
the results from the screener so that a masked design was kept. Once the eye 
examination was completed the results from the screener were made available to 
the optometrist so that if a problem was detected on screening that the optometrist 
was unaware of during the eye examination, then the patient would have been 
referred or re-examined as appropriate. 
The participants were also asked to complete a short questionnaire to evaluate the 
screening procedure. This and the other documents given to the patient at the end 
of the examination are included in the Appendix. 
4.3 Second Study  
The aim of the first study was to investigate the sensitivity and specificity of the first 
version of the computerised vision screener (CVS1) for identifying correctable 
visual loss. The results enabled cut-off values for each of the tests to be 
established that indicated the value above which further investigation was indicated 
(i.e. referral to an optometrist). As well as considering individual tests, we sought to 
investigate combinations of tests, with the aim of deriving a suitable battery of tests 
that could be incorporated into the revised computerised vision screener (CVS2) 
and a flipchart screener. The main aim of study 2 was to evaluate the refined vision 
screener on a different population of older people and also to assess the 
effectiveness of the screening tools in a more community-based environment. 
The procedure for study 2 was exactly the same that for the first study except both 
the flipchart screener and the revised vision screener were administered. Both 
systems were used to test a further 200 elderly people. These participants were 
seen in a variety of settings as described in Table 4.4. Participants were also given 
a full eye examination as in the first study. The only test that was omitted from the 
gold standard was stereo acuity, because this was not found to be useful in the first 
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study (see Chapter 7). Both the optometrist and the screener were masked to each 
other’s results. 
When uncorrected refractive errors, significant cataract, or other ocular or systemic 
pathology were detected, the participant was referred as appropriate. The same 
diagnostic criteria were used as outlined for the first study. As in the first study, 
participants were followed-up to discover the outcome. Standardised quality of life 
measures were applied at the eye examination and at follow-up as outlined for 
study 1.  
The sensitivity and specificity of both the revised computerised screener and the 
flip-chart rapid screener for identifying the target conditions were calculated. The 
secondary outcomes of Study 2 were to determine the sensitivity and specificity of 
the screening tests for detecting other visual conditions, such as glaucoma and 
age-related macular disease and to investigate the effect of vision screening on 
quality of life.  
4.3.1 Refined computer vision screener 
Two tests in CVS1 were found to be of little value for detecting the target 
conditions (Chapter 7) and were not included in CVS2. The table below 
summarises the screening tests incorporated in the three screening instruments. 
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Table 4.13 Tests incorporated into screening tools. All the tests listed in the first column were used in 
CVS1. 
Test CVS2 Rapid flipchart screener 
Symptoms and history Yes Yes 
Near acuity Yes Yes 
Visual field test Yes No 
Stereoacuity No No 
Fixation disparity No No 
High contrast distance acuity Yes Yes 
Low contrast distance acuity Yes Yes 
 
4.3.2 The rapid flipchart screener 
Analyses of the results with CVS1 (Chapter 7) enabled the key tests to be made 
available in a flipchart format. The flipchart is a cost effective simple method of 
screening that may be suitable for places where computerised testing is not 
appropriate.  This was a more a rapid screening tool and was evaluated in the 
same way as the refined computerised screener. The rationale behind the present 
research was to evaluate the flip-chart screener under conditions similar to those in 
which it may ultimately be used and therefore special lighting was not used, other 
than the best that could be provided in the available setting. For example, in the 
Woodlawns community centre the room lights were turned on and the window 
curtains kept open. 
The table below shows which tests were used in the flipchart screener. The visual 
field test that was included in the computer vision screener could not be 
implemented in a flip-chart format. 
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Table 4.14 Tests included in Rapid Flipchart Screener 
Tests Included Monocular or Binocular Font size 
Presenting near visual 
acuity 
Binocular N7, N9, N12 
Presenting distance visual 
acuity 
Monocular Logmar 0.2,0.3,0.4,0.5 
Presenting low contrast 
acuity 
Monocular Logmar 0.4, 0.5, 0.6 
 
The size of the letters chosen was based on the cut-off values derived in the first 
version of the computer screener. 
4.3.2.1 Scoring system for rapid flipchart screener 
The computerised screening tool had an automated scoring system that passed or 
failed the participant depending on the outcome of the tests and which stored the 
results for subsequent analysis. For the rapid flipchart screener, the three tests 
each had a simple scoring system resulting in a final number at the end of the 
screening procedure. The goal of developing this scoring system was to have clear 
and simple step-by-step instructions printed on the flipchart screener so that it 
could ultimately be used by lay personnel (e.g., care assistants). This scoring 
system will now be explained and images of the flipchart screener below show how 
clear the instructions are. The figure below shows the score sheet that was 
completed for each patient to determine their overall score for the flipchart 
screener. 
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Figure 4.3 Score sheet for rapid flipchart screener 
  4.3.2.2 Scoring near acuity 
Participants were invited to hold the flip-chart screener at a normal reading 
distance and view the paragraph of text printed on the page. The paragraph was 
constructed from the same simple words employed by the Wilkins Rate of Reading 
test in order to avoid contextural cues. The text on the first page was printed in 
Arial font in 7 point size and participants were asked whether they could read the 
text easily.  If the answer was “yes”, the test was repeated for the other eye.  If the 
answer was “no”, the participant was shown the next page which was printed in 9 
point text.  This process was repeated for increasing font sizes until the ceiling of 
12 point size was reached. A simple numeric scoring system was developed to 
describe the endpoint of the test (see Table 4.15). 
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Table 4.15 Scoring near acuity on the rapid flipchart screener 
page Font 
Size 
Patient 
response 
Score Next Action 
3 N7 Easy 1 End of near acuity screening, begin 
distance acuity screening 
 N7 Not easy  Move on to larger size near text. 
4 N9 Easy 2 End of near acuity screening, begin 
distance acuity screening 
 N9 Not easy  Move on to larger size near text. 
5 N12 Easy 3 End of near acuity screening, begin 
distance acuity screening 
 N12 Not easy 4 End of near acuity screening, begin 
distance acuity screening 
 
Figure 4.4 below shows a few pages from the flipchart screener that relates to the 
testing of near vision and illustrates more clearly how the instructions are 
incorporated in to the screener.  Illustrations a) and b) are shown to the participant 
in turn and this is accompanied by instructions for the person that is administering 
the screening (b and d).  
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a) 
 
b) 
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c) 
 
d) 
 
Figure 4.4 Testing of near acuity with flipchart screener 
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4.3.3.2.2 Scoring distance acuity 
Distance visual acuity is measured using the flip-chart screener by asking the 
patient to read four letters surrounded by a crowding rectangle from a distance of 4 
metres.  The letters are in a Bailey-Lovie format and have a contrast of close to 1. 
On the first page the letter size equate to LogMAR 0.2 and the screener records 
the number of letters correctly identified.  If all letters on this page are correctly 
identified the screener moves straight on to repeat the test with the other eye.  If 
one or more letters are read incorrectly, the next page of letters is shown which 
equates to 0.3 LogMAR.  This procedure is repeated until all four letters are 
correctly identified or the ceiling of 0.5 LogMAR is reached.  A simplified scoring 
method is used to keep a tally of the number of letters read which is used to work 
out the final LogMAR score (see Table 4.16) 
Table 4.16 Scoring distance visual acuity on the rapid flipchart screener. Four optotypes were present 
on each page. 
page LogMAR 
Size 
Patient 
response 
Score Next Action 
8 0.2 4 correct 0 End of test, begin low contrast testing 
  3 correct 1 Move on 0.3 logmar 
  2 correct 2 Move on to 0.3 logmar 
  1 correct 3 Move on to 0.3 logmar 
  None correct 4 Move on to 0.3 logmar 
9 0.3 4 correct 0 End of test, begin low contrast testing 
  3 correct 1 Move on to 0.4 logmar 
  2 correct 2 Move on to 0.4 logmar 
  1 correct 3 Move on to 0.4 logmar 
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  None correct 4 Move on to 0.4 logmar 
10 0.4 4 correct 0 End of test, begin low contrast testing 
  3 correct 1 Move on to 0.5 logmar 
  2 correct 2 Move on to 0.5 logmar 
  1 correct 3 Move on to 0.5 logmar 
  None correct 4 Move on to 0.5 logmar 
11 0.5 4 correct 0 End of test, begin low contrast testing 
  3 correct 1 End of test, begin low contrast testing 
  2 correct 2 End of test, begin low contrast testing 
  1 correct 3 End of test, begin low contrast testing 
  None correct 4 End of test, begin low contrast testing 
 
The scoring system for low contrast visual acuity is the same as that for high 
contrast acuity. However, with low contrast acuity the LogMAR ranges were 0.4 to 
0.6. The contrast of the low contrast charts was 10%. 
Figure 4.5 below shows the first few pages for the testing of high contrast acuity 
together with the instructions for the person administering the screening. Unlike the 
figure, in the present research an eye patch was used to occlude the eye not being 
tested. 
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(a) 
 
(b) 
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(c) 
 
(d) 
 
Figure 4.5 Testing of high contrast distance acuity with flipchart screener 
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4.4 Chapter summary 
This chapter has concentrated on the methods of the main study outlining the 
computer screening tests used and the gold standard eye examination. The tests 
used in the flipchart screener have also been described. Before the results of this 
main study are presented, the next chapter will give details of two preliminary 
studies that were conducted. The first preliminary study investigated the provision 
of NHS eyecare in South London and the second study was a supplementary study 
incorporated into Study 1 which involved investigating the grading of cataract with 
the LOCS III grading system. 
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Chapter 5   
Provision of NHS primary eyecare 
in South London  
The previous chapter outlined the procedure for the main study. Two smaller 
studies that were conducted in parallel to the main study will be described in the 
next two chapters. Both studies provided important information that was used to 
inform the design of Study 1 and were necessary to the development of Study 2. 
The first study described in this chapter was designed to assess the provision of 
NHS eyecare in South London. The second supplementary study (Chapter 6) 
focussed on the grading of cataract using the LOCS III grading system with two 
types of instruments. 
5.1 Background 
A brief overview of the eyecare services available to older people in the UK was 
provided in Chapter 1. It was noted that although eyecare is available for older 
people,  between 20 and 50% of older people do not avail themselves of the 
services and as a result have undetected reduced vision (Evans & Rowlands, 
2004k). In the majority of cases the reduced vision could be corrected with 
spectacles or cataract surgery.  
Anxiety about the cost associated with eyecare seems to be a major factor in 
deterring older people from seeking eyecare (Conway & McLaughlan, 2007). This 
is perhaps surprising because, in the UK, the NHS funds a basic ‘sight test’ for 
people aged 60 and over by primary eyecare practitioners (usually community 
optometrists). The fact that this state-funded sight test is not available to most 
adults under the age of 60 years, and that government policies on this have been 
inconsistent over the last 20 years, might explain why some older people seem 
unaware of the availability of state-funded eyecare. This recent history throws light 
Page 151 of 389 
 
on the effect of cost on the take-up of primary eyecare services and will now briefly 
be reviewed. 
Between 1958 and 1989 all citizens of the UK were eligible for a “free” sight test 
paid for by the NHS and the take up was relatively high. In 1989, eligibility for an 
NHS sight test was restricted to children, students and those on low incomes or at 
high risk of eye disease. This removal of universal NHS funded sight tests resulted 
in a considerable reduction in the number of people receiving community eyecare 
(Conway & McLaughlan, 2007) and this had a knock-on effect on the number of 
referrals to the hospital eye service. For example, the numbers of patients being 
identified as requiring treatment or follow up for glaucoma declined by nearly one 
fifth (Laidlaw et al., 1994). Pressure from the public and lobbying from various 
professional bodies and other organisations eventually led to the reintroduction of 
sight tests funded by the NHS for all people over the age of 60 years in 1999. This 
decision had an immediate effect on the number of older people seeking eyecare. 
Between 1999 and 2000, 5,434 million people over the age of 60 had an eye test 
funded by the NHS in England and Wales, an increase of 34 per cent on the 
previous year for this age group (Department of Health, 2006). However, concerns 
about the take-up of eye tests among older people remain as it is estimated that 
about 4.2 million older people (or 43% of those aged over 60 years) do not have 
eye examinations at the recommended frequency (RNIB, 2008). 
Although some optometrists are seeking to enhance the services they offer by 
charging a supplementary fee for additional tests (e.g., fundus photography), this is 
still rare and patients would still be able to obtain the basic NHS sight test free of 
charge (Association of Optometrists, 2003). 
A recent survey commissioned by the Eyecare Trust and the Central (LOC) Fund 
revealed that fear of cost seems to be a major barrier to many older people caring 
for their eyes, as 30% of those surveyed believed it would 'cost a lot of money' 
(Eyecare Trust, 2007). The main fear that older people seem to have concerning 
the costs of a visit to eyecare practitioners does not relate to the examination 
(because older people are entitled to NHS funded eye examinations) but rather the 
cost of spectacles (Conway & McLaughlan, 2007). This is perhaps surprising 
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because people on low income are entitled to an NHS Optical Voucher which can, 
depending on level of income, be used to fully or partially offset the cost of 
spectacles. Specifically, people on Pension Credit are eligible for an NHS Optical 
Voucher (GOS 3 form; described below) and nearly half of all people receiving a 
state pension are eligible for Pension Credit (Age concern, 2005). Even if older 
patients are not eligible for pension credit, they may still be entitled to an NHS 
voucher if they make a low income scheme claim by completing an HC1 form. This 
is aimed at those on a low income but whose income exceeds the amount that 
would entitle them to receive Pension Credit.  The claim may result in either an 
HC2 certificate which entitles the person to the maximum NHS voucher value or a 
HC3 certificate which entitles the person to limited help toward the cost of glasses. 
The NHS voucher scheme was introduced in July 1986. Free NHS spectacles were 
replaced by means-tested NHS optical vouchers which could be put towards the 
cost of spectacles. The voucher scheme gives eligible patients flexibility over which 
glasses or lenses to choose. Patients are able to take the voucher to the provider 
of their choice (although, as noted below, this practice is discouraged by the 
College of Optometrists because it is associated with an increased risk of 
consumer complaints). The scheme also gives patients flexibility to top up the 
voucher value (if they wish) to obtain more expensive frames of their choice. 
However, patients may be deterred from using vouchers at certain practices 
because they do not stock a range of spectacles within the voucher value 
(Government Response to the Health Committee's Report on NHS Charges, 
2006c). This report will be returned to in the discussion. In the discussion below, 
the term voucher-value spectacles (VVS) is used to describe spectacles where the 
cost is fully covered by the voucher, i.e. spectacles that are free of charge for 
eligible patients. 
Under the National Health Service (General Ophthalmic Services) Regulations 
1968, ‘opticians’ are required to display a notice showing the services available 
under the NHS General Ophthalmic Services and listing which patients are entitled 
to a free NHS sight test and/or an optical voucher towards the cost of glasses or 
contact lenses (Government Response to the Health Committee's Report on NHS 
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Charges, 2006b). The regulations at present do not compel practices to provide 
VVS. The NHS Optical Voucher has been criticised in the optical press as making 
it uneconomic to provide VVS (Optician, 1986a). Having searched PubMed and 
DoH databases, no data was found on the proportion of optical practices that 
provide VVS. If this proportion was known then it could be monitored over time to 
determine whether the availability of VVS is changing. One of the objectives of this 
preliminary research was to provide an indication of the proportion of optical 
practices which provide VVS spectacles. Frame choice is important when selecting 
spectacles and so the number of frames available for VVS was also investigated. 
 5.2 Methods 
A questionnaire (see Appendix) and a covering letter were sent to two different 
populations of optometrists. The first population included all optical practices in 
South London which were identified by searching the Opticians Register (General 
Optical Council, 2005). This population was chosen so that a list of eyecare 
practices in South London which provided VVS could be produced and given to 
participants after the gold standard eye examination as part of the main study. 
For a second, more national sample of optometrists the UK, the optometry e-mail 
discussion list was used. This is a forum, hosted by Manchester University, which 
included at the time of the survey 303 members and is used to discuss clinical and 
other issues relating to optometry. The questionnaire in the Appendix was sent to 
all members of the list. 
5.3 Statistical analyses 
For continuous variables, if the data appeared to be non-normally distributed 
(determined by comparison of mean and median and by inspection of frequency 
distributions) then non-parametric statistics were used. Where means or medians 
are cited, the 95% confidence limits are given in parentheses. The confidence 
limits were calculated for parametric data from the mean and standard deviation 
while for non-parametric data percentile rankings were used. 
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5.4 Results 
In the South London sample, 65 questionnaires were sent out and 53 responses 
were received (response rate 82%). There were 22 responses from the 303 
members of the UK optometry e-mail discussion list (response rate 7%: see 
Discussion), giving a combined sample size of 75. 
All respondents provided NHS sight tests. For patients eligible for an NHS 
Voucher, complete spectacles were provided at no additional charge by 59% of the 
respondents (70% of the South London sample and 32% of the e-mail sample). 
Of those who supplied VVS, the number of frames that were provided for patients 
to choose from ranged from 1 to 100, with a median of 16.5 (0-100). In the South 
London sample, the median was 20 (0-100) and in the e-mail sample the median 
was 10 (3.3-19.1). 
Practices that did not provide VVS were asked if the voucher at least covered the 
cost of the lenses. 13% of the practices surveyed were in this category and of 
these the minimum cost of a frame ranged from £5 to £65, with a mean of £25.  
5.5 Discussion 
Using the combined data from both sample groups, just over half of practices 
reported that they could provide spectacles whose cost is fully covered by the NHS 
Optical Voucher. However, this proportion was markedly different for the two 
sample groups. The reason for this difference will now be considered. 
There was a low participation rate in the e-mail sample (22 of 303). Many members 
of the UK optometry e-mail discussion list do not routinely contribute to the 
discussions, but merely “listen” to a minority of members who make frequent 
contributions. It is therefore not surprising that only a minority of members 
participated. It seems possible that practitioners who invest time in participating in 
this list may tend to be particularly progressive in terms of developing their clinical 
skills. What impact this may have, if any, on the NHS services that they provide is 
unclear. It is apparent from an inspection of the respondents to the survey that their 
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locations are scattered throughout the UK, and it is thought that their practices are 
likely to provide eyecare to a broad spread of socio-economic groups. 
In contrast, the South London region (Southwark, Lambeth and Lewisham) 
covered by the first sample includes a disproportionate number of areas associated 
with deprivation and poverty. A report titled, ‘London divided. Income inequality and 
poverty in the capital’ (Livingstone K, 2002) indicates that deprivation in London 
appears to be concentrated in the eastern and southern parts of inner London, with 
areas such as Lambeth and Southwark featuring strongly among the most 
deprived. It is likely that in areas where there is a higher than average proportion of 
people on low income, there will be a greater demand for VVS and patients are 
more likely to ‘shop around’ for a practice that will provide these.  
Nonetheless, even in South London nearly a third of the practices that responded 
to the survey do not provide VVS. The response rate in this area was high (82%), 
so it is likely that this figure is fairly accurate. The next section in this chapter will 
now consider the effect of this on patients on low income who may have their eyes 
examined at a practice where no VVS are available. 
5.5.1 The impact of the unavailability of spectacles fully funded by the NHS 
As noted above, patients can take their NHS Optical Voucher from the practice at 
which it was prescribed and ‘shop around’ to find a practice that will provide VVS. 
This is undesirable since there is an increase risk of spectacle non-tolerance and 
intractable consumer complaints if the spectacles are dispensed at a practice that 
is different to the practice at which they were prescribed (Optical Consumer 
Complaints Service, 2006). This is why the College of Optometrists, a public 
benefit body, recommends in advice to the public: ‘The prescribing and dispensing 
of spectacles are very closely linked and it would be in your best interests to have 
your spectacles dispensed where you have your eyes examined’ (College of 
Optometrists, 2005). 
Even if patients are not aware of this recommendation, it is usually more 
convenient for patients to obtain their spectacles from the practice at which they 
were prescribed. If the patient cannot afford the spectacles at this practice then the 
Page 156 of 389 
 
patient may decide not to have new spectacles, even when clinically necessary. 
This is particularly likely for older patients who may have mobility problems and are 
therefore less likely to take their prescription to another practice. Alternatively, 
patients may decide to have spectacles where they are prescribed, but are left with 
costs that cause them financial difficulties. This is likely to deter them from seeking 
eyecare in the future. Even when a practice does provide VVS, the results from the 
survey show that the range of frames is usually rather limited. Although the median 
number of frames available in our combined sample is 16.5, a proportion of these 
will be children’s frames. As such, only a small number of frames would be suitable 
for older people.  
Earlier in this chapter it was noted that a recent government report recommended 
that the optometry contract should be amended to require all eyecare practices 
providing General Ophthalmic Services (GOS) to provide a range of VVS 
(Government Response to the Health Committee's Report on NHS Charges, 
2006a). Such a requirement could be counter-productive if the value of the 
vouchers remains uneconomic because it could force practices to withdraw from 
providing NHS services. Since market forces apply to encourage optical practices 
to provide VVS, perhaps a more appropriate policy to increase the availability of 
VVS would be to increase the value of the voucher to an economically viable level 
(Optician, 1986b). 
Previous research and reviews have demonstrated high levels of unmet visual 
needs amongst older people (Reidy et al., 1998d) which impact of quality of life 
(Evans & Rowlands, 2004l). Many of these problems could be resolved by an 
optometric examination and the provision of suitable spectacles (Jessa et al., 
2007). Unmet visual need is  more common amongst those already disadvantaged 
through socio-economic deprivation (Reidy et al., 1998c) and those from minority 
ethnic groups (Lindesay et al., 1997). The survey indicates that sub-optimal 
availability of, and patient awareness of, VVS may exacerbate the prevalence of 
this unmet visual need. Better understanding by the public of the availability of free 
eye tests and ‘free’ spectacles, combined with better availability of VVS, is likely to 
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improve the visual welfare and quality of life of a significant proportion of elderly 
people.   
5.5.2 Limitations of the research 
It is acknowledged that the sample size for this preliminary study is modest; it 
would be interesting to carry out a national survey to establish a more accurate 
estimate and to analyse geographical variations. 
Another limitation of this study was that it was questionnaire–based and subject to 
a number of biases. For the South London survey, respondents were told that the 
primary purpose of the survey was to generate a list of practices that could be 
given to people who were found to be eligible for an NHS Optical Voucher in the 
main study. Therefore, some respondents may have been inclined to exaggerate 
the provision of VVS at their practice.  
It is also possible that some respondents included frames that are available, but 
which are not necessarily on display nor offered routinely to eligible patients as 
VVS. This is particularly likely in some of the more commercial practices where 
dispensing staff are paid on a commission basis. It would be interesting to research 
this using a ‘standardised patient’ methodology (Shah et al., 2007) that has 
recently been applied to optometry (Shah et al., in preparation).  
Even when VVS are available to people who are on low income, this will only be 
relevant if the patient meets the NHS eligibility criteria. In most cases, this means 
that the patient has to be receiving Pension Credit. As explained earlier there is 
another route to eligibility, through filling in an HC1 form, but this is a very detailed 
form and it is possible that the complexity of the HC1 form acts as a deterrent to 
many patients. New research from Age Concern shows that 6 out of 10 lower 
income pensioners are deterred from claiming benefits by the complex system, 
with almost half finding means-testing too intrusive and 48% being discouraged by 
the complicated forms (Age concern, 2007b). A recent press release by Age 
Concern indicates that a third of those entitled to claim pension credit are still not 
receiving this. Despite significant increases to the cost of living for pensioners in 
recent years, up to £2.5 billion is left unclaimed each year (Age concern, 2007a)  
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The limitations of the research that are described above would mostly result in an 
overestimation of the uptake of VVS. In other words, the best estimate is that about 
half or less of older people with low income are able to readily obtain VVS. It is 
likely that this is one of the barriers that result in so many older people in the UK 
having poor vision simply through lack of appropriate spectacles. 
The results of this preliminary study provided the information necessary to develop 
a list of all the practices in the South London area that provided spectacles whose 
cost was fully covered by the NHS. This list was given to all eligible participants at 
the end of the study together with a copy of their spectacle prescription as outlined 
in Chapter 4. A copy of the documents given to participants after the study is 
enclosed in the Appendix.  
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Chapter 6  
Comparison of cataract grading 
performed with a standard and 
portable slit-lamp biomicroscope 
6.1 Background 
Cataract is defined as a partial or complete loss of transparency of the crystalline 
lens substance or its capsule (Millodot, 2000). Although cataract can occur at any 
age, it is primarily an age-related condition. The prevalence of cataract in 
developed countries is 35% of those aged 65+ (Martinez et al., 1982b) increasing 
to 46% of those aged over 75 years (Gibson et al., 1985). 
Because the onset of the condition is gradual, the diagnostic criteria are important. 
Cataract can be described by its observed clinical characteristics or by its effect on 
vision. There are problems with judging the severity of cataract from the effect on 
vision. For example, cataract typically impairs low contrast visual acuity to a much 
greater degree than high contrast visual acuity (Elliott & Whitaker, 1992), yet 
relatively few clinics regularly measure low contrast acuity (Evans & Rowlands, 
2004h). Also, some forms of cataract (e.g., posterior sub-capsular cataract) have a 
much greater effect on vision when the pupil is constricted, as in daylight, than in a 
typical consulting room. Therefore, studies seeking to assess the prevalence of 
cataracts require a reliable and repeatable classification system.  
A number of systems have been developed to classify and grade cataracts but the 
most widely used (Pearson R M, 2003d) is the Lens Opacities Classification 
System (LOCS III) scale developed by Chylack and colleagues (Chylack, Jr. et al., 
1993c). Initially, the LOCS used black and white photographs for the classification 
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of cortical and posterior sub-capsular cataracts and a coloured photograph for the 
classification of nuclear colour and opalescence. This system subsequently 
evolved into LOCS II and LOCS III in which each type of cataract is illustrated with 
colour photographs. The figure below shows the LOCS III grading system 
developed by Chylack and colleagues (Chylack, Jr. et al., 1993e). 
 
 
Figure 6.1The Lens Opacity Classification System III 
Reproduced with permission from: Chylack LT, Jr., Wolfe JK, Singer DM, Leske MC, Bullimore MA, 
Bailey IL, Friend J, McCarthy D, & Wu SY; The Lens Opacities Classification System III. The 
Longitudinal Study of Cataract Study Group. Arch Ophthalmol 111, 831-836; Copyright © (1993) 
American Medical Association. All rights reserved. 
The LOCS III scale has been validated and used in many research studies 
(Chylack, Jr. et al., 1993b;Karbassi et al., 1993b;Balaram et al., 2000b;Hall et al., 
1997b;Davison & Chylack, 2003) but is rarely used during routine eye 
examinations.  
An informal survey via an e-mail discussion list that is subscribed to by 300 UK 
optometrists was carried out. Only three optometrists reported grading cataract. 
One had used LOCS III in a research study but in clinical practice just classified as 
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cortical, nuclear, or poster sub-capsular. Another described a local scheme used in 
West Kent where all cataracts are graded as 0-4, but the meaning of the grades is 
“left to the optometrist’s discretion”. The final practice used the grading system 
recommended by Pearson (Pearson R M, 2003a), which is a version of the LOCS 
III which has been simplified for optometric practice. 
It is perhaps surprising that formal cataract grading scales are only infrequently 
used in optometric practice. There are more than 8,500 practising optometrists in 
the UK who carry out approximately 17 million eye examinations each year, of 
which 28% are of patients aged 65 years or over (Department of Health, 2004). 
Based on these figures and those of Martinez et al (Martinez et al., 1982a) it is 
possible to estimate that UK optometrists examine about 2 million patients with 
cataract each year. Optometrists are responsible for the majority of referrals for 
cataract surgery in the UK and have the necessary skills to investigate the clinical 
and functional needs of these patients, both before and after surgery (Association 
of Optometrists, 2005). The optometrist’s role in these cases is to determine 
whether the cataract is at a stage that requires referral for surgery and, if not, then 
to decide on an appropriate re-examination interval taking account of the type and 
rate of change of cataract. When early stages of cataract are detected it is 
important for the optometrist to monitor the rate of change of the cataract, which 
would be facilitated by using a grading scale. 
This raises the question of why the most widely used cataract grading scale, the 
LOCS III, is not routinely used in optometric practice. It is felt that there are two 
main limitations of the LOCS III scale which may restrict its use in a primary care 
setting. First, the system has been developed for use with a table-mounted slit 
lamp biomicroscope and second, it requires pupillary dilation. Furthermore, the 
appearance of a cataract is poorly correlated to its effect on visual function and the 
decision to operate or not is quite rightly based on perceived visual function. 
A table-mounted slit-lamp is not ideal for examining the elderly, particularly those 
who are wheelchair users or who suffer from arthritis. It is also not suitable for 
domiciliary visits. The introduction of portable slit-lamp biomicroscopes potentially 
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overcomes both of these issues.  However, the performance of portable slit-lamps 
in the context of grading has not been investigated. 
The purpose of this study was to investigate whether the type and severity of 
cataract can be graded reliably in community settings using a hand-held slit lamp 
biomicroscope. The data reported here were gathered as part of Study 1 in order to 
establish if the hand-held slit lamp could be used in Study 2 which was far more 
community-based.  
                                                  
 Figure 6.2 Kowa SL-15 portable slit lamp biomicroscope 
6.2 Methods 
6.2.1 Training 
This study required two observers and the author was assisted by a colleague, 
Mitesh Amin. The researchers were both familiar with the literature on the LOCS III 
grading system. Before the research started they attended several training 
sessions in which they carried out LOCS III cataract grading using both 
instruments on about 15 patients and compared gradings. Where there were 
discrepancies between their gradings they re-assessed the patient together and 
compared the patient again with the LOCS III grading photographs to reach a 
consensus. The training patients had various degrees and types of cataracts. In 
addition to developing expertise with the LOCS III system, a secondary purpose of 
this training was to determine the step size that was to be used in the research. 
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Both researchers determined that the minimum step size that they could discern 
was 0.5 of a grade, for all sub-types of lens opacities (see Discussion). 
6.2.2 Participants  
Participants were aged 65 years and over who were recruited for Study 1 of the 
main screening research (see Chapter 4). Some participants were seen in 
community optometric clinics; others were recruited and examined in community 
settings as discussed in Chapter 4.  The research was widely publicised (e.g., 
social clubs, GP surgeries, libraries) in the hope of attracting older people who 
might otherwise not be participating in eyecare services. Altogether, 116 patients 
participated in the cataract grading comparative study. The selection criteria were 
as described in Chapter 4. The reasons why the number of participants in the 
cataract grading study was less than the total number in Study 1 was that a) the 
cataract grading study finished a little before the end of Study 1, b) patients who 
had already received bilateral cataract surgery were excluded and c) patients who 
declined pupillary dilation (e.g., because they were driving) were excluded. 
6.2.3 Procedure 
A full explanation of the nature and purpose of the study was given to all patients 
and accompanying family members/carers both verbally and in writing before 
commencing any testing. Questions were invited and answered and patients were 
only included in the research if they provided informed consent. The research 
conformed to the tenets of the Declaration of Helsinki and was approved by 
relevant Research Ethics Committees. 
Participants had their anterior chamber angle depth assessed by Van Herick’s 
technique (Van Herick W. et al., 1969b), so that patients with narrow angles at risk 
of closed angle glaucoma could be excluded. Two patients were excluded for this 
reason (these cases were referred for an ophthalmological opinion on the risk of 
closed angle glaucoma). Patients also had their intraocular pressures measured 
before and after dilation by the tonometry methods described in Chapter 4. The 
pressure rose in one case by about 5mmHg after dilation, but this person was 
monitored over three hours and the pressures returned to normal. This patient was 
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already under care in the Hospital Eye Service, but was given information and 
warned about the risk of closed-angle glaucoma. Pupils were dilated using 
Tropicamide as outlined in Chapter 4 and the cataract grading was carried out 
between 15-40 minutes later.  Cataract grading took place in a darkened room with 
‘room lights out’ as recommended by Chylack (personal communication, 2005). 
Patients were allocated consecutively into four groups: A,B,C,D. Members of each 
group were tested with both the table-top (TT) and the portable (P) slit-lamp 
biomicroscopes by the two researchers (MA and ZJ in Table 6.1). As Table 6.1 
indicates, some (randomly selected) participants were tested with both researchers 
using the table-top slit lamp biomicroscope (group A), some with both researchers 
using the portable slit lamp biomicroscope (group C), and some with one 
researcher using each instrument (groups B and D). The testing of participants in 
groups C and D by ZJ involved both instruments, since the protocol for the vision 
screening study (to be reported elsewhere) stated that the table-top instrument had 
to be used for the cataract grading data in this project. However, the participants in 
groups C and D were tested by ZJ first with the portable instrument and the 
gradings thus obtained were recorded before the table-top instrument was used. 
ZJ was therefore unaware of the table-top instrument results when she carried out 
the grading with the portable instrument; both researchers were masked to each 
other’s results throughout the research. Both researchers were present at all 
testing sessions. 
Table 6.1 Testing details illustrating counterbalanced design. TT, table-top; P, portable slit lamp biomicroscope. 
Group Researcher ZJ Researcher MA 
A TT TT 
B TT P 
C P (TT) P 
D P (TT) TT 
 
Some participants were invited to return for test-retest comparisons. These 
participants included those patients who were requested to return for clinical 
reasons (e.g., repeat visual fields or tonometry) and both researchers repeated the 
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gradings that they initially carried out (i.e., using the same grouping in Table 6.1 as 
at the initial examination). When carrying out these repeat gradings, the 
researchers did not look back at their initial gradings, which were not recollected in 
any case. 
6.3 Results 
6.3.1 Initial Analyses 
Frequency distributions were plotted to assess the nature of the results obtained. 
The results for nuclear colour were not used since this is less important in the 
diagnosis of cataract. Compared with other types of cataract, nuclear sclerosis has 
a lesser effect on visual function (Stifter et al., 2005; Casson and James, 2006) 
and previous studies using LOCS III seem to have placed less emphasis on 
nuclear colour than on nuclear opalescence (Hall et al., 1999; Oishi et al., 2006).  
Figure 6.3 shows the distributions of the gradings for the various characteristics 
used in the LOCS III system obtained using (a) the table-top slit-lamp and (b) the 
portable slit-lamp .The graphs show that the distribution of nuclear opalescence 
grades approximates a normal distribution, but those for cortical and posterior 
subcapsular grades do not (Figure 6.3). Non-parametric methods are therefore 
used in the rest of this section. 
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 Figure 6.3 Frequency distributions of cataract grading 
a) table-top slit-lamp biomicroscope 
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(b) Portable slit-lamp biomicroscope 
 
Distribution Of Nuclear Opalescence Grades
0
10
20
30
40
50
60
Cataract Grades
N
u
m
be
r 
O
F 
C
a
ta
ra
c
ts 0.1 - 0.9
1.0 - 1.9
2.0 - 2.9
3.0 - 3.9
4.0 -4.9
5.0 - 5.9
6.0 - 6.9
 
 
Description Of Cortical Cataract Grades
0
20
40
60
80
100
120
140
160
Cataract Grades
N
u
m
be
r 
O
f 
C
a
ta
ra
c
ts 0.1 - 0.9
1.0 - 1.9
2.0 - 2.9
3.0 - 3.9
4.0 - 4.9
5.0 - 5.9
 
Distribution Of Posterior Subcapsular Grades
0
20
40
60
80
100
120
140
160
Cataract Grades
N
u
m
b
er
 
O
f 
C
a
ta
ra
c
ts 0.1 - 0.9
1.0 - 1.9
2.0 - 2.9
3.0 - 3.9
4.0 - 4.9
5.0 - 5.9
 
 
 
 
Page 168 of 389 
 
6.3.2 Inter-observer agreement 
Inter-observer agreement was assessed for the gradings obtained with each 
instrument. These are illustrated using the non-parametric method of Bland and 
Altman (1999) for the three main cataract types in Figure 6.4. In every case, the 
median difference between the two observers was zero. The graphs (below) 
demonstrate that the 95% limits of agreement are within ±0.50 grades for all cases, 
except for the table-top instrument grading of posterior lens opacities where the 
95% percentile is 0.6 of a grade. 
Figure 6.4 Bland and Altman (difference v mean) plots for inter-observer agreement 
(a) Inter-observer agreement for table top slit-lamp cataract grading   
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(b) Inter-observer agreement for portable slit-lamp cataract grading 
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6.3.3 Inter-instrument agreement 
In view of the good agreement of the gradings for the two observers, the data were 
pooled to estimate the inter-instrument repeatability. For all three types of cataract, 
the 95th percentile was 0.5 and the median and 5th percentile of the difference was 
zero, as illustrated on the graphs below. In other words, there is no lower line on 
these graphs because the lower is coincident with the middle line at 0.00. 
Figure 6.5 Bland and Altman (difference v mean) plots for inter-instrument agreement 
 
. 
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6.4 Further analyses 
A Wilcoxon signed ranks test was carried out as a non-parametric alternative to the 
paired t-test. The null hypothesis assumed was that the median difference between 
the pairs of observations is zero.  The results of the tests are shown in Table 6.2 
below: 
Table 6.2Wilcoxon signed rank test  
 Nuclear 
Opalescence 
Cortical Posterior 
Subcapsular 
 
Table Top Vs 
Table Top  
Slit Lamp 
P =0.2482 
(52) 
P=0.7455 
(12) 
P=0.0080 
(61) 
 
Table Top Vs 
Hand held 
Slit lamp 
P =0.8497 
(35) 
P= 
0.0578 
(44) 
P=0.0833 
(36) 
 
In view of multiple comparisons, a Bonferroni correction was made which modified 
the usual p-value for significance of 0.05 to 0.008. From the results obtained, it can 
be seen that inter-instrument grading showed no significant difference in cataract 
grading for the 3 subtypes of cataract. Indeed, the only comparison that 
approached significance was for the inter-observer comparison of posterior 
subcapsular cataract. This, together with the graphs above, would seem to indicate 
that inter-instrument repeatability is at least as good as inter-observer repeatability. 
The intraclass correlation (ICC) was calculated as an index of reliability. It 
assesses the ratio of between-groups variances to the total variance. The ICC was 
calculated to assess inter-observer and inter-instrument grading reliability for 
nuclear opalescence. It was not appropriate for the other lens opacity types 
because these were not normally distributed. For nuclear opalescence, inter-
observer reliability was high with an ICC coefficient of 0.97 with 95% confidence 
limits of 0.95-0.98.  Inter-instrument reliability also showed a high level of reliability 
between the instruments with a calculated ICC of 0.98 (95% CI 0.97-0.99).  
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6.5 Discussion 
The results show that the inter-observer agreement is good: Figure 6.4 shows that 
the 95% limits of agreement were within ±0.50 grades in the majority of cases. The 
results also show that the inter-instrument repeatability is good, with the graphs 
showing that for all three types of cataract, the median and 5th percentile of the 
difference was zero, and the 95th percentile was 0.5. Indeed, the variability 
between using two instruments is less than the variability between the two 
observers using the table-top instrument. 
A limitation of this study is that finer step sizes were not used. The original paper 
on the LOCS III recommended a decimal scale (Chylack, Jr. et al., 1993d). Since 
then, most studies that have used the LOCS III have used a decimal scale 
(Strouthidis et al., 2005b;Stifter et al., 2005;Stifter et al., 2006;Nirmalan et al., 
2006;Karbassi et al., 1993c;Husain et al., 2005;Hall et al., 1999;Hall et al., 
1997a;Davison, 2005;Casson & James, 2006;Balaram et al., 2000a) although 
three studies have used an integer scale (Oishi et al., 2006;Strouthidis et al., 
2005a;Lim et al., 2006). 
Although from a theoretical perspective finer step sizes are better than coarser 
step sizes, from a practical point of view the step sizes in a grading scale need to 
reflect the accuracy with which clinicians are able to make judgements. This was 
established during the training phase in the present study. It is felt that more 
research would be useful to investigate whether finer grading scales could be used 
with the LOCS III system, and whether this would influence the inter-instrument 
repeatability. 
6.6 Conclusions 
The results indicate that cataract grading using a portable slit lamp biomicroscope 
is in good agreement with grading performed using a table-mounted slit lamp and 
the repeatability is comparable. Indeed, the inter-instrument repeatability is very 
similar to the inter-observer repeatability. 
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This chapter has shown that the portable slit lamp biomicroscope can be used as 
part of the main study in community venues to grade cataract according to the 
LOCS III grading system. The next chapter will focus on various conventions in 
statistical analyses before the results from the main study are presented 
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Chapter 7  
General descriptive data and 
conventions in statistical analysis 
for detection of target conditions 
 
5. Determine best test combinations
using Boolean logic (OR operator)
4. Is screener to detect
monocular or binocular visual defect?
3. Determine individual test cut-offs
(from monocular ROCs)
2. Comparison of screener data with
gold standard data
1. Descriptive statistics
 
Figure 7.1. Overview of analyses. 
Figure 7.1 provides an overview of the statistical analyses applied to the data 
obtained in the two main studies. This chapter will cover stages 1 and 2 in Figure 
7.1, and will outline the approach taken in stages 3-5 in subsequent chapters. 
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7.1 General descriptive data 
There are two aspects of the data that are reported in this thesis:  firstly, the 
distribution of the data obtained for each test will be described; secondly, the ability 
of the screening instruments to detect the target conditions will be analysed. The 
screening instruments in Study 2 differed from those in Study 1, so the ability of the 
instruments to detect the target conditions has to be considered separately for 
each study. 
Although a different cohort of participants was used in Study 1 and Study 2, the 
selection criteria were identical and it therefore seems likely that both populations 
can be pooled for the purpose of describing the outcome of the various tests. As a 
precaution, the key variables (e.g., age, target condition prevalence) in the two 
populations will be compared statistically to check that the samples are equivalent.  
7.1.1 Is it appropriate to pool the samples from both studies for the general 
descriptive data? 
 
Table 7.1 gives an overview of the study populations in the two studies. It can be 
seen that in most respects the samples were very similar and the equivalence of 
the two samples was tested to confirm whether it was appropriate to pool the 
samples for the descriptive analyses. The age of both samples was not 
significantly different (t-test, p=0.31). Although there were statistically significantly 
more females in Study 2 than Study 1 (chi-squared test, p=0.0026), this did not 
impact on the prevalence of the target conditions which did not differ significantly in 
the two samples (Chi-squared tests, p>0.05). In view of this, the two samples were 
pooled to give a sample size of 380 for the descriptive data described below. 
 
 
 
 
Page 177 of 389 
 
 
Table 7.1 Key statistics from Study 1 and Study 2 
 
STUDY 1 STUDY 2 Comparison 
test 
Total number of 
participants 
180 200  
Gender 46% male. 31% male. Chi-squared 
test, p=0.0026 
Proportion seen 
in community 
12% were seen in the 
community (22 
patients from Pulross 
Intermediate Care 
centre). 
 
14 patients (7%) were 
seen at a community 
based optometric 
practice. 
 
144 patients were 
seen at the Institute of 
Optometry 
31.5% were seen in 
the community (22 
patients from Blaiderry 
Road GP surgery and 
41 from Woodlawns 
day centre)  
 
137 patients were 
seen at the Institute of 
Optometry 
 
Age  The average age was 
77 yrs 
The median age was 
76 yrs.  
The range was 67-
99yrs 
The average age was 
77 yrs;  
The median age was 
76 yrs.  
The range was 65-94 
yrs 
t-test p=0.31 
Presenting eye 
wear 
10% presented to the 
eye examination with 
no spectacles. 
 
46.6% had multifocal 
spectacles 
 
23.9% had distance 
spectacles 
 
38.3% had near 
spectacles 
14.5%  presented to 
the eye examination 
with no spectacles 
 
44.5% had multifocal 
spectacles 
 
22.5% had distance 
spectacles 
 
31.5% had near 
spectacles. 
 
Prevalence of 
significant 
cataract 
31.7% 30.7% Chi-squared 
test, p=0.8336 
Prevalence of 
significant 
uncorrected 
refractive error 
39.4% 30% Chi-squared 
test, p=0.0542 
Prevalence of 
correctable 
visual loss 
58.3% 51%  
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Prevalence of 
significant 
macular 
degeneration 
28.9% 22.5% Chi-squared 
test, p=0.1531 
 
In the first part of this section, the optometric characteristics of the combined 
sample are described. In most cases, these descriptive data are based on the 
results from the gold standard eye examinations. An exception is symptoms and 
history, where the highly standardised method of obtaining these data with the 
screener gives a discrete, well-defined dataset. In the second part of this section, 
the results of some of the core tests in the computerised screener (e.g., visual 
acuity) are compared with equivalent tests in the gold standard eye examination. 
The research was publicised by communicating with potential participants 
individually and by word of mouth. This meant that participants who were 
interested took more information and almost always ended up participating in the 
research. It was difficult to target those patients who were not keen to take part in 
the research to fill out the non-participation questionnaire and very few non-
participation questionnaires were completed, so it was not possible to analyse the 
data from these. 
7.1.2 Last eye examination, patient history and symptoms 
The figure below shows that 20% of participants from the combined sample had 
either never had an eye examination or had not had an eye examination for at least 
two years. The Code of Ethics from the College of Optometrists gives guidelines on 
professional conduct and gives advice regarding the re-examination intervals that 
are considered good practice for defined categories of patients. The recommended 
minimum re- examination intervals for those aged between16 and 70 years is 2 
years. For patients aged 70 and over the recommended interval is 1 year and this 
also applies to those patients who are diabetic and those who are over 40 years 
old with an immediate family history of glaucoma or with ocular hypertension 
(College of Optometrists, 2008). Figure 7.2 indicates that 20% of the combined 
sample had either never had an eye examination or had not had one in the last two 
years. The distribution of ages of the combined sample can be seen in Figure 7.3 
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and shows that approximately 84% of participants were aged 70 years and over 
and as such were entitled to an NHS sight test annually. 
 
 
Figure 7.2 Last eye examination 
  
Figure 7.3 Distribution of age in the combined sample.  
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The data from the screener also provided interesting information regarding 
reported problems that participants had with their vision and also whether they had 
a history of eye conditions that would warrant monitoring. Figure 7.4 below shows 
that approximately 43% of the patients seen reported problems with their distance 
vision or their near vision or both.  
 
Figure 7.4 Prevalence of symptoms 
The figure below shows that a number of patients had a positive history of eye conditions that may 
result in reduced in vision.  
Figure 7.5 shows that approximately 14% of patients seen had a history of macular 
degeneration, glaucoma or diabetes and approximately 23% had a history of 
cataracts. 
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Figure 7.5 Prevalence of positive history. The fourth category refers to a history of cataract surgery 
 
7.1.3 Distribution of cataract 
Cataract was defined using the Lens Opacities Classification System III (LOCSIII), 
described in Chapter 4. The diagnostic criteria for cataract used in this study have 
been used by previous researchers based on the LOCS criteria of LOCS III score 
of 4 or more for nuclear cataract, and 2 or more for cortical or posterior sub-
capsular cataract (Foster et al., 2003b;Saw et al., 2003c). Figure 7.6 shows the 
distribution of cataract type for the right eye and the left eye using the combined 
sample. It can be seen that there is virtually no difference between the two eyes.  
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Figure 7.6 Distribution of significant cataract 
 
Figure 7.7 Cataract type 
Figure 7.7 above shows that the levels of significant posterior subcapsular are very 
similar in both studies. The levels of significant cortical lens opacities are greater in 
Study 2 than Study 1 and the levels of significant nuclear sclerosis are greater in 
Study 1 than Study 2. The possible reasons for this are explored in Chapter 12. 
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7.1.4 Clinical data from the gold standard eye examination 
The table below contains information that was extracted from the gold standard 
eye examination. The two studies have been combined to give an overall sample 
of 380 patients. Table 7.2 contains descriptive data from several tests in the gold 
standard eye examination. 
Table 7.2 Descriptive data from gold standard eye examination 
 Comment 
Heterophoria 46% of participants (174 patients) had a heterophoria 
either for distance or near or both. The median distance 
deviation was zero (range 15∆ exophoria to 6∆ 
esophoria) and the median near deviation was also zero 
(range 15∆ exophoria to 5∆ esophoria) 
Heterotropia 3% of participants (11 patients) had a heterotropia either 
for distance, near or both.  
Prismatic 
correction 
required  
3% of participants (11 patients) required prismatic 
correction for distance, near or both. 
Amsler grid 
distortion 
5% of participants from the combined sample had some 
distortion in one or both eyes on the Amsler grid 
Amsler grid 
scotoma 
Less than 1% (3 patients) of participants had a scotoma 
on the Amsler grid test 
Anisocoria 2% of participants from the combined sample had 
anisocoria and less than 1% (3 patients) had an afferent 
pupillary defect 
Convergence The average (and median) near point of convergence 
measurement  from the combined sample was 8cm 
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(range 4cm to 12cm) 
Stereoacuity In Study 1, stereoacuity was measured using the Randot 
stereo test as described in Chapter 4. The total number 
of patients that had their stereoacuity measured was 172 
and the results obtained ranged from 20 seconds of arc 
to 1000 seconds of arc with a median stereocuity of 70 
seconds of arc. 
 
Study 1 and 2 have been combined for the analysis of the subjective refraction in 
the gold standard eye examination. The three graphs below show the distributions 
of the spherical refractive error, cylindrical refractive error and cylindrical axes.  
 
Figure 7.8 Distribution of spherical refractive error. The bins include data from the values stated +/-
0.49. 
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Figure 7.9 Distribution of cylindrical refractive error, measured in negative cylinder notation in 0.25DC 
steps. The 0.00 bin includes spherical, 0.25DC, 0.50DC, 0.75DC; -1.00 includes -1.00, -1.25, -1.50, -1.75; 
etc. 
 
Figure 7.10 Distribution of cyl axis 
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7.1.5 Overall analysis of visual acuity 
High contrast acuity 
The methods for measuring visual acuity have been discussed in Chapter 4. The 
graphs below show the frequency distributions of the presenting visual acuities 
achieved from the screener and from the gold standard eye examination. 
 
Figure 7.11 Distribution of presenting HCVA in RE. The gold standard test measurement range is -0.10 
to >1.60; the screener test measurement range was 0.10 to 0.50. 
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Figure 7.12 Distribution of presenting HCVA in LE. The gold standard test measurement range is -0.10 
to >1.60; the screener test measurement range was 0.10 to 0.50. 
 
Figure 7.11 and Figure 7.12 show the distributions of high contrast visual acuities 
measured in the gold standard eye examination and with the computerised vision 
screener. The graphs reveal the upper and lower limits of the measurement range 
of the screener. The figures below show the association between the acuity 
achieved in the gold standard eye examination and the acuity achieved with the 
screener.  The scatter graphs in Figure 7.13 and Figure 7.14 will be influenced by 
the measurement range of the screener test (0.10 to 0.50), as illustrated in Figure 
7.11 and Figure 7.12. To give an accurate estimate of the inter-test agreement 
between the high contrast visual acuity tests of the screener and the gold standard 
test, Bland and Altman graphs (Bland and Altman, 1986) were plotted based on the 
central range of data, for which the two tests are comparable (data points that for 
the gold standard lay between 0.20 and 0.40). These are shown for the right and 
left eyes in Figure 7.15 and Figure 7.16. 
Page 188 of 389 
 
 
Figure 7.13  Association between screener and clinical VA (right eye). The association is confounded 
by the upper limit (0.5 LogMAR) and lower limit (0.1 LogMAR) of the screener for measuring HCVA.  
 
Figure 7.14  Association between screener and clinical VA (left eye). The association is confounded by 
the upper limit (0.5 LogMAR) and lower limit (0.1 LogMAR) of the screener for measuring HCVA.  
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Figure 7.15  Bland and Altman plot of the difference in VA v mean VA in right eye, for gold standard 
and screener high contrast VA. The central range of data used excludes those with a gold standard 
acuity of less than 0.2 LogMAR and greater than 0.4 LogMAR (N=143). The mean difference (solid 
horizontal line) is 0.018 and the standard deviation is 0.12. The upper and lower dashed lines represent 
+ and – 2 standard deviations from the mean (0.26 and -0.23).  
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Figure 7.16 Bland and Altman plot of the difference in VA v mean VA in right eye, for gold standard and 
screener high contrast VA. The central range of data used excludes those with a gold standard acuity 
of less than 0.2 LogMAR and greater than 0.4 LogMAR (N=155). The mean difference (solid horizontal 
line) is 0.039 and the standard deviation is 0.10. The upper and lower dashed lines represent + and – 2 
standard deviations from the mean (0.25 and -0.17).  
The horizontal reference lines in Figure 7.15 and Figure 7.16 show the key 
variables for the inter-test repeatability of high contrast visual acuity. The mean 
difference between the two measurement methods is 0.018 for the right eye and 
0.039 for the left eye and the 95% limits are approximately two lines for each 
method.   
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Low contrast acuity 
 
Figure 7.17 Distribution of presenting LCVA in RE. The gold standard test measurement range is -0.10 
to >1.60; the screener test measurement range was 0.30 to 0.70. 
 
Figure 7.18 Distribution of presenting LCVA in LE. The gold standard test measurement range is -0.10 
to >1.60; the screener test measurement range was 0.30 to 0.70. 
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Figure 7.19 Association between screener and clinical LCVA (right eye). The association is confounded 
by the upper limit (0.7 LogMAR) and lower limit (0.3 LogMAR) of the screener for measuring LCVA. 
 
Figure 7.20 Association between screener and clinical LCVA (left eye). The association is confounded 
by the upper limit (0.7 LogMAR) and lower limit (0.3 LogMAR) of the screener for measuring LCVA. 
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Figure 7.21 Bland and Altman plot of the difference in LCVA v mean LCVA in right eye for gold 
standard and screener high contrast VA. The central range of data used excludes those with a gold 
standard presenting low contrast acuity of less than 0.4 LogMAR and greater than 0.6 LogMAR 
(N=146). The mean difference (solid horizontal line) is 0.060 and the standard deviation is 0.12. The 
upper and lower dashed lines represent + and – 2 standard deviations from the mean (0.30 and -0.18).  
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Figure 7.22 Bland and Altman plot of the difference in LCVA v mean LCVA in left eye for gold standard 
and screener high contrast VA. The central range of data used excludes those with a gold standard 
presenting low contrast acuity of less than 0.4 LogMAR and greater than 0.6 LogMAR. (N=143) The 
mean difference (solid horizontal line) is 0.063 and the standard deviation is 0.12. The upper and lower 
dashed lines represent + and – 2 standard deviations from the mean (0.30 and -0.17).  
7.2 Conventions for statistical analysis of ability of screening instruments 
to detect target conditions 
There are a various statistical conventions that can be used in the analysis of 
results from diagnostic studies and this chapter summarises the key aspects that 
were considered when analysing the results from Study 1 and Study 2. Different 
approaches were taken in the analyses of the two studies and the main reason for 
this was because the two studies had different objectives. The main goal of the first 
study was to determine which tests would be useful to incorporate in the refined 
vision screener. The second study focused on which combinations of tests would 
be useful in the detection of correctable visual loss. Therefore, in the analysis of 
Study 2 a greater emphasis was placed on combining tests.  
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7.2.1 Statistical analyses of multi eye data 
One of the difficulties when analysing results from ophthalmic research is that each 
participant contributes two data points, one from each eye. Measurements from the 
two eyes of a single subject are usually positively correlated. This is because a 
multitude of factors, including environmental and genetic factors, have an impact 
on the probability of a finding occurring in both eyes. Therefore, pooling the data 
from each eye of participants doubles the sample size but results in an 
overestimation of the precision of statistical estimates. In accordance with best 
practice (Ray and O’Day, 1985; Murdoch et al., 1998) and the approaches used in 
other studies of vision screening (Ivers et al., 2001a;Woods et al., 1998b), it was 
decided to perform statistical analysis to determine the best cut-off points on the 
left eye data only. The left eye was selected since clinical convention is to test this 
eye second, so that the right eye can be considered as a “practice eye”. In later 
stages of the analyses, where test combinations are being evaluated to determine 
the overall ability of the screener to detect the target conditions in either eye, then 
the data for each eye is used as appropriate (see Section 7.6).  
7.2.2 Key Statistics 
A number of statistics can be used to describe the outcome of a screening / 
diagnostic test including sensitivity, specificity and predictive values. These are 
defined in Table 7.3 below. 
Table 7.3 Summary of evaluation of screening test. 
(PV, predictive value) Gold standard (full eye examination) 
Positive Negative 
Screening test  
Result 
Test positive TP (true positive) FP (false positive) 
Test negative FN (false negative) TN (true 
negative) 
Sensitivity = TP/TP+FN    Specificity = TN/FP+TN   
  +ve PV = TP/TP+FP    -ve PV = TN/FN+TN 
 
The sensitivity of a test is a measure of the accuracy of the test for detecting 
individuals affected by the target condition while specificity is a measure of the 
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accuracy of the test in detecting patients who do not have the target condition. 
Calculations of the sensitivity and the specificity of the tests for detecting the target 
conditions were used throughout the analyses of both studies, particularly to 
determine the cut-off values for the tests.  
However, in order to determine the sensitivity and specificity of a test, all 
participants must be assessed by the screening test and the Gold Standard test, as 
happened in the present research. In practice, this information is seldom available 
in an established screening programme because those that pass the screening are 
not re-assessed. In these circumstances, the probability that the condition is 
present when the test is positive (positive predictive value) or that the condition is 
absent when the test is negative (negative predictive value) can be calculated 
(Garb, 1996).  
These key statistics were used in the evaluation of the screening tests. Another 
key statistic that was used was ‘area under the curve’ which was derived from the 
ROC curves. ROC curves formed an important part of the analyses and will now be 
discussed. 
7.3 Importance of ROC curves in evaluating screening tests 
In order to determine the “effectiveness” of the various screening tools that have 
been developed, it was necessary to establish that they were failing the 
appropriate patients (i.e. those that have significant correctable visual loss, 
according to the gold standard) and passing the appropriate patients (i.e. those 
whose vision was within acceptable standards according to the gold standard). In 
order to do this, the first step was to establish cut-off values (pass/ fail criteria) for 
the screening tests (i.e., the value above which the patient ought to be referred for 
an eye examination). ROC curves provide a useful method for establishing an 
optimum cut-off value. 
ROC curves are generated by plotting sensitivity against (1-specificity) for a range 
of different pass/fail criteria. The pass/fail criterion which gives the optimum 
sensitivity and specificity can then be determined. Haynes and colleagues explain 
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the properties of ROC curves and  these are summarised in Table 7.4 (Haynes et 
al., 2006). An example of an ROC curve can be seen in Figure 7.23 
Table 7.4 Properties of ROC curves 
It illustrates the performance of a dichotomous diagnostic test when different cut off points 
are selected to distinguish “normal” from “abnormal” results.  
The effect of using different cut off values on the ROC curve will be discussed below.  
It demonstrates the fact that any increase in sensitivity will be accompanied by a decrease 
in specificity, and vice versa. 
The closer the curve gets to the upper left corner of the graph, the better the overall 
accuracy of the test. 
The closer the curve comes to the 45-degree diagonal of the ROC space, the less 
accurate the test. 
The area under the curve provides an overall measure of a test’s accuracy. This property 
is useful when trying to decide which of two competing tests for the same target disorder is 
the better one. This will be explained in more detail later in this section 
 
 
Figure 7.23 Example of an ROC curve showing the suitability of various cut off values of high contrast 
visual acuity (HCVA) for determining significant gain in acuity through refractive correction. The data 
labels indicate the X and Y co-ordinates 
7.3.1 The effect of changing cut off values on ROC Curves 
A perfect screening test would have a sensitivity and specificity of 1.00 and the 
ROC graph would pass through the top left corner of the graph. A screening test 
with no discriminative ability would produce a line with unit gradient passing from 
(0,0) to (1,1). In practice, most screening tests lie between these extremes and the 
extent that the curve deviates from the 45 diagonal line provides a visual 
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indication of the effectiveness of the test. The optimum cut-off value depends on 
the nature of the screening and the relative importance of false negatives and false 
positives. Cut off values can be manipulated to increase or decrease the sensitivity 
depending on whether it is more important for the test to be sensitive or specific 
(Garb, 1996). In this way the best compromise between sensitivity and specificity 
can be achieved. 
7.3.2 Area under the curve (AUC) 
The Area under the Curve (AUC) is frequently used to provide a single index of the 
effectiveness of a screening tool (Hanley & McNeil, 1982). This area is equal to the 
probability that a random person with the disease has a higher value of the 
measurement than a random person without the disease. The area is 1 for a 
perfect test and 0.5 for an uninformative test (Altman, 2007f). 
Calculating the area under the curve can be done in 3 ways (Hanley & McNeil, 
1983d); the first is using the slope and the intercept of the ROC curve. The second 
method is the Trapezoidal method, this non parametric method corresponds to 
Wilcoxon statistics (Lee & Rosner, 2001).  The third method utilizes the maximum 
likelihood estimation technique, and is a method that is more accessible than the 
others (Hanley & McNeil, 1983). The non parametric method of calculation tends to 
systematically underestimate the area compared to the maximum likelihood 
technique (Hanley & McNeil, 1983;Centor & Schwartz, 1985). However, these 
differences are generally small, particularly with ROC curves derived from five or 
more cut-off points. Results of the significance of differences between two ROC 
curves will be similar, regardless of which method is used, as long as the same 
estimation technique is used on the two curves and as long as the two ROC curves 
being compared are of similar shape (Centor & Schwartz, 1985). 
There are various computer programs that assist in the calculation of the area 
under the ROC curve. A paper published in 2003, comparing 8 such programs 
including SPSS and Analyse-it (both these programs were available for the 
analyses of the present research) concluded that although the programs may have 
used different calculations, they produced equivalent results (areas under the 
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curves and their characteristics) (Stephan et al., 2003). SPSS uses a non 
parametric approach based on the trapezoidal algorithm outlined by Hanley 
(Hanley & McNeil, 1983) and is the statistical package that has been used to 
calculate the AUC in the present study. 
7.4 Combining tests 
One of the main objectives of the research was to determine the most appropriate 
test or battery of tests to detect correctable visual loss. Most previous studies have 
relied on the outcome of single tests (Ivers et al., 2001) arguing that combining the 
results of more than one test would make the test too difficult to administer. 
However, with the advent of the computerised screener, it has become feasible to 
build in a more complex analysis of multiple results without affecting its ease of 
use. 
Bayesian theory suggests that given two unrelated measures, which can each 
discriminate disease, discriminability is increased by using both tests. A positive 
result with both tests (an AND criterion) would indicate a greater likelihood of the 
presence of disease. Clinicians intuitively use this approach in their reasoning 
when making a diagnosis. However, by combining the tests in this way, there is a 
reduced chance of a patient failing the screening test (as in order to fail, the patient 
would have to fail all parts of the test combination). This would have the effect of 
reducing the sensitivity although increasing the specificity of the test. As the 
different components of our screening computer program assess different aspects 
of visual function, it was thought inappropriate to combine tests using AND (i.e., the 
requirement that the individual has to fail all tests in the combination.  
Of the two relevant Boolean operators (AND and OR), the OR term would seem 
most appropriate for the present research. For example, uncorrected refractive 
error might cause blur at distance or near and it would therefore seem appropriate 
to combine the distance and near screening visual acuity tests using an OR 
criterion. Similarly, high contrast visual acuity is likely to detect uncorrected 
refractive errors, but low contrast visual acuity might be better at detecting cataract. 
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Therefore, combining the screener high contrast and low contrast acuity results 
using an OR criterion would seem more appropriate.  
7.5 Either eye or both eyes 
One occasion where an OR operator might be more relevant than an AND operator 
is in the decision about whether to base the analyses on one eye or both eyes. 
This is a fundamental decision which affects the rest of the analyses. Valid 
arguments can be made for either using the AND operator or the OR operator. If a 
person has a marked visual impairment in both eyes then they are likely to have 
greater problems in everyday life than a person who has visual impairment in only 
one eye. For example, the legal requirements for a normal driving license allow a 
person with reduced or no vision in one eye to drive, but not if the poor vision is in 
both eyes. From this perspective, it could be argued that analyses of the 
monocular data should be done using an AND operator: a person only ‘fails’ a test 
if they have poor vision in both eyes, not just if they have poor vision in one eye.  
However, there are also very good arguments for using an OR operator in this 
context. A growing body of research in recent years has emphasised the 
importance of having two good eyes. Much of this has been related to cataract 
surgery and, to quote from a recent paper (Hoffmeister et al., 2007): ‘Several 
studies have demonstrated the benefit of second-eye surgery especially in 
stereopsis and in patient-reported visual disability’. The reason for this is easy to 
understand in terms of the effect on stereoacuity, which requires good monocular 
input and which is important in the prevention of falls (Lord & Dayhew, 2001). An 
additional reason why it may be important to have good vision in each eye is if 
binocular visual acuity could be impaired by reduced vision in one eye. This relates 
to binocular summation and the literature on binocular summation will now be 
briefly reviewed. 
7.6 Binocular summation 
Binocular summation, defined as an increase in the binocular response compared 
with the monocular, occurs when the sensitivities of the two eyes are equal or 
similar so that two eyes produce a better sensitivity than one (Pardhan et al., 
Page 201 of 389 
 
1990). However, when the image in one eye is degraded, the binocular response 
decreases until, with increased degradation, the binocular sensitivity falls below the 
monocular (Pardhan et al., 1990). This binocular inhibition is also apparent with 
monocular glare sources (Pardhan et al., 1990;Pardhan & Gilchrist, 1990). In 
unilateral cataract, binocular inhibition is more marked at high than at low spatial 
frequencies (Pardhan & Gilchrist, 1991). 
For vernier acuity, binocular sensitivity is better than monocular when the targets 
are of low contrast, but the binocular advantage disappears when high contrast 
targets are used, apparently as a result of saturation (Banton & Levi, 1991). A 
similar effect has been reported in patients with unilateral cataract using letter 
charts (Pardhan, 1993). Normal subjects showed binocular summation but 
cataractous patients showed no summation at high contrast and binocular 
inhibition with low contrast charts (Pardhan, 1993). 
Binocular summation also occurs in motion detection (Hess et al., 2007). Binocular 
summation is reduced in older subjects, for central high spatial frequency (Gagnon 
& Kline, 2003) stimuli and for peripheral (Pardhan & Whitaker, 2003) stimuli. 
The relevance of these findings to unilateral cataract is not just theoretical; it has 
been shown that second eye cataract surgery improves binocular summation as 
well as stereoacuity (Laidlaw & Harrad, 1993). 
These results have a number of implications for the studies described in this thesis. 
First, it cannot be assumed that the binocular performance for a given test will 
always be the same or slightly better than the best monocular performance. In 
some cases, a degraded monocular image (e.g., from cataract or uncorrected 
refractive error) might render the binocular percept worse than the monocular. This 
effect is likely to be most marked for low contrast and detailed targets. 
In summary, binocular visual acuity can be impaired by reduced vision in one eye 
and this is especially true for low contrast stimuli. This adds weight to the argument 
that vision screening instruments should detect reduced visual acuity in either eye, 
using a right OR left criterion. Another goal of the research was to develop vision 
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screening tests for detecting visual problems that the patient might be unaware of, 
which would particularly include a monocular deficit. It was therefore decided that 
the analyses should concentrate on combining monocular data using an OR 
criterion 
The computerised screener and the flipchart screener measure distance high and 
low contrast visual acuity monocularly. These tests will therefore detect significant 
monocular deficits and therefore it was argued that within the context of screening, 
a single binocular measurement of near acuity would be sufficient. 
7.6.1 Limitations of using Boolean operators 
Although the OR operator seems most appropriate for clinical tests, symptoms are 
less straightforward: they are by definition subjective and can be non-specific. For 
example, patients might complain of blurred near vision simply because their 
lighting is poor. Indeed symptoms are so common amongst elderly patients that 
using the presence of any symptom as a basis of a screening fail would result in 
the majority of patients being referred. It seems more sensible to use an AND 
operator for symptoms: a person with symptoms would only fail the screener if they 
also had an abnormal test result on one of the screener vision tests. But since we 
would like to detect participants who are unaware of their visual problem, it would 
not make sense to apply this logic in reverse: to only fail a person with an abnormal 
vision test result if they also have symptoms. This is a disadvantage of using 
simple pass/fail criteria with Boolean logic. 
Another disadvantage is that using simple pass/fail (binary) criteria for the vision 
tests does not take account of borderline results. For example, a person who just 
failed the low contrast acuity result but easily passed high contrast distance and 
near acuity might not necessarily be more impaired than a person who only just 
passed all three tests. Yet the first person would fail and the second would pass. 
An alternative approach would be to develop a test algorithm, where test results 
could be combined in a more sophisticated way. For example, the test and 
symptom results could be scored, using scoring systems that were weighted 
according to the clinical significance and diagnostic power of each test, and 
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summated to determine whether the person passed or failed (Thomson & Evans, 
1999). The weighting in this algorithm approach should be based on the diagnostic 
power of each individual test, and the first priority of the analyses below is to 
determine this.  There is scope for future research in this area to investigate if an 
algorithm can be developed which performs better than a simple combination of 
test results using Boolean operators. Further ideas for future research are 
discussed in Chapter 12. 
7.7 A note on confidence intervals (CIs) 
Sensitivity and specificity are the most commonly cited indices of the effectiveness 
of screening. However, these merely describe the effectiveness in relation to the 
sample screened rather than the wider population. The likelihood that the values 
provide a good estimate for the wider population can be gauged by calculating the 
confidence intervals. In other words, the confidence interval around an estimate 
provides the range of values that is believed to encompass the actual (“true”) 
population value (Medina & Zurakowski, 2003a) or “the main purpose of 
confidence intervals is to indicate the im(precision) of the sample study estimates 
as population values” (Altman, 2007e). Wider confidence intervals indicate lesser 
precision, while narrower ones indicate better precision (Medina & Zurakowski, 
2003b). The width depends essentially on three factors. First, the sample size: 
larger sample sizes will give more precise results with narrower confidence 
intervals. Wide confidence intervals emphasize the unreliability of conclusions 
based on small samples. Second, the variability of characteristics being studied: 
the less variable it is (between subjects, within subjects, from measurement error 
and from other sources) the more precise the sample estimate and the narrower 
the confidence interval. Third, the degree of confidence required: if greater or 
lesser confidence is required different intervals can be constructed. Greater 
confidence that the population difference is within a confidence interval is obtained 
with wider intervals (Altman, 2007).  
If one repeatedly obtained samples from the population and constructed CIs for 
each sample, then one would expect a certain percentage of the CIs to include the 
value of the true population and a certain percentage of them not to include that 
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value. For example, with a 95% CI, the level of certainty is 95% of such CIs 
obtained in repeated sampling including the true parameter value and only 5% of 
the CIs not including the true parameter value (Medina & Zurakowski, 2003c). 
7.7.1 Methods of calculating confidence intervals for proportions 
The traditional methods of calculating confidence intervals are based on the 
standard approach of taking a multiple of the standard error either side of the 
sample proportion (Altman, 2007). Although these methods perform quite well in 
many cases, they have certain deficiencies and are not valid when zeros or small 
numbers are involved (Newcombe, 1998;Newcombe, 1998). Traditional methods of 
calculating confidence intervals should not be used for very low observed 
proportions, such as the prevalence of a disease or very high ones, such as the 
sensitivity or specificity of a good diagnostic test (Altman, 2007). Alternative 
methods (Newcombe, 1998;Newcombe, 1998;Wilson, 1926) are available that 
although not as simple or intuitive, give much better results across all 
circumstances (Altman, 2007).  The recommended method used to calculate a 
confidence interval for a proportion is the Wilson score method without continuity 
correction (Newcombe, 1998). This is the method used to calculate confidence 
intervals throughout the study. 
This chapter has focused on descriptive statistics, comparisons of the screener 
data with gold standard data (stages 1 and 2 in Figure 7.1), and conventions in 
statistical analyses that can be used when evaluating data from screening tests (an 
outline of stages 3-5 in Figure 7.1). The next chapter will present the results from 
CVS1.  The monocular cut off values together with the key statistics will be 
presented using ROC curves in order to determine appropriate cut-off values of the 
tests in the computer screener for the detection of target conditions. The definitions 
for the target conditions have been outlined in Chapter 4 and it is these definitions 
that have been used to plot the ROC curves. 
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Chapter 8  
Study one: Preliminary 
investigation of the effectiveness 
of a computer-based system for 
screening the vision of older 
people in the community 
8.1 Introduction 
The computer-based screener described in Chapter 4 was used to screen older 
people aged 65 and over for correctable visual loss. All participants also received a 
gold standard eye examination. The suitability of the tests in the screener were 
evaluated so that the appropriate tests could be incorporated into the refined vision 
screener. The computerised screener was well received by all participants and 
none of the participants found the instructions hard to understand.  This Chapter 
describes the results from the first version of the computer vision screener (CVS1). 
The results from the refined computerised screener (CVS2) and the rapid flip chart 
screener are described in subsequent chapters. 
A total of 180 patients participated in study one (46% male, 54% female). The 
mean age was 77 (range 67 to 99 year). The descriptive data from the study is 
outlined in Chapter 7. 22 patients (12%) were examined in the Pulross 
Intermediate Care centre, 14 patients (7%) were seen at a community-based 
optometric practice and the remainder (144 patients) were seen at the Institute of 
Optometry. The descriptive data including histograms showing the distributions of 
cataract, visual acuity and refractive error can be found in Chapter 7. 
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8.2 Monocular data: selection of appropriate cut offs 
Receiver operator curves for Study 1 are presented below for each of the target 
conditions together with key statistics to evaluate the ability of the test to detect the 
target condition. 95% confidence intervals are quoted in parentheses. A full 
description of ROC curves can be found in Section 7.3. It should be noted that the 
ROCs in the next few sections, although necessary to select the optimum cut-offs 
for the screener, are likely to underestimate the screener’s ability to detect patients 
with poor vision. This is because many of these ROCs compare a grading of the 
appearance of an ocular condition (e.g., cataract or AMD) in the gold standard 
examination with the functional status of the eye (e.g., high contrast visual acuity) 
as measured with the screener. Apart from the intuitive limitation of attempting to 
correlate structure with function, these ROCs will also be limited because many 
different conditions influence the functional measures (e.g., visual acuity). It could 
be argued that a more valid measure of screener performance is to evaluate 
whether it detects those cases that an optometrist would be likely to feel needed an 
eye examination taking account the spectrum of clinical findings. Such an 
evaluation is carried out in Section 8.2.7. 
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8.2.1 The ability of presenting screener visual acuity to determine significant 
cataract 
(a)                                                                (b) 
 
Figure 8.1 Graph illustrating the sensitivity versus 1-specificity for (a) high contrast visual acuity and 
(b) low contrast visual acuity of the left eye obtained with CVS1 for predicting presence of significant 
cataract in the left eye as defined in Chapter 4. The data labels state the X and Y coordinates 
The key statistics for Figure 8.1 can be found in Table 8.1 
 Table 8.1 The key statistics for the LogMAR acuity cut off values obtained from Figure 8.1 
Study 1 Cataract High Contrast 
Acuity 
Low Contrast Acuity 
Ideal Cut Off (LogMAR) VA>0.19 VA>0.39 
Sensitivity (%) 86.5  
(72- 94.1) 
78.4  
(62.8- 88.6) 
Specificity (%) 51.4  
(43.2- 59.6) 
55 
(46.7- 63) 
PPV (%) 32  
(23.7- 41.7) 
31.5  
(22.9- 41.6) 
AUC  0.743 
(0.663-0.823) 
0.672 
(0.580-0.765) 
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8.2.2 The ability of screener visual acuity to detect significant gain in acuity 
with new refractive correction (Rx) 
(a)                                                              (b) 
 
Figure 8.2 Graph illustrating the sensitivity versus 1-specificity for (a) high contrast visual acuity and 
(b) low contrast visual acuity of the left eye obtained with CVS1 for predicting presence of significant 
gain in acuity with new refractive correction as defined in Chapter 4. The data labels state the X and Y 
coordinates 
 
Table 8.2 The key statistics for the LogMAR acuity cut off values obtained from Figure 8.2  
Study 1  
Refractive correction 
High Contrast 
Acuity 
Low Contrast Acuity 
Ideal Cut Off (LogMAR) VA>0.19 VA>0.39 
Sensitivity (%) 79.6  
(67.1-88.2) 
68.5  
(55.3-79.3) 
Specificity (%) 53.7 
 (44.9-62.2) 
55.3 
 (46.5-63.8) 
PPV (%) 43  
(33.7- 52.8) 
40.2  
(30.8- 50.4) 
AUC  0.690  
(0.603-0.777) 
0.660 
 (0.565-0.755) 
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8.2.3 The ability of presenting visual acuity to detect correctable visual loss 
(CVL) 
The results so far in this chapter have looked at the ability of distance acuity (high 
contrast and low contrast) to detect significant gain in distance acuity through 
refractive correction and the detection of significant cataract.  For the purpose of 
the ROC curve below correctable visual loss is defined as the presence of 
significant cataract (defined in Chapter 4) and/or significant gain in distance acuity 
through refractive correction (defined in Chapter 4).   
(a)                                                             (b) 
 
Figure 8.3 Graph illustrating the sensitivity versus 1-specificity for (a) high contrast visual acuity and 
(b) low contrast visual acuity of the left eye obtained with CVS1 for predicting presence of CVL as 
defined above. The data labels state the X and Y coordinates 
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Table 8.3 The key statistics for the LogMAR acuity cut off values obtained from Figure 8.3 
Study 1  
CVL 
High Contrast  
Acuity 
Low Contrast 
Acuity 
Ideal Cut Off 
(LogMAR) 
VA>0.19 VA>0.39 
Sensitivity (%) 78.7  
(68.1-86.4) 
66.7  
(55.4-76.3) 
Specificity (%) 59.8  
(50.1-68.8) 
58.8  
(49.1-67.9) 
PPV (%) 59  
(49.2-68.1) 
54.3  
(44.2- 64.1) 
AUC  0.740 
(0.667-0.814) 
0.665  
(0.583-0.747) 
 
Figure 8.3 and Table 8.3 illustrate the fact that not all visual acuity deficits are 
correctable and this is discussed further in Chapter 12 
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8.2.4 The ability of presenting visual acuity to detect macular degeneration 
(MD) 
(a)                                                                (b) 
 
Figure 8.4 Graph illustrating the sensitivity versus 1-specificity for (a) high contrast visual acuity and 
(b) low contrast visual acuity of the left eye obtained with CVS1 for predicting presence of significant 
macular degeneration as defined in Chapter 4. The data labels state the X and Y coordinates. 
 
Table 8.4 The key statistics for the LogMAR acuity cut off values obtained from Figure 8.4 
Study 1  
MD 
High Contrast Acuity Low Contrast Acuity 
Ideal Cut Off LogMAR) VA>0.19 VA>0.39 
Sensitivity (%) 75.6  
(61.3-85.8) 
75.6  
(61.3-85.8) 
Specificity (%) 50  
(41.6-58.4) 
56.1  
(47.5 -64.2) 
PPV (%) 34 
 (25.5-43.7) 
37  
(27.8-47.2) 
AUC 0.655  
(0.563-0.748) 
0.691  
(0.603- 0.778) 
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8.2.5 The ability of presenting visual acuity to detect refractive error, cataract, 
and MD 
The presence of refractive error, cataract, or MD is labelled in the graphs below as 
‘significant acuity impairing eye conditions’ (SAIEC). 
(a)                                                          (b) 
 
Figure 8.5 Graph illustrating the sensitivity versus 1-specificity for (a) high contrast visual acuity and 
(b) low contrast visual acuity of the left eye obtained with CVS1 for predicting SAIEC as defined above. 
The data labels state the X and Y coordinates 
Table 8.5 The key statistics for the LogMAR acuity cut off values obtained from Figure 8.5 
Study 1 
SAIEC 
High Contrast Acuity Low Contrast 
Acuity 
Ideal Cut Off (LogMAR) VA>0.19 VA>0.39 
Sensitivity (%) 73.3  
(63.9-80.9) 
66.3  
(56.7-74.8) 
Specificity (%) 65.8  
(54.6-75.5) 
67.1  
(55.9-76.6) 
PPV (%) 74  
(64.6-81.6) 
72.8  
(63-80.9) 
AUC 0.739  
(0.665-0.813) 
0.691  
(0.612-0.770) 
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8.2.6 The ability of presenting visual acuity to determine significant acuity 
impairing eye conditions in either eye 
The ROC curves above evaluated the ability of distance acuity in detecting 
significant acuity impairing eye conditions (SAIEC) in the left eye. The ROC curves 
below give an indication of how well HCVA and LCVA in the worst eye can detect 
significant acuity impairing eye conditions (i.e. significant uncorrected refractive 
error, significant cataract and/or macular degeneration) in either eye. 
(a)                                                               (b) 
   
Figure 8.6 Graph illustrating the sensitivity versus 1-specificity for (a) high contrast visual acuity and 
(b) low contrast visual acuity of the worst eye obtained with CVS1 for predicting SAIEC as defined 
above. The data labels state the X and Y coordinates 
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Table 8.6 The key statistics for the LogMAR acuity cut off values obtained from Figure 8.6 
Study 1 
SAIEC  
(either eye) 
High Contrast Acuity Low Contrast Acuity 
Ideal Cut Off 
(LogMAR) 
VA>0.19 VA>0.39 
Sensitivity (%) 75.8 
(67.6-82.5) 
72.6 
(64.1-79.7) 
Specificity (%) 54.7 
(41.5-67.3) 
56.6 
(43.3-69) 
PPV (%) 79.7 
(71.5-85.9) 
79.6 
(71.3-86) 
AUC 0.726 
(0.646-0.806) 
0.691  
(0.612-0.770) 
 
The value of testing distance acuity can be seen from the ROC curves presented in 
the chapter so far. The suitability of the near vision screening test in detecting 
correctable visual loss is evaluated later in the chapter. Table 8.7 below gives a 
summary of the cut off values obtained so far with the distance acuity screening 
tests 
Table 8.7 Summary of CVS1 HCVA and LCVA cut off values 
 
HCVA LCVA 
Condition Cut off 
value 
(LogMAR) 
Sensitivity 
(%) 
Specificity 
(%) 
Cut off 
value 
(LogMAR) 
Sensitivity 
(%) 
Specificity 
(%) 
Cataract VA>0.19 86.5 51.4 VA>0.39 78.4 55 
Rx VA>0.19 76.9 53.7 VA>0.39 68.5 55.3 
CVL VA>0.19 78.7 59.8 VA>0.39 66.7 58.8 
MD VA>0.19 75.6 50 VA>0.39 75.6 56.1 
SAIEC 
(left eye) 
VA>0.19 73.3 65.8 VA>0.39 66.3 67.1 
SAIEC 
(either 
eye) 
VA>0.19 75.8 54.7 VA>0.39 72.6 56.6 
 
The table above shows that HCVA consistently has a reasonably high sensitivity 
for the detection of the conditions mentioned in the table and measuring LCVA 
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results in a slightly better specificity in most cases. This sensitivity is higher than 
might have been expected considering the point made at the beginning of Section 
8.2 about the limitation of using visual function to predict structural appearance. If 
the results of these screening tests are combined (e.g., participants are selected 
who fail both or either test) then this combination may give the best sensitivity and 
specificity. This has also been noted in the data from Study 2 (Chapter 9) and is 
investigated further in the present Chapter and more so in Chapter 9. 
8.2.7 Performance of the screener from an optometric perspective 
It is noted at the beginning of Section 8.2 that the analyses above set a high 
criterion for the performance of the screener. In particular, the analyses investigate 
the ability of tests of visual function to detect conditions that are diagnosed by 
appearance during examination (e.g., cataract, AMD). From an optometric 
perspective, it could be argued that the screener needs to detect patients who a 
typical optometrist feels are likely to benefit from an eye examination.  This could 
be defined, in a pragmatic operational way, as reduced high contrast visual acuity 
in one or both eyes and those who have not attended for an eye examination in the 
last year. Alternatively, it could be argued that optometrists may feel it appropriate 
to conduct an eye examination on those with reduced high contrast acuity or those 
who have not had an examination within the last year. The results of both of these 
criterion combinations are given in the table below. As with previous combinations 
in the present chapter, reduced high contrast acuity has been defined as VA>0.19 
LogMAR.  
Table 8.8 Performance of screener from an optometric perspective 
Performance of screener 
from an optometric 
perspective 
Sensitivity 
(%) 
Specificity (%) PPV (%) 
HCVA >0.19 and no eye 
examination in the last 
year 
82.2 
(73.6-88.4) 
82.9 
(72.9-89.7) 
86.5 
(78.2-91.9) 
HCVA>0.19 or no eye 
examination in the last 
year 
97.6 
(93.9-99.1) 
75 
(46.8-91.1) 
98.2 
(94.8-99.4) 
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8.2.8 The ability of fixation disparity (FD) to detect a history of falls 
Fixation disparity was included in the initial test battery because one study (only) 
found an association between hyperphoria and driving accidents (Davison, 1985). 
Very few of the participants in the current study were drivers, but no studies were 
found that investigated whether there is a relationship between hyperphoria and 
falls and so the fixation disparity was included to investigate this. 25 participants 
reported a history of falls in the last 1 year. Only 13 participants had a hyperphoria 
and only 2 of these had a history of falls. 12 participants either had a hyperphoria, 
a horizontal fixation disparity, or suppression on the horizontal fixation disparity 
test.  
Table 8.9 Evaluation of the fixation disparity screening test in CVS1. The coloured cells in the table 
below show that participants who had fixation disparity were not more likely to have a history of falls. 
    screening values 
ACTUAL Falls no falls  sensitivity 48.00 
FD 12 67 79 specificity 55.92 
no FD 13 85 98 positive predictive value 15.19 
 25 152 177 negative predictive value 86.73 
    overall accuracy 54.80 
      
    CHI-SQUARED p of chi-square 
    Falls 0.73 
EXPECTED Falls no falls  No falls 0.89 
FD 11. 68 79 FD 0.79 
no FD 14 84 98 No FD 0.81 
 25 152  comparison 0.71476 
 
The presence of fixation disparity was not significantly associated with a history of 
falls (chi-squared, p=0.71) and as such fixation disparity was not thought an 
appropriate test to include in the revised version of the computer screener. It 
should be noted that an additional reason for including fixation disparity testing 
might be to detect asthenopia, although since this was not a target condition and 
would not meet the Wilson criteria (Chapter 1) this was not analysed. 
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8.2.9 The ability of stereo-acuity to detect a history of falls 
The stereo-acuity test was failed by an unexpectedly high proportion of participants 
(131 out of 177 participants). Therefore, no criterion gave better specificity than 
25% for detecting a history of falls.  
The reason why so many participants could not perceive any of the stimuli 
stereoscopically was investigated by looking at the effect of the coloured filters 
used in this test on visual acuity. Both filters reduced visual acuity by, on average, 
0.17 LogMAR units. A paired t-test showed that the reduction in VA with the red 
filter was not significantly different to the reduction in VA with the green filter 
(p=0.78). It is possible that the visual acuity was reduced to a level that meant that 
participants could not resolve the pixels in the stereo-acuity test. 
This might also explain a recent finding of reduced stereoacuity in older people 
with the TNO test, which also uses red/green filters (Garnham & Sloper, 2006). 
The results indicate that the stereoacuity test used in the screener was not suitable 
alone to detect a history of falls. In order to investigate whether another type of 
stereoacuity test would be useful, the gold standard data was investigated and the 
ROC curve for this is shown in Figure 8.7. 
Figure 8.7 indicates that although the test is reasonably sensitive it is not specific 
at all. Taking this graph into account, it appears that stereoacuity has little value in 
this context and should not be included in the revised version of the computer 
screener. As noted in the introductory chapters and discussion, falls are 
multifactorial and it is perhaps not surprising that a single vision test, even one as 
intuitively relevant as stereoacuity, does not have good predictive ability in the 
present context. 
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Figure 8.7 Graph illustrating the sensitivity versus 1-specificity for stereoacuity data obtained with the 
gold standard eye examination for detecting a history of falls within the last year. The data labels state 
the X and Y coordinates. 
8.2.10 The ability of the visual field screening test (VF) to detect patients with 
or at risk of glaucoma  
This category included patients who were already diagnosed with glaucoma as well 
as patients who were referred to the hospital eye service on the basis of the gold 
standard test results: fields, pressures, optic nerve head fundoscopy and in many 
cases GDX. It also included cases where it was necessary to monitor the patient 
closely due to the risk of glaucoma based on the gold standard test results.  This 
definition has been outlined in Chapter 9 where more in depth analyses of the 
screener’s ability to detect glaucoma are presented. 
The graph below shows how well the data from the visual field test of the left eye 
on the screener was able to detect those with glaucoma or those who are 
‘suspected’ of having glaucoma in the left eye. The monocular cut off point in this 
case is defined as the number of points missed above which a person may need to 
be referred for further investigation to rule out glaucoma. 
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Figure 8.8 Graph illustrating the sensitivity versus 1-specificity for the visual field test data of the left 
eye obtained with CVS1 for detecting patients with or at risk of glaucoma in the left eye. The data 
labels state the X and Y coordinates 
 
Table 8.10 The key statistics for the visual field test cut off value obtained from Figure 8.8 
 
 
 
 
 
 
 
 
Study 1 
VF test for 
Glaucoma 
Points missed on 
VF test 
Ideal Cut Off Points missed >5 
Sensitivity 
(%) 
60 
 (35.7-80.2) 
Specificity 
(%) 
80.2 
(73.4-85.6) 
PPV (%) 22 
(12-36.7) 
AUC 0.731 
(0.599-0.862) 
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When developing the computer screener it was thought important to include a 
visual field test because it was the only one of the three main glaucoma tests that 
was amenable to inclusion in a computerised vision screener. It was decided to 
include such a test so that its performance could be evaluated. Nonetheless, it was 
accepted from the outset that such a test was unlikely to match the accuracy of a 
full eye examination for detecting glaucoma. 
The results from the above initial analyses of the visual field test incorporated in 
the screener indicate that it does have some value in the detection of glaucoma. It 
was decided to incorporate this test in the revised version of the computer screener 
in Study 2 so that further analyses could be conducted to investigate the 
performance of the visual field test when combined with the other screening tests 
(Chapter 9).  
8.3 Evaluation of near acuity vision screening test 
Most of the analyses so far in this chapter have considered screening tests where 
data for both the right and the left eye were obtained. As explained earlier in the 
chapter the CVS was designed to assess binocular near visual acuity. Therefore, in 
this section the graphs and tables illustrate the ability of the binocular near visual 
acuity to predict binocular target conditions (i.e. binocular cataract and binocular 
near refractive error and binocular correctable visual loss). At the end of this 
section, Table 8.14 which contains all the cut off values for near acuity, will 
summarise the section before the results of various test combinations are 
presented. 
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8.3.1 The ability of screener binocular near visual acuity test to detect 
significant gain in binocular near acuity with new near refractive correction 
(NvRx). 
 
Figure 8.9 Graph illustrating the sensitivity versus 1-specificity for binocular near acuity obtained with 
CVS1 for predicting significant gain in binocular near acuity with new refractive correction as defined 
in Chapter 4. The data labels state the X and Y coordinates 
Table 8.11 The key statistics for near acuity cut off values obtained from Figure 8.9 
Study 1 
Near visual acuity  
predicting binocular 
 NvRx 
Near acuity 
Ideal Cut Off (N) NVA> N 11.90 
Sensitivity (%) 58 
(36.3 -76.9) 
Specificity (%) 44  
(36.2 -51.5) 
PPV (%) 11 
(6.3 – 18.6) 
AUC 0.569 
(0.428 –0.709) 
 
It is noted that the statistics in Table 8.11 obtained from the near acuity test show 
that the test does not appear to be as useful in the detection of the target 
conditions as the distance acuity tests that were evaluated earlier in the chapter. 
This becomes even more apparent in the analysis below and possible reasons for 
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this will be discussed in Chapter 12. These include the points made at the 
beginning of Section 8.2. 
8.3.2 The ability of screener binocular near visual acuity test to detect 
significant binocular cataract 
 
Figure 8.10 Graph illustrating the sensitivity versus 1-specificity for binocular near acuity obtained with 
CVS1 for predicting significant binocular cataract as defined in Chapter 4. The data labels state the X 
and Y coordinates 
Table 8.12 The key statistics for near acuity cut off values obtained from Figure 8.10  
Study 1 
Near visual acuity  
predicting binocular 
Significant cataract 
Near acuity 
Ideal Cut Off (N) NVA> N 15.90 
Sensitivity (%) 63.3 
(45.5-78.1) 
Specificity (%) 70.1 
(62.2-76.9) 
PPV (%) 30.2  
(20.2-42.4) 
AUC 0.605  
(0.493-0.716) 
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8.3.3 The ability of screener binocular near visual acuity test to detect 
significant binocular correctable visual loss (BinCVL) 
 
Earlier in the chapter, when evaluating distance acuity correctable visual loss was 
defined as significant gain in distance acuity with new refractive correction or 
significant cataract. For the purpose of evaluating the binocular near vision 
screening test the definition of correctable visual loss will be amended for the next 
ROC curve to take into account the binocular near acuity test. Correctable visual 
loss has now been defined as the presence of significant binocular distance 
refractive error &/or presence of binocular cataract &/or significant binocular near 
refractive error. 
 
 
 
 
 
 
 
Figure 8.11 Graph illustrating the sensitivity versus 1-specificity for binocular near acuity obtained with 
CVS1 for predicting binocular correctable visual loss as defined above. The data labels state the X and 
Y coordinates 
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Table 8.13 The key statistics for near acuity cut off values obtained from Figure 8.11 
Study 1 
Near visual acuity  
Predicting BinCVL 
 
Near acuity 
Ideal Cut Off (N) NVA> N 11.90 
Sensitivity (%) 73.2  
(61.9-82.1) 
Specificity (%) 55 
(45.2-63.9) 
PPV (%) 52 
(42.3-61.5) 
AUC 0.561  
(0.474-0.648) 
 
This section will end with a summary table that states the near acuity cut off values 
obtained for the target conditions evaluated in this section.  
Table 8.14 Summary of CVS1 near acuity cut off values 
 
Near acuity 
Condition Cut off 
value 
(N) 
Sensitivity 
(%) 
Specificity 
(%) 
Binocular 
Cataract 
VA> N 15.9 63.3 70.1 
NvRx VA> N 11.9 58 44 
Binocular 
CVL 
VA> N 11.9 73.2 55 
 
The chapter so far has shown that high contrast acuity is an important test to 
include in the revised computer screener (CVS2) due to the relatively high 
sensitivity obtained for the target conditions. Low contrast acuity may also be 
useful to include in CVS2 due to slightly better specificity it produces for the 
detection of the target conditions. In particular the combination of both these acuity 
tests may be valuable in detecting the majority of the patients with correctable 
visual loss. This combination of high contrast and low contrast acuity will be 
evaluated in the next section and in more detail in Chapter 9 with the results from 
Study 2. The visual field test was found to be of some value in the detection of 
glaucoma and glaucoma suspects and as such will be included in CVS2 and will be 
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evaluated in more detail with the results from Study 2. The near acuity screening 
test is the only method that the screening programme has of detecting uncorrected 
near refractive error and so this test will be incorporated in CVS2, even though the 
results indicate that distance acuity is more efficient at detecting the target 
conditions. It is possible that the near acuity test will perform better when in 
combination with other vision tests and this will be investigated in Chapter 9 with 
the results from Study 2. 
8.4 Combining tests in CVS1 
The purpose of this section is to give an overview of the performance of the 
screener before detailed test combinations for Study 2 are presented in Chapter 9. 
The initial ROC curves showed the most appropriate cut-off values for the tests in 
the screener.  In this section these tests are combined using an OR combination 
(i.e. the requirement that the individual has to fail either of the tests in the given 
combination in order to fail the screener) to obtain sensitivity and specificity values. 
This is calculated for the 3 conditions; significant gain in VA through refractive 
correction, significant cataract and correctable visual loss (combining significant 
refractive error and significant cataract).  
The purpose of combining the tests in this way is to give a more general overview 
of the performance of the screener. For example if a patient  presented with 
symptoms or has reduced HCVA in either eye or has reduced LCVA in either eye 
what is the likelihood that they will be correctly identified by the screener and be 
referred for a full eye examination. Furthermore, how many of those referred would 
actually have correctable visual impairment?   
The sensitivity and specificity values are shown below and it is also possible to see 
how the sensitivity and specificity changes with the addition of each test. The 
screening tests that have been used in various combinations are HCVA, LCVA and 
the presence of visual symptoms. Tests of near acuity and visual fields will be 
incorporated in test combinations in the next chapter. In this chapter, the presence 
of symptoms has also been combined in an OR combination , as discussed earlier 
in this chapter, symptoms are likely to reflect more than one aspect of visual 
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function and as such it may be better to combine this test in an AND combination. 
This has been done in subsequent chapters. 
By combining the tests in the way outlined, it is recognised that there is an 
increased chance of a patient failing the screening test (as in order to fail, the 
patient would only have to fail one test in the given combination). This would have 
the effect of increasing the sensitivity although decreasing the specificity of the 
test. In order to compensate for this, the cut-off value given in the initial ROC 
curves has been adjusted to a higher value. However, in doing this it is recognised 
that the correct weightings that each test has upon the target condition are not 
being accounted for.  
In the tables below, the sensitivity and specificity of the combined tests was 
calculated when the cut-off values were decreased by one step (lowering the 
threshold so that patients would fail the test at a better acuity) and increased by 
one step (increasing the threshold so that patients would fail at a worse acuity).  
In each table of combinations below, the best combinations for detecting the target 
conditions have been highlighted. In most cases this is clearly apparent from 
looking at the sensitivity and specificity values obtained. The combinations chosen 
as the most appropriate represent a compromise between sensitivity and 
specificity. As the instruments used in this study were for the purpose of screening, 
the choices of the best combinations have given priority to higher sensitivity values 
as opposed to specificity values. However care was taken not to compromise 
specificity more than was necessary. It is understood that there is a subjective 
element in the choices made below. The same method was used to find the most 
appropriate combinations in Chapter 9 (Section 9.4) and Chapter 10 (section 10.5). 
8.4.1 The ability of screener test combinations to predict significant gain in 
acuity with new refractive correction 
HCVA was found to be more valuable than LCVA in the detection of uncorrected 
refractive error and HCVA and the presence of symptoms have been combined in 
Table 8.15 below. In its present form, the screener could not be expected to 
differentiate between the different causes of reduced visual acuity. The inclusion of 
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a pinhole test might help to differentiate between those with uncorrected refractive 
error and other causes of reduced acuity, However, as discussed in Chapter 2, 
there are many disadvantages of using the pinhole. 
Table 8.15 Test combinations from CVS1 for the detection of uncorrected refractive error. The cut off 
values used are in brackets. The shaded cell highlights the best combination. 
TEST COMBINATIONS FOR 
REFRACTIVE ERROR 
Sensitivity 
(%) 
Specificity (%) PPV (%) 
Symptoms alone 59 63 51 
HCVA alone, either eye 
(0.19) 
74 38 43 
Symptoms or HCVA(0.19) 88 29 44 
Symptoms or HCVA (0.29) 80 41 46 
Symptoms or HCVA (0.09) Beyond limit of computer screener 
Symptoms or HCVA (0.14) 92 23 43 
  
Key Points  The table above shows that when the original cut off of 0.19 is coupled with 
symptoms in an OR combination the sensitivity is greater than when HCVA 
is taken alone. However, there is also a decrease in specificity when 
combining the tests in the way shown above. 
 
 The effect of using a different cut off is also clear from the table. A slightly 
higher visual acuity cut off, results in the test becoming slightly harder to fail 
(as the patient would need a worse acuity than before) and so when this is 
coupled in an OR combination with symptoms, there is a slight compromise 
in sensitivity, but this is compensated for by a higher specificity value. 
 
 A lower cut off would be more appropriate if the tests were combined in an 
‘AND’ method where the patient would have to fail both tests in the 
combination in order to fail the screening.  The ‘AND’ combination would 
make the screening harder to fail, in order to compensate for this a lower cut 
off can be used (this would enable patients to fail at better levels of acuity). 
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Using a lower cut off in the context of an ‘OR’ combination is not 
appropriate, as it makes the screening test even easier to fail.  
 
 The positive predictive value indicates how many patients who fail the 
screening actually have the target condition when further investigated. 
When the tests are combined the greatest positive predictive value is 46%. 
This means that 46 out of every 100 patients who fail the screening tests in 
this combination will have significant gain in acuity through a new refractive 
correction. 
 
 The shaded cells represent the best combination of tests for detecting 
significant gain in acuity through refractive correction. This is the 
combination where symptoms are combined with a higher cut off HCVA 
value. 
8.4.2 The ability of screener test combinations to determine significant 
cataract 
As has been noted throughout this chapter, these analyses are relating the 
appearance of cataract with the visual function of visual acuity. The correlation 
between function and appearance will be limited and other causes of poor visual 
acuity will also adversely affect the sensitivity and specificity. This is returned to in 
Chapter 12. 
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Table 8.16 Test combinations from CVS1 for the detection of significant cataract. The cut off values 
used are in brackets. The shaded cells highlight the best combinations. 
TEST COMBINATIONS FOR 
CATARACT 
Sensitivity 
(%) 
Specificity 
(%) 
PPV (%) 
Symptoms alone 55 58 36 
HCVA alone (0.19) 87 43 40 
LCVA alone (0.39) 83 44 39 
Symptoms or HCVA (0.19) 92 28 35.5 
Symptoms or LCVA (0.39) 89 31 35 
Symptoms or HCVA(0.29) 83 39.5 37 
Symptoms or LCVA(0.49) 79 39.5 36 
Symptoms or HCVA(0.19) 
or LCVA(0.39) 
94 24 35 
Symptoms or HCVA(0.29) 
or LCVA(0.49) 
89 35 37 
 
Key Points  It is particularly interesting to note that the above table shows that adding 
symptoms as a screening test does not help significantly in the detection of 
cataract. The decrease in specificity that is obtained when combining 
symptoms with HCVA is greater than the increase in sensitivity that is 
achieved. Even when symptoms are combined with a higher value HCVA 
cut off, this is no better than using HCVA alone. 
 Another approach is for the test combinations in Table 8.16 to be split in to 3 
categories: the most appropriate single test for cataract detection; the most 
appropriate 2 test combination and the most 3 test combination. The shaded 
cells in the above table represent the most appropriate combination for each 
of these 3 categories.  When comparing the shaded cells it can be seen that 
for determining significant cataract, HCVA (cut off value 0.19) alone seems 
to be the best screening test. 
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8.4.3 The ability of screener test combinations to detect correctable visual 
loss 
Table 8.17 Test combinations from CVS1 for the detection of correctable visual loss. The cut off values 
used are in brackets. The shaded cells highlight the best combinations. 
TEST COMBINATIONS FOR 
CORRECTABLE VISUAL 
LOSS 
Sensitivity 
(%) 
Specificity 
(%) 
Positive 
predictive 
value(%) 
Symptoms alone 54 65 67.9 
HCVA alone (0.19) 76 47 66 
LCVA alone (0.39) 70.5 45 64 
Symptoms or HCVA(0.19) 88 36  65.2 
Symptoms or LCVA(0.39) 83 36 64 
Symptoms or HCVA(0.29) 78 48 67 
Symptoms or LCVA(0.49) 75 47 66 
HCVA (0.19) or LCVA(0.39) 80.4 41.3 65 
HCVA(0.29)orLCVA(0.49) 66 56 67 
Symptoms or HCVA (0.19) 
or LCVA(0.39) 
80.4 17.3 57 
Symptoms or HCVA (0.29) 
or LCVA (0.49) 
82 41 66 
 
Key Points  The PPV values in this table are generally higher than in the other two tables, 
this is because the above table considers correctable visual loss which can be 
due to significant cataract or significant gain in acuity through refractive 
correction or both. 
  The above table shows that many of the combinations would be suitable as a 
screening test to detect correctable visual loss. The shaded cells show the most 
appropriate single test for detection of correctable visual loss and the most 
appropriate two test and three test combinations. 
  The shaded cells in the above table show that the two test combination of 
HCVA (cut off value 0.29) and symptoms is most appropriate and gives the best 
compromise between sensitivity and specificity.  
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8.4.3 The ability of screener test combinations to detect significant acuity 
impairing eye conditions (SAIEC) 
Significant acuity impairing eye conditions has been defined earlier in the chapter 
as the presence of refractive error, cataract, or MD in either eye. 
Table 8.18 Test combinations from CVS1 for the detection of SAIEC. The cut off values used are in 
brackets. The shaded cells highlight the best combinations. 
 
 
 
 
 
 
 
Key points  Once again, the positive predictive values are generally higher than the 
previous tables, this is because, the ability of the screener to detect SAIEC 
takes in to account three conditions; refractive correction, cataract and macular 
degeneration. 
 
 As before, the best single test, two test combinations and three test 
combination have been identified in the shaded cells. From the shaded cells the 
best combination for the detection of SAIEC is obtained when all 3 tests are 
combined with the higher cut off values to compensate for combining the tests 
in an OR combination 
The best combinations that have been identified this section have been 
summarised in the table below 
TEST COMBINATIONS FOR 
SAIEC 
Sensitivity 
(%) 
Specificity 
(%) 
Positive 
predictive 
value(%) 
Symptoms alone 53 72 83 
HCVA alone (0.19) 74 52 80 
LCVA alone (0.39) 71 54 80 
Symptoms or HCVA(0.19) 86 42 79 
Symptoms or LCVA(0.39) 83 44 79 
Symptoms or HCVA(0.29) 77 58 82 
Symptoms or LCVA(0.49) 74 54 80 
HCVA (0.19) or 
LCVA(0.39) 
79 48 79 
HCVA(0.29)or LCVA(0.49) 65 66 83 
Symptoms or HCVA (0.19) 
or LCVA(0.39) 
89 38 78 
Symptoms or HCVA (0.29) 
or LCVA (0.49) 
81 50 80 
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Table 8.19 Summary table incorporating the best test combinations (from HCVA, LCVA and symptoms) 
from CVS1 for the detection of the target conditions  
  Best test combination Sensitivity Specificity  PPV 
Gain in VA 
through refraction 
Symptoms or HCVA 
(0.29) 
80 41 46 
Cataract HCVA alone (0.19) 87 43 40 
CVL Symptoms or 
HCVA(0.29) 
78 48 67 
SAIEC Symptoms or HCVA 
(0.29) or LCVA (0.49) 
81 50 80 
 
This section and Table 8.19 shows the value of combining tests and manipulating 
cut off values in order to achieve an acceptable compromise between sensitivity 
and specificity for the detection of the target conditions. This is explored in more 
detail in the following chapters.  
The results from Study 1, presented in this chapter, have shown which tests are 
appropriate to incorporate in CVS2 and which tests would not be necessary in the 
detection of correctable visual loss. This chapter has also provided an initial insight 
into combining tests and manipulation of cut off values. The information at the start 
of this chapter regarding conventions in statistical analyses will be taken into 
consideration when evaluating the results from Study 2. Since the goal of Study 2 
is to assess the efficacy of the final computerised vision screener to detect the 
target conditions, a more detailed analysis of various test combinations will be 
carried out for this study. 
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Chapter 9  
Study two: Investigation of the 
effectiveness of a refined 
computer-based system for 
screening the vision of older 
people in the community  
9.1 Introduction 
Analyses of the screening results from Study 1 involved calculating the sensitivity 
and specificity of various tests in combination, so that the most appropriate battery 
of tests could be identified and incorporated in to CVS2 and also to evaluate the 
performance of the screener for the target conditions. This chapter focuses solely 
on the revised computer vision screener (CVS2); the next chapter will give details 
of the results obtained from the rapid flipchart screener. 
Study 1 showed that tests of stereoacuity and fixation disparity were not likely to 
produce a high yield of the target conditions and so these tests were not included 
in CVS2. Tests of high contrast acuity and low contrast acuity were found to be 
useful in the detection of correctable visual loss. The full battery of tests included in 
CVS2 is discussed in Chapter 4. The analyses of CVS2 began with calculating the 
monocular cut off values for distance acuity for the target conditions obtained from 
the ROC curves. The definitions for the target conditions have been outlined in 
Chapter 4 and it is these definitions that have been used to plot the ROC curves. 
As with Chapter 8, the tables below the graphs give the key statistics of the cut off 
values chosen from the graphs. A full description of ROC curves can be found in 
Section 7.3.The procedure for the analyses of CVS2 followed that of CVS1. The 
left eye was used to obtain the monocular cut off values. These cut off values were 
then used to assess the effectiveness of CVS2 at detecting the target conditions in 
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either eye (i.e., right eye, left eye or both). The tests were then combined using an 
OR operator as discussed in Chapter 7 to give an idea of the overall performance 
of the screener. Distance acuity was evaluated first followed by near acuity. The 
screener measured near acuity binocularly. In the analysis of near acuity, the 
target conditions were considered significant only if both eyes were affected as 
outlined in Chapter 7. This chapter will end with a section on the ability of CVS2 to 
detect those patients with glaucoma or at risk of glaucoma. 
The flow chart at the beginning of Chapter 7 (Figure 7.1) provided an overview of 
the analysis for this study. The descriptive statistics and the comparison of the 
screener data with the gold standard data has already been dealt with at the 
beginning of Chapter 7. The first section in this chapter will determine the individual 
test cut offs from monocular ROCs. 
As in the previous chapter, it should be pointed out that most of the ROC curves 
below attempt to relate the appearance of a target condition (e.g., grade of 
cataract) to a function (e.g., visual acuity). This approach, although necessary to 
determine cut-off values and to gain an insight into the ability of a test to detect a 
condition, will inevitably limit the performance of a test for two reasons. First, a 
disease (e.g., cataract or AMD) may influence structure (e.g., appearance) 
relatively independent of its influence on function. Second, functions like visual 
acuity are influenced by a variety of factors. From a pragmatic optometric 
viewpoint, it could be argued that the screener will perform well if it detects those 
patients who an optometrist would wish to see for an eye examination. This is 
considered in Section 9.2.8. 
 
 
 
 
Page 235 of 389 
 
9.2 Monocular data: selection of appropriate cut offs  
The suitability of the screening distance acuity test for determining various eye 
conditions will now be presented.  At the end of this section, Table 9.8 which 
contains all the cut off values for distance acuity, will summarise the section before 
the results of the near acuity test are presented. 
9.2.1 The ability of presenting screener visual acuity to determine 
significant cataract 
(a)                                          (b)                                                                         
 
Figure 9.1 Graph illustrating the sensitivity versus 1-specificity for (a) high contrast visual acuity and 
(b) low contrast visual acuity of the left eye obtained with CVS2 for predicting presence of significant 
cataract in the left eye as defined in Chapter 4. The data labels state the X and Y coordinates 
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Table 9.1 The key statistics for the LogMAR acuity cut off values obtained from Figure 9.1 
Study 2 Cataract High Contrast Acuity Low Contrast Acuity 
Ideal Cut Off (LogMAR) VA>0.19 VA>0.39 
Sensitivity (%) 64.4  
(49.8-76.8) 
64.4 
 (49.8-76.8) 
Specificity (%) 59.4  
(51.5-66.8) 
64.5  
(56.7-71.6) 
PPV (%) 31.5 
 (22.9-41.6) 
34.5 
 (25.2-45.2) 
AUC  0.659  
(0.572-0.746) 
0.668 
(0.581-0.756) 
 
9.2.2 The ability of screener visual acuity to detect significant gain in acuity 
with new refractive correction (Rx)  
(a)                                                               (b) 
 
Figure 9.2 Graph illustrating the sensitivity versus 1-specificity for (a) high contrast visual acuity and 
(b) low contrast visual acuity of the left eye obtained with CVS2 for predicting presence of significant 
gain in acuity with new refractive correction as defined in Chapter 4. The data labels state the X and Y 
coordinates 
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Table 9.2 The key statistics for the LogMAR acuity cut off values obtained from Figure 9.2 
Study 2  
Refractive correction 
High Contrast Acuity Low Contrast 
Acuity 
Ideal Cut Off (LogMAR) VA>0.19 VA>0.39 
Sensitivity (%) 72.5 
 (57.2-83.9) 
70  
(54.6-81.9) 
Specificity (%) 60.6 
 (52.9-67.9) 
65  
(57.3-72) 
PPV (%) 31.5 
 (22.9-.41.6) 
33.3  
(24.2-43.9) 
AUC  0.667 
 (0.569-0.765) 
0.688 
 (0.588-0.788) 
 
9.2.3 The ability of presenting visual acuity to detect correctable visual loss 
(CVL) 
The results so far in this chapter have looked at the ability of distance acuity (high 
contrast and low contrast) to detect significant gain in distance acuity through 
refractive correction and the detection of significant cataract. Correctable visual 
loss is defined as the presence of significant cataract and/or significant gain in 
distance acuity through refractive correction.  Further on in this chapter, the 
definition of CVL will be amended to take account of significant binocular gain in 
near acuity through near refractive correction. This will be done when evaluating 
the binocular near acuity screening test.  
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(a)                                                             (b) 
 
Figure 9.3 Graph illustrating the sensitivity versus 1-specificity for (a) high contrast visual acuity and 
(b) low contrast visual acuity of the left eye obtained with CVS2 for predicting presence of CVL as 
defined above. The data labels state the X and Y coordinates 
 
Table 9.3 The key statistics for the LogMAR acuity cut off values obtained from Figure 9.3 
Study 2 CVL High Contrast Acuity Low Contrast Acuity 
Ideal Cut Off (LogMAR) VA>0.19 VA>0.39 
Sensitivity (%) 64.9  
(53.5-74.8) 
63.5  
(52.1-73.6) 
Specificity (%) 65.1  
(56.4-72.8) 
70.6  
(62.2-77.9) 
PPV (%) 52.2  
(42.1-62.1) 
56  
(45.3-66.1) 
AUC  0.670 (0.593-0.747) 0.699 (0.623-0.776) 
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9.2.4 The ability of presenting visual acuity to detect Macular Degeneration 
(MD) 
The ability of the screener to detect MD is illustrated in Figure 9.4 and Table 9.4. 
High sensitivity and specificity are not to be expected for the reasons outlined in 
Section 9.1 (see Section 9.2.8) and this is returned to in Chapter 12. 
(a)                                                                 (b) 
 
Figure 9.4 Graph illustrating the sensitivity versus 1-specificity for (a) high contrast visual acuity and 
(b) low contrast visual acuity of the left eye obtained with CVS2 for predicting presence of significant 
macular degeneration as defined in Chapter 4. The data labels state the X and Y coordinates 
Table 9.4 The key statistics for the LogMAR acuity cut off values obtained from Figure 9.4 
Study 2 MD High Contrast Acuity Low Contrast Acuity 
Ideal Cut Off (LogMAR) VA>0.19 VA>0.39 
Sensitivity (%) 63.2  
(47.3-76.6) 
65.8  
(49.9-78.8) 
Specificity (%) 58.0  
(50.3-65.4) 
63.6  
(55.9-70.6) 
PPV (%) 26.1  
(18.2-35.9) 
29.8  
(21-40.2) 
AUC 0.636 
(0.531-0.740) 
0.666  
(0.562-0.771) 
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9.2.5 The ability of presenting visual acuity to detect Macular degeneration 
risk of progression (MD risk prog) 
This category has been introduced in study 2 and is based on the risk of macular 
degeneration progressing to advanced macular degeneration (neovascular disease 
or geographic atrophy) as defined in Chapter 4. 
(a)                                                                (b) 
 
Figure 9.5 Graph illustrating the sensitivity versus 1-specificity for (a) high contrast visual acuity and 
(b) low contrast visual acuity of the left eye obtained with CVS2 for predicting presence of macular 
degeneration at risk of progression as defined in Chapter 4. The data labels state the X and Y 
coordinates 
Table 9.5 The key statistics for the LogMAR acuity cut off values obtained from Figure 9.5 
Study 2 
MD risk prog 
High Contrast Acuity Low Contrast Acuity 
Ideal Cut Off (LogMAR) VA>0.29 VA>0.49 
Sensitivity (%) 85.7  
(60.1-96) 
85.7 
 (60.1-96) 
Specificity (%) 78.0 
(71.5-83.3) 
78.5  
(72-83.8) 
PPV (%) 22.6  
(13.5-35.5) 
23.1  
(13.7-36.1) 
AUC 0.877 
(0.772-0.982) 
0.882 
(0.776-0.988) 
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It can be seen that the ability of the screener to detect macular degeneration at risk 
of progression is better than the ability of the screener to detect macular 
degeneration. This is because the category of macular degeneration at risk of 
progression included patients with advanced stages of macular disease who were 
more likely to have poor vision. The ability of the screening tests to detect these 
patients was better than with the detection of macular degeneration where 
although clinical signs may be seen, vision in the early stages may not always be 
as significantly affected as with degeneration at risk of progression. 
Further on in this chapter the screening tests will be combined to assess their 
suitability to detect the target conditions (significant refractive correction and 
cataract). Macular degeneration at risk of progression will be combined with the 
target conditions when test combinations are being evaluated. A more pragmatic 
assessment of the screener’s performance will also be obtained in Section 9.2.8. 
9.2.6 The ability of presenting visual acuity to detect refractive error, cataract, 
and MD 
The presence of refractive error, cataract, or MD is labelled in the graphs below as 
significant acuity impairing eye conditions (SAIEC). This definition will be amended 
as further analyses are presented to give a more overall impression of the ability of 
the screener at detecting the target conditions. The graphs below show the ability 
of the screener to detect SAIEC in the left eye. Further in the chapter, the ability of 
the screener to detect SAIEC in either eye will also be presented. 
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(a)                                                                 (b) 
 
 Figure 9.6 Graph illustrating the sensitivity versus 1-specificity for (a) high contrast visual acuity and 
(b) low contrast visual acuity of the left eye obtained with CVS2 for predicting SAIEC as defined above. 
The data labels state the X and Y coordinates. 
Table 9.6 The key statistics for the LogMAR acuity cut off values obtained from Figure 9.6 
 
 
 
 
 
 
 
 
Study 2 
SAIEC (left eye) 
High Contrast Acuity Low Contrast Acuity 
Ideal Cut Off (LogMAR) VA>0.19 VA>0.39 
Sensitivity (%) 62.2  
(52.4-71.2) 
62.2  
(52.4-71.2) 
Specificity (%) 69.6  
(60.1-77.7) 
77.5  
(68.4-84.5) 
PPV (%) 66.3  
(56.2- 75.1) 
72.6  
(62.3-81) 
AUC 0.696  
(0.623-0.770) 
0.730  
(0.659-0.801) 
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9.2.7 The ability of presenting visual acuity to determine significant acuity 
impairing eye conditions in either eye (SAIEC). 
In order to give an idea of the overall screener performance, the ROC curves 
below give an indication of how well HCVA and LCVA can detect any significant 
acuity impairing eye conditions (i.e. the presence of refractive error, cataract, or 
MD) in either eye.  
(a)                                                              (b) 
 
Figure 9.7 Graph illustrating the sensitivity versus 1-specificity for (a) high contrast visual acuity and 
(b) low contrast visual acuity of either eye obtained with CVS2 for predicting SAIEC as defined above. 
The data labels state the X and Y coordinates 
Table 9.7 The key statistics for the LogMAR acuity cut off values obtained from Figure 9.7 
 
 
 
Study 2 
SAIEC (either eye) 
High Contrast Acuity Low Contrast Acuity 
Ideal Cut Off (LogMAR) VA>0.19 VA>0.39 
Sensitivity (%) 74.8 
 (66.6-81.5) 
70.9 
 (62.4-78.1)  
Specificity (%) 72.6  
(61.4-81.5 
79.5 
 (68.8-87.1) 
PPV (%) 82.6  
(74.7-88.5) 
85.7  
(77.8-91.1) 
AUC (%) 0.793  
(0.728-0.858) 
0.800 
 (0.737-0.862) 
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The values in Table 9.7 indicate that the best sensitivity is obtained with the high 
contrast acuity and the best specificity is obtained with low contrast acuity. This 
has implications for the possibility of combining tests: if the results of these 
screening tests are combined (e.g., participants are selected who fail both or either 
test) then will this combination give best sensitivity and specificity? This is analysed 
in section 9.4 
The table below gives a summary of the cut off values obtained so far with the 
distance acuity screening tests. 
Table 9.8 Summary of CVS2 HCVA and LCVA cut off values  
 
HCVA LCVA 
Condition Cut off 
value 
(LogMAR) 
Sensitivity 
(%) 
Specificity 
(%) 
Cut off 
value 
(LogMAR) 
Sensitivity 
(%) 
Specificity 
(%) 
Cataract VA>0.19 64.4 59.4 VA>0.39 64.4 64.5 
Rx VA>0.19 72.5 60.6 VA>0.39 70 65 
CVL VA>0.19 64.9 65.1 VA>0.39 63.5 70.6 
MD VA>0.19 63.2 58 VA>0.39 65.8 63.6 
MD risk 
prog 
VA.0.29 85.7 78 VA>0.49 85.7 78.5 
SAIEC 
(left eye) 
VA>0.19 62.2 69.6 VA>0.39 62.2 77.5 
SAIEC 
(either 
eye) 
VA>0.19 74.8 72.6 VA>0.39 70.9 79.5 
 
9.2.8 Performance of the screener from an optometric perspective 
As discussed at the beginning of this Chapter, it is perhaps unreasonable to expect 
a screener which measures visual performance to reliably detect conditions 
defined by their appearance when it is well known that the appearance of 
conditions such as cataracts and macular degeneration is poorly correlated with 
visual function.  The analysis in Table 9.9 shows the ability of the screener to 
detect patients who a “typical” optometrist feels would need an eye examination.  
This has been defined in Chapter 8 as patients with a reduced high contrast visual 
acuity in one or both eyes and those who have not attended for an eye 
examination in the last year. An alternative criterion may be set including all those 
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with reduced high contrast acuity or those who have not had an examination within 
the last year. The results of both of these criterion combinations are stated in the 
table below. Reduced high contrast acuity has been defined as VA>0.19 LogMAR.  
Table 9.9 Performance of screener from an optometric perspective 
Performance of screener 
from an optometric 
perspective 
Sensitivity 
(%) 
Specificity (%) PPV (%) 
HCVA >0.19 and no eye 
examination in the last 
year 
81.8  
(73.1-88.2) 
94.1  
(87.6-97.2) 
93.1 
(85.8-96.1) 
HCVA>0.19 or no eye 
examination in the last 
year 
94.6 
(90.3-97) 
93.8  
(71.7-99.7) 
99.4 
(96.8-100) 
 
A simple combination of acuity testing and knowledge of the patient’s last eye 
examination can result in a high sensitivity  and specificity for detecting those 
patients that should be seen by an optometrist whether this be for a routine eye 
examination or to receive intervention to improve their vision.  
9.3 Evaluation of near acuity vision screening test 
The analyses so far in this chapter have considered screening tests where data for 
both the right and the left eye were obtained. In view of the comments in Chapter 
7, the left eye’s data were taken (i.e., the ROC curves have been drawn to illustrate 
how well the left eye’s screening test data predict the presence of the target 
condition in the left eye). For reasons explained in Chapter 7, the CVS was 
designed to assess binocular near visual acuity. Therefore, in this section the 
graphs and tables illustrate the ability of the binocular near visual acuity to predict 
binocular conditions. At the end of this section, Table 9.13 which contains all the 
cut off values for near acuity, will summarise the section before the results of 
various test combinations are presented. 
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9.3.1 The ability of screener binocular near visual acuity test to detect 
significant gain in binocular near acuity with new near refractive correction 
(NvRx). 
 
Figure 9.8 Graph illustrating the sensitivity versus 1-specificity for binocular near acuity obtained with 
CVS2 for predicting significant gain in binocular near acuity with new refractive correction as defined 
in Chapter 4. The data labels state the X and Y coordinates  
Table 9.10 The key statistics for near acuity cut off values obtained from Figure 9.8 
Study 2 
Near visual acuity  
predicting binocular 
 NvRx 
Near acuity 
Ideal Cut Off (N) NVA> N 11.90 
Sensitivity (%) 48.4  
(32 -65.2) 
Specificity (%) 86.4  
(80.4-90.8) 
PPV (%) 39.5  
(25.6 – 55.3) 
AUC 0.684 
(0.570 –0.798) 
 
As noted with CVS1 in Chapter 8 the screening near acuity test does not appear to 
be as useful in the detection of the target conditions as the distance acuity tests. 
Possible reasons for this will be discussed in Chapter 12. These include the points 
made at the beginning of Section 9.2. 
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9.3.2 The ability of screener binocular near visual acuity test to detect 
significant binocular cataract 
 
 
Figure 9.9 Graph illustrating the sensitivity versus 1-specificity for binocular near acuity obtained with 
CVS2 for predicting significant binocular cataract  as defined in Chapter 4. The data labels state the X 
and Y coordinates 
Table 9.11 The key statistics for near acuity cut off values obtained from Figure 9.9 
Study 2 
Near visual acuity  
predicting binocular 
Significant cataract 
Near acuity 
Ideal Cut Off (N) NVA> N 11.90 
Sensitivity (%) 17.8  
(9.3-31.3) 
Specificity (%) 80.6  
(73.7-86.1) 
PPV (%) 21.1  
(11.1-36.3) 
AUC 0.539  
(0.444-0.634) 
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9.3.3 The ability of screener binocular near visual acuity test to detect 
significant binocular correctable visual loss (BinCVL) 
When evaluating the distance acuity screening test earlier in the chapter, 
correctable visual loss was defined as significant gain in distance acuity with new 
refractive correction or significant cataract. The ROC curve for this (Figure 9.3) was 
calculated for the left eye because the computer screener tested presenting acuity 
monocularly. The definition of correctable visual loss will be amended for the next 
ROC curve to take into account the binocular near acuity test. For the purposes of 
evaluating the near vision test, correctable visual loss has now been defined as the 
presence of significant binocular distance refractive error &/or presence of 
binocular cataract &/or significant binocular near refractive error. 
 
 
Figure 9.10 Graph illustrating the sensitivity versus 1-specificity for binocular near acuity obtained with 
CVS2 for predicting binocular correctable visual loss as defined above. The data labels state the X and 
Y coordinates 
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 Table 9.12 The key statistics for near acuity cut off values obtained from Figure 9.10 
Study 2 
Near visual acuity  
Predicting BinCVL 
 
Near acuity 
Ideal Cut Off (N) NVA> N 11.90 
Sensitivity (%) 28.4  
(19.7-39) 
Specificity (%) 87.4 
(80.2-92.2) 
PPV (%) 60.5 
(44.7 -74.4) 
AUC 0.618  
(0.538- 0.699) 
 
This section will end with a summary table (Table 9.13) that states the near acuity 
cut off values obtained for the eye conditions evaluated in this section. The next 
section of this chapter will focus on test combinations to give an overall view of the 
performance of the screener. This will involve not only combining the screening 
tests, but also combining the eye conditions and evaluating the ability of the 
screener to detect these conditions in either eye as opposed to just the left eye as 
done earlier in the chapter. 
Table 9.13 Summary of CVS2 near acuity cut off values 
 
Near acuity 
Condition Cut off 
value 
(N) 
Sensitivity 
(%) 
Specificity 
(%) 
Binocular 
Cataract 
VA> N 11.9 17.8 80.6 
NvRx VA> N 11.9 48.4 86.4 
Binocular 
CVL 
VA> N 11.9 28.4 87.4 
 
9.4 Combining tests 
The next stage in the analyses will involve calculating how well the overall 
performance of the screener is able to detect significant acuity impairing eye 
conditions (SAIEC) identified in the gold standard. The definition of SAIEC has 
been amended from earlier in the chapter and has been defined as refractive error 
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that can be corrected with spectacles or significant cataract or macular 
degeneration that is at risk of rapid progression. This definition is summarised in 
the table below.  
Table 9.14 Defining significant acuity impairing eye conditions (SAIEC) 
Significant acuity 
impairing eye conditions 
Monocular/Binocular 
Significant gain in distance 
acuity through refractive 
correction. 
 RE or LE or Both 
Significant gain in near acuity 
through refractive correction 
Both eyes only 
Significant cataract RE or LE or Both 
Risk of rapid progression 
macular degeneration 
RE or LE or Both 
 
Having now defined SAIEC, ‘overall performance of screener’ also needs to be 
defined.  ‘Overall performance’ will initially take into account all the tests that are 
included in the computer vision screener except visual fields, which will be 
discussed later in the chapter. All these tests will be combined in an ‘OR’ method 
to give the overall screener performance. The only exception to this will be the 
presence of symptoms, which will be combined in an ‘AND’ method and also in an 
‘OR’ method in order to determine the ideal combination. The criterion for the 
definition of overall performance of screener is summarised in the table below. 
Table 9.15 Defining overall performance of screener 
Overall screener 
performance 
Monocular/Binocular 
Presenting HCVA RE or LE or Both 
Presenting LCVA RE or LE or Both 
Presenting near acuity Both eyes only 
Presenting symptoms Distance/near or both  
RE or LE or both 
 
In the analyses below, all the combinations of vision tests will be evaluated. In 
each combination the effect of incorporating symptoms will be noted and also the 
cut off values will be altered to see what effect this has on the key statistics. The 
combinations of the vision tests used are given in the table below. 
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Table 9.16 Combinations of vision tests to be used in analyses 
Vision test combinations 
HCVA OR LCVA OR NVA 
HCVA,OR LCVA 
HCVA OR NVA 
HCVA 
LCVA OR NVA 
LCVA 
 
For each combination the sensitivity, specificity and the PPV will be calculated. It 
was originally thought that overall accuracy may also be of use: this is a measure 
of the proportion of people correctly classified by a diagnostic test. Alberg et al 
(2004) pointed out that this measure is strongly influenced by prevalence and 
cautioned that “Despite its intuitive appeal as a single summary estimate of test 
validity, overall accuracy blurs the distinction between sensitivity and specificity, 
allowing the relative importance of each to be arbitrarily dictated by the level of 
disease prevalence." These authors cited 25 examples from the literature showing 
the misleading nature of this statistic and it was decided therefore not to present 
this variable. 
9.4.1 Screener test combinations for detecting significant acuity impairing eye 
condition (SAIEC) 
The tables below show the various test combinations and the change in sensitivity 
and specificity that occurs when one of the tests is eliminated. The combinations in 
red represent the best compromise between sensitivity and specificity. At the end 
these combinations will be compared to give the ideal test combination. By 
narrowing down the best combinations in this way, the ideal compromise can be 
found between sensitivity and specificity to give best overall combination. It should 
be noted that one of the limitations described in Section 9.1 still applies. For 
cataract and MD the screener is still being required to use a test of visual function 
to detect a condition that is being defined, with the gold standard, by appearance. 
This issue is returned to in Chapter 12.  
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Table 9.17  Overall screener performance for detecting SAIEC. The combinations in red represent the 
best compromise between sensitivity and specificity 
 
 
Table 9.18 Overall screener performance (excluding presenting NVA) for detecting SAIEC.  The 
combinations in red represent the best compromise between sensitivity and specificity 
 
 
Test Combination Sensitivity  Specificity PPV 
HCVA(0.19) or 
LCVA(0.39) or NVA 
 
80.3 
(72.4-86.4) 
66.7 
(55.6-76.1) 
79 
(71-85.3) 
HCVA(0.19) or 
LCVA(0.39) or NVA & 
symptoms 
 
38.5 
(30.4-47.4) 
87.2 
(78-92.9) 
82.5 
(70.6-85.3) 
HCVA(0.19) or 
LCVA(0.39) or NVA or 
symptoms 
 
88.5 
(81.7-93) 
48.7 
(37.9-59.6) 
73 
(65.3-79.5) 
HCVA(0.29) or 
LCVA(0.49) or NVA  
 
68.9 
(60.2-76.4) 
80.8 
(70.7-88) 
84.8 
(76.5-90.6) 
HCVA(0.29) or 
LCVA(0.49) or NVA & 
symptoms 
 
33.6 
(25.8-42.4) 
89.7 
(81-94.7) 
83.7 
(71-91.5) 
HCVA(0.29) or 
LCVA(0.49) or NVA or 
symptoms 
 
82 
(74.2-87.8) 
60.3 
(49.2-70.4) 
76.3 
(68.4-82.8) 
  Test Combination Sensitivity  Specificity PPV 
HCVA(0.19) or   
LCVA(0.39)  
77.9 
(69.7-84.3) 
 
69.2 
(58.3-78.4) 
79.8 
(71.7-86.1) 
HCVA(0.19) or 
LCVA(0.39) & symptoms 
 
37.7 
(29.6-46.6) 
88.5 
(79.5-93.8) 
83.6 
(71.7-91.1) 
HCVA(0.19) or 
LCVA(0.39) or symptoms 
 
86.9 
(79.8-91.8) 
50 
(39.2-60.8) 
73.1 
(65.4-79.7) 
HCVA(0.29) or 
LCVA(0.49)  
 
65.6 
(56.8-73.4) 
87.2 
(78-92.9) 
88.9 
(80.7-93.9) 
HCVA(0.29) or 
LCVA(0.49) & symptoms 
 
32 
(24.4-40.7) 
93.6 
(85.9-97.2) 
88.6 
(76-95) 
HCVA(0.29) or 
LCVA(0.49) or symptoms 
 
80.3 
(72.4-86.4) 
62.8 
(51.7-72.7) 
77.2 
(69.1-83.6) 
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Table 9.19 Overall screener performance (excluding presenting LCVA) for detecting SAIEC. The 
combinations in red represent the best compromise between sensitivity and specificity 
 
 
 
 
 
 
 
 
 
Table 9.20 Overall screener performance (excluding presenting LCVA & NVA) for detecting SAIEC. The 
combinations in red represent the best compromise between sensitivity and specificity 
 
 
 
 
 
Test Combination Sensitivity  Specificity PPV 
HCVA(0.19) or NVA 
 
79.5 
(71.5-85.7) 
67.9 
(57-77.3) 
79.5 
(71.5-85.7) 
HCVA(0.19) or NVA & 
symptoms 
 
38.5 
(30.4-47.4) 
87.2 
(78-92.9) 
82.5 
(70.6-90.2) 
HCVA(0.19) or NVA or 
symptoms 
 
46.7 
(38.1-55.5) 
69.2 
(58.3-78.4) 
70.4 
(59.7-79.2) 
HCVA(0.29) or NVA  
 
65.6 
(56.8-73.4) 
80.8 
(70.7-88) 
84.2 
(75.6-90.2) 
HCVA(0.29) or NVA & 
symptoms 
 
32 
(24.4-40.7) 
89.7 
(81-94.7) 
83 
(69.9-91.1) 
HCVA(0.29) or NVA or 
symptoms 
 
80.3 
(72.4-86.4) 
60.3 
(49.2-70.4) 
76 
(67.9-82.5) 
Test Combination Sensitivity  Specificity PPV 
HCVA(0.19)  77  
(68.8-83.6) 
 
73.1 
(62.3-81.7) 
81.7 
(73.7-87.7) 
HCVA(0.19) & symptoms 
 
37.7 
(29.6-46.6) 
89.7 
(81-94.7) 
85.2 
(73.4-92.3) 
HCVA(0.19) or 
symptoms 
 
86.1 
(78.8-91.1) 
52.6 
(41.6-63.3) 
73.9 
(66.2-80.5) 
HCVA(0.29)  
 
60.7 
(51.8-68.9) 
88.5 
(79.5-93.8) 
89.2 
(80.7-94.2) 
HCVA(0.29) & symptoms 
 
29.5 
(22.1-38.1) 
94.9 
(87.5-98) 
90 
(76.9-96) 
HCVA(0.29) or 
symptoms 
 
77.9 
(69.7-84.3) 
62.8 
(51.7-72.7) 
76.6 
(68.4-83.2) 
Symptoms 
 
46.7 
(38.1-55.5) 
69.2 
(58.3-78.4) 
70.4 
(59.7-79.2) 
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Table 9.21  Overall screener performance (excluding presenting HCVA) for detecting SAIEC. The 
combinations in red represent the best compromise between sensitivity and specificity 
Test Combination Sensitivity  Specificity PPV 
LCVA(0.39) or NVA 
 
74.6 
(66.2-81.5) 
74.4 
(63.7-82.7) 
82 
(73.8-88) 
LCVA(0.39) or NVA 
&symptoms 
 
36.9 
(28.8-45.7) 
87.2 
(78-92.9) 
81.8 
(69.7-89.8) 
LCVA(0.39) or NVA or 
symptoms 
 
84.4 
(77-89.8) 
56.4 
(45.4-66.9) 
75.2 
(67.3-81.7) 
LCVA(0.49) or NVA  
 
65.6 
(56.8-73.4) 
83.3 
(73.5-90) 
86 
(77.5-91.6) 
LCVA(0.49) or NVA & 
symptoms 
 
33.6 
(25.8-42.4) 
89.7 
(81-94.7) 
83.7 
(71-91.5) 
LCVA(0.49) or NVA or 
symptoms 
 
78.7 
(90.6-85) 
62.8 
(51.7-72.7) 
76.8 
(68.7-83.3) 
 
Table 9.22 Overall screener performance (excluding presenting HCVA & NVA) for detecting SAIEC. The 
combinations in red represent the best compromise between sensitivity and specificity 
Test Combination Sensitivity  Specificity PPV 
LCVA(0.39)  71.3 
(62.7-78.6) 
76.9 
(66.4-84.9) 
82.9 
(74.5-88.9) 
LCVA(0.39) & 
symptoms 
 
35.2 
(27.3-44.1) 
88.5 
(79.5-93.8) 
82.7 
(70.3-90.6) 
LCVA(0.39) or 
symptoms 
 
82.8 
(75.2-88.5) 
57.7 
(46.6-68) 
75.4 
(67.4-81.9) 
LCVA(0.49)  
 
59 
(50.1-67.3) 
89.7 
(81-94.7) 
90 
(81.5-94.8) 
LCVA(0.49) & 
symptoms 
 
28.7 
(21.4-37.3) 
93.6 
(85.9-97.2) 
87.5 
(73.9-94.5) 
LCVA(0.49) or 
symptoms 
77 
(68.8-83.6) 
65.4 
(54.3-75) 
77.7 
(69.5-84.2) 
Symptoms 
 
46.7 
(38.1-55.5) 
69.2 
(58.3-78.4) 
70.4 
(59.7-79.2) 
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9.4.2 Best Combinations for detecting significant acuity impairing eye 
conditions 
From all the above tables it seems as though the best combinations in each table 
occur  when the tests are used at their original cut off values without  incorporating 
symptoms, or when the tests are used at the higher cut off values incorporating 
symptoms in an OR method. The best combinations will now be compared in the 
table below. 
Table 9.23  Best test combinations for detecting SAIEC. The significance of the yellow highlighted cell 
is described in the text below the table. The combinations in red represent the best compromise 
between sensitivity and specificity 
Test Combination Sensitivity  Specificity PPV 
HCVA(0.19) or 
LCVA(0.39) or NVA 
 
80.3 
(72.4-86.4) 
66.7 
(55.6-76.1) 
79 
(71-85.3) 
HCVA(0.29) or 
LCVA(0.49) or NVA or 
symptoms 
 
82 
(74.2-87.8) 
60.3 
(49.2-70.4) 
76.3 
(68.4-82.8) 
HCVA(0.19) or 
LCVA(0.39)  
77.9 
(69.7-84.3) 
 
69.2 
(58.3-78.4) 
79.8 
(71.7-86.1) 
HCVA(0.29) or 
LCVA(0.49) or symptoms 
 
80.3 
(72.4-86.4) 
62.8 
(51.7-72.7) 
77.2 
(69.1-83.6) 
HCVA(0.19) or NVA 
 
79.5 
(71.5-85.7) 
67.9 
(57-77.3) 
79.5 
(71.5-85.7) 
HCVA(0.29) or NVA or 
symptoms 
 
80.3 
(72.4-86.4) 
60.3 
(49.2-70.4) 
76 
(67.9-82.5) 
HCVA(0.19)  77  
(68.8-83.6) 
 
73.1 
(62.3-81.7) 
81.7 
(73.7-87.7) 
LCVA(0.39) or NVA 
 
74.6 
(66.2-81.5) 
74.4 
(63.7-82.7) 
82 
(73.8-88) 
LCVA(0.49) or NVA or 
symptoms 
 
78.7 
(90.6-85) 
62.8 
(51.7-72.7) 
76.8 
(68.7-83.3) 
LCVA(0.39)  71.3 
(62.7-78.6) 
76.9 
(66.4-84.9) 
82.9 
(74.5-88.9) 
LCVA(0.49) or symptoms 77 
(68.8-83.6) 
65.4 
(54.3-75) 
77.7 
(69.5-84.2) 
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Summary 
The following key points can be derived from the above table: All the combinations 
give reasonable sensitivity but the combinations that give a suitable compromise 
between sensitivity and specificity are highlighted in red. The addition of near 
acuity provides a slightly higher sensitivity and may be useful in a situation where it 
is important to detect as many people as possible with visual loss.  
 In a country where there are few optometric services (e.g., developing 
countries), specificity may be more important than sensitivity and in this 
case low contrast VA alone may be a simple screening tool that it is 
appropriate (see cell highlighted in yellow in table). This single test provides 
the best specificity out of all the combinations. 
 Combining all the tests together increases the chances of detecting visual 
loss (i.e. a high sensitivity value) but the high number of false positives 
(those who are normal according to the gold standard but are  identified as 
been abnormal according to the screener) results in a low specificity value 
which may lead to unnecessary referrals for further eye care. 
 The single best test to use for screening of visual loss is HCVA which 
provides both relatively high sensitivity and specificity. However, a higher 
sensitivity can be obtained, with minimal effect on specificity, by combining 
this with other tests. 
 From a pragmatic viewpoint, the most appropriate assessment of screener 
performance in the UK may be the screening test’s performance at detecting 
the cases who an optometrist would feel require eye examinations. The 
screener obtains 94.6 % sensitivity and 93.8% specificity in this type of 
analysis. 
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9.5 Glaucoma 
Glaucoma is not one of the target conditions as discussed in Chapter 4, but 
nonetheless the screening test’s performance at detecting glaucoma 
patients/suspects was analysed. The discussion in Chapter 4 acknowledges that it 
would be difficult to detect glaucoma with vision screening since all three 
commonly used glaucoma tests have a low sensitivity and/or specificity in isolation, 
(Harper & Reeves, 1999a) and using all three tests in screening would be 
impractical. Although visual loss from glaucoma cannot be treated, further visual 
loss can be prevented through timely detection. The most appropriate test for the 
detection of glaucoma that could be incorporated into a vision screener was a 
visual field test.  
“With or at risk of glaucoma” was defined as those cases that a community 
optometrist would be likely to refer or wish to closely monitor because of 
glaucoma/suspicion of glaucoma. This definition is summarised in Table 9.24. 
Table 9.24 Defining ‘with or at risk of glaucoma’ 
Patients who are already diagnosed with glaucoma 
Patients who were  referred to the hospital eye service on the basis of the gold 
standard test results: fields, pressures, optic nerve head fundoscopy and in many 
cases GDX 
In cases where it was necessary to monitor the patient closely due to the risk of 
glaucoma based on the gold standard test results.  
 
 There were 19 patients in Study 2 that fell in to the category of ‘with or at risk of 
glaucoma’ as defined Table 9.24. The clinical characteristics of these patients are 
outlined in the table below. The defining clinical characteristics of ‘with or at risk of 
glaucoma’ included optic nerve head assessment, intraocular pressure readings 
and visual field assessment. The presence of a family history of glaucoma was 
also noted. Where ever possible, a GDX test was performed to assess the health 
of the retinal nerve fibre layer around the optic disc.   
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 Table 9.25 Clinical characteristics of patients ‘with or at risk of glaucoma’ as defined in Table 9.24 
 
Optic nerve 
head 
 
cup: disc ratio 
and description 
including 
integrity of 
neural retinal 
rim (NNR) 
Intraocular 
pressure 
(mmHg) 
Visual fields 
Repeated on 2 
occasions 
 
1) Within normal 
limits 
2) borderline 
3) Outside normal 
limits 
 
 
GDX 
Nerve fibre 
indicator 
analysis 
 
1) Low risk 
2) Suspect 
3) high risk 
Family 
history of 
glaucoma 
Outcome 
 
1)Already diagnosed 
and under hospital 
eye service 
2) referred for 
possible glaucoma 
3) monitor for “at risk’ 
of glaucoma 
1 R) 0.55 L) 0.3 
R appears 
pale with 
inferior 
thinning of 
NRR 
R) 18 
L) 18 
R) 3 
L) 1 
R) 2 
L) 2 
None 2 
2 R) 0.5 L)0.5 
Pale with 
inferior loss 
of NRR  
R) 18 
L) 18 
R) 3 
L) 3 
 None 1 
3 R) 0.45 
L)0.45 
Very deep 
Slightly pale, 
but NRR 
even 
R)13 
L 12 
R) 3 
L) 3 
 None 3 
4 R) 0.25 L) 
0.25 
Moderate 
depth, pale, 
NRR even 
R) 13 
L) 15 
R) 2 
L) 3 
R) 2 
L) 2 
Yes 1 
5 R) 0.45 L) 0.4 
Moderate 
depth, 
NRR even 
R) 11 
L) 13 
R) 3 
L) 3 
R)1  
L) 1 
None 1 
6 R) 0.45 L) 
0.45 
Moderate 
depth  
NRR even 
R) 15 
L) 17 
R) 3 
L) 3 
R) 1 
L) 1 
But 
significant 
asymmetry  
Yes 2 
7 R) 0.3 L) 0.4 
NRR inferior 
notching L 
eye 
 
 
R) 16 
L) 17 
R) 3 
L) 3 
 none 2 
8  R) 0.3 L) 0.35 
Slightly pale, 
NRR even 
R) 12 
L) 11 
R) 3 
L) 3 
R) 3 
L) 3 
yes 2 
9 R) 0.25 L) 
0.25 
Very pale, 
deep, 
indistinct 
margins 
R) 17 
L) 18 
R) 3 
L) 3 
 none 2 
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10  R) 0.2 L) 0.2 
NRR even 
moderate 
depth 
R) 11 
L) 11 
R) 3 
L) 2 
R) 1 
L) 1 
Yes 3 
11 R) 0.6 L) 0.5 
Very pale and 
uneven NRR 
R) 15 
L) 15 
R) 3 
L) 3 
R) 3 
L) 3 
 
none 2 
12  R) 0.35 
L)0.35 
Moderate 
depth 
NRR even 
R) 14 
L) 13 
R) 2 
L) 1 
R) 1 
L) border 
between 1 
and 2 
yes 3 
13 R) 0.7 L)0.7 
Deep and 
pale 
R) 15 
L 17 
R) 3 
L) 3 
R) 2 
L) 2 
 2 
14 R) 0.75 L) 
0.85 
Inferior NRR 
loss, deep 
and pale 
R) 12 
L) 12 
R) 3 
L) 3 
  1 
15 R) 0.25 L0.25 
Moderate 
depth NRR 
even 
R) 14 
L) 14 
R) 1 
L) 2 
R) 1 
L) 2 
 3 
16 R) 0.75 
L)0.80 
Pale, loss of 
NRR 
R) 11 
L) 12 
R) 3 
L) 3 
  1 
17 R) 0.6 L) 0.6 
Deep, pale, 
thinning of 
NRR 
R) 11 
L) 12 
R) 3 
L) 3 
  1 
18 R) 0.6 L)0.8 
Pale with 
uneven NRR 
R) 14 
L) 17 
R) 3 
L) 3 
  2 
19 R) 0.4  L)0.4 
Slightly pale, 
moderate 
depth 
NRR slight 
thinning of 
NRR 
R) 11 
L) 11 
R) 3 
L) 3 
R) 2 
L) 2 
None   
2 
 
The definition of SAIEC has been amended in the table below to incorporate those 
with glaucoma or those at risk of glaucoma in one eye or both eyes. This is stated 
in Table 9.26 
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Table 9.26  Defining SAIEC, incorporating glaucoma 
Significant acuity impairing eye conditions Monocular/Binocular 
Significant gain in distance acuity through 
refractive correction. 
 RE or LE or Both 
Significant gain in near acuity through refractive 
correction 
Both eyes only 
Significant cataract RE or LE or Both 
Risk of rapid progression macular degeneration RE or LE or Both 
Those with glaucoma/glaucoma suspect. RE or LE or Both 
 
In the analyses described earlier in this chapter it was found that HCVA alone and 
HCVA or NVA produced good sensitivity and specificity for detecting SAIEC 
(excluding glaucoma). These two combinations will now be combined with the 
visual field test in an OR method to give a complete overview of screener 
performance for detecting SAIEC. Study 1 showed that the most appropriate cut off 
for the visual field test was missing more than 5 points (VF>5), Study 2 found a 
different cut off: missing more than 10 points (VF>10). Both these cut off values will 
be used to find the most appropriate combination. As with HCVA and LCVA, it was 
thought important that the visual field test was able to detect a monocular defect 
and so the visual field data were analysed monocularly.  
This section of the analysis will also look at the ability of LCVA together with visual 
field results to screen for glaucoma. Research has shown that LCVA may be 
abnormal in glaucoma and other visual pathway dysfunction that is not detected by 
HCVA (Regan & Neima, 1984). Also in this part of the analysis, all the vision 
screening tests including the visual field test are combined together to see how 
well the screener detects significant acuity impairing eye conditions including 
glaucoma. The various test groupings and the key statistics derived are included in 
the section below.  
9.5.1 Screener test combinations for detecting significant acuity impairing eye 
conditions including glaucoma. 
The key statistics for the above combinations are given in the table below. A further 
column has been added to the table below to show the number of glaucoma 
patients/ glaucoma suspects that were correctly identified by the screener using 
the various combinations. The gold standard eye examination indicated that there 
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were 19 patients who had glaucoma or were at risk of glaucoma in accordance 
with the above definition.  
 
Table 9.27 Test combinations with visual fields for the detection of  SAIEC  including glaucoma. The 
significance of the yellow highlighted cell is described in the section below the table. The 
combinations in red represent the best compromise between sensitivity and specificity 
Test Combination Sensitivity  Specificity PPV Glaucoma 
detection 
HCVA(0.19) 71.2 
(63-78.2) 
69.1 
(57.4-78.8) 
81.7 
(73.7-87.7) 
7/19 
HCVA(0.19) or NVA 74.2 
(66.2-80.9) 
64.7 
(52.8-75) 
80.3 
(72.4-86.4) 
8/19 
LCVA (0.39) 65.9 
(57.5-73.4) 
73.5 
(62-82.6) 
82.9 
(74.5-88.9) 
7/19 
HCVA(0.19) or LCVA(0.39) 
or NVA 
75 
(67-81.6) 
63.2 
(51.4-73.7) 
79.8 
(71.9-86) 
8/19 
VF>5 72  
(63.8-78.9) 
32.4  
(22.4-44.2) 
67.4 
(59.3-74.6) 
14/19 
VF>10 50  
(41.6-58.4) 
72  
(60.4-81.3) 
77.6 
(67.7-85.2) 
10/19 
HCVA (0.19) OR VF>5 87.9 
(81.2-92.4) 
25 
(16.2-36.4) 
69.5 
(62.1-75.9) 
15/19 
HCVA (0.19) OR VF>10 80.3 
(72.7-86.2) 
51.5 
(39.8-62.9) 
76.3 
(68.5-83.6) 
11/19 
LCVA (0.39) OR VF>5 85.6 
(78.6-90.6) 
26.5 
(17.4-38) 
69.3 
(61.9-75.9) 
15/19 
LCVA (0.39) OR VF>10 76.5 
(68.6-82.9) 
54.4 
(42.7-65.7) 
76.5 
(68.6-82.9) 
11/19 
HCVA OR NVA OR VF>5 87.9 
(81.2-92.4) 
25 
(16.2-36.4) 
69.5 
(62.1-75.9 
15/19 
HCVA OR NVA OR VF>10 81.1 
(73.5-86.8) 
50 
(38.4-61.6) 
75.9 
(68.2-82.2) 
11/19 
HCVA(0.19) or LCVA(0.39) 
or NVA OR VF (>5) 
87.9 
(81.2-92.4) 
25 
(16.2-36.4) 
69.5 
(62.1-75.9) 
15/19 
HCVA(0.19) or LCVA(0.39) 
or NVA OR VF (>10) 
81.1 
(73.5-86.8) 
48.5 
(37.1-60.2) 
75.4 
(67.7-81.7) 
11/19 
 
Summary 
Although the vision tests alone produce a good sensitivity and specificity result, the 
ability to detect glaucoma patients is poor, this is improved by using the visual field 
test  The highest specificity value for the detection of all common ocular 
abnormalities, including glaucoma, is achieved by the visual field test alone 
(highlighted cell). Introducing the visual field test in to the combinations does help 
to increase the number of glaucoma patients that are detected and also increases 
the sensitivity, but the overall specificity values are reduced. The combinations that 
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give a suitable compromise between sensitivity, specificity and glaucoma detection 
are highlighted in red. As mentioned in Chapter 8 (Section 8.4), there is a 
subjective element in the choices made. The bottom two rows of the table 
represent a combination of the entire screening tool which results in high sensitivity 
and glaucoma detection but low specificity. 
9.6 Conclusions 
The above analyses highlight that the combination of tests that are most 
appropriate in screening for eye disease in older patients is dependent on the aim 
of the screening program and also on the resources that are available after the 
screening has taken place. Below is table that summarises this, and which also 
includes the data on the pragmatic analysis of the cases that require an eye 
examination. 
Table 9.28  Summary table of test combinations for the detection of SAIEC. The combinations in red 
represent the best compromise between sensitivity and specificity 
Test Combination Sensitivity  Specificity PPV Comment 
HCVA(0.19) or 
NVA 
 
79.5 
(71.5-85.7) 
67.9 
(57-77.3) 
79.5 
(71.5-85.7) 
These two combinations give a good 
compromise between sensitivity and 
specificity for detecting SAIEC 
excluding glaucoma. The glaucoma 
detection values on these 
combinations are very low. 
HCVA(0.19)  77  
(68.8-83.6) 
 
73.1 
(62.3-81.7) 
81.7 
(73.7-87.7) 
LCVA(0.39)  71.3 
(62.7-78.6) 
76.9 
(66.4-84.9) 
82.9 
(74.5-88.9) 
This combination gives a slightly 
higher specificity value for detecting 
SAIEC excluding glaucoma and may 
be useful in an area where eye care 
resources are limited. 
HCVA (0.19) OR 
VF>10 
80.3 
(72.7-86.2) 
51.5 
(39.8-62.9) 
76.3 
(68.5-83.6) 
This combination gives a high 
sensitivity value for detection of SAIEC 
including glaucoma. The glaucoma 
detection was 11/19. This may be 
useful in area where eye care services 
are not limited and where the aim of 
the screening program is to detect as 
many people as possible with visual 
problems. 
LCVA (0.39) OR 
VF>10 
76.5 
(68.6-82.9) 
54.4 
(42.7-65.7) 
76.5 
(68.6-82.9) 
This combination is possibly a better 
compromise than the above for the 
detection of SAIEC including 
glaucoma. It still results in a glaucoma 
detection of 11/19 but gives a slightly 
better specificity 
Performance of 
screener from an 
optometric 
94.6 
(90.3-97) 
93.8  
(71.7-99.7) 
99.4 
(96.8-100) 
 
This shows the ability of the screener 
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perspective Reduced 
HCVA or no eye 
examination in the 
last year 
to detect patients who a typical 
optometrist feels would need an eye 
examination. 
Performance of 
screener from an 
optometric 
perspective Reduced 
HCVA and no eye 
examination in the 
last year 
81.8  
(73.1-88.2) 
94.1  
(87.6-97.2) 
93.1 
(85.8-96.1) 
 
If one of the aims of the screening program is to include glaucoma detection (as 
well as significant refractive error, significant cataract and MD progression), then 
LCVA OR VF>10 would be the best combination. If glaucoma detection is not one 
of the conditions that the screening program is including then HCVA alone would 
be the best compromise or LCVA alone would give a higher specificity in areas 
where resources are limited. The three most appropriate combinations have been 
highlighted in red.  
In the next chapter, the results from the rapid flipchart will be analysed. 
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Chapter 10  
Investigation of the effectiveness 
of a rapid flipchart screener for 
screening the vision of older 
people in the community  
10.1 Rapid flipchart screener 
The first version of the computer screener was used to determine the best test 
battery to be incorporated in to the revised computerised vision screener (CVS2). 
In addition to the computerised screener, the key tests were made available in a 
flipchart format.  In this chapter the flipchart vision screener (FVS) will be evaluated 
in the same way as the computerised screener. 
Receiver operator curves for the flipchart screener are presented below for each of 
the target conditions together with key statistics to evaluate the ability of the test to 
detect the target conditions. The target conditions were defined previously in 
Chapter 4 and these definitions are used to define the conditions found in the gold 
standard with which the screening tests are compared. High Contrast visual acuity 
(HCVA) and low contrast visual acuity (LCVA) have been evaluated first because 
these were monocular tests; this is followed by near visual acuity (NVA) which was 
evaluated binocularly.  
The cut off values for both CVS1 and CVS2 relate to LogMAR values. However, 
the scoring system for the FVS is slightly different. The scoring system for distance 
acuity when using the FVS as discussed in Chapter 4, relates to how many letters 
the patient could not read or read incorrectly. Each letter incorrectly read relates to 
a score of 1; if the patient read all the letters correctly this would give a score of 0. 
The near acuity is scored in the same way but is based on how difficult the patient 
found the text to read. In order to relate the scores from the FVS to logmar acuity, 
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conversion tables at the back of the FVS enabled the scores to be converted into 
acuity values. These tables are reproduced below. 
Table 10.1 Conversion table for distance HCVA FVS scores to LogMAR and Snellen acuities 
Snellen 6/9.5 6/12 6/15 6/18 6/24 
+ 
LogMA
R 
0.2 0.3 0.4 0.5 0.6 
FVS 
Score 
0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 
 
Table 10.2 Conversion table for converting distance LCVA FVS scores to LogMAR and Snellen acuities 
Snellen 6/15 6/18 6/24 + 
LogMAR 0.4 0.5 0.6 
FVS 
score 
0 1 2 3 4 5 6 7 8 
 
Table 10.3 Conversion table for converting NVA FVS scores to N notation 
N Notation N7 Easy N9 Easy N12 Easy N12 (Not easy) 
FVS score 1 2 3 4 
 
The analyses in this chapter will present the cut off values using the FVS score. 
The distance acuity tests will be evaluated first using the left eye, followed by near 
acuity and then test combinations will be analysed. At the end of the next section 
evaluating the monocular cut-offs, Table 10.11 which contains all the cut-off values 
for distance acuity, will summarise the section before the results of the near acuity 
test are presented. The near acuity cut-off values will be summarised in Table 
10.16 before the results of the test combinations are presented.  
In accordance with the flow chart at the beginning of Chapter 7 (Figure 7.1) The 
descriptive statistics and the comparison of the data from the FVS with the gold 
standard data will be dealt with first before the individual test cut-offs from 
monocular ROCs are determined.  
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10.2 Descriptive statistics of FVS results 
This section will give an overall analysis of the acuity tests in the FVS. The data 
from the screening tool will be compared to the gold standard eye examination in a 
similar approach to that used for the CVS1 and CVS2 in Chapter 7. 
High contrast acuity 
The methods for measuring visual acuity have been discussed in Chapter 4. The 
graphs below show the frequency distributions of the presenting visual acuities 
achieved from the FVS and from the gold standard eye examination. 
 
 
Figure 10.1 Distribution of presenting HCVA in RE for Study 2. The FVS test measurement range was 
0.20 to 0.60 (see text). 
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Figure 10.2 Distribution of presenting HCVA in LE for Study 2. The FVS test measurement range 
was 0.20 to 0.60 (see text). 
Figure 10.1 and Figure 10.2 show the distributions of high contrast visual acuities 
measured in the gold standard eye examination and with the FVS. The results are 
not directly comparable as the FVS has a minimum size of 0.2 LogMAR and a 
maximum size of 0.6 LogMAR resulting in “ceiling” effects at both ends of the 
distribution. As noted in Chapter 7 with figures 7.13 and 7.14, graphs showing the 
correlation between the acuity achieved in the gold standard eye examination and 
the acuity achieved with the screener will be influenced by the measurement range 
of the screener test (0.20 to 0.60 LogMAR for HCVA with the FVS). To give a more 
accurate estimate of the inter-test agreement between the high contrast visual 
acuity tests of the screener and the gold standard test, Bland and Altman graphs 
(Bland and Altman, 1986) were plotted based on the central range of data, for 
which the two tests are comparable (data points that for the gold standard lay 
between 0.30 and 0.50 LogMAR). These are shown for the right and left eyes in 
Figure 10.3 and Figure 10.4. 
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Figure 10.3 Bland and Altman plot of the difference in VA v mean VA in right eye, for gold standard and 
FVS high contrast VA. The central range of data used excludes those with gold standard acuity of less 
than 0.3 LogMAR and greater than 0.5 LogMAR (N=56). The mean difference (solid horizontal line) is 
0.072 and the standard deviation is 0.10. The upper and lower dashed lines represent + and – 2 
standard deviations from the mean (0.27 and -0.13).  
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Figure 10.4 Bland and Altman plot of the difference in VA v mean VA in left eye, for gold standard and 
FVS high contrast VA. The central range of data used excludes those with a gold standard acuity of 
less than 0.3 LogMAR and greater than 0.5 LogMAR (N=55). The mean difference (solid horizontal line) 
is 0.059 and the standard deviation is 0.11. The upper and lower dashed lines represent + and – 2 
standard deviations from the mean (0.27 and -0.16). 
The horizontal reference lines in Figure 10.3 and Figure 10.4 show the key 
variables for the inter-test repeatability of high contrast visual acuity. The mean 
difference between the two measurement methods is 0.072 for the right eye and 
0.059 for the left eye and the 95% limits are approximately two lines for each 
method.  These results are consistent with the results from the computer vision 
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screener (Figures 7.15 and 7.16) and as noted in Chapter 7, these findings are 
fairly consistent with the literature on repeatability of visual acuity measurements.  
Low contrast acuity 
 
Figure 10.5 Distribution of presenting LCVA in RE for Study 2. The FVS test measurement range was 
0.40 to 0.70. 
 
Figure 10.6 Distribution of presenting LCVA in LE for Study 2. The FVS test measurement range was 
0.40 to 0.70. 
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Figure 10.5 and Figure 10.6 show the distributions of low contrast visual acuities 
measured in the gold standard eye examination and with the FVS. Again, the 
graphs show the upper and lower ceiling effect imposed by the measurement 
range of the FVS. The graphs below (Figure 10.7 and Figure 10.8) give an 
estimate of the inter-test agreement between the low contrast visual acuity tests of 
the screener and the gold standard test. As with high contrast acuity (Figure 10.3 
and Figure 10.4), Bland and Altman graphs (Bland and Altman, 1986) were plotted 
based on the central range of data, for which the two tests are comparable (data 
points that for the gold standard low contrast acuity lay between 0.45 and 0.65 
LogMAR). The central range for low contrast acuity was obtained by eliminating 
measurements that were in the 0.5 LogMAR extremes. This is slightly different 
than for high contrast acuity in Figure 10.3 and Figure 10.4 where gold standard 
acuity values that were in the 1.0 LogMAR extremes of the measurement range of 
the screener were eliminated. The reason for this is because the screener had a 
greater measurement range for high contrast acuity (0.2 - 0.6 LogMAR) than for 
low contrast acuity (0.40 – 0.70 LogMAR). 
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Figure 10.7 Bland and Altman plot of the difference in LCVA v mean LCVA in right eye, for gold 
standard and FVS low contrast VA. The central range of data used excludes those with gold standard 
acuity of less than 0.45 LogMAR and greater than 0.65 LogMAR (N=52). The mean difference (solid 
horizontal line) is -0.014 and the standard deviation is 0.09. The upper and lower dashed lines 
represent + and – 2 standard deviations from the mean (0.17 and -0.19) 
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Figure 10.8 Bland and Altman plot of the difference in LCVA v mean LCVA in left eye, for gold standard 
and FVS low contrast VA. The central range of data used excludes those with a gold standard acuity of 
less than 0.45 LogMAR and greater than 0.65 LogMAR (N=41). The mean difference (solid horizontal 
line) is -0.007 and the standard deviation is 0.09. The upper and lower dashed lines represent + and – 2 
standard deviations from the mean (0.18 and -0.19) 
The horizontal reference lines in Figure 10.7 and Figure 10.8 show the key 
variables for the inter-test repeatability of high contrast visual acuity. The mean 
difference between the two measurement methods is -0.014 for the right eye and -
0.007 for the left eye and the 95% limits are approximately two lines. It is 
interesting to note that the mean difference for low contrast acuity for the right and 
left eye are both negative values. This is because measurement of low contrast 
acuity with the FVS was giving worse acuities (higher LogMAR values) than with 
the gold standard. This is discussed further in Chapter 12. 
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Near acuity 
Near acuity was measured binocularly with the flipchart screener and monocularly 
with the gold standard. Figure 10.9 below has used the gold standard near acuity 
data from the better eye to compare with the binocular measurement from the 
flipchart screener. The range of near acuity measured with the flipchart was N7- 
N12 (0.3-0.5 LogMAR). The scoring system for near acuity was not based on how 
many letters were incorrectly read as it was for distance acuity but on how easy the 
patient found the text to read. For the purpose of the graph below, patients that 
found the N7 text “easy” to read have been assumed to have a near acuity of N6 
(although it may have been better than this). Patients that found the N12 text “not 
easy” have been assumed to have a near acuity of N14 (although it may have 
been worse than this).Therefore, the measurement range of the screener has been 
taken to be N6- N14 (0.2- 0.6 LogMAR). As with the Bland and Altman graphs so 
far in this chapter, Figure 10.9 below has been plotted based on the central range 
of data, for which the two tests are comparable (data points that for the gold 
standard near acuity lay between 0.25 and 0.55 LogMAR).  
The horizontal reference lines in Figure 10.9 show the key variables for the inter-
test repeatability of near visual acuity. The mean difference between the two 
measurement methods is 0.118. 
An important point to consider is that the near vision test on the screener is simply 
trying to determine if reading is easy or not with different size prints. It is not 
attempting to measure an acuity threshold.  
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Figure 10.9 Bland and Altman plot of the difference in near acuity v mean near acuity, for gold standard 
and FVS. The central range of data used excludes those with a gold standard near acuity of less than 
0.25 LogMAR and greater than 0.55 LogMAR (N=46). The mean difference (solid horizontal line) is 0.118 
and the standard deviation is 0.08. The upper and lower dashed lines represent + and – 2 standard 
deviations from the mean (0.28 and -0.04). 
The above section has focussed on the descriptive data from the FVS. In the next 
section ROCs will be used to derive the monocular cut off values for each of the 
tests. A full description of ROC curves can be found in Section 7.3 and the 
limitations of the ROCs in this study have been noted in Chapter 8 and Chapter 9. 
The same limitations apply here, including the high criterion set to assess the 
screener’s performance and the difficulty with relating structural appearance to 
functional measures. These points will be discussed further in Chapter 12. As 
acknowledged in previous chapters the ROCs will also be limited because many 
different conditions influence the functional measures, it could be argued that a 
more valid measure of screener performance is to evaluate whether it detects 
those cases that an optometrist would be likely to feel needed an eye examination. 
Such an evaluation is carried out in Section 10.3.8. 
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10.3 Monocular data: selection of appropriate cut offs  
The suitability of the screening distance acuity test for determining various eye 
conditions will now be investigated.  At the end of this section, Table 10.11 which 
contains all the cut off values for distance acuity, will summarise the section before 
the results of the near acuity test are presented. 
10.3.1 The ability of presenting screener visual acuity to determine significant 
cataract 
(a) (b)  
 
Figure 10.10. Graph illustrating the sensitivity versus 1-specificity for (a) high contrast visual acuity 
and (b) low contrast visual acuity of the left eye obtained with FVS for predicting presence of 
significant cataract in the left eye as defined in Chapter 4. The data labels state the X and Y 
coordinates. 
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Table 10.4 The key statistics for the FVS score cut off values obtained from Figure 10.10 
Study 2 
Flipchart 
Cataract  
High Contrast 
Acuity 
Low Contrast 
Acuity 
Ideal Cut 
Off 
Score>0.9 Score>4.9 
Sensitivity 
(%) 
57.8 
(43.3-71) 
68.9  
(54.3-80.5) 
Specificity 
(%) 
67.7 
(60-74.6) 
63.2 
(55.4-70.4) 
PPV (%) 34.2  
(24.5-45.4) 
35.5 
(26.1-45.6) 
AUC  0.633  
(0.538-0.727) 
0.662 
(0.573-0.751) 
10.3.2 The ability of screener distance visual acuity to determine significant 
gain in acuity with new refractive correction (Rx)  
(a)                                                              (b) 
 
Figure 10.11 Graph illustrating the sensitivity versus 1-specificity for (a) high contrast visual acuity and 
(b) low contrast visual acuity of the left eye obtained with FVS for determining significant gain in acuity 
with new refractive correction as defined in Chapter 4. The data labels state the X and Y coordinates 
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Table 10.5 The key statistics for the FVS score cut off values obtained from Figure 10.11 
Study 2  
flipchart 
RX 
High Contrast 
Acuity 
Low Contrast 
Acuity 
Ideal Cut 
Off 
Score>0.9 Score>6.9 
Sensitivity 
(%) 
62.5  
(47-75.8) 
70  
(54.6-81.9) 
Specificity 
(%) 
68.1 
(60.6-74.8) 
70  
(62.5-76.6) 
PPV (%) 32.9  
(23.4-44.1) 
36.8 
 (26.9-48.1) 
AUC 0.659  
(0.555-0.763) 
0.719 
 (0.629-0.810) 
 
10.3.3 The ability of presenting visual acuity to detect correctable visual loss 
(CVL) 
Defining Correctable Visual loss 
The results so far in this chapter have looked at the ability of distance acuity (high 
contrast and low contrast) to detect significant gain in distance acuity through 
refractive correction and the detection of significant cataract.  As with the results 
from CVS2 (Chapter 9, p.238) correctable visual loss is defined as the presence of 
significant cataract and/or significant gain in distance acuity through refractive 
correction.  Further on in this chapter, the definition of CVL will be amended to take 
account of significant binocular gain in near acuity through near refractive 
correction. This will be done when evaluating the binocular near acuity screening 
test.  
Page 279 of 389 
 
(a)       (b) 
 
Figure 10.12 Graph illustrating the sensitivity versus 1-specificity for (a) high contrast visual acuity and 
(b) low contrast visual acuity of the left eye obtained with FVS for determining correctable visual loss 
as defined above. The data labels state the X and Y coordinates 
 
Table 10.6 The key statistics for the FVS score cut off values obtained from Figure 10.12 
 
 
 
 
 
 
The next 4 graphs will demonstrate the effectiveness of the FVS in detecting 
macular degeneration and macular degeneration at risk of progression. These two 
Study 2 
Flipchart 
 CVL 
High Contrast 
Acuity 
Low Contrast 
Acuity 
Ideal Cut 
Off 
Score>0.9 Score>4.9 
Sensitivity 
(%) 
55.4  
(44.1-66.2) 
70.3  
(59.1-79.5) 
Specificity 
(%) 
72.2 
 (63.8-79.3) 
71.4  
(63-78.6) 
PPV (%) 53.9 
 (42.8-64.7) 
59.1  
(48.6-68.8) 
AUC 0.647  
(0.506-0.728) 
0.723 
(0.649-0.796) 
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categories have been defined in Chapter 4. As discussed in Chapter 4, although 
macular degeneration was not initially one of the target conditions it was thought 
important that tests of visual acuity in the screening tools ought to be able to detect 
macular conditions because of the significant effect it has on central vision.  
10.3.4 The ability of presenting visual acuity to detect macular 
degeneration (MD) 
 
(a)                                                                         (b) 
 
Figure 10.13 Graph illustrating the sensitivity versus 1-specificity for (a) high contrast visual acuity and 
(b) low contrast visual acuity of the left eye obtained with FVS for determining macular degeneration as 
defined in Chapter 4. The data labels state the X and Y coordinates 
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Table 10.7 The key statistics for the FVS score cut off values obtained from figure 10.13                   
 
 
 
 
 
 
 
10.3.5 The ability of presenting visual acuity to detect macular degeneration 
risk of progression             
(a) (b) 
 
 Figure 10.14 Graph illustrating the sensitivity versus 1-specificity for (a) high contrast visual acuity 
and (b) low contrast visual acuity of the left eye obtained with FVS for determining macular 
degeneration at risk of progression as defined in Chapter 4. The data labels state the X and Y 
coordinates 
 
Study 2 
Flipchart 
MD 
High 
Contrast 
Acuity 
Low Contrast 
Acuity 
Ideal Cut 
Off 
Score>4.9 Score>6.9 
Sensitivity 
(%) 
50  
(34.8-65.2) 
63.2  
(47.3-76.6) 
Specificity 
(%) 
79  
(72.1-84.6) 
67.9  
(60.4-74.6) 
PPV (%) 35.8  
(24.3-49.3) 
31.6  
(22.2-42.7) 
AUC 0.617 
 (0.507-
0.726) 
0.651 
 (0.550-0.751) 
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Table 10.8 The key statistics for the FVS score cut off values obtained from  Figure 10.14 
Study 2 
Flipchart 
MD risk of 
Progression 
High Contrast 
Acuity 
Low Contrast 
Acuity 
Ideal Cut Off Score>4.9 Score>8.9 
Sensitivity 
(%) 
85.7  
(60.1-946) 
85.7 
(60.1-96) 
Specificity 
(%) 
78.0  
(71.5-83.3) 
72.6  
(65.8-78.5) 
PPV (%) 22.6  
(13.5-35.5) 
19 
 (11.2-30.4) 
AUC 0.851  
(0.728-0.9) 
0.822  
(0.713-0.931) 
 
The above results indicate that as with CVS2, FVS is far better when detecting MD 
at risk of progression compared with the basic measure of MD. As discussed in 
Chapter 9 this outcome is expected because visual loss is more significant in MD 
at risk of progression and it based on the higher grades of MD.  
Further on in this chapter the screening tests will be combined to assess their 
suitability to detect the target conditions and macular degeneration at risk of 
progression will be combined with the target conditions when test combinations are 
being evaluated. A more practical assessment of the screener’s performance will 
also be obtained in section 10.3.8 
10.3.6 The ability of presenting visual acuity to detect refractive error, 
cataract, and MD 
The presence of refractive error, cataract, or MD is labelled in the graphs below as 
significant acuity impairing eye conditions (SAIEC). This is defined in the same way 
as in Chapter 9 (p.242). As in the analyses of CVS2, this definition of CVS2 will be 
amended as further analyses are presented to give a more overall impression of 
the ability of the screener at detecting the target conditions. The graphs below 
show the ability of the screener to detect SAIEC in the left eye.  
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(a)                                                                 (b) 
 
Figure 10.15 Graph illustrating the sensitivity versus 1-specificity for (a) high contrast visual acuity and 
(b) low contrast visual acuity of the left eye obtained with FVS for determining SAIEC as above. The 
data labels state the X and Y coordinates 
Table 10.9 The key statistics for the FVS score cut off values obtained from  
 
 
 
 
 
 
The validity of LCVA in detecting SAIEC can be seen in the above table and its 
performance remains stable across both screening tools. It is interesting to note 
that with FVS, LCVA performs better than HCVA. 
 
Study 2 
Flipchart 
SAIEC 
High Contrast 
Acuity 
Low Contrast 
Acuity 
Ideal Cut 
Off 
Score>0.9 Score>4.9 
Sensitivity 
(%) 
52  
(42.3-61.7) 
66.3  
(56.5-74.9) 
Specificity 
(%) 
75.5  
(66.3-82.8) 
77.5  
(68.4-84.5) 
PPV (%) 67.1  
(55.9-76.6) 
73.9  
(63.8-81.9) 
AUC 0.651  
(0.550-0.751) 
0.746 
(0.678-0.815) 
Page 284 of 389 
 
10.3.7 The ability of presenting visual acuity to determine significant eye 
condition in either eye. 
 The ROC curves above evaluated the ability of distance acuity in detecting SAIEC 
in the left eye. The ROC curves below give an indication of how well HCVA and 
LCVA can detect SAIEC (i.e. the presence of refractive error, cataract, or MD) in 
either eye. 
(a)                                                                 (b) 
 
Figure 10.16 Graph illustrating the sensitivity versus 1-specificity for (a) high contrast visual acuity and 
(b) low contrast visual acuity of either eye obtained with FVS for determining SAIEC as defined above. 
The data labels state the X and Y coordinates 
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Table 10.10 The key statistics for the FVS score cut off values obtained from Figure 10.16 
 
 
 
 
 
 
 
The values in Table 10.10 show the importance of LCVA in the detection of 
significant acuity impairing eye conditions (SAIEC). The results show that the 
sensitivity and specificity of LCVA for the detection of SAIEC in either eye is slightly 
better than HCVA. The effect of combining tests will be evaluated further in section 
10.4. 
Before the evaluation of the near acuity screening test the table below gives a 
summary of the cut off values obtained so far with the distance acuity screening 
tests. 
Table 10.11 Summary of FVS HCVA and LCVA cut off values  
 
HCVA LCVA 
Condition Cut off value 
FVS score 
Sensitivity 
(%) 
Specificity 
(%) 
Cut off value 
FVS score 
Sensitivity 
(%) 
Specificity 
(%) 
Cataract Score>0.9 57.8 67.7 Score>4.9 68.9 63.2 
Rx Score>0.9 62.5 68.1 Score>6.9 70 70 
CVL Score>0.9 55.4 72.2 Score>4.9 70.3 71.4 
MD Score>4.9 50 79 Score>6.9 63.2 67.9 
MD risk 
prog 
Score>4.9 85.7 78 Score>8.9 85.7 72.6 
SAIEC (left 
eye) 
Score>0.9 52 75.5 Score>4.9 66.3 77.5 
SAIEC 
(either eye) 
Score>0.9 70.9 74.0 Score>4.9 73.2 76.7 
 
Study 2 
Flipchart 
SAIEC 
Either eye 
High Contrast 
Acuity 
Low Contrast 
Acuity 
Ideal Cut Off Score>0.9 Score>4.9 
Sensitivity 
(%) 
70.9  
(62.4-78.1) 
73.2  
(64.9-80.2) 
Specificity 
(%) 
74.0  
(62.9-82.7) 
76.7  
(65.8-84.9) 
PPV (%) 82.6  
(74.4-88.5) 
84.5  
(76.6-90.1) 
AUC (%) 0.771 
 (0.707-0836) 
0.786  
(0.722-0.850) 
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It can be seen that the distance acuity tests demonstrate a greater sensitivity and 
specificity for determining SAIEC in either eye compared with just the left eye. This 
is an expected outcome and gives a more accurate indication of screener 
performance. The importance of the screener to be able to detect monocular 
deficits is discussed in Chapter 7. 
10.3.8 Performance of the screener from an optometric perspective  
As discussed at the beginning of this Chapter, the ROC analyses above set a high 
criterion for the performance of the screener. In particular, the analyses investigate 
the ability of tests of visual function to detect conditions that are diagnosed by 
appearance during examination (e.g., cataract, AMD).  The analysis in Table 
10.12 shows the ability of the screener to detect patients that in the opinion of a 
“typical” optometrist is likely to benefit from an eye examination.  This has been 
defined in Chapter 8 (p.245) as patients with a reduced high contrast visual acuity 
in one or both eyes and those who have not attended for an eye examination in the 
last year. An alternative criterion was also evaluated in Chapter 8: those with 
reduced high contrast acuity or those who have not had an examination within the 
last year. The results of both of these criteria combinations are stated in the table 
below. The ROCs so far show that the optimum cut-off value for HCVA using the 
FVS is score>0.9. If this score is converted to a LogMAR acuity using Table 10.1, a 
score of 0.9 corresponds to a LogMAR acuity of 0.2. This is in accordance with the 
findings from CVS1 and CVS2 and for the calculation in this section reduced HCVA 
for the gold standard has been defined as VA>0.19 LogMAR (as in Chapter 8 and 
9) and reduced HCVA for the FVS has been defined as a score>0.9.  
Table 10.12 Performance of screener from an optometric perspective 
Performance of screener 
from an optometric 
perspective 
Sensitivity 
(%) 
Specificity (%) PPV (%) 
Reduced HCVA and no 
eye examination in the last 
year 
76.8  
(67.5-84) 
95.0  
(88.9-97.9) 
93.8  
(86.4-97.3) 
Reduced HCVA or no eye 
examination in the last 
year 
94.0  
(89.6-96.6) 
87.5  
(64-96.5) 
98.9  
(95.9-99.7) 
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The above table shows that combining acuity testing with knowledge of the 
patient’s last eye examination can result in a high sensitivity and specificity for 
detecting those patients that should be seen by an optometrist. 
So far, the results above have focused on the ability of distance acuity to detect the 
target conditions. The section below will evaluate the ability of the binocular near 
acuity test to detect binocular acuity impairing eye conditions. 
10.4 Evaluation of near acuity screening test 
In this section the graphs and tables illustrate the ability of the binocular near visual 
acuity to predict binocular conditions. At the end of this section, Table 10.16 which 
contains all the cut-off values for near acuity, will summarise the section before the 
results of various test combinations are presented. This is the same procedure that 
was implemented for the analysis of CVS2 in Chapter 9 and the decision to 
analyse near visual acuity binocularly has been discussed in Chapter 8. 
10.4.1 The ability of the binocular near vision screening test to detect 
significant under- corrected binocular near refractive error (NvRx). 
Patients whose binocular visual acuity was at least 0.2 LogMAR units better with 
near subjective refractive findings than presenting binocular near visual acuity were 
defined as having a significantly under-corrected binocular near refractive error.  
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Figure 10.17 Graph illustrating the sensitivity versus 1-specificity for binocular near acuity obtained 
with CVS2 for predicting significant gain in binocular near acuity with new refractive correction as 
defined above. The data labels state the X and Y coordinates 
Table 10.13 The key statistics for near acuity cut off values obtained from Figure 10.17 
Study 2 Flipchart 
Near visual acuity  
Predicting significant 
binocular NvRx 
Significant uncorrected 
near refractive 
error being defined as  
0.2LogMar unit increase 
Ideal Cut Off Score>1.9 
Sensitivity (%) 58.1 
(40.8-73.6) 
Specificity (%) 85.2  
(79.1-89.8) 
PPV (%) 41.9  
(28.4-56.7) 
AUC 0.722  
(0.612-0.832) 
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10.4.2 The ability of the binocular near vision screening test to detect 
significant binocular cataract. 
 
 
Figure 10.18 Graph illustrating the sensitivity versus 1-specificity for binocular near acuity obtained 
with FVS for predicting significant binocular cataract as defined in Chapter 4. The data labels state the 
X and Y coordinates 
Table 10.14 The key statistics for near acuity cut off values obtained from Figure 10.18 
 
 
 
 
 
STUDY 2  Flipchart 
Near visual acuity  
Predicting binocular 
 Significant cataract 
Near Acuity 
Score 
Ideal Cut Off Score >1.9 
Sensitivity (%) 26.7  
(16-41) 
Specificity (%) 80  
(73-85.5) 
PPV (%) 27.9  
(16.7-42.7) 
AUC 0.528  
(0.432-0.625) 
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10.4.3 The ability of the binocular near vision screening test to detect 
significant binocular correctable visual loss (BinCVL) 
For the purposes of evaluating the near vision test, correctable visual loss has 
been defined as the presence of significant binocular distance refractive error &/or 
presence of binocular cataract &/or significant binocular near refractive error. 
This is the same procedure that was followed when evaluating the near acuity test 
in CVS2 (Chapter 9) 
 
Figure 10.19 Graph illustrating the sensitivity versus 1-specificity for binocular near acuity obtained 
with CVS2 for predicting binocular correctable visual loss as defined above. The data labels state the X 
and Y coordinates 
Table 10.15 The key statistics for near acuity cut off values obtained from Figure 10.19 
 
 
 
 
 
Study 2 Flipchart 
Near visual acuity  
Predicting BinCVL 
 
Ideal Cut Off Score>1.9 
Sensitivity (%) 33.3 
 (24-44.1) 
Specificity (%) 86.6 
 (79.3-91.6) 
PPV (%) 62.8  
(47.9-75.6) 
AUC 0.598  
(0.517-0.680) 
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This section will end with a summary table (Table 10.16) that states the near acuity 
cut off values obtained for the eye conditions evaluated in this section. The next 
section of this chapter will focus on test combinations to give an overall view of the 
performance of the screener. As in Chapter 9, this will involve not only combining 
the screening tests, but also combining the eye conditions and evaluating the 
ability of the screener to detect these conditions in either eye as opposed to just 
the left eye as done earlier in the chapter. 
Table 10.16 Summary of FVS near acuity cut off values 
 
Near acuity 
Condition Cut off 
value 
FVS score 
Sensitivity 
(%) 
Specificity 
(%) 
Binocular 
Cataract 
Score> 1.9 26.7 80 
NvRx Score>1.9 58.1 85.2 
Binocular 
CVL 
Score>1.9 33.3 86.6 
 
As mentioned earlier in the chapter, the screener does not measure the near acuity 
but rather the minimum font size required to read text easily since it was judged 
important to detect older people whose vision made reading difficult.  In view of the 
acuity reserve, this may be some way above the acuity threshold. A disadvantage of 
this pragmatic approach is that the criterion used is likely to be more variable than 
threshold acuity because it is dependent on the patient’s interpretation of 
"easy". Consequently, one would expect that an evaluation of the near vision 
screening test using the ROC curves, although necessary to determine the cut off 
values, would not be expected to reveal high levels of sensitivity or specificity. If it is 
assumed that most near vision tasks are of size N9 or larger (LogMAR>0.39) then 
participants with an acuity of this measured in the gold standard might be expected to 
also fail the screener (cut off score > 1.9).  
Table 10.17 below shows the sensitivity and specificity values obtained when 
evaluating the performance of the screener in this way. 
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Table 10.17 Performance of FVS for near vision 
Performance of 
screener for near vision 
Sensitivity  
(%) 
Specificity 
 (%) 
PPV  
(%) 
Reduced gold standard 
near acuity (worse 
eye>0.39 LogMAR) 
61.9 
(40.9-79.2) 
 
96.4 
(92.4-98.3) 
 
68.4 
(46-84.6) 
 
The table above shows that the near vision test in the flipchart screener is of value 
in detecting those with reduced near acuity that may be experiencing problems in 
everyday tasks. 
The next section of the chapter will evaluate various test combinations in the FVS. 
10.5 Rapid Flipchart Screener test combinations 
The tests in the flipchart have been evaluated to give cut-off values for failing 
individual tests. The cut-off values for HCVA and LCVA were determined using 
monocular data because it was thought important that the screener was able to 
detect a monocular visual defect (see p.201). However near visual acuity was 
conducted as a binocular test and the cut-off for this was determined using data 
from the right eye and the left eye, rather than right eye or left eye. 
The next stage in the analyses will involve evaluating the overall performance of 
the flip-chart screener for detecting significant acuity impairing eye conditions 
identified in the gold standard. In this section “significant acuity impairing eye 
conditions” has been defined as refractive error that can be corrected with 
spectacles or significant cataract or macular degeneration that is at risk of rapid 
progression. This definition is stated in Chapter 9, Table 9.14. 
Having now defined significant eye disease, ‘overall performance of screener’ also 
needs to be defined.  ‘Overall performance’ will initially take into account all the 
tests that are included in the flipchart screener. All these tests will be combined in 
an ‘OR’ method to give the overall screener performance. The criterion for the 
definition of overall performance of screener is summarised in the table below. 
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Table 10.18 Defining overall performance of FVS 
Overall screener 
performance 
Monocular/Binocular 
Presenting HCVA RE or LE or Both 
Presenting LCVA RE or LE or Both 
Presenting near acuity Both eyes only 
 
The sensitivity and specificity of various test combinations to determine significant 
eye disease has also been calculated in order to establish the minimum test 
battery that would be efficient in detecting the target conditions. The combinations 
of screening tests are outlined in Chapter 9, Table 9.16.  
10.5.1 Overall screener performance for detecting significant acuity impairing 
eye conditions.  
Table 10.19 below show the various test combinations for detecting SAIEC.  The 
combinations in red represent the best compromise between sensitivity and 
specificity. At the end these combinations will be compared to give the ideal test 
combination. It should be noted that one of the limitations described in Section 10.1 
still applies: for cataract and MD the screener is still being required to use a test of 
visual function to detect a condition that is being defined, with the gold standard, by 
appearance. Table 10.19 therefore also includes the data on the pragmatic 
analysis of the cases that require an eye examination (Section 10.3.8) and this 
issue is returned to in Chapter 12. 
Table 10.19  Overall FVS screener performance for detecting SAIEC. The combinations in red represent 
the best compromise between sensitivity and specificity 
Test Combination, 
with FVS  cut off 
scores in brackets 
Sensitivity  
(%) 
Specificity 
(%) 
PPV 
(%) 
HCVA(0.9) or 
LCVA(4.9) or NVA (1.9) 
 
82  
(74.2-87.8) 
61.5  
(50.4-71.6) 
76.9  
(69-83.3) 
HCVA (0.9) or LCVA 
(4.9) 
79.5 
(71.5-85.7) 
66.7  
(55.6-76.1) 
78.9  
(70.8-85.1) 
HCVA (0.9) or NVA 
(1.9) 
75.4 
(67.1-82.2) 
69.2 
(58.3-78.4) 
79.3 
(71.1-85.7) 
HCVA (0.9) 73  
(64.5-80) 
74.4 
(63.7-82.7) 
81.7  
(73.4-87.8) 
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LCVA (4.9) or NVA 
(1.9) 
78.7  
(70.6-85) 
70.5  
(59.6-79.5) 
80.7  
(72.7-86.8) 
LCVA (4.9) 75.4 
(67.1-82.2) 
76.9  
(66.4-84.9) 
83.6  
(75.6-89.4) 
Performance of 
screener from an 
optometric perspective 
Reduced HCVA or no 
eye examination in the 
last year 
94.0  
(89.6-96.6) 
87.5  
(64-96.5) 
98.9  
(95.9-99.7) 
Performance of 
screener from an 
optometric perspective 
Reduced HCVA and no 
eye examination in the 
last year 
76.8  
(67.5-84) 
95.0  
(88.9-97.9) 
93.8  
(86.4-97.3) 
 
The table above shows that, as expected, an increased sensitivity is achieved 
when more tests are used, but this has the effect of decreasing specificity. The 
results show that if one test should be used on the rapid flipchart tool, it ought to be 
LCVA with a cut off score of 4.9. This means that patients who achieve a score of 5 
or more (0.5 LogMAR) should be referred for an eye examination. It is particularly 
interesting to note that LCVA fares better than HCVA as a single test to detect 
correctable visual loss in the flipchart format.  
From a pragmatic viewpoint, the most appropriate assessment of screener 
performance in the UK may be the screening test’s performance at detecting the 
cases who an optometrist would feel requires an eye examination. The screener 
obtains 94% sensitivity and 87.5% specificity with this type of analysis. 
The above section has evaluated the results from the flipchart screener. The next 
chapter will look at the data from the quality of life questionnaires that participants 
completed before the eye examination and after any intervention. 
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Chapter 11  
Quality of Life 
11.1 Introduction 
The review by Evans and Rowlands (2004) found considerable evidence that 
reduced vision is associated with impaired quality of life (QoL) and ability to carry 
out activities of daily living, depression, falls and other accidents (Evans & 
Rowlands, 2004p). The primary objectives of the present study outlined in chapter 
3 centred around the development of screening tools with a battery of tests that 
could be used to detect correctable visual loss in older people. However, QoL 
measures were also incorporated into the study in order to establish the effect of 
screening and the eye examination on the QoL of older patients. The data on QoL 
will be outlined below and will give an indication of the effect that reduced vision 
may have on QoL.  
11.2 Quality of life descriptive data 
The method of measuring quality of life has been explained in Chapter 4. The 
participants completed the quality of life questionnaire before and up to 3 months 
after any intervention. Patients were contacted between 2 and 3 months after 
intervention was recommended. Data were obtained before and after the study 
using the same implementation method (either by phone or post) (Wolffsohn & 
Peterson, 2003). The Quality of Life questionnaire (LVQOL) has a summed score 
between 0 (a low quality of life) and 125 (a high quality of life).  
The normality of the QoL data was investigated by plotting the frequency 
distributions and carrying out the Kolmogorov-Smirnov test of normality. There was 
a ceiling effect apparent with the test so that the data significantly differed from a 
normal distribution (p<0.01). An additional variable was calculated, ‘gain in QoL’, 
by subtracting the first reading from the second. This variable was also not 
normally distributed, with a high number of zero results. Non-parametric analyses 
were therefore used in this section, although in addition to the median, a mean and 
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standard deviation are quoted below where these are compared with other workers 
who have used the mean and standard deviation. 
The table below gives a brief summary of the results obtained from the 
questionnaires. The results shows that the average increase in the quality of life 
achieved by intervention is comparable with the results of Wolffsohn and Cochrane 
(2000)(Wolffsohn & Cochrane, 2000). A copy of the LVQOL can be found in the 
appendix.  
Table 11.1 Key statistics from Quality of Life questionnaires.  
 
Study 2 Scores according to 
Wolffsohn (Wolffsohn & 
Cochrane, 2000) 
Number of participants 200  
Number of participants that 
responded to follow up 
194.  
Response rate of 97% 
 
 Initial Post study The average LVQOL score for a 
population with low vision (60.9 
+/- 25.1) was significantly lower 
than the average score of those 
with normal vision (100.3 +/- 
20.8). 
Average LVQOL Score 108 
 
114 
 
Median LCQOL Score 111 119 
Min LVQOL Score 54 59 
Max LVQOL score 125 125 
Average increase between initial 
and post study scores 
 
 
7  +/- 7.3  
(where 7.3 is the SD) 
 
 
Rehabilitation improved the 
LVQOL score of those with low 
vision by an average of 6.8 +/- 
15.6. (where 15.6 is the SD)  
Median increase between initial 
and post study score 
5 
Min difference between initial and 
post study LVQOL scores 
0  
Max difference between Initial 
and Post study 
48  
Patients whose score remained 
the same initial and post study 
56 patients out of 194, 
reported no difference in 
the QoL. This is a 
proportion of 29% 
 
Patients whose score decreased 
after the eye examination 
No one reported a decrease in QoL. The questions in the 
LVQOL questionnaire relate to visual problems only and this 
may be a reason why no patients reported a decrease in QoL. 
Those that did not take up the 
recommended intervention 
21 patients did not respond 
to intervention out of 148 
patients that were 
recommended intervention. 
This is a proportion of 14% 
that did not respond to 
recommended intervention 
 
No Intervention needed 24% of patients did not 
require intervention 
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11.3 Further analyses 
A comparison of the first QoL data with the second QoL data in all subjects showed 
a significant improvement (Wilcoxon signed ranks test, Z=10.5, p<0.001). The 
participants were divided into three groups: those (N=75) who were recommended 
a spectacle intervention and received this; those (n=46) who were recommended 
no intervention (mostly because no abnormality was detected) and those (N=21) 
who were recommended an intervention but did not accept this recommendation 
and therefore received no intervention. Wilcoxon signed ranks test revealed 
significant improvements in QoL in all three subgroups after an eye examination, 
with the largest effect size in the spectacle intervention group (Z=-7.33, p<0.001), 
then the no intervention recommended (Z=-4.69, p<0.001) and least improvement 
in the no intervention accepted group (Z=-2.91, p=0.004). An inspection of the QoL 
data reveals that a significant improvement occurred even in the no intervention 
accepted group is due to the question ‘How well has your eye condition been 
explained to you?’ These differences between the groups are explored further 
below and in the table by examining the gain in QoL. 
The QoL data in the three groups are summarised in Table 11.2 and the frequency 
distributions of the gain in QoL are plotted in Figure 11.1. 
Table 11.2 Quality of life scores, including gain in quality of life for different patient groups 
  All 
subjects 
No 
intervention 
required 
(NIR) 
No 
intervention 
accepted 
(NIA) 
Spectacle 
intervention 
(Spec) 
N  194 46 21 75 
Initial-QoL Median 111 120 109 108 
 Minimum 54 96 75 54 
 Maximum 125 125 121 125 
Post study-
QoL 
Median 119 123 111 120 
 Minimum 59 96 77 68 
 Maximum 125 125 121 125 
Gain Median 5 0 0 12 
 Minimum 0 0 0 0 
 Maximum 48 5 7 48 
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Below are the distributions of the gain in quality of life in the three groups described 
above. 
(a) 
 
 (b) 
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(c) 
 
Figure 11.1The above histograms show the gain in quality of life in 3 groups of participants; a) where 
spectacle intervention was accepted, b) where no intervention was accepted c) where intervention was 
not recommended 
A Kruskall-Wallis test was used to investigate the gain in quality of life in the three 
groups outlined in Table 11.2 and revealed that the gain differed significantly 
amongst the groups (p<0.001). Pairwise comparisons with the Mann-Whitney U 
test showed that the “no intervention” group improved (median 0 in both groups) 
significantly (p<0.001) less than the “spectacles” group (median 12), but the 
degree of gain in the “no intervention required” group was not significantly (p=0.88) 
different to the gain in the “no intervention accepted” group. 
The following key points can be derived from the histograms in Figure 11.1: 
 More patients had an overall gain in QoL with spectacle intervention (75 
participants) than in the group where intervention was recommended but not 
accepted (21 participants) 
 In the group that did not accept intervention, 11 out of 21 (52%) patients had 
a gain between 0-2 points, whereas only 3 out of 75 (4%) had a gain 
between 0-2 points in the spectacle intervention group. This is because the 
spectacle intervention group had higher gains in QoL scores compared with 
the group that did not accept intervention 
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 In the group that did not accept intervention, there were no participants that 
had a gain of over 8 points compared to 53 participants (71%) in the 
spectacle intervention group that had a gain of over 8 points. 
 An increase in quality of life was also seen in the group that required no 
intervention. The patients in this group benefited from the question that dealt 
with the explanation of ocular health discussed earlier in this section. It 
could be argued that this highlights the importance of frequent eye 
examination regardless of whether ocular health is normal and spectacle 
intervention is not necessary.  
Having established from the above graphs that the group with the spectacle 
intervention had a more significant increase in QoL than the group in which no 
intervention was accepted, the spectacle intervention group will now be further 
evaluated. In particular, was the magnitude of change in spectacle prescription 
correlated with the gain in quality of life? The histograms below look at the 
spectacle intervention group and show the gain in quality life in those patients that 
were found to have a significantly improved acuity (i.e. 0.2 LogMAR increase as 
defined in Chapter 4) following new spectacles after the gold standard eye 
examination compared to those who were found to have no increase in acuity or 
those whose gain in acuity was not significant. 
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(a) 
 
(b) 
 
Figure 11.2 Graphs showing quality of life gain with spectacle intervention in a) patients that did not 
have a significant increase in acuity due to refractive correction and b) patients with a significant gain 
in acuity with refractive correction.   
The graphs above show that in the group that did not have a significant increase in 
VA there are more patients with a small gain in QoL compared to those that have a 
significant gain in acuity where the gain in QoL is less at the lower values and more 
at the higher values. The graphs above show the gain in QoL in patients who had 
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significant gain in VA compared to those who did not have significant VA gain in 
the spectacle intervention group. The scatter plot below shows the average gain in 
VA (from the gold standard eye examination) against the gain in QoL. 
 
Figure 11.3 Average gain in VA from the gold standard eye examination (calculated from RE gain in VA 
and LE gain in VA) against the gain in QoL. 
The trendline indicates that there is a positive correlation between average VA gain 
found in the gold standard eye examination and the gain in quality of life after 
spectacle intervention.  The R-squared value is 0.154. This indicates that 
approximately 15% of the variability in the data can be explained by the association 
between average gain in acuity and gain in quality of life. 
The quality of life results indicate that the screening tools and eye examination had 
a positive impact on the quality of life of the participants. An example of a case 
scenario showing the positive impact on the quality of life score can be seen in 
Table 11.3 
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Table 11.3 Case study of a participant in the research who benefited from refractive correction. The 
participant is a 75 year old man seen at a community day centre. 
Variable Before After 
Symptoms None reported. No prescribed spectacles, just ready-readers. 
Last eye examination 4 years ago. 
CVS2 result Failed 
FVS result Failed 
Management New spectacles 
QoL 103 121 
Presenting 
vision 
R 6/20+    L 6/9.5 R 6/9.5+   L6/9.5+ 
 
This chapter has presented the results from the quality of life questionnaires. The 
results from the main study have now been presented and the following chapter 
will discuss the main aspects of the results and address several key topics in order 
to derive conclusions from the present research. 
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Chapter 12  
Discussion 
This chapter will summarise and discuss the main outcomes from each section of 
the study. The main features of the results will be discussed together with the 
limitations of the research. This will then lead to a consideration of the key 
questions surrounding the validity and usefulness of the screening tools in the 
detection of the target conditions. The detection of glaucoma will be discussed in 
the context of the prediction at the start of the study (Chapter 4) that the screeners 
would not be good at detecting glaucoma. This will then lead on to a discussion on 
the ethics of screening. Ideas for future research will be discussed at the end of the 
chapter. 
12.1 Participants, descriptive data, and prevalence of visual problems. 
The descriptive data comparing the characteristics of the subjects participating in 
the two phases of the project can be found in Chapter 7, Table 7.1. The table 
shows that the two populations were generally similar and this is particularly 
evident when looking at the overall prevalence of significant cataract (31.7% in 
Study 1 and 30.7% in Study 2). The average and median ages of the two 
populations were identical with a small difference in the age range of the 
participants. There were differences in some variables such as the prevalence of 
significant macular degeneration and the prevalence of uncorrected refractive 
error. 
Table 7.1 shows that the number of male participants was greater in Study 1 than 
in Study 2. The data also shows that this difference was not due to age because 
the average and median ages for both studies were the same. The difference may 
be due to the fact that Study 2 was more community-based; this may have resulted 
in more females participating in the study as they may be more likely to attend 
community venues such as day centres. This is supported by research of the 
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Economic and Social Research Council in 2005 where it was found that men were 
less likely to attend day centres than females (Arber, 2007).  
The types of spectacles worn was similar in both studies especially with regard to 
multifocal spectacles. There were a slightly greater number of participants with no 
spectacles in Study 2 than Study 1. 
The prevalence of the target conditions as detected by the gold standard eye 
examination, including significant macular degeneration was less in Study 2 than 
Study 1. This may seem counter-intuitive as the prevalence of the target conditions 
might have been expected to be higher in the community away from clinic based 
settings. There are a number of possible explanations for this; firstly those with 
visual problems are less likely to be mobile and so may not attend places like day 
centres or GP surgeries. Secondly, those older people that do attend community 
venues may be likely to be those who do not have eyecare needs or those that 
have eyecare needs that are being met already. The prevalence of correctable 
visual loss (cataract and/or significant refractive correction) is over 50% for both 
studies which highlights the significance of undetected correctable visual loss 
among older people regardless of whether the study is based in the community or 
in a clinic based environment. 
Both studies had a large sample size from a variety of venues and so are likely to 
be reasonably representative of older people in general. However, a limitation of 
the present research is that individual residences were not targeted, which 
probably means that the present research has underestimated the overall 
prevalence of undetected visual loss among older people.  Taking the study into 
individual residencies would have enabled certain areas to be targeted, for 
example areas with a concentration of people with low incomes. For the present 
research, this would have been logistically difficult, expensive and would have 
raised a number of health and safety issues. The flipchart screening tool would be 
a very quick, easy and cost effective way of screening older people in their homes 
and it would be feasible for community health care staff to use when making home 
visits. 
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12.2 Supplementary studies  
The supplementary studies outlined in Chapters 5 and 6, will now be briefly 
discussed before the screening tools are discussed in the next section. 
12.2.1 Provision of NHS eyecare in South London 
This preliminary study investigating the provision of NHS eyecare and NHS funded 
eyewear in South London raised awareness among older people about their 
entitlement to NHS spectacles. The information resulting from the study was used 
to provide the patients in the two main research studies with a list of community 
optometric practices that provide spectacles whose cost is fully covered by the 
NHS optical voucher scheme for eligible patients. 
The study showed that in the South London area, almost a third of practices that 
responded to the survey do not provide voucher value spectacles (VVS), which are 
spectacles whose cost is fully covered by the NHS optical voucher.  It is thought 
that in other areas that are perhaps more affluent, optical practices may be less 
likely to supply VVS than those in South London. The study also highlighted that 
often the practices that supply VVS have a very limited selection of frames that are 
suitable for older people. 
Although raising awareness among older people of their entitlement to VVS is 
crucial in improving the uptake of community eyecare services, it is of limited value 
if VVS are not readily available. Quite often it is not feasible for older people to 
‘shop around’ to find a practice that provides VVS and it is thought that this may 
deter older people from updating their spectacles even though this would improve 
their vision. 
Despite the limitations of this preliminary study including the modest sample size 
and the possibility of respondent bias (discussed in Chapter 5), the results do 
highlight the potential difficulty that older people face when needing to purchase 
spectacles. It is thought that the limited availability of VVS together with the lack 
awareness of the entitlement to VVS may be one of the reasons why a significant 
proportion of older people have poor vision due to under-corrected refractive error. 
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12.2.2 Cataract grading 
It was necessary to implement this supplementary study early on in the research 
because the outcome would influence the choice of venues for Study 2. The results 
indicated that the portable slit lamp biomicroscope gives comparable results to the 
table top slit lamp biomicroscope for the grading of cataracts with the LOCS III 
grading system. The results showed not only a good inter-instrument repeatability 
but also a good inter-observer repeatability.  
The results from this study meant that the venues chosen for Study 2 could be 
community based using the portable slit lamp to grade cataract for the purpose of 
the gold standard eye examination. The table top slit lamp would have been 
difficult to transport between venues and would have limited the number of venues 
used in Study 2.  
The limitations of this supplementary study have been outlined in Chapter 6 and 
include issues surrounding the size of the grading steps used. The original paper 
on the LOCS III recommended a decimal scale (Chylack, Jr. et al., 1993a) and 
from a theoretical perspective finer step sizes would have resulted in improved 
accuracy of results. However, from a practical perspective, this is difficult to 
implement and it was felt that the fine clinical judgements were impractical in a 
community setting where variables such as lighting cannot be controlled as 
precisely as in a clinic.  
12.3 Are the screening instruments valid? 
Before the validity of the screening instruments is discussed a brief summary of the 
screening tools will be given. The first version of the computer screener (CVS1) 
contained a near acuity test (binocular), visual field test (monocular), fixation 
disparity, stereoacuity, high contrast distance acuity (monocular) and low contrast 
acuity (monocular). In the refined computer vision screener (CVS2), tests of 
stereoacuity and fixation disparity were eliminated because these tests were not 
found to be useful in the detection of correctable visual loss. Tests of near acuity 
(binocular), visual fields (monocular), high contrast distance acuity (monocular) and 
low contract acuity (monocular) were included in CVS2. The flip chart screener 
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incorporated the key acuity tests from CVS2. This included near acuity (binocular), 
high contrast acuity (monocular) and low contrast acuity (monocular). 
The validity of the computer vision screener and the flipchart screener can be 
evaluated by comparing the results of the acuity tests from the screening tools with 
the tests from the gold standard. To give an accurate estimate of the inter-test 
agreement between the acuity tests of the screeners and the gold standard tests, 
Bland and Altman graphs (Bland and Altman, 1986) were plotted based on the 
central range of data, for which the tests are comparable. 
The results from study 1 and study 2 were pooled together for the Bland and 
Altman plots in Chapter 7 evaluating the data from the computer vision screeners.  
For high contrast acuity (Figure 7.15 and Figure 7.16), the mean difference 
between the two measurement methods (CVS and gold standard) is 0.018 for the 
right eye and 0.039 for the left eye and the 95% limits are approximately two lines 
for each method. The Bland and Altman plots in Chapter 10 evaluate the HCVA 
test with the flipchart screener in Study 2 (Figure 10.3 and Figure 10.4)  and the 
mean difference between the two measurement methods (FVS and gold standard) 
is 0.072 for the right eye and 0.059 and the 95% limits are also approximately two 
lines for each method.  This finding is fairly consistent with the literature. More 
sophisticated measures of visual acuity, which are more time consuming than the 
screener, can achieve 95% confidence limits of 0.10 to 0.15,(Cho & Woo, 
2004;Ruamviboonsuk et al., 2003;Woods et al., 1998d) but test-retest variability 
increases as visual performance declines (Woods, 1993). In advanced eye disease 
the 95% confidence limits of test-retest visual acuity are 0.20 (Kiser et al., 2005). 
Since the two test methods were different, 95% limits of approximately ±0.20 in the 
present populations are not surprising. 
It is interesting to note that the mean difference between screening and gold 
standard results for high contrast acuity is greater with the FVS than with the CVS 
and this may be because the gold standard test of visual acuity was a 
computerised method and in this respect was more similar to the CVS than the 
FVS. The mean differences for both screening tools were positive values and this 
indicates that the gold standard was measuring slightly worse acuities (higher 
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LogMAR values) than the screening tools. This could possibly be due to a 
difference in crowding as both the FVS and CVS have a linear layout in contrast to 
the chart layout implemented in the gold standard eye exam.  
The Bland and Altman plots for low contrast acuity with the CVS (Figure 7.21 and 
Figure 7.22) show that the mean difference between the two measurement 
methods (CVS and gold standard) is 0.060 for the right eye and 0.063 for the left 
eye. Evaluation of the low contrast acuity test with the FVS (Figure 10.7 and 
Figure10.8) shows that the mean difference between the two measurement 
methods to be -0.014 for the right eye and -0.007 for the left eye. These negative 
values indicate that the FVS is measuring worse acuities (higher LogMAR values) 
than the gold standard technique. The gold standard technique was a 
computerised chart and this may account for the negative mean difference as the 
internally illuminated computer screen may have helped patients to achieve better 
low contrast acuity (lower LogMAR values) than the FVS which may have been 
subject to too little lighting or shadows. 
Throughout the results chapters both HCVA and LCVA have been shown to be of 
value in the detection of correctable visual loss both as tests on their own and in 
combination with other tests. The Bland and Altman plots have shown the tests to 
be valid and the usefulness of the screening tools will be discussed further on in 
this chapter. With regard to near acuity, the results chapters have shown that near 
acuity testing is not as efficient as distance acuity testing in the detection of 
correctable visual loss as a test on its own. It has shown to be of some value when 
used in combination with other tests but both screening tools have shown near 
acuity testing to be less efficient than distance acuity testing. This may be because 
reduced near acuity is affected by many different ocular conditions and also 
environmental factors such as lighting and glare, possibly affecting near acuity to a 
greater extent than it would distance acuity. For near visual acuity, a Bland and 
Altman plot reveals that the mean difference between the gold standard and the 
FVS (Figure 10.9) is 0.118 (N=46). This difference is considerably greater than that 
obtained with the distance acuity tests, but this is true for a smaller N value of 46 
for near compared with 56 for distance.  Also, as mentioned earlier, the near vision 
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screening test on the FVS does not attempt to measure near acuity but rather the 
minimum size required for comfortable vision and because of acuity reserve, this is 
bound to be a larger font size than a near acuity measurement. It may be argued 
that the ease at which older people can read different size fonts is a more relevant 
measure of near vision than near acuity. 
12.4 Overview of results for computerised vision screener  
CVS1 was the first version of the computerised screener and it proved that 
correctable visual problems in the older population can be detected by 
computerised screening methods. CVS 2 built on the results from CVS 1 to 
develop a refined computerised tool that contained the tests that would be most 
appropriate for detecting correctable visual loss. Analysis of results from CVS 1 
showed that tests of stereoacuity and fixation disparity added little value to the 
screening and so were omitted in CVS 2.  
Initial analyses of results from Study 2 showed that the sensitivity values were 
considerably lower than in Study 1 and the specificity values in Study 2 were 
higher than in Study 1. This occurred despite the fact that the cut-off values derived 
from the ROC curves were the same in Study 1 and 2. Possible explanations for 
these differences in sensitivity and specificity between the two studies are now 
discussed. 
First, the difference in sensitivity and specificity values between the 2 studies for 
each of the main target conditions are given in Table 12.1 a and b. 
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Table 12.1 Comparing sensitivity and specificity values obtained for a) HCVA and b) LCVA for 
predicting the presence of the target conditions. The large difference in the sensitivity values between 
the two studies can be seen with the highlighted cells. This is discussed below. 
(a) High contrast visual acuity 
 
SENSITIVITY SPECIFICITY 
HCVA STUDY 1 STUDY 2 STUDY 1 STUDY 2 
CATARACT 86.5  
(72-94.1) 
 
64.4  
(49.8-76.8) 
51.4  
(43.2-59.6) 
59.4  
(51.5-66.8) 
REFRACTIVE 
ERROR 
79.6 
(67.1-88.2) 
72.5 
(57.2-83.9) 
53.7 
(44.9-66.2) 
60.6 
(52.9-67.9) 
CVI 78.7 
(68.1-86.4) 
64.9 
(53.5-74.8) 
59.8 
(50.1-68.8) 
65.1 
(56.4-72.8) 
 
(b) Low contrast acuity 
 
SENSITIVITY SPECIFICITY 
LCVA STUDY 1 STUDY 2 STUDY 1 STUDY 2 
CATARACT 78.4 
(62.8-88.6) 
64.4 
(49.8-76.8) 
55 
(46.7-63) 
64.5 
(56.7-71.6) 
REFRACTIVE 
ERROR 
68.5 
(55.3-79.3) 
 
70 
(54.6-81.9) 
55.3 
(46.5-63.8) 
65 
(57.3-72) 
CVI 66.7 
(55.4-76.3) 
63.5 
(52.1-73.6) 
58.8 
(49.1-67.9) 
70.6 
(62.2-77.9) 
 
The tables above indicate that there is a marked difference in the sensitivity values 
in the two studies for the detection of cataract. Refractive error also shows a 
difference but this is smaller than that found with cataract.  In order to investigate 
this further, the raw data provided information on the various types of cataract 
found in both studies. The table shows the total number of each type of lens 
opacity (i.e. the sum of the number of opacities in the right eye and the left eye). 
The data showed that the number of patients with nuclear sclerosis was markedly 
higher in Study 1 than in 2 and the number with cortical lens opacities was higher 
in Study 2 compared to Study 1. The difference in the type of cataract found can be 
clearly seen in the table below using the raw data from the right eye and left eye. 
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 Table 12.2 Types of cataract (NS-nuclear sclerosis, C-cortical, PSC-posterior subcapsular cataract) 
Type of 
cataract 
NS Cortical PSC 
Study 1 25 40 38 
Study 2 11 72 36 
 
It is known that vision is more significantly affected by nuclear and posterior sub 
capsular lens opacities than with cortical lens opacities (Kanthan et al., 2008). This 
may explain why in Study 2, more patients were passing the acuity test on the 
vision screener despite having significant cataract and this would account for the 
decrease in sensitivity in detecting cataract in study 2. The decrease in sensitivity 
in Study 2 would have been due to an increase in the number false negatives (the 
number of individuals who have significant cataract according to gold standard, but 
that pass the vision tests during screening).  
Although there was a similar prevalence of cataract in both studies, there was a 
clear difference in the distribution of the types of cataract. This has had an impact 
on the ability of the screener to detect certain types of cataract, in particular those 
patients with cortical lens opacities that may not affect vision as significantly as 
nuclear sclerosis or posterior subcapsular cataract. The tables above (Table 12.1) 
show that there is a degree of overlap of the confidence intervals between the 2 
studies. This indicates that the sensitivity values and the specificity values are not 
significantly different with probability <0.05.  
In summary, the detection of significant cataract in the gold standard examination 
was based on anatomical appearance, which detected all types of cataract, 
whereas detection of cataract by the screener was based on visual function, which 
was more likely to be reduced for nuclear and posterior subcapsular lens opacities. 
The usefulness of the screening tools in the detection of cataract is discussed 
further in Section 12.6.2 
Analyses of CVS2 showed that a number of test combinations give good sensitivity 
for detecting the target conditions. The test combinations that give the best 
compromise between sensitivity and specificity for detecting significant acuity 
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impairing eye conditions (SAIEC) are given below. This table is derived from 
Chapter 9 (Table 9.28) and contains the key combinations in the detection of 
SAIEC. 
Table 12.3 Summary of best combinations from CVS2 for detecting SAIEC   
Combination  Sensitivity Specificity Comment 
HCVA  77  
(68.8-83.6) 
 
73.1 
(62.3-81.7) 
The single best test to use for 
screening of visual loss is HCVA which 
provides both a high sensitivity and 
specificity. 
HCVA or NVA 
 
79.5 
(71.5-85.7) 
67.9 
(57-77.3) 
The addition of near acuity provides a 
slightly higher sensitivity and may be 
useful in a situation where it is 
important to detect as many people as 
possible with visual loss. 
LCVA  71.3 
(62.7-78.6) 
76.9 
(66.4-84.9) 
In a country where there are few 
optometric services (e.g., developing 
countries), specificity may be more 
important than sensitivity and in this 
case low contrast VA alone may be a 
simple screening tool that it is 
appropriate. This single test provides 
the best specificity out of all the 
combinations. 
HCVA or LCVA 
or NVA 
 
80.3 
(72.4-86.4) 
66.7 
(55.6-76.1) 
Combining all the tests together 
increases the chances of detecting 
visual loss (i.e. a high sensitivity value) 
but the high number of false positives 
results in a low specificity value. 
 
If the screening tool is to be used to detect glaucoma as well as SAIEC then the 
addition of the visual field tests in an OR combination with HCVA or LCVA provides 
the best combination.  The introduction of the visual field test results in an overall 
increase in sensitivity but a reduction in specificity. The ability of the screener to 
detect glaucoma will be discussed later in the chapter (Section 12.6.4). 
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As discussed in Chapter 3, one of the benefits of computerised screening is that 
tests can be excluded or included depending on the situation. Table 12.3 illustrates 
how this approach would be useful depending on the following factors: aims of the 
screening programme, target conditions, screening venue, and resources that are 
available after the screening has taken place. The importance of adapting the 
screening tools to take into account the aims of the screening programme is 
returned to in Chapter 13. 
12.5 Overview of results for flip chart screener 
The key tests from CVS1 were incorporated into a flip chart to provide a rapid 
screening tool that was evaluated alongside CVS2.  The test combinations that 
provided the best compromise between sensitivity and specificity in the detection of 
SAIEC were the same combinations found using the computer vision screener and 
these have been summarised below. 
Table 12.4 Summary of best combinations from flip chart screener for detecting SAIEC 
Combination  Sensitivity Specificity 
HCVA or NVA 
 
75.4 
 (67.1-82.2) 
69.2 
 (58.3-78.4) 
HCVA 73  
(64.5-80) 
 
74.4 
 (63.7-82.7) 
LCVA  75.4 
(67.1-82.2) 
 
76.9  
(66.4-84.9) 
HCVA or LCVA 
or NVA 
 
82  
(74.2-87.8) 
61.5  
(50.4-71.6) 
 
The sensitivity and specificity results obtained are similar to those from the 
computer vision screener in Table 12.3. The results show that in the flip chart 
format, LCVA fares better than HCVA as a single test to use for screening of visual 
loss. The single most useful test with the CVS2 was HCVA whereas LCVA showed 
the best sensitivity and specificity as a single test for the FVS. It is tempting to 
attribute this to properties of the computer monitor, but this had been carefully 
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calibrated. The 95% confidence limits for these differences overlap, so these 
results may be attributable to chance. 
The chapter so far has given a summary of the results from the present research. 
The next section will take an overall look at the usefulness of the screening tools in 
detecting vision loss.  
12.6. Are the screening instruments useful? 
The present research supports previous findings (Reidy et al., 1998b) that there is 
a high prevalence of correctable visual loss in older people. The notion that older 
people with visual problems will fully engage in eyecare services is clearly nothing 
more than an ideal and this supports the need for methods that will encourage 
older people to seek regular eyecare. The screening instruments that have been 
investigated here are reasonably efficient at detecting people with visual problems 
and it was found that when participants were given personal advice that they would 
be likely to benefit from an intervention then most were keen to follow this advice.  
The usefulness of the screening tools in the detection of the target conditions will 
now be discussed.  This will be addressed in three ways. Firstly the ability of the 
tools to detect the target conditions in combination will be discussed.  The 
combination of the target conditions has been categorised as significant acuity 
impairing eye conditions (SAIEC) and this has been defined as binocular gain in 
NVA through refractive correction or a monocular gain in distance acuity through 
refractive correction or significant cataract in either eye or the risk of rapid 
progression MD in either eye. Secondly the ability of the tools to detect the target 
conditions individually will be addressed. As mentioned in previous Chapters the 
evaluation of each of the target conditions in isolation was essential in deriving the 
cut off values from the ROCs but there are limitations to this approach. One 
limitation is that the ROCs for certain target conditions attempted to correlate 
structure with function; for example relating the appearance of cataract using the 
LOCS grading scale with visual acuity measurements.  Also, many different 
conditions influence measures of visual function (e.g., visual acuity) and this too is 
a limitation of the ROC analyses. It could be argued that a more valid measure of 
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screener performance is to evaluate whether it detects those cases which an 
optometrist would be likely to feel needed an eye examination. This will be 
discussed in the third approach that will be taken to evaluate the usefulness of the 
screening tools and will involve summarising the overall performance of the 
screeners in detecting the need for optometric eyecare. 
12.6.1 Detection of significant acuity impairing eye conditions 
The results show that the screening tools have proved to be useful in the detection 
of significant acuity impairing eye conditions. The simple HCVA test in CVS2 
detected 75% of cases of uncorrected refractive error or cataract or AMD. By 
combining tests in the screener a sensitivity of over 80% can be achieved, 
although the specificity drops. A specificity of about 70% was possible and the best 
test combination was obtained by selecting participants who failed the high 
contrast VA or near VA tests.  
The FVS performed similarly to CVS2. For detecting cataract, correctable refractive 
error, and significant AMD a sensitivity of about 80% could be achieved with a 
specificity approaching 70%. These values were obtained by selecting people who 
failed either the high contrast or low contrast distance VA tests, and 79% of people 
who failed one of these tests had one of these conditions. 
It is interesting to note that the results show that the best single test on the rapid 
flipchart tool is LCVA. This achieves 75% sensitivity and 77% specificity for the 
detection of SAIEC and 84% of patients that failed the LCVA test on the FVS had 
one or more of the target conditions (the positive predictive value). It is particularly 
interesting to note that LCVA fares better than HCVA as a single test to detect 
SAIEC in the flipchart format.  With the CVS2, LCVA alone provided the best 
specificity (77%) of all the combinations for the detection of SAIEC in CVS2. 
However, the single best test to use for the detection of SAIEC when using CVS2 
is HCVA. This achieves a sensitivity of 77% and specificity of 73% and 82% of 
patients that failed the HCVA test on CVS2 had one or more of the target 
conditions as defined by SAIEC (the positive predictive value). 
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It can be seen that the screening tools are useful in the detection of SAIEC and 
even a single test can be reasonably efficient at detecting those with vision loss 
that may be correctable. Combining tests to detect SAIEC always has the effect of 
increasing the sensitivity but reducing the specificity. When using CVS2, the 
sensitivity and the specificity of the screening tool can be manipulated by 
eliminating or adding tests depending on where the screening programme is being 
implemented and the availability of eye care services in that area. In some 
situations it may be appropriate to have a high specificity even though it may mean 
a reduced sensitivity and this may mean only screening with one or two tests. In 
other situations it may be better to have a high sensitivity with low specificity by 
using all the tests in the screening package. In the majority of situations a 
compromise between sensitivity and specificity will be needed and tests can be 
easily eliminated or added using CVS2 to achieve the desired sensitivity and 
specificity values. 
The next section will look at the target conditions in isolation before the usefulness 
of the screening tools will be discussed in terms of their overall performance in 
detecting the need for optometric eyecare. 
12.6.2 Detection of cataract 
The gold standard eye examination assessed cataract by using the LOCS III 
grading system as described in Chapter 4.The type of lens opacities present in the 
population had an effect on the ability of the screener to detect significant cataract 
as outlined earlier in the chapter. The detection of significant cataract in the gold 
standard examination was based on anatomical appearance, which detected all 
types of cataract, whereas detection of cataract by the screener was based on 
visual function, which had a predisposition to the detection of nuclear and posterior 
subcapsular lens opacities. The sensitivity and specificity values for the detection 
of cataract by acuity tests of the computer vision screeners can be seen in Table 
12.1 and by the flipchart screener in Chapter 10 (Table 10.4) 
It may be argued that as cortical lens opacities have less of a detrimental effect on 
vision then it may not be as vital for the screener to detect this type of lens opacity 
Page 318 of 389 
 
compared to nuclear sclerosis and posterior subcapsular opacities.  When cortical 
lens opacities reach advanced stages then the screener would be able to detect 
this because visual function would be affected.  Although anatomical appearance 
of cataract is an important factor in determining whether it is appropriate for a 
cataract procedure to be conducted, functional vision is even more important. Even 
if a significant lens opacity was present (as anatomically determined by the gold 
standard), but functional vision was not significantly impaired and the patient was 
not experiencing problems it may be thought inappropriate to refer for cataract 
extraction. However, a full eye examination might detect detrimental effects of 
cataract on vision other than visual acuity, such as poor night vision or glare. 
It is recognised that the grading system and method used in the gold standard to 
assess cataract may not be commonly used in everyday optometric practice. In a 
normal eye examination it is likely to be mainly a combination of the appearance of 
cataract and the visual acuity that influences whether referral is indicated. Also, 
cataract referral is very much dependent on whether the patient is finding it difficult 
to perform everyday tasks that they would like to. It is likely therefore that the use 
of LOCS III as a gold standard means that the sensitivity obtained for the 
screeners in the present research is likely to be conservative. 
12.6.3 Detection of refractive error 
The HCVA test on the computer vision screener proved to be effective at detecting 
uncorrected refractive error as can be seen in Table 12.1. LCVA is also a good 
predictor of uncorrected refractive error achieving a sensitivity and specificity of 
70% with FVS. 
The near VA test did not fare so well, only achieving a sensitivity of 48% (with 
CVS2) and 58% (with FVS) for detecting uncorrected refractive error at near. This 
particular test had even worse ability to detect cataract with both screening tools, 
and therefore was not valuable at detecting correctable visual loss (either of these 
two conditions). However, this only reflects the value of this test when considered 
in isolation and, it was found to be of some value when its results are taken in 
combination with other tests. Furthermore, the objective of the screening tools was 
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not to measure near acuity but to give an indication of the ease at which older 
patients could read small print. 
12.6.4 Detection of glaucoma 
It was anticipated from the outset (Chapter 4) that the screening tools would not 
have a high sensitivity or specificity for detecting glaucoma and this was found to 
be the case. Even in a gold standard eye examination where three or more 
glaucoma tests are available, the detection of glaucoma is challenging (Weinreb & 
Khaw, 2004).  
Harper and colleagues indicated that the most predictive measures for glaucoma 
were visual field screening, optic disc cupping and intraocular pressure (Harper & 
Reeves, 1999). However as discussed in Chapter 4, it would not be possible to 
implement all three tests in a screening programme. Harper and colleagues stated 
that although single tests do not provide sufficiently good discrimination, the visual 
field test was the best single predictor of glaucoma (Harper & Reeves, 1999). As 
such, this test seemed the most appropriate to include in the computerised 
screening tool.  The visual field in CVS2 detected 15 of 19 cases who had or were 
at risk of glaucoma, but this greatly reduced the specificity of the screener causing 
it to ‘fail’ about three-quarters of those who were visually normal.  This indicates 
that although the specificity of the visual field test was poor, the sensitivity was 
approximately 80% (15/19). This sensitivity value is in the same range as that 
obtained for the other target conditions. 
Harper and colleagues show that sensitivities and specificities of more than 90% 
can be obtained for detecting glaucoma when visual field screening, optic disc 
cupping and intraocular pressure were combined. The College of Optometrists 
advises the public that those aged over 40 years should receive a combination of 
at least two of the three predictive tests (College of Optometrists., 2008). Harper 
and colleagues show that when a two test combination of intraocular pressure (cut 
off value >22 mmHg) or optic disc cupping (cut-off value >0.6) is used in the 
detection of glaucoma the sensitivity and specificity of approximately 85% is 
achieved. 
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Screening tools for the detection of glaucoma need further investigation (see 
section 12.10) and the screening tools in the present study are not appropriate for 
screening for the presence of glaucoma due to the low specificity achieved with the 
visual field test.  
The screening tools in the present study do not replace the need for regular eye 
care and this would be important to explain to patients who undergo vision 
screening.  Patients who pass the screening test still need to have regular eye 
examinations so that conditions such as glaucoma can be detected. However, a 
scenario may arise where an undiagnosed glaucoma patient passes the vision 
screening and as a result does not feel it necessary to attend for an eye 
examination, even if this conflicts with advice given at the time of screening. This 
raises the issue of whether it would be ethical to use the screening tools from the 
present research. The ethical issues surrounding screening will be discussed 
further on in this Chapter. 
12.6.5 Evaluating the screening tools from an optometric perspective 
The section above has focused on the ability of the screening tools to detect the 
target conditions based on various cut-off values derived from ROC curves. As 
noted in Chapter 8, 9 and 10, although the ROCs are necessary to select the 
optimum cut-offs for the screener, this method of evaluating the screening tools 
may be viewed as overly critical of the screener performance. This is because 
many of the ROCs in this study compare a grading of the appearance of an ocular 
condition (e.g., cataract or AMD) in the gold standard examination with the 
functional status of the eye (e.g., high contrast visual acuity) as measured with the 
screener. The ROCs will also be limited because many different conditions 
influence the functional measures (e.g., visual acuity). It could be argued that a 
more valid measure of screener performance is to evaluate whether it detects 
those cases which an optometrist would be likely to feel needed an eye 
examination. This could be defined, in a pragmatic operational way, as reduced 
high contrast visual acuity in one or both eyes and those who have not attended for 
an eye examination in the last year. Alternatively, it could be argued that 
optometrists may feel it appropriate to conduct an eye examination on those with 
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reduced high contrast acuity or those who have not had an examination within the 
last year. This evaluation was carried out for both versions of the computer 
screener (Chapters 8 and 9) and also the rapid flipchart screener (Chapter 10).  
Table 12.5 Summary table: Performance of screening tools from an optometric perspective 
Performance of 
screener from an 
optometric 
perspective 
CVS1 CVS2 FVS 
Sensitivity 
(%) 
Specificity 
(%) 
Sensitivity 
(%) 
Specificity 
(%) 
Sensitivity 
(%) 
Specificity 
(%) 
HCVA >0.19 and no 
eye examination in 
the last year 
82.2 
(73.6-88.4) 
82.9 
(72.9-89.7) 
81.8  
(73.1-88.2) 
94.1  
(87.6-97.2) 
76.8  
(67.5-84) 
95.0  
(88.9-97.9) 
HCVA>0.19 or no 
eye examination in 
the last year 
97.6 
(93.9-99.1) 
75 
(46.8-91.1) 
94.6 
(90.3-97) 
93.8  
(71.7-99.7) 
94.0  
(89.6-96.6) 
87.5  
(64-96.5) 
 
This approach to assessing the screening tools has shown that they have a very 
good ability to detect those older people who an optometrist would be likely to feel 
needed an eye examination.  A summary of the results from this approach to 
assessing the tools can be seen in Table 12.5.  
This section has demonstrated the value of the screening tools in the detection of 
the target conditions collectively, individually and in a more pragmatic way. It is 
noted however, that the screening tools do not achieve 100% sensitivity and 
specificity and also are not very effective in the detection of glaucoma.  This raises 
issues surrounding the ethics of screening, which will now be discussed. 
12.7 Ethics of screening 
In this context, the primary purpose of screening is to encourage participants to 
have regular eye examinations, particularly those with poor vision.  However, there 
is a risk that those who pass the screening feel reassured and become less likely 
to have a full eye examination. For this reason it is very important that people who 
undergo vision screening receive verbal and written information stressing that a 
‘pass’ in the vision screening test should not be seen as an alternative to regular 
professional eyecare. This is particularly important in cases of glaucoma where a 
full eye examination is vital for its early detection. It is also important for people 
with diabetes who have photographic screening for diabetic retinopathy, but should 
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still have professional eyecare to check for other conditions (e.g., glaucoma). But 
the present research indicates that these screening methods are an effective way 
of encouraging many older people to re-engage with eyecare services. 
Screening programmes are becoming increasingly popular. Quite often, screening 
programmes can be expensive to implement and the treatment following screening 
can also be expensive. The screening itself may lead to side effects and harm if 
the screening procedure is invasive; there is also a risk of unnecessary intervention 
for inconsequential disease which may never become clinically significant or life-
threatening. Screening has also been criticised for increasing anxiety in the public 
about healthcare issues. Vision screening does not pose these concerns to same 
extent as some other forms of screening. The tools used in the present research 
are not expensive to operate and can be administered by lay personnel and are 
likely to be reasonably cost effective. The treatment following screening is also 
relatively inexpensive. Patients who fail the screening would be alerted to have an 
eye examination and so the risk of unnecessary intervention is reduced. Since the 
emphasis of the vision screening is on detecting correctable visual problems, in 
most cases it leads to a positive outcome which is unlikely to cause excessive 
anxiety. 
Although screening tests cannot guarantee the detection of all 'abnormal' cases, 
and will lead to false reassurance for some, this disadvantage needs to be weighed 
against the potential benefits. The gain in quality of life through the detection of 
previously undetected correctable visual loss is significant and vision screening 
may play a central role in reducing the prevalence of visual loss among older 
people.  If the correct verbal and written information is given to patients then the 
use of the screening tools can be two fold; firstly to detect those patients that have 
reduced vision that may be improved through simple intervention and secondly to 
increase awareness among the older population about the need for regular 
eyecare. The CVS is particularly well-suited to producing appropriate written advice 
after screening, since it is possible for a computer to produce personalised reports, 
with an appropriate font size, stressing the continued need for routine eyecare in all 
cases. 
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On balance, it is concluded that the benefits of vision screening outweigh the 
possible disadvantages, as long as care is taken to ensure that participants 
understand that the screening does not obviate the need for regular eyecare. 
12.8 Have the research objectives been met? 
The chapter so far has shown how the primary objectives in Chapter 3 have been 
met. These objectives relate to the battery of tests suitable for screening in older 
people and appropriate test combinations.  The study has shown the suitability of 
various tests for older people and has also shown how these can be incorporated 
in a screening tool to detect correctable visual loss in the older population. The 
research has shown that both screening tools are suitable for different situations 
and the advantages and disadvantages of the two tools are summarised in Table 
12.6.  
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Table 12.6 Summary of suitability of screening tools 
 
Advantages Disadvantages 
Computer  
Vision  
Screener 
Tests can be excluded or 
included depending on the aims 
of the screening programme 
May not be suitable in situations where  
computerised screening is too complex for 
the person administering the screening 
The results are automatically 
analysed and a report can be 
printed summarising the 
results. 
May not be suitable for use in situations 
where there are logistic constraints on the 
use of computers (e.g., security, mains 
power) 
The inclusion of the visual field 
test may be useful in locations 
where a high prevalence of 
glaucoma is suspected. 
May not be suitable for use in situations 
where the cost of running a computerised 
system is too high 
Flip chart 
screener 
Cost effective to manufacture The results from the flip chart need to be 
manually recorded 
Even more portable than the 
computer screener 
The flip chart screener does not contain a 
visual field test and can play no role in the 
detection of glaucoma 
Suitable in situations where 
computer screening is not ideal 
The flip chart does not have the flexibility of 
test choice as with the computerised 
screener 
 
The secondary objective was to determine whether people whose visual problems 
are detected with screening do, as a result of the screening, receive treatment for 
their visual problems and appropriate support. The quality of life data evaluated in 
Chapter 11 does give an indication of the proportion of those screened where an 
intervention was recommended and the proportion of these individuals who 
actually received an intervention based on the gold standard data.  It also 
illustrates the increase in the quality of life in those patients that took up the 
intervention. However, the screening and the gold standard eye examination were 
conducted on all participants. So it cannot be said with certainty that if older 
patients were only screened, they would as a result of the screening attend for an 
eye examination and then receive treatment of their visual problems. This would 
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require further research and will be discussed later in this Chapter. The quality of 
life data is discussed further below. 
Apart from the objectives, it was thought that when conducting the study additional 
observations may be made on the suitability of different venues for screening 
vision in older people (Chapter 3). Both screening tools were easy to use in the 
venues chosen for the present study. It is thought that the computer screener is 
best suited for a formal vision screening programme or as part of a wider health 
screening programme for older people. The flip chart screener is better suited to 
community settings for example when at Woodlawns day centre and would be 
ideal to use when making home visits or in the developing world. In the UK it could, 
for example, be used by a community nurse or occupational therapist when visiting 
patients at home, for example after a fall. 
The second additional observation outlined in Chapter 3, was to comment on the 
characteristics of older people with poor vision in South London. In particular, to 
make observations on the relationship between ethnicity/poverty and correctable 
visual loss. As discussed in the preliminary study of the provision of NHS eyecare 
(Chapter 5), South London has a number of areas associated with deprivation and 
poverty. The population is from a diverse range of ethnic backgrounds and socio-
economic status and this was particularly evident in Study 2 where the screening 
tools were taken into the community. The study showed that 18.5% of participants 
from Study 2 were from an ethnic minority. This was determined from the names of 
patients; this technique is sometimes used in health research to increase the 
number of persons from racial and ethnic groups represented in surveys. Although 
this achieves the goal of identifying those from ethnic origin (Davern et al., 2007)  it 
is understood that this technique is not optimal for detailed statistical evaluation.  
Although a detailed analysis of the effects of ethnicity and poverty on visual 
problems was beyond the scope of the present research, studies have shown that 
correctable reduced vision is likely to be particularly prevalent amongst people who 
suffer from the effects of poverty (Reidy et al., 1998a) and/or are from ethnic 
minorities (Lindesay et al., 1997;Pardhan & Mahomed, 2002). The present 
research has demonstrated the efficacy of the vision screening tools and it seems 
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likely that these could be used in future research to improve the ways in which 
people from ethnic backgrounds and those who are suffering the effects of poverty 
can better access eye care services. 
12.9 Quality of life and Hawthorne effect 
This section discusses the Hawthorne effect with respect to the quality of life data 
presented in Chapter 11. The quality of life data does give an indication of the 
number of people that were recommended intervention and those that actually 
received intervention based on the gold standard data.  It also illustrates the 
increase in the quality of life in those patients that took up intervention. 
The Hawthorne effect was first reported in industrial research, but it has significant 
implications for clinical research and routine practice (McCarney et al., 2007). The 
Hawthorne effect is a component of the non-specific effects of trial participation, 
but is not controlled for by usual controlled trial designs. The Hawthorne effect on 
clinical trial results indicate that patients in clinical trials appear to fare better than 
those in routine practice by virtue of their participation (McCarney et al., 2007). 
The Hawthorne effect is important to consider when evaluating Quality of Life 
because if there is a demonstrable benefit from participating in clinical research, for 
whatever reason, then this has implications for good clinical practice and for 
improving care. It may be argued that if the quality of life gain was due to the 
Hawthorne effect then it is likely that the very act of older people having a regular 
eye examination would produce a similar effect. The reason for this is because the 
tests and procedures used in the study are very similar to those implemented in 
community-based optometric care. However, we cannot rule out an improvement in 
quality of life resulting from participants’ awareness of being involved in a research 
study, over and above an effect from the clinical tests. To investigate this further a 
study would be needed to evaluate if the same gain in QoL was produced if a 
patients were to attend an eye examination when not participating in the study. 
However, it is unlikely that the QoL results obtained can be solely attributed to the 
Hawthorne effect because the group in which no intervention was required did 
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have a lower quality of life gain that the spectacle intervention group. This can be 
seen in Table 12.7. 
Table 12.7  Direct comparison between QoL scores from patients in spectacle intervention group and 
those in the no intervention required group for three variables: initial QoL, Post QoL, and Gain 
(individually calculated as Post-Initial) 
Spectacle 
Intervention N= 
75 
No intervention 
required N= 46 
Median Median Minimum 
 
Minimum Maximum Maximum 
Initial  108 120 54 96 125 125 
Post 120 123 68 96 125 125 
Gain 12 0 0 0 48 5 
 
The above table shows that although the initial quality of life is higher in the group 
that required no intervention, the gain in quality of life is higher in the spectacle 
intervention group. It is appreciated that the Hawthorne effect is an important 
potentially confounding variable that needs to be considered in relation to our 
quality of life data. Further research would be required to investigate this fully. 
12.10 Suggestions for future research 
The present research has highlighted the need for further studies in a number of 
areas and these areas will now be discussed. 
The preliminary study on the provision of NHS funded primary eyecare and NHS 
funded spectacles in South London (Chapter 5) could be extended to include a 
larger sample size, on a national scale. It would be interesting to investigate 
geographical variations concerning the provision of NHS funded spectacles for 
older patients on low income. 
The supplementary study on cataract grading (Chapter 6) raises questions about 
why cataract grading is not used more often in clinical practice. This could be 
investigated further, for example to detect whether cataract grading is possible 
without pupillary dilation and what grading step sizes are appropriate for clinical 
use. 
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As predicted in Chapter 4, and noted in the above section the screening tools that 
have been investigated in this project perform quite well at detecting all common 
eye disorders in older people except for glaucoma. There are a number of 
promising techniques under development which may lead to new screening 
instruments specifically aimed at early glaucoma detection (Cordeiro et al., 
2004;Bach, 2006;Bach et al., 2006). Another area for future research could be to 
investigate the use of one or more of these new techniques in conjunction with one 
of the two screening tools that have been used in the present research. This 
research has investigated various test combinations and future research can build 
on this by further exploring the optimum algorithm for combining test results, 
especially if new glaucoma screening technology could be incorporated into the 
battery of screening tests researched in this study.  
In order to investigate the direct impact of screening on the uptake of eyecare 
services it would be interesting to carry out an interventional study, using three 
groups. One group would receive vision screening, like that used in the present 
research. A second group would receive publicity alerting them to the need for 
optometric eye care and the third group would have no intervention. The cohorts 
could then be compared, after perhaps three months, to see if visual screening of 
older people has a greater impact on the uptake of eye care services than general 
publicity or no intervention. It would also be interesting to evaluate whether or not 
the computerised or flip chart screener would be successful in alerting older people 
to have eye examinations if it was implemented as part an overall health screening 
programme. 
Stereoacuity was not found to be a valuable test in the initial computerized vision 
screener, but this may be because the study was not specifically designed to 
detect the risk of falls. It would be interesting for future research to investigate a 
stereoacuity test, and possibly other tests of binocular function, as predictors of 
falls. This research would probably to be longitudinal and may require a larger 
sample size. 
As noted in Section 4.3.2, lighting was not controlled with the flip chart screener 
because a goal of the research was to investigate the screener under conditions 
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that are similar to those in which it may ultimately be used. It is assumed that most 
testing environments would be able to provide a level of lighting which would not 
greatly influence the results, since Bennett and Rabbetts (1998) suggest that as 
long as the luminance is above about 80cd/m2, VA is reasonably independent of 
luminance. Further research could investigate this assumption. 
This Chapter has given an overview of the results and discussed key aspects of 
the study as well make recommendations for future research. The next Chapter will 
look at what conclusions can be drawn from the present research 
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Chapter 13  
Conclusions 
13.1 General conclusions 
There are number of general conclusions that can be drawn from the present 
research. The first is that there are a significant number of older people in South 
London that have undetected vision loss.  Approximately one third of older people 
in South London were found to have significant cataracts, about a third to have 
under corrected refractive error, and over half to have at least one of these 
conditions. 
Conclusions can also be drawn about the provision of NHS eyecare services. The 
preliminary study has shown that although NHS eyecare is easily accessible, the 
provision of voucher-value spectacles (VVS) is variable. Anecdotally, the research 
noted during the studies reported in this thesis a lack of awareness among older 
people about their entitlement to VVS. Optometric practices may be reluctant to 
offer VVS because of the uneconomic voucher values and this in turn may be a 
significant barrier to the uptake of eyecare services among older people. 
The study has shown that vision loss in older people can be readily detected with 
screening tools such as a computerised vision screener that can be administered 
by lay people with minimal training. The gold standard eye examination has shown 
that in a significant number of older people these cases of undetected reduced 
vision can be readily corrected. Vision screening of older people can also be 
successfully implemented using a rapid flip chart tool which can be used when 
computerised screening is not appropriate. The computer screener and flipchart 
tool were both good at detecting significant cataract and refractive errors. About 
80% of cases of visual loss due to these problems or due to AMD could be 
detected with either of the screening tools. Using a pragmatic operational criterion, 
the screening tools detect about 94% of cases who might be considered by an 
optometrist to be in need of an eye examination (either overdue or reduced visual 
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acuity). Glaucoma is a difficult disease to diagnose and it was found, as expected, 
hat neither screening instrument was very good at detecting glaucoma. 
The research has also revealed when older patients accept the recommended 
intervention to improve their vision after an eye examination there is an increase in 
their quality of life. This is most significantly noticed in patients that accept a 
spectacle intervention to improve their vision.  This strongly indicates that if NHS 
provision for VVS was readily accessible to older patients and this barrier to 
eyecare was eliminated or at least reduced then older patients would benefit from a 
better quality of life as a result of obtaining spectacles necessary to improve their 
vision. 
It is concluded that the high prevalence of correctable but uncorrected vision 
problems in older people requires action. Vision screening does not replace the 
need for professional eyecare, but acts as a tool to better inform the public of the 
need for regular eyecare, to detect problems requiring urgent attention, and to 
raise awareness of the correctable nature of many eye problems in older people. 
13.2 Considering the aims of screening 
The research has shown that the tests included in a visual screening tool are very 
dependent on the aims of the screening programme. The more complex the aims 
are, the more likely it is that more tests will need to be incorporated into the 
screening tool which will impact on the sensitivity and specificity of the tool. 
Inevitably, the research has shown that with an increased number of tests the 
specificity is likely to increase but at the expense of sensitivity. The increased 
specificity may be ideal in a situation where accessing eye care is a challenge but 
may not appropriate in an area where eye care is easily accessible.  
Table 13.1below takes the aims of screening into consideration to suggest tests 
that would be appropriate for particular aims. It can be seen that more tests are 
needed when the aims are more complex or when the aims are combined 
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Table 13.1 Recommended tests for various screening aims  
Aims of screening Recommended 
tests 
Suitability of CVS Suitability of FVS 
To detect those overdue for 
eye exam 
Questioning Very good  
To detect those with reduced 
HCVA 
HCVA Very good Very good 
To detect those overdue and 
with reduced HCVA  
Questioning 
 HCVA 
Very good Good 
To detect those overdue & 
with HCVA or LCVA deficit 
Questioning 
HCVA 
LCVA 
Very good Good 
To detect those with possible 
uncorrected refractive error 
HCVA  
 
Very good Very good 
To detect those with possible 
significant cataract 
HCVA 
LCVA 
Very good Very good 
To detect those with possible 
correctable visual loss 
(uncorrected refractive error  
and/or cataract) 
HCVA 
LCVA 
NVA 
Very good Very good 
To detect those with possible 
correctable visual loss 
(uncorrected refractive error  
and/or cataract) 
HCVA 
LCVA 
NVA 
Very good  
Sensitivity 80.3% 
Specificity 66.7% 
Very good 
Sensitivity 82% 
Specificity 62.5% 
To detect those who are in 
need of an eye examination 
from an optometric 
perspective 
Questioning 
HCVA 
Very good 
 
Good 
  
To detect those with possible 
correctable visual loss 
(uncorrected refractive error  
and/or cataract) and those 
overdue for an eye exam 
Questioning 
HCVA 
LCVA 
NVA 
Very good good 
 
The computer vision screener is particularly advantageous when conducting 
screening in different areas where the aims of the screening programme may 
change from venue to venue. The tests in the computer screener can be easily 
added or eliminated depending on the goals of the screening programme. 
13.3 Inferences for designing visual screening tools for older people 
From the present research a number of conclusions can be drawn specifically 
relating to the design of visual screening tools for older people and these are listed 
below in the table with comments. 
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Table 13.2 Inferences for designing visual screening tools for older people 
Inference Comment 
The screening tools should be able to 
be administered by non health care 
professionals 
Older people are more likely to come into 
contact with non health care professionals such 
as community workers. It is important that the 
screening tools are not too complicated to 
administer. 
The screening tools should be portable, 
so that they can be taken to patients 
with mobility problems 
Older people are more likely to have mobility 
difficulties and as such it would be ideal to be 
able to conduct the screening by moving the 
screening tool to the older person rather than 
asking the older person to move.  
The screening tests should be quick 
and easy to do 
Incorporating lots of tests in the screening tool 
is likely to lead to fatigue and loss of 
concentration in older people. 
The screening tools should contain 
tests of HCVA and LCVA with the 
option of having further tests depending 
on the situation 
These two tests proved to be very important in 
the detection of correctable visual loss in older 
people 
In a non clinic based setting a flipchart 
tool would be appropriate 
The computerised tool is suitable in a clinic 
environment such as a GP clinic, but for 
community venues and home visits a flip chart 
tool is a more practical option 
 
It is hoped that the research described in this thesis will have an impact on the 
detection of correctable visual problems in older people and provide the basis for 
future research in this area. It is also hoped that vision screening using the tools 
outlined in this study can be implemented in the older population, whether this be 
in day centres or during home visits by non eyecare professionals. It is thought that 
vision screening will help to increase awareness among the older population of the 
need for regular eye examinations.   
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Appendix 1 
Participant Enquiry Pack 
Improving vision in older people 
Thank you for your enquiry about our research. Please find enclosed a 
participant enquiry pack, which contains: 
1. Information sheet 
2. Consent form 
3. Questionnaire on previous eye care 
4. Non participation questionnaire 
 
The information sheet contains information on why the research is 
being done and what it will involve. Please take a few moments to read 
the information before deciding whether you wish to take part. If you 
would like to take part or would like to discuss any aspect of the 
research please contact: Zahra Jessa (0207 234 9644) or fill out the 
slip at the back of the leaflet and send it to Zahra Jessa at the above 
address. 
If you decide to take part, we would appreciate it if you could sign the 
consent form and complete the questionnaire on previous eye care and 
bring these forms with to the appointment. If you do not wish to take 
part then we would be very grateful if you spare a few minutes to fill out 
the non-participation questionnaire and send it to us, a stamped 
addressed envelope has been provided. 
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Appendix 2 
INFORMATION SHEET 
Improving vision in older people 
You are being invited to take part in a research study. 
Below is some information regarding why the research is 
being done and what it will involve. Please take time to 
read the following information before deciding whether 
you wish to take part. 
Previous research suggests that many older people have 
vision problems that could quite simply be corrected. 
Many people with these problems do not seem to receive 
the help that they need to make their vision better. 
The purpose of our research study is to see if simple 
vision screening tests can help to detect these problems. 
We will be using a computer to carry out a simple and 
quick vision test. One of our team, Zahra Jessa, will also 
carry out a detailed eye examination. The results of the 
computerised vision screening will be compared with the 
full eye examination. The screening and the eye 
examinatio will take approximately 1hr and 30 minutes. 
The eye examination will be very thorough and you will 
be given the time that is needed without feeling rushed, 
and will be offered rest periods if you wish. All the 
testing will involve routine tests, similar to those that you 
might have when you visit the optician (optometrist). 
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None of the tests are painful and none of the tests are 
likely to cause you discomfort.  
One of the tests involves some drops (Tropicamide 1%), 
which may blur your vision for up to a few hours. It is 
best not to drive until the drops have worn off. These eye 
drops are widely used by optometrists and eye doctors 
and hardly ever cause any problems. Very rarely, they 
can cause a reaction where the eye becomes red and 
painful. This reaction is so rare that in one study it 
occurred in less than 1 in 5,000 people. If you do 
experience any unusual symptoms after the eye drops 
then you should contact us immediately (Zahra Jessa on 
 or Bruce Evans on ) or seek 
immediate medical advice. 
If we discover that your vision can be improved with new 
glasses then we will tell you and give you a list of all the 
registered opticians in the area that can provide you with 
glasses. We will also explain your entitlement to NHS 
glasses. 
If, as a result of the research, we discover that you have a 
visual problem or other health problem that should be 
checked by a doctor then we will discuss this with you. 
We will, if you agree to this, refer you to a doctor for the 
treatment or care that you need. 
Once you have taken part in the research we will not 
discuss your results with anyone without your permission 
and you will not be identified in anything we write. We 
will keep you informed of the results from the study over 
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the 3-year period that the research is been conducted and 
we may contact you again if there are other research 
studies that we feel you may be interested in. Please 
inform us if you would not like to receive any further 
contact. We will not forward your contact details to any 
third party. 
The study is being funded by the Institute of Optometry 
and has been reviewed by several ethical committees and 
independent reviewers.  
If you are worried about any matter concerning the 
research please contact Zahra Jessa, whose contact details 
are below. If you would like time to think about taking 
part in this project then please take this form away and 
ask us if you would like any further information. If you 
would like us to discuss this research with any of your 
family, friends, or carers then please ask them to contact 
us. More information, including this form in large print 
and other languages, can be obtained from Zahra Jessa, 
Research Fellow, Institute of Optometry, 56-62 
Newington Causeway, London, SE1 6DS;   
If you decide to take part, you will be given this 
information sheet to keep and be asked to sign a consent 
form. If you decide to take part you will be free to 
withdraw from the research at any time without having to 
explain why.  Withdrawal will not affect your usual care 
or visual treatments in any way.  
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Appendix 3 
Patient Identification Number for this trial: 
CONSENT FORM 
Improving vision in older people 
Name of Researcher: Zahra Jessa,  
   Research Fellow, 
      Institute of Optometry 
         Please initial box 
1. I confirm that I have read and understand the information sheet 
dated 31/01/2005 for the above study and have had the 
opportunity to ask questions.                                                                     
 2. I understand that my participation is voluntary and that I am free 
to withdraw at any time without giving any reason, without my 
medical care or legal rights being affected.                                                
 3. I agree to take part in the above study.                                           
    
________________           _________________                                        
Name of Patient Date Signature 
 
_________________________ ________________   
Name of Person taking consent Date Signature 
 
_________________________ ________________  
Researcher Date Signature 
1 for patient; 1 for researcher; 1 to be kept with research notes     
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Appendix 4 
Questionnaire on previous eye care 
 
 
Question 1 
Have you had an eye examination within the past two years?  Yes            No 
Question 2 
Do you wear any spectacles?    
Yes           No   If yes please specify below: 
 
Distance vision spectacles        
Near vision spectacles              
Varifocals/bifocals                     
Question 3   
Are you aware of having any eye conditions that may affect your vision?  
 Yes     No             If yes please specify below: 
 
Cataract     
Glaucoma    
Age Related Macular Degeneration  
Other        Please specify below:  
 
………………………………………………………………………………………………
………………………………………………………………………………………………
……  
Confidential 
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  Question 4 
Is there a history of any eye conditions in your immediate family?  
Yes             No          If yes please specify below: 
 
Glaucoma  
 
Other    Please specify below: 
……………………………………………………………………………………………… 
Question 5 
Are you experiencing symptoms of reduced vision even your spectacles? 
 
Yes             No          If yes please specify below: 
 
Is it at distance?   
Is it at near?    
Is it at distance and near?   
Question 6 
Have you been experiencing headaches recently? Yes              No           
 
Have you been experiencing any other symptoms? Yes             No           
 If yes please specify below: 
……………………………………………………………………………………………… 
Question 7 
Do concerns about cost of glasses deter you from attending your local optician? 
Yes              No           
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Appendix 5 
Non-participation questionnaire 
 
We are sorry that you are not able to take part in our research, but thank you 
anyway for your interest. We are keen to find out a little about people who do not 
wish to participate. We would therefore be grateful if you could answer the few 
questions below. You do not have to give your name and your responses will be 
kept confidential. 
 
Roughly how long ago was your  
last  (sight test)?  
 
 
How happy are you with your vision 
(when wearing any glasses that you  
currently use)? 
 
Have you had a fall within the past  
12 months?   
 
How easy do you feel the study  
information was to understand? 
  
How much did concerns about cost of  
glasses deter you from taking part in the 
study? 
 
How much did the worry of possibly  
being advised that you shouldn’t drive  
deter you from taking part in the study? 
 
How much did the worry of possibly  
being told that your eyes were  
“becoming worse” deter you from taking part in the study? 
 
Do you feel that deterioration in vision 
is an inevitable consequence of ageing? 
   
Any other comments regarding why you declined to take part in the study would be 
very much appreciated. 
            
A stamped addressed envelope has been provided to post the completed 
questionnaire. 
                    Thank you 
 
Confidential 
Months 
Not 
happy 
Satisfied Very 
happy 
Yes No 
Not 
easy 
Moderately 
easy 
Very 
easy 
No 
worry 
Moderate 
worry 
Great 
worry 
Moderate 
worry 
Great worry 
Great 
worry  
Moderate 
worry 
No 
worry 
No Yes 
No 
worry 
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Appendix 6 
THE LOW VISION QUALITY-OF-LIFE QUESTIONNAIRE (LVQOL) 
 
Distance Vision, Mobility and Lighting            GRADING 
How much of a problem do you have: None Moderate Great 
With your vision in general 5 4 3 2 1 x n/a 
With your eyes getting tired (e.g only being able to do a task 
for a short period of time) 
5 4 3 2 1 x n/a 
With your vision at night inside the house 5 4 3 2 1 x n/a 
Getting the right amount of light to be able to see 5 4 3 2 1 x n/a 
With glare (e.g dazzled by car lights or the sun) 5 4 3 2 1 x n/a 
Seeing street signs 5 4 3 2 1 x n/a 
Seeing the television (appreciating the pictures) 5 4 3 2 1 x n/a 
Seeing moving objects (e.g. cars on the road) 5 4 3 2 1 x n/a 
With judging the depth or distance of items (e.g. reaching 
for a glass) 
5 4 3 2 1 x n/a 
Seeing steps or curbs 5 4 3 2 1 x n/a 
Getting around outdoors (e.g. on uneven pavements) 
because of your vision 
5 4 3 2 1 x n/a 
Crossing a road with traffic because of your vision 5 4 3 2 1 x n/a 
  
    Adjustment 
Because of your vision, are you: 
  
 
No 
 
 
Moderately 
 
 
Greatly 
Unhappy at your situation in life 5 4 3 2 1 x n/a 
Frustrated at not being able to do certain tasks 5 4 3 2 1 x n/a 
Restricted in visiting friends or family 5 4 3 2 1 x n/a 
 
 
  
Well 
  
Poorly  Not explained 
How well has your eye condition been explained to you 5 4 3 2 1 x 
 
Reading and Fine Work 
With your reading aids / glasses, if used, how 
  
much of a problem do you have: None Moderate Great 
Reading large print (e.g. newspaper headlines) 5 4 3 2 1 x n/a 
Reading newspaper text and books 5 4 3 2 1 x n/a 
Reading labels (e.g. on medicine bottles) 5 4 3 2 1 x n/a 
Reading your letters and mail 5 4 3 2 1 x n/a 
Having problems using tools (e.g. threading a needle or 
cutting)  
5 4 3 2 1 x n/a 
 
Activities of Daily Living 
With your reading aids / glasses, if used, how 
  
much of a problem do you have: None Moderate Great 
Finding out the time for yourself 5 4 3 2 1 x n/a 
Writing (e.g. cheques or cards) 5 4 3 2 1 x n/a 
Reading your own hand writing 5 4 3 2 1 x n/a 
With your every day activities (e.g. house-hold chores) 5 4 3 2 1 x n/a 
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Appendix 7 
Research on vision screening of older people 
Thank you for participating in our research study. The results of the test suggest 
that you need glasses for: 
 Distance vision (looking at things far away) 
 Moving around 
 Television 
 Eating 
 Reading and writing 
My tests today suggest that new glasses would be likely / very likely  to improve 
your vision for 
 Distance vision (looking at things far away) 
 Moving around 
 Television 
 Eating 
 Reading and writing 
Below is a prescription for these glasses. I believe that you should be able to have 
glasses made up whose cost is covered or contributed to by the NHS. The list on 
the reverse of this page gives the names of some local places where you can 
obtain these glasses. 
OPTOMETRIC PRESCRIPTION  
Patient name   
Date of eye examination:                              Re-examination advised in         months 
 Sphere Cylinder Axis Prism Base VA BVD Add 
R      6/   
L      6/   
 
Additional details   
 
Research optometrist: Miss Zahra Jessa   Signed   .                
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Appendix 8 
OPTOMETRIC PRACTICES THAT PROVIDE NHS SPECTACLES 
        A & I Lask 60A Brixton Road Brixton SW9 6BS 
        Anthony Ruddock (D&A 
Franch] 297 Walworth Road Walworth SE17 2TG 
        Brian Ashby (Opticians) Ltd 54 Lee High Road London SE13 5PT 
       Day & Elliot [D&A Franchise] 6 Astoria Parade 
Streatham High 
Road SW16 1PR 
       Dollond & Aitchison 125 Rushey Green Catford SE6 4AA 
       Dollond & Aitchison 151 Clapham High Street Clapham SW4 7SS 
       DT MacDonald 141 Dulwich Road Herne Hill SE24 0NG 
       Edgar Darter Opticians 195 High Street Lewisham SE13 6AA 
       Hatton Opticians 157 Lambeth Walk Kennington SE11 6EE 
       Hatton Opticians 4 Westbourne Terrace Forest Hill SE23 2ND 
       Insight Opticians 4 Lee Gate Lee Green SE12 8SS 
       J G Bentley 204 Southwark Park Road 
South 
Bermonsey SE16 3RW 
       J S Robin Whittington Centre 
11-13 Rutford 
Road SW16 2DO 
       K.A. Rowland Ltd 112 Rushey Green London SE6 4HW 
       L.A. Sackwild 90 Towerbridge Road Bermondsey SE1 4TP 
       London Eye Care Centre 30 Knights Hill West Norwood SE27 0HY 
       Marratt & Ellis Opticians 50 London Road Forest Hill SE23 3HF 
       Medirex Opticians 28-29 Wilcox Close Lambeth SW8 2UD 
       Monoptics Ltd 11 Stockwell Road Stockwell SW9 9AU 
       Monoptics Ltd 25 Brockley Cross Brockley SE4 2AB 
       Nash Opticians 303 Evelyn Street Deptford SE8 5AJ 
       Nash Opticians 254 Southwark Park Road 
South 
Bermondsey SE16 3RN 
       Optical Express Southern  25 Central Mall South Riverdale Centre SE13 7EP 
       Peckham Specsavers Ltd 
Unit 3, The Aylesham 
Centre Rye Lane SE15 5EW 
       Provision Opticians 263 Old Kent Road London SE1 5LU 
       Quinlan's Opticians 7 Bedale Street London Bridge SE1 9AL 
       R & J Optical 39-41 East Street London SE17 2DS 
       R Woodfall (Norwood) 286 Norwood Road West Norwood SE27 9AF 
       R Woodfall (Sydenham) 6 Sydenham Road Sydenham SE26 5QW 
       Realeyes Ltd 107 Streatham Hill London SW2 4UG 
       Rodney Opticians 7 Camberwell Green Camberwell SE5 7AF 
       S Squared Ltd 33 Lower Marsh London SE1 7RG 
      Specsavers Brixton 492 Brixton Road Brixton SW9 8EQ 
      Specsavers Opticians 174 High Street Lewisham SE13 6JL 
      Specsavers Streatham Ltd 192 Streatham High Road Streatham SW16 1BB 
      The Institute of Optometry 
56-62 Newington 
Causeway 
Elephant & 
Castle SE1 6DS 
      The Sight Centre 78 Deptford High Street Deptford SE8 4RT 
      Vision Express JV Unit 39 
The Lewisham 
Centre SE13 7HB 
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Appendix 9 
 Participant evaluation of screening programme 
 
 
1. How easy did you feel the instructions  
 were to understand? 
 
2. How easy did you find the screening  
tasks to do? 
 
3. How easy was it to concentrate on  
the screening tasks? 
 
4. Do you think that the screening 
 programme took too long. 
 
5. How stressful did you feel the 
procedure was? 
 
6. How valuable do you feel the  
  screening programme is? 
 
7. Would a screening programme such as this  
 prompt you to have a full eye  examination  
if the screening indicated that you needed it? 
 
8. Was the place where the screening 
 was conducted a convenient location for you? 
Any suggestions or comments regarding the screening programme would be very 
much appreciated. In particular, if you have any suggestions for other venues 
where the screening programme could be used then please give these below. 
             
Thank you 
CONFIDENTIAL 
Not easy 
Very 
easy 
Not 
stressful 
Fairly stressful Very 
stressful 
Not 
valuable 
Very 
valuable 
No 
Fairly 
easy 
Very 
easy 
Not easy Fairly 
easy 
Very 
easy 
Fairly 
easy 
Not easy 
Fairly valuable 
Yes 
No Yes 
Yes No 
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Appendix 10 
Improving the vision of older people 
Questionnaire on the provision of NHS eye care in South London 
       
Thank you for completing this questionnaire. As explained in the covering letter, we 
plan to use this information to give older people participating in our research a list 
of local optical practices where they can obtain NHS eye examinations & glasses 
whose cost is fully covered by the NHS voucher (for those who are eligible to a 
voucher). We may also analyse these results & publish a paper summarising the 
availability of glasses covered by the NHS voucher, but no practitioners or practices 
would be named in such a paper. 
1. Do you provide NHS eye examinations? Yes          No 
 
2. Do you supply complete glasses (frame and lenses) to eligible patients whose 
price is fully covered by the NHS voucher?   
 
   Yes    No 
3. If your answer is ǲyesǳ to question 2, approximately how many frames are 
available in this range for patients to choose from?   
 
4. If your answer is ǲnoǳ to question 2 and you do provide NHS services, does the 
voucher cover the complete cost of the lenses?  
                  Yes                          No 
 
If your answer is ǲnoǳ, what is the minimum amount needed to top up the voucher in  
order to obtain lenses?  
                 Single Vision?         Bifocals?            Varifocals?  
 
 
5. If your answer is ǲnoǳ to question 2 and you do provide NHS services, what 
would be the minimum cost of a frame? 
  
Name:      Practice:      
£ £ 
 
CONFIDENTIAL 
£ 
£ 
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